0001072613-23-000275.txt : 20230330 0001072613-23-000275.hdr.sgml : 20230330 20230330163251 ACCESSION NUMBER: 0001072613-23-000275 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 80 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230330 DATE AS OF CHANGE: 20230330 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NETWORK-1 TECHNOLOGIES, INC. CENTRAL INDEX KEY: 0001065078 STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794] IRS NUMBER: 113027591 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-15288 FILM NUMBER: 23781159 BUSINESS ADDRESS: STREET 1: 65 LOCUST AVENUE CITY: NEW CANAAN STATE: CT ZIP: 06840 BUSINESS PHONE: 2039201055 MAIL ADDRESS: STREET 1: 65 LOCUST AVENUE CITY: NEW CANAAN STATE: CT ZIP: 06840 FORMER COMPANY: FORMER CONFORMED NAME: NETWORK 1 TECHNOLOGIES INC DATE OF NAME CHANGE: 20131015 FORMER COMPANY: FORMER CONFORMED NAME: NETWORK 1 SECURITY SOLUTIONS INC DATE OF NAME CHANGE: 19980629 10-K 1 network1_10k-123122.htm FORM 10K FOR YEAR ENDED DECEMBER 31, 2022
0001065078 false 2022 FY 0001065078 2022-01-01 2022-12-31 0001065078 2022-06-30 0001065078 2023-03-23 0001065078 2022-12-31 0001065078 2021-12-31 0001065078 2021-01-01 2021-12-31 0001065078 us-gaap:CommonStockMember 2020-12-31 0001065078 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001065078 us-gaap:RetainedEarningsMember 2020-12-31 0001065078 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001065078 nssi:TotalStockholdersEquityMember 2020-12-31 0001065078 us-gaap:CommonStockMember 2021-12-31 0001065078 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001065078 us-gaap:RetainedEarningsMember 2021-12-31 0001065078 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001065078 nssi:TotalStockholdersEquityMember 2021-12-31 0001065078 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001065078 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001065078 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001065078 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001065078 nssi:TotalStockholdersEquityMember 2021-01-01 2021-12-31 0001065078 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001065078 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001065078 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001065078 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001065078 nssi:TotalStockholdersEquityMember 2022-01-01 2022-12-31 0001065078 us-gaap:CommonStockMember 2022-12-31 0001065078 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001065078 us-gaap:RetainedEarningsMember 2022-12-31 0001065078 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001065078 nssi:TotalStockholdersEquityMember 2022-12-31 0001065078 2020-12-31 0001065078 nssi:ILiADBiotechnologiesLLCMember 2022-12-31 0001065078 nssi:FullyPaidLicensesMember 2022-01-01 2022-12-31 0001065078 nssi:FullyPaidLicensesMember 2021-01-01 2021-12-31 0001065078 nssi:RoyaltyBearingLicensesMember 2022-01-01 2022-12-31 0001065078 nssi:RoyaltyBearingLicensesMember 2021-01-01 2021-12-31 0001065078 srt:MinimumMember 2022-01-01 2022-12-31 0001065078 srt:MaximumMember 2022-01-01 2022-12-31 0001065078 nssi:StockIncentivePlan2022Member 2022-12-31 0001065078 nssi:StockIncentivePlan2013Member 2022-12-31 0001065078 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001065078 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-12-31 0001065078 us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001065078 us-gaap:RestrictedStockUnitsRSUMember 2021-12-31 0001065078 nssi:ChairmanAndChiefExecutiveOfficerMember 2022-10-01 2022-10-27 0001065078 nssi:ChairmanAndChiefExecutiveOfficerMember 2022-10-27 0001065078 us-gaap:StockOptionMember 2021-12-31 0001065078 us-gaap:StockOptionMember 2020-12-31 0001065078 us-gaap:StockOptionMember 2022-01-01 2022-12-31 0001065078 us-gaap:StockOptionMember 2021-01-01 2021-12-31 0001065078 us-gaap:StockOptionMember 2022-12-31 0001065078 nssi:CostBasisMember 2022-12-31 0001065078 nssi:GrossUnrealizedGainsMember 2022-12-31 0001065078 nssi:GrossUnrealizedLossesMember 2022-12-31 0001065078 nssi:FairValueMember 2022-12-31 0001065078 nssi:CostBasisMember 2021-12-31 0001065078 nssi:GrossUnrealizedGainsMember 2021-12-31 0001065078 nssi:GrossUnrealizedLossesMember 2021-12-31 0001065078 nssi:FairValueMember 2021-12-31 0001065078 nssi:IliadMember nssi:ClassCUnitsMember 2022-12-31 0001065078 nssi:IliadMember 2022-01-01 2022-12-31 0001065078 nssi:ILiADBiotechnologiesLLCMember 2022-08-24 0001065078 nssi:IliadMember 2021-01-01 2021-12-31 0001065078 nssi:IliadMember 2022-12-31 0001065078 2021-10-01 2022-09-30 0001065078 2020-10-01 2021-09-30 0001065078 2022-03-01 2022-03-25 0001065078 nssi:CoxPatentPortfolioMember 2022-12-31 0001065078 nssi:CoxPatentPortfolioMember 2021-12-31 0001065078 2013-05-01 2021-12-31 0001065078 2022-05-01 0001065078 srt:ChiefExecutiveOfficerMember nssi:NewEmploymentAgreementMember 2022-03-01 2022-03-22 0001065078 srt:ChiefExecutiveOfficerMember 2022-01-01 2022-12-31 0001065078 srt:ChiefExecutiveOfficerMember 2021-01-01 2021-12-31 0001065078 us-gaap:RestrictedStockUnitsRSUMember srt:ChiefExecutiveOfficerMember 2022-03-01 2022-03-22 0001065078 us-gaap:RestrictedStockUnitsRSUMember srt:ChiefExecutiveOfficerMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2022-03-01 2022-03-22 0001065078 us-gaap:RestrictedStockUnitsRSUMember srt:ChiefExecutiveOfficerMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2023-03-01 2023-03-22 0001065078 us-gaap:RestrictedStockUnitsRSUMember srt:ChiefExecutiveOfficerMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2024-03-01 2024-03-22 0001065078 us-gaap:RestrictedStockUnitsRSUMember srt:ChiefExecutiveOfficerMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2022-03-01 2022-03-22 0001065078 us-gaap:RestrictedStockUnitsRSUMember srt:ChiefExecutiveOfficerMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2022-03-01 2022-03-22 0001065078 us-gaap:RestrictedStockUnitsRSUMember srt:ChiefExecutiveOfficerMember nssi:ShareBasedCompensationAwardTrancheFourMember 2022-03-01 2022-03-22 0001065078 srt:VicePresidentMember 2022-01-01 2022-12-31 0001065078 srt:VicePresidentMember 2021-01-01 2021-12-31 0001065078 srt:ChiefFinancialOfficerMember 2022-01-01 2022-12-31 0001065078 nssi:GoogleMember 2017-05-08 2017-05-09 0001065078 nssi:FacebookMember 2017-05-08 2017-05-09 0001065078 nssi:NetgearMember 2017-05-08 2017-05-09 0001065078 nssi:AristaNetworksMember 2017-05-08 2017-05-09 0001065078 nssi:RemotePowerPatentMember 2021-01-01 2021-12-31 0001065078 nssi:LicenseesTwoMember 2021-01-01 2021-12-31 0001065078 nssi:BoardOfDirectorsMember 2022-05-29 2022-06-01 0001065078 nssi:BoardOfDirectorsMember 2021-06-11 0001065078 2011-08-01 2022-12-31 0001065078 nssi:BoardOfDirectorsMember 2022-02-01 2022-02-23 0001065078 nssi:BoardOfDirectorsMember 2021-09-01 2021-09-09 0001065078 us-gaap:SubsequentEventMember nssi:BoardOfDirectorsMember 2023-03-01 2023-03-03 0001065078 us-gaap:SubsequentEventMember us-gaap:RestrictedStockUnitsRSUMember 2023-03-01 2023-03-03 0001065078 us-gaap:SubsequentEventMember nssi:SettlementAgreementsMember 2023-01-24 2023-03-10 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure nssi:Integer

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 10-K

 

 

☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended December 31, 2022

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ____________ to ___________.

 

Commission File Number: 1-15288

                                           

 

NETWORK-1 TECHNOLOGIES, INC.

(Exact Name of Registrant as Specified in Its Charter)

                                           

 

Delaware   11-3027591

(State or Other Jurisdiction of

Incorporation or Organization)

  

(I.R.S. Employer

Identification Number)

     

65 Locust Avenue, Third Floor

          New Canaan, Connecticut 06840          

(Address of Principal Executive Offices)

 

 

Registrant's telephone number, including area code:   (203) 920-1055

 

 

Securities registered pursuant to Section 12(b) of the Act:

 

    Title of each class         Trading symbol         Name of each exchange on which registered    
Common Stock $.01 par value NTIP NYSE American
     

 

    Common Stock, $.01 par value    

(Title of Class)

 

                                           

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐    No ☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934. Yes ☐    No ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒    No ☐

 

 

 
 

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).   Yes ☒    No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer  ☐ Accelerated filer  ☐
Non-accelerated filer  ☒ Smaller Reporting Company  ☒
Emerging growth company  ☐  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.  ☐

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in this filing reflect the correction of an error to previously issued financial statements. ☐ 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D.1(b).  ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).   Yes ☐    No ☒

The aggregate market value of the voting and non-voting common stock held by non-affiliates computed by reference to the price at which the common stock was last sold as of June 30, 2022 was approximately $39,885,677 based on the closing price as reported on NYSE American Exchange.  Shares of voting stock held by each officer and director and by each person, who as of June 30, 2022, the last business day of the Registrant’s most recently completed second quarter, may be deemed to have beneficially owned more than 10% of the voting stock have been excluded. This determination of affiliate status is not necessarily a conclusive determination of affiliate status for any other purpose.

The number of shares outstanding of Registrant's common stock as of March 23, 2023 was 23,817,505.

 

 

 

 

 

 

 

 

 

 

 

 

 
 

NETWORK-1 TECHNOLOGIES, INC.

2022 FORM 10-K

TABLE OF CONTENTS

Page No.

PART I

Item 1.       Business 2
Item 1A.   Risk Factors 10
Item 1B.    Unresolved Staff Comments 19
Item 2.       Properties 19
Item 3.       Legal Proceedings 19
Item 4.      Mine Safety Disclosures 21

 

PART II

  
Item 5.       Market For Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 21
Item 6.       (Reserved) 24
Item 7.       Management's Discussion and Analysis of Financial Condition and Results of Operations 24
Item 7A.   Quantitative and Qualitative Disclosures About Market Risk 31
Item 8.       Financial Statements and Supplementary Data 31
Item 9.       Changes in and Disagreements With Accountants on Accounting and Financial Disclosure 31
Item 9A.   Controls and Procedures 31
Item 9B.    Other Information 32
Item 9C.    Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 33

 

PART III

  
Item 10.     Directors, Executive Officers and Corporate Governance 33
Item 11.     Executive Compensation 38
Item 12.    Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 43
Item 13.    Certain Relationships and Related Transactions and Director Independence 45
Item 14.    Principal Accountant Fees and Services 45

 

PART IV

  
Item 15.     Exhibits and Financial Statement Schedules 46
Signatures 49

 

-1- 
 

PART I

Forward-looking statements:

THIS ANNUAL REPORT ON FORM 10-K CONTAINS STATEMENTS ABOUT FUTURE EVENTS AND EXPECTATIONS WHICH ARE “FORWARD-LOOKING STATEMENTS”. ANY STATEMENT IN THIS 10-K THAT IS NOT A STATEMENT OF HISTORICAL FACT MAY BE DEEMED TO BE A FORWARD-LOOKING STATEMENT WITHIN THE MEANING OF SECTION 27A OF THE SECURITIES EXCHANGE ACT OF 1933, AS AMENDED, OR SECTION 21E OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. FORWARD-LOOKING STATEMENTS PROVIDE CURRENT EXPECTATIONS OF FUTURE EVENTS BASED ON CERTAIN ASSUMPTIONS AND INCLUDE ANY STATEMENT THAT DOES NOT DIRECTLY RELATE TO ANY HISTORICAL OR CURRENT FACT. STATEMENTS CONTAINING SUCH WORDS AS “MAY,” “WILL,” “EXPECT,” “BELIEVE,” “ANTICIPATE,” “INTEND,” “COULD,” “ESTIMATE,” “CONTINUE” OR “PLAN” AND SIMILAR EXPRESSIONS OR VARIATIONS ARE INTENDED TO IDENTIFY FORWARD-LOOKING STATEMENTS.  THESE STATEMENTS ARE BASED ON THE BELIEFS AND ASSUMPTIONS OF OUR MANAGEMENT BASED ON INFORMATION CURRENTLY AVAILABLE TO MANAGEMENT. SUCH FORWARD-LOOKING STATEMENTS ARE SUBJECT TO CURRENT RISKS, UNCERTAINTIES AND ASSUMPTIONS RELATED TO VARIOUS FACTORS SET FORTH IN THIS REPORT AND IN OTHER FILINGS MADE BY US WITH THE SECURITIES AND EXCHANGE COMMISSION. BASED UPON CHANGING CONDITIONS, SHOULD ANY ONE OR MORE OF THESE RISKS OR UNCERTAINTIES MATERIALIZE, INCLUDING THOSE DISCUSSED AS “RISK FACTORS” IN ITEM 1A AND ELSEWHERE IN THIS REPORT, OR SHOULD ANY OF OUR UNDERLYING ASSUMPTIONS PROVE INCORRECT, ACTUAL RESULTS MAY VARY MATERIALLY FROM THOSE DESCRIBED IN THIS REPORT. WE UNDERTAKE NO OBLIGATION TO UPDATE, AND WE DO NOT HAVE A POLICY OF UPDATING OR REVISING THESE FORWARD-LOOKING STATEMENTS. READERS ARE CAUTIONED NOT TO PLACE UNDUE RELIANCE ON FORWARD-LOOKING STATEMENTS, WHICH SPEAK ONLY AS OF THE DATE THE STATEMENT WAS MADE. UNLESS THE CONTEXT OTHERWISE REQUIRES, THE TERMS “NETWORK-1,” “COMPANY,” “WE,” “OUR,” “US” MEAN NETWORK-1 TECHNOLOGIES, INC. AND ITS WHOLLY-OWNED SUBSIDIARIES, MIRROR WORLDS TECHNOLOGIES, LLC AND HFT SOLUTIONS, LLC.

ITEM 1.   BUSINESS

 

Overview

 

Our principal business is the development, licensing and protection of our intellectual property assets. We presently own ninety-seven (97) U.S. patents, fifty-two (52) of such patents have expired, and eight foreign patents relating to (i) our Cox patent portfolio (the “Cox Patent Portfolio”) relating to enabling technology for identifying media content on the Internet and taking further actions to be performed after such identification; (ii) our M2M/IoT patent portfolio (the “M2M/IoT Patent Portfolio”) relating to, among other

 

 

 

-2- 
 

 

things, enabling technology for authenticating, provisioning and using embedded Sim (Subscriber Identification Module) technology in next generation IoT, Machine-to-Machine, and other mobile devices, including smartphones, tablets and computers; (iii) our HFT patent portfolio (the “HFT Patent Portfolio”) covering certain advanced technologies relating to high frequency trading, which inventions specifically address technological problems associated with speed and latency and provide critical latency gains in trading systems where the difference between success and failure may be measured in nanoseconds; (iv) our Mirror Worlds patent portfolio (the “Mirror Worlds Patent Portfolio”) relating to foundational technologies that enable unified search and indexing, displaying and archiving of documents in a computer system; and (v) our remote power patent (the “Remote Power Patent”) covering the delivery of Power over Ethernet (PoE) cables for the purpose of remotely powering network devices, such as wireless access ports, IP phones and network based cameras.  In addition, we review opportunities to acquire or license additional intellectual property as well as other strategic alternatives.

We have invested $7,000,000 in ILiAD Biotechnologies, LLC (“ILiAD”), a clinical stage biotechnology company with an exclusive license to sixty-four (64) patents. On December 31, 2022, we owned approximately 6.8% of the outstanding units of ILiAD on a non-fully diluted basis and 6.3% of the outstanding units on a fully diluted basis (after giving effect to the exercise of all outstanding options and warrants).

Our current strategy includes continuing our efforts to monetize our intellectual property.  In addition, we continue to seek to acquire additional intellectual property assets to develop, commercialize, license or otherwise monetize. Our strategy includes working with inventors and patent owners to assist in the development and monetization of their patented technologies. Our patent acquisition and development strategy is to focus on acquiring high quality patents which management believes have the potential to generate significant licensing opportunities as we have achieved with respect to our Remote Power Patent and our Mirror Worlds Patent Portfolio. In addition, we may also enter into strategic relationships with third parties to develop, commercialize, license or otherwise monetize their intellectual property.

We have been dependent upon our Remote Power Patent for a significant portion of our revenue. We no longer receive licensing revenue for our Remote Power Patent for any period subsequent to March 7, 2020 (the expiration date of the patent). Our future revenue is largely dependent on our ability to monetize our other patent assets.

We have pending litigation involving our assertion of infringement claims concerning certain patents within our Cox Patent Portfolio and our Remote Power Patent. In addition, we have a pending appeal to the U.S. Court of Appeals for the Federal Circuit of the District Court judgment of non-infringement dismissing our case against Meta Platforms, Inc. (formerly Facebook, Inc.) involving certain patents within our Mirror Worlds Patent Portfolio (see “Legal Proceedings” at pages 19-21 of this Annual Report).

At December 31, 2022, we had cash and cash equivalents and marketable securities of $48,439,000 and working capital of $47,359,000. Based on our current cash position, we believe that we will have sufficient cash to fund our operations for the foreseeable future.

 

 

-3- 
 

 

Overview of Our Patents

We currently own ninety-seven (97) U.S. patents and eight foreign patents relating to patents within our Cox Patent Portfolio, M2M/IoT Patent Portfolio, HFT Patent Portfolio, Mirror World Patent Portfolio and our Remote Power Patent. With respect to our ninety-seven (97) U.S. patents, fifty-two (52) of such patents have expired. However, we can assert expired patents against third parties but only for past damages up to the expiration date. We currently have pending litigation involving expired patents including our Remote Power Patent, and certain patents within our Cox and Mirror Worlds Patent Portfolios (see “Legal Proceedings” at pages 19-21 hereof).

Cox Patent Portfolio

Our Cox Patent Portfolio, acquired from Dr. Ingemar Cox in February 2013, currently consists of thirty-nine (39) U.S. patents relating to enabling technology for identifying media content on the Internet, such as audio and video, and taking further actions to be performed based on such identification. All of the patents within our Cox patent portfolio expired in September 2021 except for two patents which expire in July 2023 and November 2023. We have pending litigation against Google Inc. and YouTube, LLC involving assertion of certain patents within our Cox Patent Portfolio (see “Legal Proceedings” at page 19 hereof). The patents within our Cox Patent Portfolio are based on a patent application filed in 2000. Since the acquisition of the Cox Patent Portfolio in February 2013, we have been issued thirty-four (34) additional patents relating to this portfolio. The claims in these thirty-four (34) additional patents are generally directed towards systems of content identification and performing actions following therefrom.

We are obligated to pay Dr. Cox 12.5% of the net proceeds generated by us from licensing, sale or enforcement of the Cox Patent Portfolio. Dr. Cox provides consulting services to us with respect to the Cox Patent Portfolio and assists our efforts to develop the patent portfolio.

Dr. Cox is currently a Professor at the University of Copenhagen and University College London where he is head of its Information and Decision Systems Group. Dr. Cox was formerly a member of the Technical Staff at AT&T Bell Labs and a Fellow at NEC Research Institute. He is a Fellow of the ACM, IEEE, the IET (formerly IEE), and the British Computer Society and is a member of the UK Computing Research Committee. In 2019, Dr. Cox was the recipient of the Tony Kent Strix Award in recognition of his contribution to the field of information retrieval. He was founding co-editor in chief of the IEE Proc. on Information Security and was an associate editor of the IEEE Trans. on Information Forensics and Security. He is co-author of a book entitled “Digital Watermarking” and its second edition “Digital Watermarking and Steganography”. He is an inventor or co-inventor of over seventy (70) U.S. patents.

 

 

 

 

 

 

 

-4- 
 

 

M2M/IoT Patent Portfolio

Our M2M/IoT Patent Portfolio, acquired in December 2017 from M2M and IoT Technologies, LLC (“M2M”), relates to, among other things, enabling technology for authenticating, provisioning and using embedded SIM technology in next generation IoT, Machine-to-Machine and other mobile devices including smartphones, tablets and computers as well as automobiles and drones. The M2M/IoT Patent Portfolio currently consists of thirty-four (34) issued U.S. patents, four pending U.S. patent applications, seven registered foreign patents and seven additional pending non-U.S. patent applications. Since we acquired the M2M/IoT Patent Portfolio in December 2017, we have been issued twenty-two (22) additional U.S. patents with respect to the portfolio. We anticipate further issuances of additional claims for this portfolio. The expiration dates of the thirty-four (34) issued U.S. patents currently within our M2M/IoT Patent Portfolio range from September 2033 to May 2034.

We have an obligation to pay M2M 14% of the first $100 million of net proceeds (after deduction of expenses) and 5% of net proceeds greater than $100 million from Monetization Activities (as defined) related to our M2M/IoT Patent Portfolio. In addition, M2M will be entitled to receive from us $250,000 of additional consideration upon the occurrence of certain future events related to the patent portfolio.

John Nix, the Managing Member of M2M, provides consulting services to us with respect to our M2M/IoT Patent Portfolio. Mr. Nix is an entrepreneur and inventor, and founder and Chief Executive Officer of Vobal Technologies, LLC. In 2016, Mr. Nix was recognized as “Creator of the Year” by the Intellectual Property Law Association of Chicago for his intellectual property related to embedded SIM technology.

HFT Patent Portfolio

On March 25, 2022, we acquired the HFT Patent Portfolio. This portfolio covers certain advanced technologies relating to high frequency trading, which inventions specifically address technological problems associated with speed and latency and provide critical latency gains in trading systems where the difference between success and failure may be measured in nanoseconds. The HFT Patent Portfolio currently includes nine issued U.S. patents and two pending U.S. patents.

In addition to the purchase price that we paid at closing, we have an obligation to pay the seller an additional cash payment of $500,000 and $375,000 of our common stock contingent upon achieving certain milestones with respect to the HFT Patent Portfolio. We also have an obligation to pay the seller 15% of the first $50 million of net proceeds (after deduction of expenses) generated from the patent portfolio and 17.5% of net proceeds greater than $50 million.

Mirror Worlds Patent Portfolio

Our Mirror Worlds Patent Portfolio, acquired in May 2013, consists of ten (10) U.S. patents and covers foundational technologies that enable unified search and indexing, displaying and archiving of documents in a computer system. All of our patents within our Mirror Worlds Patent Portfolio have expired. The Mirror Worlds Patent Portfolio includes U.S. Patent No. 6,006,227 (the “227 Patent”), U.S. Patent No. 7,865,538 and U.S. Patent No. 8,255,439 which are currently being asserted in our litigation against Meta Platforms, Inc. (formerly Facebook, Inc.) (see “Legal Proceedings” at pages 19-20 hereof). Our 227 Patent was previously asserted in litigations against Apple Inc. and Microsoft Corporation which were settled resulting in aggregate payments to us of $29,650,000.

-5- 
 

 

The inventions relating to document stream operating systems covered by our Mirror Worlds Patent Portfolio resulted from the work done by Yale University computer scientist, Professor David Gelernter, and his then graduate student, Dr. Eric Freeman, in the mid-1990s. Certain aspects of the technologies developed by David Gelernter were commercialized in their company's product offering called “Scopeware.” Technologies embodied in Scopeware are now common in various computer and web-based operating systems. Professor Gelernter and Dr. Freeman each entered into consulting agreements with us as part of our acquisition of the Mirror Worlds Patent Portfolio.

As part of our acquisition of the Mirror Worlds Patent Portfolio in 2013, we also entered into an agreement with Recognition Interface, LLC (“Recognition”), an entity that financed the commercialization of the Mirror Worlds patent portfolio prior to its sale to Mirror Worlds, LLC and also retained an interest in the licensing proceeds of the Mirror Worlds patent portfolio. Pursuant to the terms of the agreement with us, we are obligated to pay Recognition an interest in the net proceeds realized from our monetization of the Mirror Worlds Patent Portfolio as follows: (i) 10% of the first $125 million of net proceeds; (ii) 15% of the next $125 million of net proceeds; and (iii) 20% of any portion of the net proceeds in excess of $250 million. Since entering into the agreement with Recognition in May 2013, we have paid Recognition an aggregate of $3,127,000 with respect to such net proceeds interest in our Mirror Worlds Patent Portfolio (no such payments were made during the years 2022 and 2021).

Remote Power Patent

Our Remote Power Patent (U.S. Patent No. 6,218,930) covers the delivery of power over Ethernet cables for the purpose of remotely powering network devices such as wireless access ports, IP phones and network based cameras. Our Remote Power Patent expired on March 7, 2020. Notwithstanding the expiration of the Remote Power Patent in March 2020, we are currently asserting the patent in separate actions against five defendants for damages prior to March 7, 2020 (expiration date) (see “Legal Proceedings” at page 20 hereof).

On June 13, 2003, the Institute of Electrical Engineers (IEEE), a non-profit, technical professional association, approved the 802.3af Power over Ethernet standard (the “Standard”), which covers technologies deployed in delivering power over Ethernet networks. The Standard provides for the Power Sourcing Equipment (PSE) to be deployed in switches or as standalone midspan hubs to provide power to remote devices such as wireless access points, IP phones and network-based cameras. The technology is commonly referred to as Power over Ethernet (“PoE”). In 2009, the IEEE Standards Association approved 802.3at, a new PoE standard which, among other things, increased the available power for delivery over Ethernet networks. We believe that our Remote Power Patent covers several of the key technologies covered by both the 802.3af and 802.3at standards.

 

 

 

-6- 
 

Network-1 Strategy

Our strategy is to capitalize on our intellectual property assets by entering into licensing arrangements with third parties that utilize our intellectual property's proprietary technologies as well as any additional proprietary technologies covered by patents which may be acquired by us in the future. Our current patent acquisition and development strategy is to focus on acquiring high quality patents which management believes have the potential to generate significant licensing opportunities as has been the case with our Remote Power Patent and Mirror Worlds Patent Portfolio. Our Remote Power Patent has generated licensing revenue in excess of $187,000,000 from May 2007 through December 31, 2022. Since acquisition of our Mirror Worlds Patent Portfolio in May 2013, we have received licensing and other revenue of $47,150,000 through December 31, 2022. In addition, we may enter into third party strategic relationships with inventors and patent owners to assist in the development and monetization of their patent technologies. Based on our cash position, we review opportunities to acquire additional intellectual property as well as evaluate other strategic alternatives.

In connection with our activities relating to the protection of our intellectual property assets, or the intellectual property assets of third parties with whom we may have strategic relationships in the future, it may be necessary to assert patent infringement claims against third parties whom we believe are infringing our patents or those of our strategic partners. We are currently involved in several litigations to protect our patents including certain patents within our Cox Patent Portfolio, Mirror Worlds Patent Portfolio and Remote Power Patent (see “Legal Proceedings” at pages 19-21 hereof). We have previously successfully asserted litigation with respect to our Remote Power Patent and our Mirror Worlds Patent Portfolio and have also been successful in defending proceedings at the USPTO challenging the validity of our Remote Power Patent and certain patents within our Cox Patent Portfolio.

 

 

 

 

 

 

-7- 
 

 

Significant Licensees

We had no revenue for the year ended December 31, 2022. Revenue from our Remote Power Patent constituted 100% of our revenue for the year ended December 31, 2021, of which two licensees constituted 99% of our revenue for such year.

Competition

With respect to our ability to acquire additional intellectual property assets or enter into strategic relationships with third parties to monetize their intellectual property assets, we face considerable competition from other companies, many of which have significantly greater financial and other resources than we have. The patent licensing and enforcement industry has grown and there has been a material increase in the number of companies seeking to acquire intellectual property assets from third parties or to provide financing to third parties seeking to monetize their intellectual property. Entities including, among others, Acacia Research Corporation (NASDAQ:ACTG), Intellectual Ventures, WI-LAN Inc., a subsidiary of Quarterhill Inc. (NASDAQ:QTRH), VirnetX Holdings Corporation (NYSE MKT:VHC) and RPX Corporation, seek to acquire intellectual property or partner with third parties to license or enforce intellectual property rights. In addition, we also compete with strategic corporate buyers with respect to the acquisition of intellectual property assets. It is expected that others will enter this market as well. Many of these competitors have significantly greater financial and human resources than us.

We may also compete with litigation funding firms such as Burford Capital Limited, Validity Finance, LLC, Fortress Investment Group, LLC, Parabellum Capital LLC and Bentham Capital LLC, venture capital firms and hedge funds for intellectual property acquisitions and licensing opportunities. Many of these competitors also have greater financial resources and human resources than us.

Regulatory Environment

If new legislation, regulations or rules are implemented either by Congress, the USPTO or the courts that impact the patent application process, the patent enforcement process or the rights of patent holders, these changes could negatively affect our business, financial condition and results of operations. Certain legislation, regulations, and rulings by the courts and actions by the USPTO have materially increased the risk and cost of enforcement of patents. U.S. patent laws were amended by the Leahy-Smith America Invents Act, referred to as the “America Invents Act”, which became effective on March 16, 2013. The America Invents Act included a number of significant changes to U.S. patent law. In general, it addressed issues surrounding the enforceability of patents and the increase in patent litigation by, among other things, establishing new procedures for patent litigation and new administrative post-grant review procedures to challenge the patentability of issued patents outside of litigation, including Inter Partes Review (IPR) and Covered Business Method Review (CBM) proceedings which provide third parties a timely and cost effective alternative to district court litigation to challenge the validity of an issued patent. The America Invents Act and its implementation has increased the uncertainties and costs surrounding the enforcement of patent rights has made it more difficult to successfully enforce our patents.

 

-8- 
 

In addition, future changes in patent law could adversely impact our business. Such changes may not be advantageous to us and may make it more difficult to obtain adequate patent protection to enforce our patents. Increased focus on the growing number of patent lawsuits, particularly by non-practicing entities (NPEs), may result in legislative changes which increase the risk and costs of asserting patent litigation.

Investment in ILiAD Biotechnologies

During the period December 2018 to date, we made an aggregate investment of $7,000,000 in ILiAD, a privately held clinical stage biotechnology company dedicated to the prevention and treatment of human disease caused by Bordetella pertussis. ILiAD is currently focused on validating its proprietary intranasal vaccine, BPZE1, for the prevention of pertussis (whooping cough). Pertussis is a life-threatening disease caused by the highly contagious respiratory bacterium Bordetella pertussis. According to the U.S. Centers for Disease Control and Prevention, each year pertussis affects approximately 16 million people globally, accounting for nearly 200,000 deaths. ILiAD has the exclusive license to sixty-four (64) issued patents and has thirty (30) pending patent applications. On December 31, 2022, we owned approximately 6.8% of the outstanding units of ILiAD on a non-fully diluted basis and 6.3% of the outstanding units on a fully diluted basis (after giving effect to the exercise of all outstanding options, and warrants). In connection with our investment, Corey Horowitz, our Chairman and Chief Executive Officer, became a member of ILiAD’s Board of Managers.

BPZE1 was developed in the laboratory of Camille Locht, PhD, at the Institut Pasteur de Lille (IPL) and French National Institute of Health and Medical research. BPZE1 is a live-attenuated intranasal vaccine designed to overcome deficiencies of current pertussis vaccines, including poor durability of protection and failure to prevent nasopharyngeal Bordetella pertussis infections that lead to escape mutants and transmission to vulnerable infants. On January 3, 2022, ILiAD announced that the U.S. Food and Drug Administration (FDA) granted Fast Track designation for BPZE1.

On August 24, 2022, ILiAD consummated a private financing of $42,800,000 of its Class D units, of which a multi-national pharmaceutical company invested $30,000,000. As a result of the financing, we recognized a gain of $3,883,000 on our equity investment and a gain of $271,000 with respect to the conversion of our convertible note in the principal amount of $1,000,000 plus interest into equity of ILiAD.

 

  

-9- 
 

 

Corporate Information

We were incorporated under the laws of the State of Delaware in July 1990. Our principal executive offices are located at 65 Locust Avenue, Third Floor, New Canaan, Connecticut 06840 and our telephone number is (203) 920-1055.

Available Information

We file or furnish various reports, such as registration statements, quarterly and current reports, proxy statements and other materials with the SEC. Our website address is www.network-1.com. You may obtain, free of charge on our Internet website, copies of our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, proxy statements and amendments to those reports or statements filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act, as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. The information we post on our website is intended for reference purposes only; none of the information posted on our website is part of this Annual Report or incorporated by reference herein.

In addition to the materials that are posted on our website, you may read and copy any materials we file with the SEC at the SEC's Public Reference Room at 100 F Street, NE, Washington, DC 20549. You may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC also maintains an Internet site that contains reports, proxy and other information statements, and other information regarding issuers, including us, that file electronically with the SEC. The address of the SEC’s Internet site is http://www.sec.gov.

Employees and Consultants

We currently have two employees and two consultants providing monthly services to us.

 

ITEM 1A.    RISK FACTORS

 

Our operations and financial results are subject to various material risks and uncertainties, including those described below, which could adversely affect our business, financial condition, results of operations, cash flow, and the trading price of our common stock. You should carefully consider the material risks and uncertainties described below in addition to the other information set forth in this Annual Report on Form 10-K, including, but not limited to, the section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” The material risks described below are not the only risks we face. Additional risks that we do not know of or that we currently believe are immaterial may also impair our business operations. If any of the following risks actually occur, our business, financial condition, results of operations and cash flow could be materially adversely affected, and the trading price of our common stock could decline significantly.

-10- 
 

 

Risks Related to Our Business

Our revenue from licensing intellectual property is uncertain as it is generally dependent upon litigation outcomes involving our patents which we cannot predict.

Our revenue is dependent upon our litigation outcomes. We currently have pending litigation involving our Cox Patent Portfolio and Mirror Worlds Patent Portfolio as well as our Remote Power Patent (see “Legal Proceedings” at pages 19-21 hereof). Patent litigation is inherently risky and uncertain and we cannot assure you that any of our current or future litigation will result in a favorable outcome for us. Accordingly, our revenue is uncertain.

If we are unable to protect our patents, our business would be negatively impacted.

We believe our patents are valid, enforceable and valuable. Despite this belief, third parties typically defend assertion of our patents by asserting defenses, among others, of non-infringement and invalidity. In addition, in the future certain of our patents may be subject to USPTO post-grant inter partes review proceedings (IPRs) which could result in all or a part of our patents being invalidated or the claims being limited. Unfavorable outcomes in our litigation or IPRs may reduce our ability to enforce our patents or have other adverse consequences. If we are unable to protect our patents or otherwise realize value for them, our business would be negatively impacted.

The outcome of our substantial investment in ILiAD is uncertain.

To date we have invested $7,000,000 in ILiAD, a privately held clinical stage biotechnology company, with focus on validating its proprietary intranasal vaccine (BPZE1) for the prevention of pertussis (whopping cough). For the year ended December 31, 2022, we recorded a gain of $3,883,000 on our ILiAD investment in accordance with Accounting Standards Codification (ASC) 323 as a result of ILiAD’s completion of a private financing of approximately $42,800,000 in August 2022 which included an investment of $30,000,000 by a multi-national pharmaceutical company. We also recorded a gain in 2022 of $271,000 in connection with conversion of our convertible note in the principal amount of $1,000,000 plus accrued interest into equity in the ILiAD private offering (see Note B[6] and Note H to our consolidated financial statements included herein). Notwithstanding the gains we recorded in 2022, our investment in ILiAD remains subject to substantial risks.

We have been dependent upon our Remote Power Patent for a significant portion of our revenue and we may not be able to generate future revenue from our other patents.

Our Remote Power Patent has generated licensing revenue for us in excess of $187,000,000 from May 2007 through December 31, 2022. We had no revenue in 2022 and revenue from our Remote Power Patent constituted 100% of our revenue for 2021 ($36,029,000), 2020 ($4,403,000) and 2019 ($3,037,000). As a result of the expiration of our Remote Power Patent on March 7, 2020, we no longer receive licensing revenue from such patent for any period subsequent to the expiration date. Our failure to successfully monetize our other patents would have a negative impact on our business, financial condition and operating results.

 

-11- 
 

We may not achieve successful outcomes of our pending or future litigation which would have a negative impact on our business.

We are currently enforcing certain patents within our Cox Patent Portfolio against Google and YouTube, who are challenging these patents and we are also asserting our Remote Power Patent in nine separate litigations against ten defendants. We have appealed to the Federal Circuit the District Court decision granting Facebook (Meta Platforms, Inc.), summary judgment of non-infringement and dismissing our case involving certain patents within our Mirror Worlds Patent Portfolio (see “Legal Proceedings” at pages 19-20 hereof). In addition, our M2M/IoT Patent Portfolio and HFT Patent Portfolio, are not currently being asserted. We may not have success in enforcing or defending our patents, which would have a negative impact on our business.

We may not be able to capitalize in the future on our strategy to acquire high quality patents with significant licensing opportunities or enter into strategic relationships with third parties to license or otherwise monetize their intellectual property.

Based upon the success we achieved from licensing our Remote Power Patent (twenty-eight (28) license agreements which generated in excess of $187,000,000 of revenue), the revenue we generated from our Mirror Worlds Patent Portfolio ($47,150,000) and establishing a patent portfolio currently consisting of ninety-seven (97) U.S. patents and eight foreign patents as well as our cash position, we believe we have the expertise and sufficient capital to compete in the patent monetization market and to enter strategic relationships with third parties to develop, commercialize, license or otherwise monetize their patents. Our strategy is to focus on acquiring high quality patent assets which management believes have the potential for significant licensing opportunities. However, we may not be able to acquire such additional high quality patents or, if acquired, we may not achieve material revenue or profit from such patents. Acquisitions of patent assets are competitive, time consuming, complex and costly to consummate. High quality patents with significant licensing opportunities are difficult to find and are often very competitive to acquire.  In addition, such acquisitions present material risks. Even if we acquire such additional patent assets, we may not be able to achieve significant licensing revenue or even generate sufficient revenue related to such patent assets to offset the acquisition costs and the legal fees and expenses which may be incurred to enforce, license or otherwise monetize such patents. In addition, we may not be able to enter into strategic relationships with third parties to license or otherwise monetize their intellectual property and, even if we consummate such strategic relationships, we may not achieve material revenue or profit from such relationships.

 

 

 

-12- 
 

 

The patent monetization cycle is long, costly and unpredictable.

There is generally a significant time lag between acquiring a patent portfolio and recognizing revenue from those patent assets. During this time lag, significant costs are likely to be incurred which may have a negative impact on our results of operations, cash flow and financial position. Furthermore, the outcome of our efforts to monetize our patents is uncertain and we may not be successful.

Our quarterly and annual operating and financial results and our revenue are difficult to predict and are likely to fluctuate significantly in future periods.

Our quarterly and annual operating and financial results are difficult to predict and may fluctuate significantly from period to period. In 2022, we had no revenue and incurred a net loss of $2,326,000. We had revenue of $36,029,000 and net income of $14,281,000 for 2021, as compared to revenue of $4,403,000 and a net loss of $1,709,000 for 2020. We had revenue of $3,037,000 and a net loss of $1,792,000 for 2019 as compared to revenue and net income of $22,106,000 and $7,706,000 for 2018. Accordingly, our revenue, net income and results of operations may widely fluctuate as a result of a variety of factors that are outside our control including the timing and our ability to achieve successful outcomes from current and future patent litigation, our ability and timing in consummating future license agreements for our intellectual property assets, the timing and extent of payments received by us from licensees, whether we will achieve a successful outcome of our investment in ILiAD, and the timing and our ability to achieve revenue from future strategic relationships.

In the future we could be classified as a Personal Holding Company resulting in a 20% tax on our PHC Income that we do not distribute to our shareholders.

The personal holding company (“PHC”) rules under the Internal Revenue Code impose a 20% tax on a PHC’s undistributed personal holding company income (“UPHCI”), which means, in general, taxable income subject to certain adjustments and reduced by certain distributions to shareholders. For a corporation to be classified as a PHC, it must satisfy two tests: (1) that more than 50% in value of its outstanding shares must be owned directly or indirectly by five or fewer individuals at any time during the second half of the year (after applying constructive ownership rules to attribute stock owned by entities to their beneficial owners and among certain family members and other related parties) (the “Ownership Test”) and (2) at least 60% of its adjusted ordinary gross income for a taxable year consists of dividends, interest, royalties, annuities and rents (the “Income Test”). During the second half of 2022, based on available information concerning our shareholder ownership, we did not satisfy the Ownership Test and thus we were not a PHC for 2022. However, we may be determined to be a PHC in the future.  If we were determined to be a PHC in 2023 or any future year, we would be subject to an additional 20% tax on our UPHCI. In such event, we may issue a special cash dividend to our shareholders in an amount equal to the UPHCI rather than incur the 20% tax.

 

 

-13- 
 

 

We are dependent upon our CEO and Chairman.

Our success is largely dependent upon the personal efforts of Corey M. Horowitz, our Chairman, Chief Executive Officer and Chairman of our Board of Directors. On March 22, 2022, we entered into a new four year employment agreement with Mr. Horowitz pursuant to which he continues to serve as our Chairman and Chief Executive Officer. The loss of the services of Mr. Horowitz would have a material adverse effect on our business and prospects. We do not maintain key-man life insurance on the life of Mr. Horowitz.

Cash dividends may not be continued to be paid.

Our dividend policy consists of semi-annual cash dividends of $0.05 per share ($0.10 per share annually) which have been paid in March and September of each year. We have paid such semi-annual dividends since our dividend policy was enacted in December 2016. At this time we anticipate continuing to pay dividends consistent with our policy. However, our dividend policy undergoes a periodic review by our Board of Directors and is subject to change at any time depending upon our earnings, financial requirements and other factors existing at the time.  We may not be in a position to continue to pay dividends in the future.

Legislation, regulations, court rulings and actions by the USPTO have materially increased the risk and cost of enforcement of patents and may continue to do so in the future.

Legislation, regulations, court rulings and actions by the USPTO have materially increased the risk and cost of enforcing patents. U.S. patent laws were amended by the Leahy-Smith America Invents Act, referred to as the America Invents Act, which became effective on March 16, 2013. The America Invents Act included a number of significant changes to U.S. patent law. In general, it addressed issues surrounding the enforceability of patents and the increase in patent litigation by, among other things, established new procedures for patent litigation and new administrative post-grant review procedures to challenge the patentability of issued patents outside of litigation, including Inter Partes Review (IPR) and Covered Business Method Review (CBM) proceedings which provide third parties a timely, cost effective alternative to district court litigation to challenge the validity of an issued patent. In addition, the America Invents Act changed the way that parties may be joined in patent infringement actions, and increased the likelihood that such actions will need to be brought against individual parties allegedly infringing by their respective individual actions or activities. The America Invents Act and its implementation also increased the uncertainties and costs surrounding the enforcement of patent rights, which could have a material adverse effect on our business, financial condition and results of operations.

 

 

-14- 
 

 

Changes in patent law could adversely impact our business.

Patent laws may continue to change and may alter the protections afforded to owners of patent rights. Such changes may not be advantageous to us and may make it more difficult to obtain adequate patent protection to enforce our patents. Increased focus on the growing number of patent lawsuits, particularly by non-practicing entities (NPEs), may result in further legislative changes which increase the risk and costs of asserting patent litigation.

Our pending patent infringement litigations are time consuming and costly.

We have pending litigations involving our Cox Patent Portfolio, Mirror Worlds Patent Portfolio (pending appeal to the Federal Circuit of dismissal of our Facebook (Meta Platforms, Inc.) litigation) and Remote Power Patent (see “Legal Proceedings” at pages 19-21 of this Annual Report). While we have contingent legal fee arrangements, or a contingency plus a fixed cash amount arrangement, with our patent litigation counsel in each litigation, we are responsible for all or a portion of the expenses which are anticipated to be material. In addition, the time and effort required of our management to effectively pursue these litigations is likely to be significant and it may adversely affect other business opportunities.

We face intense competition to acquire intellectual property and enter into strategic relationships.

With respect to our ability to acquire additional intellectual property or enter into strategic relationships with third parties to monetize their intellectual property, we face considerable competition from other companies, many of which have significantly greater financial and other resources than we have. We face a number of competitors in the patent licensing and enforcement business seeking to acquire intellectual property rights from third parties. Many of these competitors have significantly more financial and human resources than us.

We may also compete with strategic corporate buyers, litigation funding firms, venture capital firms and hedge funds for intellectual property acquisitions and licensing opportunities. Many of these competitors have greater financial resources and human resources than us.

Our markets are subject to rapid technological change and our technologies face potential technology obsolescence.

The markets covered by our intellectual property are characterized by rapid technological changes, changing customer requirements, frequent new product introductions and enhancements, and evolving industry standards. The introduction of products embodying new technologies and the emergence of new industry standards may render our technologies obsolete or less marketable.

 

 

 

-15- 
 

 

In addition, other companies may develop competing technologies that offer better or less expensive alternatives to the technologies covered by our intellectual property. Moreover, technological advances or entirely different approaches developed by other companies or adopted by various standards groups could render our patents obsolete, less marketable or unenforceable.

The burdens of being a public company may adversely affect us including our ability to pursue litigation.

As a public company, our management must devote substantial time, attention and financial resources to comply with U.S. securities laws. This may have a material adverse effect on management's ability to effectively and efficiently pursue its business. In addition, our disclosure obligations under U.S. securities laws require us to disclose information publicly that will be available to litigation opponents. We may, from time to time, be required to disclose information that may have a material adverse effect on our litigation strategies. This information may enable our litigation opponents to develop effective litigation strategies that are contrary to our interests.

General Risk Factors

Investors may have limited influence on stockholder decisions because ownership of our common stock is concentrated.

As of March 10, 2023, our executive officers and directors beneficially owned 30.8% of our outstanding common stock. As a result, these stockholders may be able to exercise substantial control over all matters requiring stockholder approval, including the election of directors and approval of significant corporate transactions, such as a merger or other sale of our company or its assets. This concentration of ownership will limit other stockholders' ability to influence corporate matters and may have the effect of delaying or preventing a third party from acquiring control over us.

Our common stock may be delisted from the NYSE American exchange if we fail to comply with continued listing standards.

Our common stock is currently traded on the NYSE American exchange under the symbol “NTIP”. If we fail to meet any of the continued listing standards of the NYSE American exchange, our common stock could be delisted. Such delisting could adversely affect the price and trading (including liquidity) of our common stock.

 

 

 

-16- 
 

 

There are inherent uncertainties involved in estimates, judgments and assumptions used in the preparation of financial statements in accordance with U.S. GAAP. Any changes in estimates, judgments and assumptions could have a material adverse effect on our business, financial condition, and operating results.

The preparation of financial statements in accordance with accounting principles generally accepted in the Unites States (“U.S. GAAP”) involves making estimates, judgments and assumptions that affect reported amounts of assets (including intangible assets), liabilities and related reserves, revenues, expenses, and income. Estimates, judgments, and assumptions are inherently subject to change in the future, and any such changes could result in corresponding changes to the amounts of assets, liabilities, expenses, and income. Any such changes could have a material adverse effect on our business, financial condition, and operating results.

Provisions in our corporate charter, by-laws and in Delaware law could make it more difficult for a third party to acquire us, discourage a takeover and adversely affect existing stockholders.

Our certificate of incorporation authorizes the Board of Directors to issue up to 10,000,000 shares of preferred stock. The preferred stock may be issued in one or more series, the terms of which may be determined at the time of issuance by our Board of Directors, without further action by stockholders, and may include, among other things, voting rights (including the right to vote as a series on particular matters), preferences as to dividends and liquidation, conversion and redemption rights, and sinking fund provisions, any of which could adversely affect holders of our common stock. Although there are currently no shares of preferred stock outstanding, future holders of preferred stock may have rights superior to our common stock and such rights could also be used to restrict our ability to merge with or sell our assets to third parties.

We are also subject to the “anti takeover” provisions of Section 203 of the Delaware General Corporation Law, which could prevent us from engaging in a “business combination” with a 15% or greater stockholder for a period of three years from the date such person acquired that status unless appropriate board or stockholder approvals are obtained.

In addition, our By-laws contain advance notice requirements for director nominations and for new business to be brought up at stockholder meetings. Stockholders wishing to submit director nominations or raise matters to a vote of stockholders must provide notice to us within specified date windows and in very specific forms in order to have that matter voted on at a stockholders meeting.

The aforementioned provisions could deter unsolicited takeovers or delay or prevent changes in our control or management, including transactions in which stockholders might otherwise receive a premium for their shares over the then current market price. These provisions may also limit the ability of stockholders to delay, deter or prevent a change of control, or approve transactions that they may deem to be in their best interests.

 

 

-17- 
 

Our stock price may be volatile.

The market price of our common stock may be highly volatile and could fluctuate widely in price in response to various factors, many of which are beyond our control, including the following:

•the outcome of our litigation against Google and YouTube involving certain patents within our Cox Patent Portfolio;
•our ability to further develop, license and monetize our M2M/IoT Patent Portfolio;
•our ability to further develop, license and monetize our HFT Patent Portfolio;
•our ability to achieve a successful outcome of our investment in ILiAD;
•the outcome of our appeal to the Federal Circuit of the District Court ruling granting Facebook summary judgment of non-infringement and dismissing our case involving certain patents within our Mirror Worlds Patent Portfolio;
•our ability to acquire additional intellectual property;
•our ability to enter into strategic relationships with third parties to license or otherwise monetize their intellectual property;
•variations in our quarterly and annual operating results;
•our ability to continue to pay cash dividends;
•our ability to raise capital if needed;
•sales of our common stock;
•technology changes;
•legislative, regulatory and competitive developments; and
•economic and other external factors.

In addition, the securities markets have from time to time experienced significant price and volume fluctuations that are unrelated to the operating performance of particular companies. These market fluctuations may also have a material and adverse effect on the market price of our common stock.

  

-18- 
 

 

ITEM 1B.  UNRESOLVED STAFF COMMENTS

None.

ITEM 2.  PROPERTIES

Our principal executive offices are located in New Canaan, Connecticut, where we lease approximately 2,000 square feet of office space at a base rent of $5,500 per month pursuant to a lease amendment, dated May 1, 2022, which term expires on April 30, 2025. We believe that our office facility is suitable and appropriate to support our current needs.

ITEM 3.  LEGAL PROCEEDINGS

Cox Patent Portfolio Litigation

On April 4, 2014 and December 3, 2014, we initiated litigation against Google Inc. (“Google”) and YouTube, LLC (“YouTube”) in the U.S. District Court for the Southern District of New York for infringement of several of our patents within our Cox Patent Portfolio which relate to the identification of media content on the Internet. The lawsuit alleges that Google and YouTube have infringed and continue to infringe certain of our patents by making, using, selling and offering to sell unlicensed systems and related products and services, which include YouTube’s Content ID system.

The litigations against Google and YouTube were subject to court ordered stays which were in effect from July 2, 2015 until January 2, 2019 as a result of proceedings then pending at the Patent Trial and Appeal Board (PTAB) and the appeals to the U.S. District Court of Appeals for the Federal Circuit. Pursuant to a joint stipulation and order, entered on January 2, 2019, the parties agreed, among other things, that the stays with respect to the litigations were lifted. In January 2019, the two litigations against Google and YouTube were consolidated. Discovery is complete and the parties have each submitted summary judgment motions. A trial date has not yet been set.

Mirror Worlds Patent Portfolio Litigation

Meta (Facebook) Litigation

On May 9, 2017, Mirror Worlds Technologies, LLC, our wholly-owned subsidiary, initiated litigation against Facebook, Inc. (“now Meta Platforms, Inc., “Meta”) in the U.S. District Court for the Southern District of New York, for infringement of U.S. Patent No. 6,006,227, U.S. Patent No. 7,865,538 and U.S. Patent No. 8,255,439 (among the patents within our Mirror Worlds Patent Portfolio). The lawsuit alleges that the asserted patents are infringed by Meta’s core technologies that enable Meta’s Newsfeed and Timeline features. We seek, among other things, monetary damages based upon reasonable royalties.

On May 7, 2018, Meta filed a motion for summary judgment on non-infringement. On August 11, 2018, the Court issued an order granting Facebook’s motion for summary judgment of non-infringement and dismissed the case. On January 23, 2020, the U.S. Court of Appeals for the Federal Circuit ruled in our favor and reversed the summary judgment finding on non-infringement of the District Court and remanded the litigation to the Southern District of New York for further proceedings.

 

-19- 
 

On March 7, 2022, the District Court entered a ruling granting in part and denying in part a motion for summary judgment by Meta. In its ruling the Court (i) denied Meta’s motion that the asserted patents were invalid by concluding that all asserted claims were patent eligible under §101 of the Patent Act and (ii) granted summary judgment of non-infringement in favor of Facebook and dismissed the case. We strongly disagree with the decision on non-infringement and on April 4, 2022 we filed an appeal to the U.S. Court of Appeals for the Federal Circuit. The appeal is pending.

Remote Power Patent Litigation

October-November 2022 Litigation

In October and November 2022, we initiated nine separate litigations against ten defendants for infringement of our Remote Power Patent seeking monetary damages based upon reasonable royalties, as follows:

•On October 6, 2022, we initiated such litigation against Arista Networks, Inc., Fortinet, Inc., Honeywell International Inc. and Ubiquiti Inc. in the United States District Court, District of Delaware;
•On October 27, 2022, and November 3, 2022, we initiated such litigation against TP-Link USA Corporation and Hikvision USA, Inc. in the United States District Court for the Central District of California;
•On November 4, 2022, we initiated such litigation against Panasonic Holdings Corporation and Panasonic Corporation of North America in the United States District Court for the Eastern District of Texas (Marshall Division); and
•On November 8, 2022 and November 16, 2022, we initiated such litigation against Antaira Technologies, LLC and Dahua Technology USA in the United States District Court for the Central District of California.

During the period January 24, 2023 through March 10, 2023, we entered into settlement agreements with Arista Networks, Inc., Antaira Technologies, LLC, Panasonic Holdings Corporation and TP-Link USA Corporation with respect to the above referenced litigations resulting in aggregate settlement payments to us of $537,300 and a conditional payment of $150,000.

 

 

-20- 
 

 

Netgear Litigation

On December 15, 2020, we filed a lawsuit against Netgear in the Supreme Court of the State of New York, County of New York, for breach of a Settlement and License Agreement, dated May 22, 2009, with us for Netgear’s failure to make royalty payments, and provide corresponding royalty reports to us based on sales of Netgear’s PoE products. On October 22, 2021, Netgear filed a Demand for Arbitration with the American Arbitration Association (“AAA”) seeking to arbitrate certain issues raised in the litigation in the Supreme Court, State of New York, County of New York. We have objected to jurisdiction at the AAA. On April 22, 2022, Netgear filed a counterclaim in the New York court action alleging that we breached the License Agreement by not offering Netgear lower royalties. On September 22, 2022, the arbitration brought by Netgear was dismissed by the AAA on jurisdiction grounds. The case remains pending in the Supreme Court of the State of New York, County of New York.

ITEM 4.  MINE SAFETY DISCLOSURES

None.

PART II

ITEM 5.MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Market Information. Our common stock is listed for trading on the NYSE American exchange under the symbol “NTIP”. On March 23, 2023, the closing price for our common stock as reported on the NYSE American Exchange was $2.10 per share. The number of record holders of our common stock was 39 as of March 23, 2023. In addition, we believe there were in excess of approximately 1200 holders of our common stock in “street name” as of March 23, 2023.

Dividend Policy.  Our dividend policy consists of semi-annual cash dividends of $0.05 per share ($0.10 per share annually) which have been paid in March and September of each year.  On February 23, 2022, our Board of Directors declared a semi-annual cash dividend of $0.05 per share with a payment date of March 24, 2022 to all common shareholders of record as of March 9, 2022. On September 9, 2022, our Board of Directors declared a semi-annual cash dividend of $0.05 per share with a payment date of September 30, 2022 to all common shareholders of record as of September 20, 2022. On March 3, 2023, our Board of Directors declared a semi-annual cash dividend of $0.05 per share with a payment date of March 31, 2023 to all common shareholders of record as of March 15, 2023. At this time we anticipate continuing to pay dividends consistent with our policy. However, our dividend policy undergoes a periodic review by our Board of Directors and is subject to change at any time depending upon our earnings, financial requirements and other factors existing at the time.

 

 

 

 

 

-21- 
 

 

As of December 31, 2022, we accrued dividends of $37,000 for unvested restricted stock units with dividend equivalent rights.

Recent Issuances of Unregistered Securities. There were no unregistered sales of equity securities during the quarter ended December 31, 2022.

Stock Repurchases. On June 11, 2021, our Board of Directors authorized an extension and increase of the share repurchase program (“Share Repurchase Program”) to repurchase up to $5,000,000 of shares of our common stock over the subsequent 24 month period. The common stock may be repurchased from time to time in open market transactions or privately negotiated transactions in our discretion. The timing and amount of the shares repurchased is determined by management based on its evaluation of market conditions and other factors. The Share Repurchase Program may be increased, suspended or discontinued at any time.

 

 

 

 

 

 

 

 

 

 

 

-22- 
 

 

During the months of October, November and December 2022, we repurchased common stock pursuant to our Share Repurchase Program as indicated below:

 

Period

 Total Number of
Shares Purchased		 Average Price
Paid Per Share		 Total Number of
Shares Purchased
as Part of Publicly
Announced Plans
or Programs		 Maximum Number
(or Approximate
Dollar Value) of
Shares) that May
Yet Be Purchased
Under the Plans or
Programs
October 1, 2022 to
October 31, 2022		 — — — $3,508,374
November 1, 2022 to
November 30, 2022		 4,210 $2.23 4,210 3,498,965
December 1, 2022 to
December 31, 2022		 46,027 $2.20 46,027 3,397,891
Total 50,237 $2.20 50,237  

During the year ended December 31, 2022, we repurchased an aggregate of 228,530 shares of our common stock pursuant to our Share Repurchase Program at a cost of $531,000 (exclusive of commissions) or an average price per share of $2.33.

Since inception of our Share Repurchase Program (August 2011) to December 31, 2022, we repurchased an aggregate of 9,212,664 shares of our common stock at a cost of $17,758,000 (exclusive of commissions) or an average per share price of $1.93.

Equity Compensation Plan Information

The following table summarizes share and exercise price information for our equity compensation plans as of December 31, 2022.

   

Number of

securities to be

issued upon

exercise of

outstanding

options and rights

  

Weighted-average

exercise price of

outstanding

options and

rights

  

Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column(a))

    (a)   (b)   (c)
             
Equity compensation plans
approved by security holders		  

625,000(1)

   $ —(2)  

2,300,000(3)

             
Equity compensation plans not
approved by security holders		  

$ —

  

$ —

   —
             
Total   625,000       $ —   2,300,000

 

(1)       Consists of shares issuable upon vesting of outstanding restricted stock units issued under the 2013 Stock Incentive Plan.

(2)       Does not take into account outstanding restricted stock units as these awards have no exercise price.

(3)       Represents shares of common stock reserved for issuance under our 2022 Stock Incentive Plan. We have discontinued issuing awards under our 2013 Stock Incentive Plan as a result of adoption of the 2022 Stock Incentive Plan.

 

           

-23- 
 

 

Our 2022 Stock Incentive Plan (“2022 Plan”) provides for the grant of any or all of the following types of awards: (a) stock options, (b) restricted stock units (c) restricted stock, (d) stock appreciation rights, (e) unrestricted stock awards, (f) cash based awards, and (g) other stock-based awards. Awards under the 2022 Plan may be granted singly, in combination, or in tandem.  Subject to standard anti-dilution adjustments as provided in the 2022 Plan, the 2022 Plan provides for an aggregate of 2,300,000 shares of our common stock to be available for distribution pursuant to the 2022 Plan.  The Compensation Committee (or the Board of Directors) will generally have the authority to administer the 2022 Plan, determine participants who will be granted awards under the 2022 Plan, the size and types of awards, the terms and conditions of awards and the form and content of the award agreements representing awards. Awards under the 2022 Plan may be granted to our employees, directors and consultants. As of December 31, 2022, there were no awards outstanding under our 2022 Plan and 625,000 shares issuable upon vesting restricted stock units under our 2013 Stock Incentive Plan (“2013 Plan”).

ITEM 6. (RESERVED)

Not applicable.

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the financial statements and related notes contained elsewhere in this Annual Report on Form 10-K. The following discussion contains forward-looking statements that reflect our plans, estimates and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. Factors that could cause or contribute to these differences include those discussed below and elsewhere in this Annual Report on Form 10-K, particularly in the “Risk Factors” Section on pages 10-18 hereof.

OVERVIEW

Our principal business is the development, licensing and protection of our intellectual property assets. We presently own ninety-seven (97) U.S. patents and [eight] foreign patents relating to: (i) our Cox Patent Portfolio relating to enabling technology for identifying media content on the Internet and taking further action to be performed after such identification; (ii) our M2M/IoT Patent Portfolio relating to, among other things, enabling technology for authenticating, provisioning and using embedded Sim (Subscriber Identification Module) technology in next generation IoT, Machine-to-Machine, and other mobile devices, including smartphones, tablets and computers; (iii) our HFT Patent Portfolio covering certain advanced technologies relating to high frequency trading, which inventions specifically address technological problems associated with speed and latency and provide critical latency gains in trading systems where the difference between success and failure may be measured in nanoseconds; (iv) our Mirror Worlds Patent Portfolio relating to foundational technologies that enable unified search and indexing, displaying and archiving of documents in a computer system; and (v) our Remote Power Patent covering the delivery of power over Ethernet (PoE) cables for the purpose of remotely powering network devices, such as wireless access ports, IP phones and network based cameras. In addition, we continually review opportunities to acquire or license additional intellectual property as well as other strategic alternatives.

 

-24- 
 

 

At December 31, 2022, our principal sources of liquidity consisted of cash and cash equivalents and marketable securities of $48,439,000 and working capital of $47,359,000. Based on our cash position, we continually review opportunities to acquire additional intellectual property as well as evaluate other strategic opportunities.

To date we have invested $7,000,000 in ILiAD, a clinical stage biotechnology company with an exclusive license to sixty-four patents. Although in 2022 we recorded gains on our investment in ILiAD as referenced below, our investment continues to involve significant risk and the outcome is uncertain.

We had no revenue for the year ended December 31, 2022. During the year ended December 31, 2022, we recorded a gain on our equity investment in ILiAD of $3,883,000 in accordance with ASC 323 due to an observable transaction price and dilution to our ownership of ILiAD as a result of an ILiAD private offering as well as a gain on conversion of our convertible note from ILiAD of $271,000 in the private offering (see Note B[6] and Note H to our consolidated financial statements included herein).

We have been dependent upon our Remote Power Patent for a significant portion of our revenue. Our Remote Power Patent generated licensing revenue in excess of $187,000,000 from May 2007 through December 31, 2022. We no longer receive licensing revenue for our Remote Power Patent for any period subsequent March 7, 2020 (the expiration date of the patent). During the fourth quarter of 2022, we commenced separate litigation against ten defendants involving our Remote Power Patent for patent infringement for the period prior to March 7, 2020 (see “Legal Proceedings” on page 20 hereof).

In addition, we have pending litigation involving certain patents within our Cox Patent Portfolio and have appealed the judgment of the District Court dismissing our litigation against Meta (Facebook) on the grounds of non-infringement involving certain patents within our Mirror Worlds Portfolio. We also intend to commence efforts to monetize certain patents within our M2M/IoT Patent Portfolio and HFT Patent Portfolio. We may not achieve successful outcomes of such litigation, the appeal, or future litigation involving our patent assets.

Our current strategy includes continuing our licensing efforts with respect to our intellectual property assets and the monetization of our patent portfolios. In addition, we continue to seek to acquire additional intellectual property assets to develop, commercialize, license or otherwise monetize. Our strategy includes working with inventors and patent owners to assist in the development and monetization of their patented technologies. We may also enter into strategic relationships with third parties to develop, commercialize, license or otherwise monetize their intellectual property. Our patent acquisition and development strategy is to focus on acquiring high quality patents which management believes have the potential to generate significant licensing opportunities as we have achieved with respect to our Remote Power Patent and Mirror Worlds Patent Portfolio.

 

 

-25- 
 

 

On March 25, 2022, we completed the acquisition of a new patent portfolio (the HFT Patent Portfolio) currently consisting of nine U.S. patents and two pending U.S. patents (see Note I[2] to our consolidated financial statements included in this Annual Report).

The significant components of expenses impacting our net income include income tax expense as a result of transactions with our equity method investment in ILiAD. Other significant components of expenses impacting our net income when revenue is recorded relate to contingent legal fees and expenses related to our patent litigation (see Note I[1] to our consolidated financial statements included herein) and incentive compensation payable to our Chairman and Chief Executive Officer pursuant to his employment agreement (see Note J to our consolidated financial statements included herein), both such components of expenses are based on a percentage of the licensing revenue received by us as a result of litigation or otherwise.

Our annual and quarterly operating and financial results may fluctuate significantly from period to period as a result of a variety of factors that are outside our control, including the timing and our ability to achieve successful outcomes of our patent litigation, our ability and timing of consummating future license agreements for our intellectual property, and whether we will achieve a return on our investment in ILiAD and the timing of any such return.

Our future operating results may also be materially impacted by our ability to acquire high quality patents which management believes have the potential to generate significant licensing opportunities. In the future, we may not be able to identify or consummate such patent acquisitions or, if consummated, achieve significant licensing revenue with respect to such acquisitions.

In 2023 and future years we could be classified as a Personal Holding Company. If this is the case, we would be subject to a 20% tax on the amount of any undistributed personal holding company income (as defined) for such year that we do not distribute to our shareholders (see Note E to our consolidated financial statements included in this Annual Report).

On June 9, 2021, our Board of Directors approved the continuation of our dividend policy consisting of semi-annual cash dividends of $0.05 per share ($0.10 per share annually) which have been paid in March and September of each year. In 2022 and 2021, we paid semi-annual cash dividends in accordance with our dividend policy. At this time we anticipate continuing to pay dividends consistent with our policy. However, our dividend policy undergoes a periodic review by our Board of Directors and is subject to change at any time depending upon our financial requirements, earnings and other factors existing at the time (see Note O to our consolidated financial statements included herein).

 

 

-26- 
 

 

RESULTS OF OPERATIONS

Year Ended December 31, 2022 Compared to Year Ended December 31, 2021

Revenue. We had no revenue for the year ended December 31, 2022 (“2022”) as compared to revenue of $36,029,000 for the year ended December 31, 2021 (“2021”). Revenue for 2021 resulted from our resolution of a contractual dispute with Cisco concerning licensing of our Remote Power Patent and our litigation settlement with Hewlett-Packard.

Operating Expenses. Operating expenses for 2022 were $3,903,000 as compared to $16,443,000 for 2021.

We had costs of revenue of $-0- and $12,147,000 for 2022 and 2021, respectively. Included in the costs of revenue for 2021 were contingent legal fees of $10,346,000 and incentive bonus compensation of $1,801,000 payable to our Chairman and Chief Executive Officer pursuant to his employment agreement (see Note J[1] to our consolidated financial statements included herein).

Professional fees and related costs were $809,000 for 2022 as compared to $1,500,000 for 2021 as a result of decreased expenses related to patent litigation.

Stock-based compensation was $585,000 for 2022 as compared to $238,000 for 2021. The increase in stock-based compensation expense was due to the issuance of restricted stock units to our Chairman and Chief Executive Officer pursuant to his employment agreement (see Note J[1] to our consolidated financial statements included herein).

Operating (Loss) Income. We had an operating loss of $3,903,000 for 2022 compared with operating income of $19,586,000 for 2021. The operating loss for 2022 was due to no revenue for the period as compared to revenue of $36,029,000 for 2021.

Interest and Dividend Income. Interest and dividend income for 2022 was $1,020,000 as compared to $327,000 for 2021 primarily as a result of a change in the mix of our short term fixed income investments and cash equivalents to higher yielding investments as interest rates were rising in 2022.

Gain on Conversion of Note. For 2022, we recorded a gain on conversion of our ILiAD convertible note of $271,000 as compared to $-0- for 2021 as a result of the conversion of the ILiAD convertible note and accrued interest into equity of ILiAD (see Note H to our consolidated financial statements included herein).

Gain on Equity Method Investment. For 2022, we recorded a gain on our equity method investment in ILiAD of $3,883,000 as compared to $-0- for 2021, as a result of an unrealized gain in connection with ILiAD’s August 2022 private offering, which was accounted for as an observable price transaction (see Note B[6] and Note H to our consolidated financial statements included herein).

 

 

-27- 
 

 

Realized and Unrealized Loss on Marketable Securities. For 2022, we recorded realized and unrealized losses on marketable securities of $1,351,000 as compared to $173,000 for 2021. The increased loss of $1,178,000 was due to unfavorable market conditions in the fixed income mutual funds market in 2022 compared to 2021.

Income Taxes. For 2022, we had $-0- current income tax for federal, state and local income taxes and a deferred tax expense of $607,000. For 2021, we had a current tax expense for federal, state and local income taxes of $2,952,000 and a deferred tax expense of $1,508,000. The net decrease of income tax expense of $3,853,000 was primarily due to no revenue in 2022.

Share of Net Losses of Equity Method Investee. We incurred net losses of $1,639,000 and $999,000 during 2022 and 2021, respectively, related to our equity method investment in ILiAD. The increase of $640,000 in the net losses of ILiAD includes an additional loss of $398,000 as a result of new information received from ILiAD in the fourth quarter of 2022 (see Note B[6] and Note H to our consolidated financial statements included herein).

Net (Loss) Income. As a result of the foregoing, we incurred a net loss of $2,326,000 or $0.10 per share basic and diluted for 2022 compared with net income of $14,281,000 or $0.59 per share basic and $0.58 per share diluted for 2021.  Our net loss for 2022 was due to having no revenue and our continuing operating expenses supporting our patent portfolios, offset by our gain on equity method investment of $3,883,000 and interest and dividend income of $1,020,000. In comparison, we had revenue of $36,029,000 for 2021 from the resolution of our contractual dispute with Cisco and our litigation settlement with Hewlett-Packard.

LIQUIDITY AND CAPITAL RESOURCES

We have financed our operations primarily from revenue from licensing our patents. At December 31, 2022, our principal sources of liquidity consisted of cash and cash equivalents and marketable securities of $48,439,000 and working capital of $47,359,000. Based on our current cash position, we believe that we will have sufficient cash to fund our operations for the next twelve months and the foreseeable future. Material increases in our liquidity and capital resources are primarily dependent upon litigation outcomes and licensing of our intellectual property as well as whether we will be able to achieve returns on our investment in ILiAD.

Working capital decreased by $8,306,000 at December 31, 2022 to $47,359,000 as compared to working capital of $55,665,000 at December 31, 2021.  The decrease in working capital was primarily due to our operating loss of $3,903,000, payment of income taxes of $3,004,000, cash dividends paid of $2,455,000, and an additional investment of $1,000,000 in ILiAD.

 

 

-28- 
 

 

Net cash (used in) provided by operating activities for 2022 decreased by $24,935,000 from $19,499,000 provided by operating activities for 2021 to $5,436,000 used in operating activities for 2022, primarily due to no revenue in 2022 as compared to revenue of $36,029,000 for 2021. In addition, in 2022 we paid $3,004,000 in income taxes related to 2021 taxable income.

Net cash (used in) provided by investing activities during 2022 was $(22,271,000) as compared to $2,994,000 for 2021, primarily as a result of the differential of increased purchases and decreased sales of marketable securities.

Net cash used in financing activities for 2022 and 2021 was $3,342,000 and $3,501,000, respectively. The reduction of $159,000 primarily resulted from repurchases of our common stock of $534,000 for 2022 compared to $1,077,000 of repurchases for 2021 and offset by an increase of $341,000 in the value of shares delivered to fund withholding taxes for 2022.

We maintain our cash in money market funds, government securities, certificates of deposit, and short-term fixed income securities. Accordingly, we do not believe that our investments have significant exposure to interest rate risk.

OFF-BALANCE SHEET ARRANGEMENTS

We do not have any off-balance sheet arrangements.

CONTRACTUAL OBLIGATIONS

We do not have any long-term debt, capital lease obligations, purchase obligations or other long-term liabilities except for our lease obligations for our principal office space (see Note I[4] to our consolidated financial statement included herein).

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

Our discussion and analysis of our financial condition, results of operations and cash flows are based on our audited consolidated financial statements which have been prepared in accordance with GAAP. The preparation of our financial statements included in this Annual Report on Form 10-K requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. The significant estimates and assumptions made in the preparation of our consolidated financial statements include revenue recognition, contingent legal fees and related expenses, income taxes, valuation of patents and equity method investments. Actual results could be materially different from those estimates, upon which the carrying values were based. See also Note B to our consolidated financial statements included in this Annual Report for full disclosure of our accounting policies.

 

 

-29- 
 

 

We believe our most critical accounting policies and estimates to be the following:

Equity Method Investments

Equity method investments are equity securities in entities that we do not control but over which we have the ability to exercise significant influence. These investments are accounted for under the equity method of accounting in accordance with ASC 323, Investments — Equity Method and Joint Ventures (see Note B[6] hereof). Equity method investments are measured at cost minus impairment, if any, plus or minus our share of an investee’s income or loss, and adjustments based on the investees observable price transactions, if any. Our proportionate share of the income or loss from equity method investments is recognized on a one-quarter lag. When our carrying value in an equity method investment is reduced to zero, no further losses are recorded in our financial statements unless we guaranteed obligations of the investee company or have committed additional funding. When the investee company subsequently reports income, we will not record our share of such income until it equals the amount of our share of losses not previously recognized. In the event the equity method investee enters into an observable price transaction, the Company will increase or decrease the carrying value in its equity method investment based on the transaction price. Upon sale of equity method investments, the difference between sales proceeds and the carrying amount of the equity investment is recognized in profit or loss. In determining whether an equity method investment is impaired, we take into consideration a variety of factors including the operating and financial performance of the investee, the investee’s future business plans and projections, discussions with the investee’s management, and our intent and ability to hold the investment until it recovers in value. Accordingly, we make assumptions and estimates in assessing whether an impairment has occurred and if, in the future, our assumptions and estimates made in assessing the fair value of these investments change, this could result in a material decrease in the carrying value of the investment. This would cause us to write-down the carrying value of the investment and could have a material adverse effect on our results of operations in the period the impairment charge is taken.

Income Taxes

We account for income taxes in accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 740, Income Taxes (ASC 740), which requires us to use the assets and liability method of accounting for income taxes. Under the assets and liability method, deferred income taxes are recognized for the tax consequences of temporary (timing) differences by applying enacted statutory tax rates applicable to future years to differences between financial statement carrying amounts and the tax bases of existing assets and liabilities and operating loss and tax credit carry forwards. Under this accounting standard, the effect on deferred income taxes of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recognized if it is more likely than not that some portion, or all, of a deferred tax asset will not be realized. In evaluating the need for a valuation allowance, we estimate future taxable income based on management business plans. This process involves significant management judgment about assumptions that are subject to change from period to period. Because the recognition of deferred tax assets requires management to make significant judgments about future earnings, the periods in which items will impact taxable income and the application of inherently complex tax laws, we have identified the assessment of deferred tax assets and the need for any related valuation allowance as a critical accounting estimate.

 

 

-30- 
 

ITEM 7A.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable.

ITEM 8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

The consolidated financial statements required hereby are located on pages F-1 through F-23 which follow Part III.

ITEM 9.CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

None.

ITEM 9A.CONTROLS AND PROCEDURES

(a)    Evaluation of Disclosure Controls and Procedures

Our Chief Executive Officer and Chief Financial Officer have evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934) as of the end of the period covered by this Annual Report on Form 10-K. Based upon this review, our executive officers concluded that, as of the end of the period covered by this Annual Report on Form 10-K, our disclosure controls and procedures are effective to ensure that information required to be disclosed by us in the reports we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported, within the time periods specified in applicable rules and forms and is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

(b)   Internal Control Over Financial Reporting

(i)       Management’s Annual Report on Internal Control over Financial Reporting

Our management is also responsible for establishing and maintaining adequate “internal control over financial reporting” of the Company, as defined in Rule 13a-15(f) of the Exchange Act.  Internal control over financial reporting is defined as a process designed by, or under the supervision of, the issuer’s principal executive and principal financial officer and effected by the board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the

 

-31- 
 

 

preparation of financial statements for external purposes in accordance with generally accepted accounting principles.  A company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Management, our Chief Executive Officer and Chief Financial Officer, conducted an evaluation of the effectiveness of our internal control over financial reporting as of December 31, 2022 using the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control - Integrated Framework (2013).  Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our internal controls over financial reporting were effective as of the end of the period covered by this report.

(ii)     Attestation Report of Registered Public Accounting Firm

We are a “smaller reporting company” as defined in Rule 12b-2 promulgated under the Securities Exchange Act of 1934, as amended, and as such, are not required to provide the information contained in this sub-section pursuant to Item 308(b) of Regulation S-K. Accordingly, this Annual Report on Form 10-K does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting.

(iii)     Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting that occurred during the fiscal quarter ended December 31, 2022, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

ITEM 9B.OTHER INFORMATION

None.

-32- 
 

 

ITEM 9C.DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS

Not Applicable.

 

PART III

ITEM 10.DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

The following information includes information each director and executive officer has given us about his or her age, all positions he or she holds, his or her principal occupation and business experience for at least the past five years, and the names of other publicly-held companies of which he or she currently serves as a director or has served as a director during the past five years. In addition to the information presented regarding each director’s specific experience, qualifications, attributes and skills that led our Board to the conclusion that he or she should serve as a director, we also believe that all of our directors have a reputation for integrity, honesty and adherence to high ethical standards. They each have demonstrated business acumen, exercise sound judgment, and a commitment of service to Network-1 and our Board.

Information about the number of shares of our common stock beneficially owned by each executive officer and director appears in this Annual Report under the heading “Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters” beginning on page 43 hereof. There are no family relationships among any of our directors and executive officers.

NAME AGE POSITION
Corey M. Horowitz 68 Chairman, Chief Executive Officer and Chairman of the Board of Directors
Jonathan E. Greene 61 Executive Vice President, Secretary and a Director
Robert M. Mahan 56 Chief Financial Officer
Emanuel R. Pearlman 63 Director
Niv Harizman 58 Director
Allison Hoffman 52 Director

 

 

 

 

 

 

-33- 
 

 

Corey M. Horowitz has been our Chairman and Chief Executive Officer since December 2003. Mr. Horowitz has also served as Chairman of our Board of Directors since January 1996 and has been a member of our Board of Directors since April 1994. In December 2018, Mr. Horowitz became a member of the Board of Managers of ILiAD Biotechnologies, LLC, a privately held biotechnology company, in connection with our investment in the company (see “Business-Investment in ILiAD Biotechnologies” at page 9 of this Annual Report). Mr. Horowitz is also a member of the Life Sciences Institute Leadership Council at the University of Michigan. We believe Mr. Horowitz’s qualifications to serve on our Board of Directors include his significant experience and expertise as an executive in the intellectual property field, his understanding of our intellectual property and the patent acquisition, licensing and enforcement business combined with his private equity and corporate transactional experience.

Jonathan E. Greene became our Executive Vice President in October 2013 and our Secretary and a member of our Board of Directors in September 2022. He served as a consultant to the Company from December 2004 until March 2013, providing technical and marketing analysis for our intellectual property portfolio. Mr. Greene became an employee of Network-1 in March 2013. From April 2006 to February 2009, Mr. Greene served as a marketing consultant for Avatier Corporation, a developer of identity management software. From August 2003 until December 2004, he served as a consultant to Neartek, Inc., a storage management software company (August 2003 until October 2003) and Kavado Inc., a security software company (November 2003 until December 2004). We believe Mr. Greene’s qualifications to serve on our Board include his engineering and technical expertise to assist us in our patent acquisition, licensing and enforcement business.

Robert M. Mahan became our Chief Financial Officer in December 2022. Mr. Mahan currently serves as President of Management and Financial Services, Inc., a consulting firm that he founded in 2011 which provides general management, financial and operations consulting services to private and public companies. From May 2021 to February 2022, Mr. Mahan served as Interim Chief Financial Officer of Loft Orbital Solutions, Inc., a space infrastructure company that designs, launches and operates low earth orbit satellites. From April 2019 to May 2021, he served as the Interim Chief Financial Officer of XWELL, Inc., formerly XpresSpa Group, Inc., (NASDAQ: XWEL), a global health and wellness holding company operating XpresCheck®, XpresSpa®, and Treat™ locations in airports. From November 2016 through April 2019, Mr. Mahan served as the Chief Financial Officer of SkyBell Technologies, Inc., a company engaged in the video doorbell and smart home industry. Mr. Mahan began his career in the audit practice of PricewaterhouseCoopers from 1989 through 1992 and as a Controller/Division Chief Financial Officer of Tommy Hilfiger USA, Inc. from 1992 – 2001.

Emanuel R. Pearlman has been a member of our Board of Directors since January 2012, where he serves as Chairman of our Audit Committee and a member of our Nominating and Corporate Governance Committee. Mr. Pearlman currently serves as the Chairman and Chief Executive Officer of Liberation Investment Group, a New York based investment management and financial consulting firm, which he founded in January 2003. In March 2023, Mr. Pearlman became a member of the Board of Directors of QualTek

 

-34- 
 

 

Services Inc. (NASDAQ:QTEK, a leading turnkey provider of infrastructure services to North American 5G wireless, telecom, power grid modernization and renewable energy sectors. Mr. Pearlman also serves as a member of the Special Committee of the Board to review and approve strategic and financial alternatives. In March 2023, Mr. Pearlman also became a member of the Board of Directors of MidCap Financial Investment Corporation (NASDAQ:MFIC), a closed-end externally managed, non-diversified management investment company that has elected to be treated as a business development company. Mr. Pearlman also serves on the Audit, Nominating and Corporate Governance, and Compensation Committee of MidCap Financial Investment Corp. In February 2023, Mr. Pearlman became a member of the Board of Directors of Diebold Nixdorf, Inc. (NYSE: DBD), a multinational financial and retail technology company, and serves as a member of its Finance Committee and the People and Compensation Committee. From March 2022 to April 2022, he was a member of the Board of Directors and Chair of the Strategic Review Committee of Red Box Entertainment, Inc. (NASDAQ:RDBX), an entertainment company that provides consumers access to a large variety of content across digital and physical media. From October 2020 to September 2021, Mr. Pearlman was a member of the Board of Directors of Atlas Crest Investment Corp. (NYSE:ACIC) and during the period February 2021 until June 2022, he served on the Board of Directors of Atlas Crest Investment Corp. II (NYSE:ACII), each entity is a special purpose acquisition company (SPAC). Mr. Pearlman served as Chairman of the Audit Committee and a member of the Compensation Committee and Nomination & Governance Committee of Atlas Crest Investment Corp. until September 2021 and held the same committee positions for Atlas Crest Investment Corp. II until June 2022. Mr. Pearlman served as Executive Chairman of Empire Resorts, Inc. (NASDAQ:NYNY) from June 2016 until November 2019, served as Non-Executive Chairman of the Board from September 2010 through May 2016, and served on the Board of Directors from May 2010 to November 2019. Mr. Pearlman was a member of the Board of Directors of CEVA Logistics, AG (SIX:CEVA) from May 2018 until October 2019 and served on its Audit Committee from May 2018 through October 2019 and its Nomination and Governance Committee from May 2018 through May 2019. We believe Mr. Pearlman’s qualifications to serve on our Board include his significant investment and financial experience and expertise combined with his Board experience.

Niv Harizman has been a member of our Board of Directors since December 2012. Mr. Harizman is a Managing Member of Tyto Capital Partners LLC, a private investment firm specializing in debt and equity investments in middle market companies and special situations, a position he has held since August 2010. Since March 2010, Mr. Harizman has also been the Managing Member of NHK Partners LLC, an entity that makes private investments and provides consulting services. Since November 2013, Mr. Harizman has been affiliated with Riverside Management Group, a merchant banking firm, and BCW Securities LLC, its affiliated broker-dealer.  We believe Mr. Harizman’s qualifications to serve on our Board include his significant investment and financial transactional experience and expertise.

Allison Hoffman has been a member of our Board of Directors since December 2012. Since August 2020, Ms. Hoffman has served as General Counsel of Phreesia, Inc. (NYSE:PHR), a leading provider of software solutions that healthcare organizations use to manage the patient intake process. From January 2016 until August 2020, Ms. Hoffman served as Chief Legal Officer and Chief Administrative Officer at Intersection Parent, Inc., an urban experience company that utilizes technology to make cities better, including bringing free Wi-Fi throughout New York City.  We believe that Ms. Hoffman’s qualifications to serve on our Board include her extensive legal background and transactional experience.

 

 

-35- 
 

Committees of the Board of Directors

Our Board of Directors currently has four standing committees: an Audit Committee; a Compensation Committee; a Nominating and Corporate Governance Committee and a Strategic Development Committee. Each of the Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee has a charter.  These charters are available on our website at: http://ir.Network-1.com/governance-docs. Each member of each committee is an “independent” director under the standards of the NYSE American LLC Company Guide. Three of our current five directors, Emanuel Pearlman, Allison Hoffman and Niv Harizman, are considered independent directors under Rule 803A(2) of the NYSE American LLC Company Guide.

Audit Committee

Our Board of Directors has a separately standing audit committee in accordance with Section 3(a)(58)(A) of the Securities Exchange Act of 1934, as amended, and Section 803B of the NYSE American Company LLC Guide consisting of Emanuel Pearlman (Chairman) and Allison Hoffman. Emanuel Pearlman qualifies as an audit committee financial expert under applicable SEC rules. Mr. Pearlman and Ms. Hoffman qualify as “independent” as independence for audit committee members is defined under Rule 10A-3 under the Securities Exchange Act of 1934, as amended, and Section 803B(2) of the NYSE American LLC Company Guide.

The Audit Committee is appointed by our Board of Directors to provide assistance to the Board in fulfilling its oversight responsibility with respect to, among other things, (i) the integrity of our financial statements, (ii) our compliance with legal and regulatory requirements, (iii) selecting and evaluating the qualifications and independence of our independent registered public accounting firm, (iv) evaluating the performance of our internal audit function and independent registered public accounting firm, and (v) our internal controls and procedures.

Compensation Committee

The Compensation Committee consists of Allison Hoffman (Chair) and Niv Harizman. The Compensation Committee is appointed by our Board of Directors to assist the Board in carrying out its responsibilities relating to compensation of our executive officers and directors.  The Committee has overall responsibility for evaluating and approving the officer and director compensation plans, policies and our programs.

 

 

-36- 
 

 

Nominating and Corporate Governance Committee

Our Board has a Nominating and Corporate Governance Committee consisting of Niv Harizman (Chairman) and Emanuel Pearlman.  The Nominating and Corporate Governance Committee is responsible for, among other things, developing and recommending to the Board a set of corporate governance policies for the Company, establishing criteria for selecting new directors, and identifying, screening and recruiting new directors. The Committee also recommends to the Board nominees for directors and recommends directors for committee membership to the Board.

Strategic Development Committee

We also have a Strategic Development Committee to assist our Chairman and Chief Executive Officer in strategic development and planning of our business relating to identifying potential strategic partners, the acquisition of new IP and other acquisition opportunities.  The Committee also assists in capital markets related activities. Niv Harizman is the sole member of the Strategic Development Committee.

Code of Ethics

We have adopted a Code of Ethics that applies to our executive officers, directors and employees. Copies of the Code of Ethics may be obtained, without charge, upon written request addressed to: Network-1 Technologies, Inc., 65 Locust Avenue, Third Floor, New Canaan, Connecticut 06840, Attn: Chief Executive Officer.

 

 

 

 

 

 

-37- 
 

 

ITEM 11.     EXECUTIVE COMPENSATION

The following table summarizes compensation for the years ended December 31, 2022 and December 31, 2021, awarded to, earned by or paid to our Chief Executive Officer (“CEO”) and to each of our executive officers who received total compensation in excess of $100,000 for the year ended December 31, 2022 for services rendered in all capacities to us (collectively, the “Named Executive Officers”).

Summary Compensation Table

Name and
Principal Position		  Year   Salary ($)   Bonus ($)   Stock
Awards($)(3)		   All Other
Compensation($)(1)		     Total($) 
                              
Corey M. Horowitz  2022   $535,000   $    175,000(2)  $1,102,940   $109,675(4)  $1,922,615 
Chairman and Chief Executive Officer  2021   $535,000   $1,976,000(2)  $—   $38,500(4)  $2,549,500 
                              
David C. Kahn  2022   $175,000   $—   $—   $17,282(5)  $192,282 
Chief Financial Officer  2021   $175,000   $22,500   $—   $29,291(5)  $226,791 
                              
Jonathan Greene  2022   $200,000   $25,000   $41,100(3)  $20,419(6)  $286,519
Executive Vice President  2021   $200,000   $40,000   $—   $36,120(6)  $276,120 

______________________________________________
(1)We have concluded that the aggregate amount of perquisites and other personal benefits paid in 2022 and 2021 to either Mr. Horowitz, Mr. Kahn or Mr. Greene did not exceed $10,000.
(2)Mr. Horowitz received for 2022 an annual discretionary bonus of $175,000. Mr. Horowitz received the following cash incentive bonus payments for 2021: (i) an annual discretionary bonus of $175,000 and (ii) incentive bonus compensation of $1,801,000 pursuant to his employment agreement (see “Employment Agreements – Termination of Employment Agreement and Change in Control Arrangements” below).
(3)The amounts in this column represent the aggregate grant date fair value of restricted stock units awards granted to the Named Executive Officers computed in accordance with FASB ASC Topic 718. In accordance with SEC rules, the grant date fair value of an award that is subject to a performance condition is based on the probable outcome of the performance condition. See Note B[10] to our consolidated financial statements included in this Annual Report for a discussion of the assumptions made by the Company in determining the grant date fair value.
(4)Includes 401(k) matching funds contributions by the Company and profit sharing under the Company's 401(k) Plan for the benefit of Mr. Horowitz of $40,500 for 2022 and $38,500 for 2021, respectively. Also includes dividends (dividend equivalent rights) on restricted stock units owned by Mr. Horowitz for 2022 of $69,175 and 2021 of $-0-.
(5)Includes profit sharing under the Company's 401(k) Plan for the benefit of Mr. Kahn of $17,282 for 2022 and $28,728 for 2021. Also includes dividends (dividend equivalent rights) on restricted stock units owned by Mr. Kahn for 2022 and 2021 of $-0- and $563, respectively. Mr. Kahn retired as Chief Financial Officer of the Company on December 21, 2022.
(6)Represents profit sharing under the Company's 401(k) Plan for the benefit of Mr. Greene of $20,419 for 2022 and $35,201 for 2021. Also includes dividends (dividend equivalent rights) on restricted stock units owned by Mr. Greene for 2022 and 2021 of $-0- and $919, respectively.

 

 

 

-38- 
 

 

Narrative Disclosure to Summary Compensation Table

Employment Agreements, Termination of Employment and Change-In-Control Arrangements

On March 22, 2022, we entered into a new employment agreement (“Agreement”) with Corey M. Horowitz, our Chairman and Chief Executive Officer, pursuant to which he continues to serve as our Chairman and Chief Executive Officer for a four year term (“Term”), at an annual base salary of $535,000 which shall be increased by 3% per annum during the Term. The Agreement established an annual target bonus of $175,000 for our Chairman and Chief Executive Officer based upon performance. For the year ended December 31, 2022 and 2021, our Chairman and Chief Executive Officer received an annual discretionary bonus of $175,000.

In addition, pursuant to the Agreement, we granted to our Chairman and Chief Executive Officer, under our 2013 Plan, 600,000 restricted stock units (the “RSUs”, each RSU awarded by us to our officers, directors and consultants represents a contingent right to receive one share of our common stock) which terms provided for vesting in four tranches, as follows: (1) 175,000 RSUs which shall vest 100,000 RSUs on March 22, 2023 and 75,000 RSUs on March 22, 2024, subject to Mr. Horowitz’s continued employment by us through each such vesting date (the “Employment Condition”) (“Tranche 1”); (2) 150,000 RSUs shall vest if at any time during the Term our common stock achieves a closing price for twenty (20) consecutive trading days (“Closing Price”) of a minimum of $3.50 per share (subject to adjustment for stock splits) and the Employment Condition is satisfied through the date such minimum per share Closing Price is achieved (“Tranche 2”); (3) 150,000 RSUs shall vest if at any time during the Term our common stock achieves a Closing Price of a minimum of $4.00 per share (subject to adjustment for stock splits) and the Employment Condition is satisfied through the date such minimum per share Closing Price is achieved (“Tranche 3”); and (4) 125,000 RSUs shall vest if at any time during the Term, our common stock achieves a Closing Price of a minimum of $4.50 per share (subject to adjustment for stock splits) and the Employment Condition is satisfied through the date such minimum per share Closing Price is achieved (“Tranche 4”).  In the event of a Change of Control (as defined), Termination Other Than for Cause (as defined) or a termination by Mr. Horowitz for Good Reason (as defined) in each case prior to the last day of the Term, the vesting of all RSUs (Tranches 1, 2, 3 and 4) shall accelerate (and not be subject to any conditions) and all RSUs shall become immediately fully vested. All RSUs granted by us to our officers, directors or consultants have dividend equivalent rights.

Under the terms of the Agreement, so long as Mr. Horowitz continues to serve as an executive officer of the Company, whether pursuant to the Agreement or otherwise, Mr. Horowitz shall also receive incentive compensation in an amount equal to 5% of our gross royalties or other payments from Licensing Activities (as defined) (without deduction of legal fees or any other expenses) with respect to our Remote Power Patent and a 10% net interest (gross royalties and other payments after deduction of all legal fees and litigation expenses related to licensing, enforcement and sale activities, but in no event shall he receive less than 6.25% of the gross recovery) of our royalties and other payments relating to Licensing Activities with respect to patents other than our Remote Power Patent (including all of our existing patent portfolios and our investment in ILiAD) (collectively, the “Incentive Compensation”). During the year ended December 31, 2022 and December 31, 2021, Mr. Horowitz earned Incentive Compensation of $-0- and $1,801,000, respectively.

 

 

-39- 
 

The Incentive Compensation shall continue to be paid to Mr. Horowitz for the life of each of our patents with respect to licenses entered into with third parties during the Term or at any time thereafter, whether he is employed by us or not; provided, that, the employment of Mr. Horowitz has not been terminated by us “For Cause” (as defined) or terminated by him without “Good Reason” (as defined). In the event of a merger or sale of substantially all of our assets, we have the option to extinguish the right of Mr. Horowitz to receive future Incentive Compensation by payment to him of a lump sum payment, in an amount equal to the fair market value of such future interest as determined by an independent third party expert if the parties do not reach agreement as to such value. In the event that Mr. Horowitz’s employment is terminated by us “Other Than For Cause” (as defined) or by him for “Good Reason” (as defined), Mr. Horowitz shall also be entitled to (i) a lump sum severance payment of 12 months base salary, (ii) a pro-rated portion of the $175,000 target bonus provided bonus criteria have been satisfied on a pro-rated basis through the calendar quarter in which the termination occurs and (iii) accelerated vesting of all unvested options, RSUs or other awards.

In connection with the Agreement, Mr. Horowitz has also agreed not to compete with us as follows: (i) during the Term and for a period of 12 months thereafter if his employment is terminated “Other Than For Cause” (as defined) provided he is paid his 12 month base salary severance amount and (ii) for a period of two years from the termination date, if terminated “For Cause” by us or “Without Good Reason” by Mr. Horowitz.

Jonathan Greene serves as our Executive Vice President and Secretary on an at-will basis at an annual base salary of $200,000. Mr. Greene received a discretionary annual bonus of $25,000 for 2022 and $40,000 in 2021. On December 29, 2020, Mr. Greene was granted 10,000 RSUs under the 2013 Plan, 50% of such RSUs vested on the one year anniversary of the date of grant (December 29, 2021) and 50% of such RSUs vested on the two year anniversary of the grant (December 29, 2022). On January 18, 2022, Mr. Greene was granted 15,000 RSUs under the 2022 Plan, 50% of such RSUs vested on the one year anniversary of the date of grant (January 18, 2023) and 50% of such RSUs vest on the two year anniversary of the grant (January 18, 2024), subject to Mr. Greene’s continued employment.

David Kahn served as our Chief Financial Officer on an at-will basis at an annual base salary of $175,000, until his retirement in December 2022. On December 29, 2020, Mr. Kahn was granted 7,500 RSUs under the 2013 Plan, 50% of such RSUs vested on the one year anniversary of the grant (December 29, 2021) and 50% of such RSUs vested on the two year anniversary of the grant (December 29, 2022). In connection with his retirement, Mr. Kahn was granted severance of six months base salary and certain other benefits.

 

 

-40- 
 

 

Robert Mahan serves as our Chief Financial Officer as of December 21, 2022 on a consulting basis at an annual compensation of $175,000.

Profit Sharing 401(k) Plan

We offer all employees who have completed a year of service (as defined) participation in a 401(k) retirement savings plan, which provides a tax-advantaged method of saving for retirement. We expensed matching contributions and profit sharing of $78,000 and $102,000 under the 401(k) plan for the years ended December 31, 2022 and 2021, respectively.

Director Compensation

In 2022, we compensated each non-management director of our Company by granting to each such outside director 15,000 RSUs. The RSUs vested in equal amounts of 3,750 RSUs on each of March 15, 2022, June 15, 2022, September 15, 2022 and December 15, 2022. In addition, we pay our non-management directors cash director fees of $40,000 per annum ($10,000 per quarter). Non-management directors also receive additional cash compensation on an annual basis for serving on the following Board committees: The Audit Committee Chairperson receives $7,500 and members receive $5,000; the Chairperson and members of each of the Compensation Committee and Nominating and Corporate Governance Committee receive annual fees of $3,750 and $2,500, respectively.

The following table sets forth the compensation awarded to, earned by or paid to all persons who served as members of our Board of Directors (other than our Named Executive Officers) during the year ended December 31, 2022. No director who is also a Named Executive Officer received any compensation for services as a director in 2022.

Name

  

Fees earned or
paid in cash ($)(1)

  

Stock Awards

($)(2) (3)

  

All other
compensation ($)(4)

  

Total

($)

Emanuel Pearlman   $50,000   $38,250   $1,125   $89,375
Niv Harizman   $46,250   $38,250   $   725   $85,250
Allison Hoffman   $48,185   $38,250   $1,125   $87,560

___________________________

(1)Represents directors’ fees payable in cash to each non-management director of $10,000 per quarter ($40,000 per annum) for 2022 plus additional cash fees for serving on Board committees as disclosed above.
(2)The amounts included in this column represent the grant date fair value of restricted stock unit awards (RSUs) granted to directors, computed in accordance with FASB ASC Topic 718. For a discussion of valuation assumptions see Note B[10] to our consolidated financial statements included in this Annual Report. The 15,000 RSUs granted to each non-management director vested on a quarterly basis beginning March 15, 2022. Each restricted stock unit represents the contingent right to receive one share of common stock.
(3)As of December 31, 2022, no stock options were owned by any of the above listed directors.
(4)Includes payment of dividends (dividend equivalent rights) on RSUs for 2022.

 

 

-41- 
 

 

Outstanding Equity Awards at December 31, 2022

The following table sets forth information relating to outstanding equity awards consisting of unvested restricted stock units for each Named Executive Officer as of December 31, 2022 (there were no outstanding stock options):

 

Option Awards

Stock Awards

Name

 
Number of Securities
Underlying Unexercised
Options

Option Exercise
Price ($)

Option Expiration
Date

Equity incentive plan awards: Number of unearned shares, units or other rights that have not vested

Equity incentive plan awards: Market value of unearned shares, units or other rights that have not vested(1) ($)



Exercisable

Unexercisable

Corey M. Horowitz

Chairman and CEO

 

—

 

—

 

—

 

—

 

 600,000(2) $1,320,000

Jonathan Greene

Executive Vice President

—

 

 —

—

 

—

 

 15,000(3) $33,000

________________________________

(1)In accordance with SEC rules, market value is based on $2.20 per share representing the closing price of our common stock on the last trading day of the year.
(2)Represents 600,000 restricted stock units, the terms of the vesting of such restricted stock units are disclosed on page 39 under “Employment Agreements - Termination of Employment and Change-In-Control Arrangements.”
(3)Represents 15,000 restricted stock units, which vested 7,500 restricted stock units on January 18, 2023 and will vest 7,500 restricted stock units on January 18, 2024, subject to Mr. Greene’s continued employment.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-42- 
 

 

ITEM 12.SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

The following table sets forth information regarding the beneficial ownership of our common stock as of March 10, 2023 for (i) each of our directors, (ii) each of our executive officers, (iii) each person known by us to be the beneficial owner of more than 5% of our outstanding shares of common stock, and (iv) all of our executive officers and directors as a group.

NAME AND ADDRESS OF BENEFICIAL OWNER   AMOUNT AND NATURE OF BENEFICIAL OWNERSHIP (1)(2)     PERCENTAGE
OF COMMON STOCK BENEFICIALLY OWNED(2)		  
Executive Officers and Directors: Corey M. Horowitz(3)     6,782,292       28.4%  
CMH Capital Management Corp.(4)     2,291,372       9.6%  
Niv Harizman(5)     290,985       1.2%  
Emanuel Pearlman(6)     117,059       *  
Jonathan E. Greene(7)     93,945       *  
Allison Hoffman(8)     79,311       *  
Robert Mahan     —       —  
All officers and directors as a group
(6 Persons)		     7,363,592       30.8%  
5% Stockholders:                
Steven D. Heinemann(9)     2,052,769       8.6%  
Goose Hill Capital LLC(10)     1,467,636       6.2%  

_____________________________________

 

* Less than 1%.

(1)Unless otherwise indicated, we believe that all persons named in the above table have sole voting and investment power with respect to all shares of our common stock beneficially owned by them. Unless otherwise indicated the address for each listed beneficial owner is c/o Network-1 Technologies, Inc., 65 Locust Avenue, Third Floor, New Canaan, Connecticut 06840.
(2)A person is deemed to be the beneficial owner of shares of common stock that can be acquired by such person within 60 days from March 10, 2023 upon the exercise of stock options or restricted stock units that vest within such 60 day period. Each beneficial owner's percentage ownership is determined by assuming that all stock options and restricted stock units held by such person (but not those held by any other person) and which are exercisable or vest within 60 days from March 10, 2023 have been exercised or vested.  Assumes a base of 23,790,005 shares of our common stock outstanding as of March 10, 2023.

 

 

-43- 
 

 

(3)Includes (i) 3,868,909 shares of common stock owned by Mr. Horowitz, (ii) 100,000 shares of common stock subject to restricted stock units that vest within 60 days of March 10, 2023 (iii) 2,157,097 shares of common stock held by CMH Capital Management Corp., an entity solely owned by Mr. Horowitz, (iv) 134,275 shares of common stock owned by the CMH Capital Management Corp. Profit Sharing Plan, of which Mr. Horowitz is the trustee, (v) 67,470 shares of common stock owned by Donna Slavitt, the wife of Mr. Horowitz, (vi) an aggregate of 452,250 shares of common stock held by two trusts and a custodian account for the benefit of Mr. Horowitz’s three children, and (vii) 2,291 shares of common stock held by Horowitz Partners, a general partnership of which Mr. Horowitz is a partner. Does not include 500,000 restricted stock units owned by Mr. Horowitz that do not vest within 60 days of March 10, 2023.
(4)Includes 2,157,097 shares of common stock owned by CMH Capital Management Corp. and 134,275 shares of common stock owned by CMH Capital Management Corp. Profit Sharing Plan.  Corey M. Horowitz, by virtue of being the sole officer, director and shareholder of CMH Capital Management Corp. and the trustee of the CMH Capital Management Corp. Profit Sharing Plan, has the sole power to vote and dispose of the shares of common stock owned by CMH Capital Management Corp. and the CMH Capital Management Corp. Profit Sharing Plan.
(5)Includes (i) 287,235 shares of common stock and (ii) 3,750 shares of common stock subject to restricted stock units that vest within 60 days of March 10, 2023. Does not include 11,250 shares of common stock subject to restricted stock units owned by Mr. Harizman that do not vest within 60 days from March 10, 2023.
(6)Includes (i) 113,309 shares of common stock and (ii) 3,750 shares of common stock subject to restricted stock units that vest within 60 days of March 10, 2023. Does not include 11,250 shares of common stock subject to restricted stock units owned by Mr. Pearlman that do not vest within 60 days from March 10, 2023.
(7)Includes 93,945 shares of common stock.  Does not include 22,500 shares of common stock subject to restricted stock units owned by Mr. Greene that do not vest within 60 days from March 10, 2023.
(8)Includes (i) 75,561 shares of common stock and (ii) 3,750 shares of common stock subject to restricted stock units that vest within 60 days of March 10, 2023. Does not include 11,250 shares of common stock subject to restricted stock units owned by Ms. Hoffman that do not vest within 60 days from March 10, 2023.
(9)Includes 585,133 shares of common stock owned by Mr. Heinemann and 1,467,636 shares of common stock owned by Goose Hill Capital LLC. Goose Hill Capital LLC is a limited liability company of which Mr. Heinemann is the sole member. Mr. Heinemann, by virtue of being the sole member of Goose Hill Capital LLC, has the sole power to vote and dispose of the shares of common stock owned by Goose Hill Capital LLC. The aforementioned beneficial ownership is based upon Amendment No. 10 to Schedule 13G filed by Mr. Heinemann with the SEC on February 14, 2023.  The address for Mr. Heinemann is c/o Goose Hill Capital, LLC, 12378 Indian Road, North Palm Beach, Florida 33408.

(10)Includes 1,467,636 shares of common stock. Steven D. Heinemann, by virtue of being the sole member of Goose Hill Capital LLC, has the sole power to vote and dispose of the shares of common stock owned by Goose Hill Capital LLC. The aforementioned beneficial ownership is based upon Amendment No. 10 to Schedule 13G filed by Mr. Heinemann with the SEC on February 14, 2023. The address for Goose Hill Capital LLC is 12378 Indian Road, North Palm Beach, Florida 33408.

 

 

 

-44- 
 

 

ITEM 13.CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE

On June 1, 2022, we repurchased from Allison Hoffman, a director of the Company, 41,500 shares of its common stock at a purchase price of $2.42 per share for an aggregate purchase price of $100,430.

Review, Approval or Ratification of Transactions with Related Persons

The Audit Committee has responsibility for reviewing and approving related-persons transactions in accordance with its charter. A related person is any executive officer, director, nominee for director or more than 5% stockholder of the Company, including immediate family members, and any entity owned or controlled by such persons. In addition, pursuant to our Code of Ethics, all of our officers, directors and employees are to avoid conflicts of interest and to refrain from taking part or exercising influence in any transaction in which such party’s personal interest may conflict with the best interest of the Company.  Except for provisions of the Audit Committee Charter, there are no written procedures governing review of related-persons transactions.

Director Independence

Three of our five directors, Emanuel Pearlman, Niv Harizman and Allison Hoffman, are considered independent directors in compliance with the standard of independence in Section 803A(2) of the NYSE American LLC Company Guide. 

ITEM 14.PRINCIPAL ACCOUNTANT FEES AND SERVICES

Audit Fees

Marcum LLP, our independent registered public accounting firm as of October 11, 2022, billed us aggregate fees of $103,200 for the year ended December 31, 2022, for the audit of our annual financial statements, review of our financial statements included in our Form 10-Q for the three months ended September 30, 2022 and for other services in connection with statutory or regulatory filings. Friedman LLP, our independent registered public accounting firm until October 11, 2022, billed us aggregate fees of $48,832 and $135,535 for the years ended December 31, 2022 and 2021, respectively, for the audit of our financial statements for 2021, review of our financial statements included in our Form 10-Qs and for other services in connection with statutory and regulatory filings.

Tax Fees and Other Fees

Marcum LLP provided various tax and compliance services for which it billed us $30,320 for the year ended December 31, 2022. Friedman LLP provided various tax and compliance services for which it billed us $3,271 and $22,890, respectively, for the years ended December 31, 2022 and December 31, 2021 which included preparation of our tax returns. Marcum LLP and Friedman LLP did not render any other professional services other than those discussed above for 2022.

Audit Committee Pre-Approval Policies and Procedures

Our audit committee charter provides that our audit committee must comply with SEC rules to maintain auditor independence as set forth in Rule 2-01(c)(7)(i) of Regulation S-X. The Audit Committee has a policy to pre-approve all audit and permissible non-audit services to be provided by our independent registered public accounting firm. All the services above were approved in advance by our Board of Directors. 

 

-45- 
 

NETWORK-1 TECHNOLOGIES, INC.

 

 

 

 

 

   
 

Index to Consolidated Financial Statements

 Page
   
Reports of Independent Registered Public Accounting Firms (PCAOB Firm ID 688 and 711) F-1
   
Consolidated Balance Sheets as of December 31, 2022 and 2021 F-3
   
Consolidated Statements of Operations and Comprehensive Income (Loss) for the years ended December 31, 2022 and 2021 F-4
   
Consolidated Statements of Changes in Stockholders' Equity for the years ended December 31, 2022 and 2021 F-5
   
Consolidated Statements of Cash Flows for the years ended December 31, 2022 and 2021 F-6
   
Notes to Consolidated Financial Statements F-7
   

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-46- 
 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

 

To the Shareholders and Board of Directors of

Network-1 Technologies, Inc

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheet of Network-1 Technologies, Inc. (the “Company”) as of December 31, 2022, the related consolidated statements of operations and comprehensive (loss), changes in stockholders’ equity, and cash flows for the year ended December 31, 2022, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022, and the results of its operations and its cash flows for the year ended December 31, 2022 in conformity with accounting principles generally accepted in the United States of America.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company’s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.

 

 

Critical Audit Matters

 

Critical audit matters are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. We determined that there are no critical audit matters.

 

 

/s/ Marcum llp

 

Marcum LLP

 

We have served as the Company’s auditor since 2014 (such date takes into account the acquisition of certain assets of Friedman LLP by Marcum LLP effective September 1, 2022)

 

 

New York, New York
March 30, 2023

 

 

 

 

 

 

 

 

 

F-1

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

 

To the Board of Directors and Stockholders

Network-1 Technologies, Inc.

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheet of Network-1 Technologies, Inc. and Subsidiary (the “Company”) as of December 31, 2021, and the related consolidated statements of operations and comprehensive income, changes in stockholders’ equity and cash flows for the year ended December 31, 2021, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021, and the results of its operations and its cash flows for the year ended December 31, 2021, in conformity with accounting principles generally accepted in the United States of America.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.

 

 

/s/ Friedman LLP

 

 

We have served as the Company’s auditor from 2014 to 2022.

 

 

New York, New York
March 30, 2022

 

 

 

 

F-2

 

NETWORK-1 TECHNOLOGIES, INC.

 

CONSOLIDATED BALANCE SHEETS

           
  

December 31,

 
  

2022

  

2021

 
ASSETS:        
           
CURRENT ASSETS:          
Cash and cash equivalents  $13,448,000   $44,497,000 
Marketable securities, at fair value   34,991,000    15,126,000 
Prepaid taxes   177,000    — 
Other current assets   348,000    150,000 
           
Total Current Assets   48,964,000    59,773,000 
           
OTHER ASSETS:          
Patents, net of accumulated amortization   1,592,000    1,384,000 
Equity investment   7,252,000    2,651,000 
Convertible note investment   —    1,000,000 
Operating leases right of use asset   161,000    — 
Security deposits   —    13,000 
           
Total Other Assets   9,005,000    5,048,000 
           
TOTAL ASSETS  $57,969,000   $64,821,000 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY:          
           
CURRENT LIABILITIES:          
Accounts payable  $507,000   $459,000 
Income taxes payable   115,000    2,952,000 
Accrued contingency fees and related costs   —    137,000 
Accrued payroll   317,000    380,000 
Other accrued expenses   587,000    180,000 
Operating lease obligations, current   79,000    — 
           
Total Current Liabilities   1,605,000    4,108,000 
           
LONG TERM LIABILITIES:          
Deferred tax liability   1,161,000    554,000 
Operating lease obligation, non-current   94,000    — 
           
TOTAL LIABILITIES  $2,860,000   $4,662,000 
           
COMMITMENTS AND CONTINGENCIES (See Note I)          
           
STOCKHOLDERS' EQUITY          
           

Preferred stock, $0.01 par value; authorized 10,000,000 shares;

none issued and outstanding at December 31, 2022 and December 31, 2021

   —    — 

Common stock, $0.01 par value; authorized 50,000,000 shares;

23,863,639 and 23,792,212 shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively

   239,000    238,000 
           
Additional paid-in capital   66,939,000    66,361,000 
Accumulated deficit   (12,055,000)   (6,428,000)
Accumulated other comprehensive loss   (14,000)   (12,000)
           
TOTAL STOCKHOLDERS’ EQUITY   55,109,000    60,159,000 

 

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

  $57,969,000   $64,821,000 

 

The accompanying notes are an integral part of the consolidated financial statements 

F-3

 

NETWORK-1 TECHNOLOGIES, INC.

 

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

 

 

           
  

Years Ended
December 31,

 
  

2022

  

2021

 
REVENUE  $—   $36,029,000 
           
OPERATING EXPENSES:          
Costs of revenue   —    12,147,000 
Professional fees and related costs   809,000    1,500,000 
General and administrative   2,778,000    2,501,000 
Amortization of patents   316,000    295,000 
           
TOTAL OPERATING EXPENSES   3,903,000    16,443,000 
           
OPERATING INCOME (LOSS)   (3,903,000)   19,586,000 

 

OTHER INCOME

          
Interest and dividend income, net   1,020,000    327,000 
Gain on conversion of note   271,000    — 
Gain on equity method investment   3,883,000    — 
Net realized and unrealized loss on marketable securities   (1,351,000)   (173,000)
Total other income, net   3,823,000    154,000 
           
(LOSS) INCOME BEFORE INCOME TAXES AND SHARE OF NET LOSSES OF EQUITY METHOD INVESTEE   (80,000)   19,740,000 
           
INCOME TAXES PROVISION:          
Current   —    2,952,000 
Deferred taxes, net   607,000    1,508,000 
Total income taxes expense   607,000    4,460,000 
           

(LOSS) INCOME BEFORE SHARE OF NET LOSSES OF

EQUITY METHOD INVESTEE:

   (687,000)   15,280,000 
           
SHARE OF NET LOSSES OF EQUITY METHOD INVESTEE    (1,639,000)    (999,000)
           
NET (LOSS) INCOME  $(2,326,000)  $14,281,000 
           
Net (Loss) Income Per Share:          
Basic  $(0.10)  $0.59 
Diluted  $(0.10)  $0.58 
           
Weighted average common shares outstanding:          
Basic   23,825,917    24,136,821 
Diluted   23,825,917    24,530,568 
           
Cash dividends declared per share  $0.10   $0.10 
           
NET (LOSS) INCOME  $(2,326,000)  $14,281,000 
           
OTHER COMPREHENSIVE LOSS          
Net unrealized holding loss on corporate bonds and notes
arising during the year, net of tax		   (2,000)   (2,000)
           
COMPREHENSIVE (LOSS) INCOME  $(2,328,000)  $14,279,000 

 

 

 

 

The accompanying notes are an integral part of the consolidated financial statements 

F-4

 

NETWORK-1 TECHNOLOGIES, INC.

 

 CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

 

 

 

                               
   Common Stock                Total Stockholders’ Equity 
   Shares   Amount   Additional Paid-in Capital   Accumulated Deficit   Accumulated Other Comprehensive (Loss)  

Total

Stockholders’ Equity

 
                               
Balance – January 1, 2021   24,105,879   $241,000   $66,124,000   $(17,193,000)  $(10,000)  $49,162,000 
Dividends and dividend equivalents declared   —    —    —    (2,429,000)   —    (2,429,000)
Stock-based compensation   —    —    238,000    —    —    238,000 
Vesting of restricted stock units   70,000    1,000    (1,000)   —    —    — 
Value of shares delivered to pay withholding taxes   (5,192)   —    —    (14,000)   —    (14,000)
Treasury stock purchased and retired   (378,475)   (4,000)   —    (1,073,000)   —    (1,077,000)
Net unrealized loss on corporate bonds and notes   —    —    —    —    (2,000)   (2,000)
Net income   —    —    —    14,281,000    —    14,281,000 
Balance – December 31, 2021   23,792,212   $238,000   $66,361,000   $(6,428,000)  $(12,000)  $60,159,000 
Dividends and dividend equivalents declared   —    —    —    (2,418,000)   —    (2,418,000)
Stock-based compensation   —    —    585,000    —    —    585,000 
Vesting of restricted stock units   182,500    2,000    (2,000)   —    —    — 
Cashless exercise of stock options   500,000    5,000    (5,000)   —    —    — 
Value of shares delivered to pay exercise price and withholding taxes   (382,543)   (3,000)   —    (352,000)   —    (355,000)
Treasury stock purchased and retired   (228,530)   (3,000)   —    (531,000)   —    (534,000)
Net unrealized loss on corporate bonds and notes   —    —    —    —    (2,000)   (2,000)
Net loss                   —                   —                        —    (2,326,000)                     —    (2,326,000)
Balance – December 31, 2022   23,863,639   $239,000   $66,939,000   $(12,055,000)  $(14,000)  $55,109,000 

 

 

 

 

 

 

 

The accompanying notes are an integral part of the consolidated financial statements

F-5

 

NETWORK-1 TECHNOLOGIES, INC.

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

           
   Years Ended
              December 31,             		 
   2022   2021 
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net (loss) income  $(2,326,000)  $14,281,000 

Adjustments to reconcile net (loss) income to net cash
used in operating activities:

          
Amortization of patents   316,000    295,000 
Stock-based compensation   585,000    238,000 
Loss allocated from equity investment   1,639,000    999,000 
Deferred tax expense   607,000    1,508,000 
Amortization of right of use asset, net   43,000    — 
Gain on equity method investment   (3,883,000)   — 
Accrued interest on convertible note   (86,000)   — 
Gain on conversion of note   (271,000)   — 
Unrealized loss on marketable securities   880,000    148,000 
Changes in operating assets and liabilities:          
Other current assets   (208,000)   (30,000)
Prepaid taxes   (167,000)   — 
Accounts payable   48,000    (142,000)
Income taxes payable   (2,837,000)   2,952,000 
Security deposit   13,000    8,000 
Operating lease obligations   (31,000)   — 
Accrued expenses   242,000    (758,000)
           
NET CASH (USED IN) PROVIDED BY OPERATING ACTIVITIES   (5,436,000)   19,499,000 
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
Sales of marketable securities   13,156,000    17,154,000 
Purchases of marketable securities   (33,903,000)   (13,059,000)
Development of patents   (524,000)   (101,000)
Equity Investment   (1,000,000)   — 
Convertible note investment   —    (1,000,000)
           
NET CASH (USED IN) PROVIDED BY INVESTING ACTIVITIES   (22,271,000)   2,994,000 
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Cash dividends paid   (2,453,000)   (2,410,000)
Value of shares delivered to fund withholding taxes   (355,000)   (14,000)
Repurchases of common stock, inclusive of commissions   (534,000)   (1,077,000)
           
NET CASH USED IN FINANCING ACTIVITIES   (3,342,000)   (3,501,000)
           
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS   (31,049,000)   18,992,000 
           
CASH AND CASH EQUIVALENTS, beginning of year   44,497,000    25,505,000 
           
CASH AND CASH EQUIVALENTS, end of year  $13,448,000   $44,497,000 
           
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:          
Cash paid during the years for:          
Interest  $     —   $— 
Income taxes  $3,004,000   $— 
           
NON-CASH FINANCING ACTIVITY          
Accrued dividend rights on restricted stock units  $37,000   $20,000 
Right of use asset obtained in exchange for lease liability  $204,000    — 
Conversion of note receivable  $1,086,000    — 

 

 

The accompanying notes are an integral part of the consolidated financial statements

F-6

 

NETWORK-1 TECHNOLOGIES, INC. 

 

 

 

 

Note A – Business

 

Network-1 Technologies, Inc. (the “Company”) is engaged in the development, licensing and protection of its intellectual property assets. The Company presently owns ninety-seven (97) U.S. patents, fifty-two (52) of such patents have expired, and eight (8) foreign patents related to (i) the Cox patent portfolio (the “Cox Patent Portfolio) relating to enabling technology for identifying media content on the Internet and taking further actions to be performed after such identification; (ii) the M2M/IoT patent portfolio (the “M2M/IoT Patent Portfolio”) relating to, among other things, enabling technology for authenticating, provisioning and using embedded SIM (Subscriber Identification Module)technology in next generation IoT, Machine-to-Machine, and other mobile devices, including smartphones, tablets and computers; (iii) the HFT patent portfolio (the “HFT Patent Portfolio”) covering certain advanced technologies relating to high frequency trading, which inventions specifically address technological problems associated with speed and latency and provide critical latency gains in trading systems where the difference between success and failure may be measured in nanoseconds; (iv) the Mirror Worlds patent portfolio (the “Mirror Worlds Patent Portfolio”) relating to foundational technologies that enable unified search and indexing, displaying and archiving of documents in a computer system; and (v) the remote power patent (the “Remote Power Patent”) covering delivery of Power over Ethernet (PoE) cables for the purpose of remotely powering network devices, such as wireless access ports, IP phones and network based cameras.

The Company’s current strategy includes continuing to pursue licensing opportunities for its intellectual property assets. In addition, the Company continually reviews opportunities to acquire or license additional intellectual property as well as other strategic alternatives. The Company’s patent acquisition and development strategy is to focus on acquiring high quality patents which management believes have the potential to generate significant licensing opportunities as the Company has achieved with respect to its Remote Power Patent and Mirror Worlds Patent Portfolio. In addition, the Company may also enter into strategic relationships with third parties to develop, commercialize, license or otherwise monetize their intellectual property.

The Company has made equity investments totaling $7,000,000 in ILiAD Biotechnologies, LLC (“ILiAD”), a clinical stage biotechnology company (see Note H hereof).

Note B – Summary of Significant Accounting Policies

 

[1]Principles of Consolidation

The Company’s consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The accompanying financial statements include the accounts of the Company and its wholly-owned subsidiaries, Mirror Worlds Technologies, LLC and HFT Solutions, LLC. All intercompany transactions and balances are eliminated in consolidation.

 

[2]Use of Estimates and Assumptions

The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods. The significant estimates and assumptions made in the preparation of the Company’s consolidated financial statements primarily include costs related to the Company’s assertion of litigation, the valuation of the Company’s patent portfolios, stock-based compensation, the recoverability of deferred tax assets and carrying value of the Company’s equity method investments. Actual results could be materially different from those estimates, upon which the carrying values were based.

Certain amounts recorded to reflect the Company’s share of income or losses of its equity method investee, accounted for under the equity method, are based on estimates and the unaudited results of operations of the equity method investee and may require adjustment in the future when the audit is complete. The Company reports its share of the results of its equity method investee on a one quarter lag basis.

 

 

F-7

 

NETWORK-1 TECHNOLOGIES, INC. 

 

 

 

 

Note B – Summary of Significant Accounting Policies (continued)

 

[3]Cash and Cash Equivalents

The Company maintains cash deposits in high quality financial institutions insured by the Federal Deposit Insurance Corporation ("FDIC"). Accounts at each institution are insured by the FDIC up to $250,000. At December 31, 2022 and 2021, the Company had $1,715,000 and $8,109,000, respectively, in excess of the FDIC insured limit.

 

The Company considers all highly liquid short-term investments, including certificates of deposit and money market funds, that are purchased with an original maturity of three months or less to be cash equivalents.

 

[4]Marketable Securities

 

The Company’s marketable securities are comprised of certificates of deposit with original maturity greater than three months from date of purchase, government securities, fixed income mutual funds, and a corporate bond (see Note G). At December 31, 2022 and December 31, 2021, included in marketable securities, the Company had aggregate certificates of deposit of $2,976,000 and $0, respectively. The Company’s marketable securities are measured at fair value and are accounted for in accordance with ASU 2016-01. Unrealized holding gains and losses on certificates of deposit, government securities, and fixed income mutual funds are recorded in net realized and unrealized gain (loss) from investments on the consolidated statements of operations and comprehensive income (loss). Unrealized holding gains and losses, net of the related tax effect, on corporate bonds and notes are excluded from earnings and are reported as a separate component of stockholders’ equity until realized. Dividend and interest income are recognized when earned. Realized gains and losses are included in earnings and are derived using the specific identification method for determining the cost of the marketable securities.

 

[5]Revenue Recognition

 

Under ASC 606, revenue is recognized when the Company completes the licensing of its intellectual property to its licensees, in an amount that reflects the consideration the Company expects to be entitled to in exchange for licensing its intellectual property.

 

The Company determines revenue recognition through the follow steps:

 

•identification of the license agreement;
•identification of the performance obligations in the license agreement;
•determination of the consideration for the license;
•allocation of the transaction price to the performance obligations in the contract; and
•recognition of revenue when the Company satisfies its performance obligations.

Revenue disaggregated by source is as follows (the Company had no revenue for the year ended December 31, 2022):

          
   Years Ended December 31, 
   2022   2021 
Fully-Paid Licenses  $—   $17,000,000(1)
Royalty Bearing Licenses   —    19,029,000(2)
Total Revenue  $—   $36,029,000 

__________________________

(1)Includes $17,000,000 received from Hewlett-Packard related to settlement of a patent litigation (see Note K[1] hereof).
(2)Includes (1) $18,691,890 of royalty revenue from Cisco Systems, Inc. from resolution of a dispute under its license agreement with the Company and (2) $337,000 of royalty revenue received from Plantronics, Inc.

 

F-8

 

NETWORK-1 TECHNOLOGIES, INC.

 

 

 

 

Note B – Summary of Significant Accounting Policies (continued)

Revenue from the Company’s patent licensing business is typically generated from negotiated license agreements. The timing and amount of revenue recognized from each licensee depends upon a variety of factors, including the terms of each agreement and the nature of the obligations of the parties. These agreements may include, but not be limited to, elements related to past infringement liabilities, non-refundable upfront license fees, and ongoing royalties on licensed products sold by the licensee. Generally, in the event of settlement of litigation related to the Company’s assertion of patent infringement involving its intellectual property, defendants will either pay (i) a non-refundable lump sum payment for a non-exclusive fully-paid license, or (ii) a non-refundable lump sum payment (license initiation fee) together with an ongoing obligation to pay quarterly or monthly royalties to the Company for the life of the licensed patent.

 

[6]Equity Method Investments

Equity method investments are equity securities in entities the Company does not control but over which it has the ability to exercise significant influence. These investments are accounted for under the equity method of accounting in accordance with ASC 323, Investments — Equity Method and Joint Ventures (see Note H hereof). Equity method investments are measured at cost minus impairment, if any, plus or minus the Company’s share of an investee’s income or loss. The Company’s proportionate share of the income or loss from equity method investments is recognized on a one-quarter lag. When the Company’s carrying value in an equity method investment is reduced to zero, no further losses are recorded in the Company’s financial statements unless the Company guaranteed obligations of the investee company or has committed additional funding. When the investee company subsequently reports income, the Company will not record its share of such income until it equals the amount of its share of losses not previously recognized.

Upon a sale of an equity method investment by the Company, the difference between sales proceeds and the carrying amount of the equity investment is recognized in profit or loss. Upon the issuance of securities in an observable price transaction, the Company will account for the share issuance by the equity method investee as if the Company had sold a proportionate share of its investment in the observable price transaction. The Company will record a gain or loss associated with the dilution of its investment to reflect third party investments in the investee and will increase or decrease its basis in the equity method investee accordingly. The gain or loss is recorded within other income or expense in the Company’s consolidated statements of operations and comprehensive income (loss).

During the year ended December 31, 2022, the Company recorded a change in its share of net losses of the equity method investee as a result of the Company receiving new information from the equity method investee during the fourth quarter of 2022. The effect of this change was an increase in the Company’s share of the net losses of the equity method investee of $398,000 and a corresponding decrease in the Company’s net income, and a decrease in basic and diluted earnings of $0.02 per share.

The Company performed an assessment to determine significance of the equity method investee under the investment, asset and income tests utilizing the 20% threshold. The Company determined that the equity method investee satisfied the income test and has included summarized financial data of the equity method investee in Note H hereof.

 

[7]Patents

The Company owns patents that relate to various technologies. The Company capitalizes the costs associated with acquisition, registration and maintenance of its acquired patents and amortizes these assets over their remaining useful lives on a straight-line basis. Any further payments made to maintain or develop the patents would be capitalized and amortized over the balance of the useful life for the patents.

[8]Costs of Revenue and Related Costs

The Company includes in costs of revenue for the year ended December 31, 2022 and 2021 contingent legal fees payable to patent litigation counsel, any other contractual payments to third parties related to net proceeds from monetization of patents (see Note I[1] hereof) and incentive bonus compensation payable to its Chairman and Chief Executive Officer (see Note J[1] hereof).

 

 

 

F-9

 

NETWORK-1 TECHNOLOGIES, INC.

 

 

 

 

Note B – Summary of Significant Accounting Policies (continued)

 

[9]Income Taxes

The Company accounts for income taxes in accordance with Financial Accounting Standards Board (FASB) ASC Topic 740, Income Taxes (ASC 740), which requires the Company to use the assets and liability method of accounting for income taxes. Under the assets and liability method, deferred income taxes are recognized for the tax consequences of temporary (timing) differences by applying enacted statutory tax rates applicable to future years to differences between financial statement carrying amounts and the tax bases of existing assets and liabilities and operating loss and tax credit carry forwards. Under this accounting standard, the effect on deferred income taxes of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recognized if it is more likely than not that some portion, or all, of a deferred tax asset will not be realized.

ASC 740-10, Accounting for Uncertainty in Income Taxes, defines uncertainty in income taxes and the evaluation of a tax position as a two-step process. The first step is to determine whether it is more likely than not that a tax position will be sustained upon examination, including the resolution of any related appeals or litigation based on the technical merits of that position. The second step is to measure a tax position that meets the more-likely-than-not threshold to determine the amount of benefit to be recognized in the financial statements. A tax position is measured at the largest amount of benefit that is greater than 50 percent likelihood of being realized upon ultimate settlement. Tax positions that previously failed to meet the more-likely-than-not recognition threshold should be recognized in the first subsequent period in which the threshold is met. Previously recognized tax positions that no longer meet the more-likely-than-not criteria should be de-recognized in the first subsequent financial reporting period in which the threshold is no longer met. The Company had no uncertain tax positions as of December 31, 2022 and 2021.

U.S. federal, state and local income tax returns prior to 2019 are not subject to examination by any applicable tax authorities, except that tax authorities could challenge returns (only under certain circumstances) for earlier years to the extent they generated loss carry-forwards that are available for those future years.

 

[10]Stock-Based Compensation

The Company accounts for its stock-based compensation awards to employees and directors in accordance with FASB ASC Topic 718, Compensation — Stock Compensation (“ASC 718”). ASC 718 requires all stock-based compensation to employees, including grants of employee stock options and restricted stock units, to be recognized in the consolidated statements of operations and comprehensive income (loss) based on their grant date fair values.

Compensation expense related to awards to employees is recognized on a straight-line basis based on the grant date fair value over the associated service period of the award, which is generally the vesting term. The Company uses the Black-Scholes option pricing model to determine the grant date fair value of options granted. The fair value of restricted stock units is determined based on the number of shares underlying the grant and either the quoted market price of the Company’s common stock on the date of grant for time-based and performance-based awards, or the fair value on the date of grant using the Monte Carlo Simulation model for market-based awards.

 

[11]Earnings Per Share

The Company reports earnings per share in accordance with U.S. GAAP, which requires presentation of basic and diluted earnings per share in conjunction with the disclosure of the methodology used in computing such earnings per share. Basic earnings per share excludes dilution and is computed by dividing income available to common shareholders by the weighted average common shares outstanding during the period. Diluted earnings per share takes into account the potential dilution that could occur if securities or other contracts, such as warrants and options to purchase common stock were exercised and shares were issued pursuant to outstanding restricted stock units. Common stock equivalents having an anti-dilutive effect on earnings per share are excluded from the calculation of diluted earnings per share.

 

 

F-10

 

NETWORK-1 TECHNOLOGIES, INC.

 

 

 

 

Note B – Summary of Significant Accounting Policies (continued)

 

[12]Fair Value Measurements

ASC Topic 820, Fair Value Measurement and Disclosures, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. This topic also establishes a fair value hierarchy which requires classification based on observable and unobservable inputs when measuring fair value.

There are three levels of inputs that may be used to measure fair value:

Level 1: Observable inputs such as quoted prices (unadjusted) in an active market for identical assets or liabilities.

Level 2: Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.

Level 3: Unobservable inputs that are supported by little or no market activity; therefore, the inputs are developed by the Company using estimates and assumptions that the Company expects a market participant would use, including pricing models, discounted cash flow methodologies, or similar techniques.

The carrying value of the Company’s financial instruments, including cash and cash equivalents and accounts payable, approximates fair value because of the short-term nature of these financial instruments.

The Company’s marketable securities are classified within Level 1 because they are valued using quoted market prices in an active market.

The Company’s equity method investment is measured on a non-recurring basis and is classified within Level 2 as it is valued using an observable price transaction for similar assets in a market that is not active (see Note B[6] and Note H hereof).

 

[13]Carrying Value, Recoverability and Impairment of Long-Lived Assets

An impairment loss shall be recognized only if the carrying amount of a long-lived asset (asset group) is not recoverable and exceeds its fair value. The carrying amount of a long-lived asset (asset group) is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset (asset group). That assessment shall be based on the carrying amount of the asset (asset group) at the date it is tested for recoverability. An impairment loss shall be measured as the amount by which the carrying amount of a long-lived asset (asset group) exceeds its fair value. If an impairment loss is recognized, the adjusted carrying amount of a long-lived asset shall be its new cost basis. For a depreciable long-lived asset, the new cost basis shall be depreciated (amortized) over the remaining useful life of that asset. Restoration of a previously recognized impairment loss is prohibited. At December 31, 2022 and 2021, there was no impairment to the Company’s patents and equity investment.

The Company’s equity investment in ILiAD is evaluated on a non-recurring basis for impairment, when and if a triggering event occurs.

 

 

F-11

 

NETWORK-1 TECHNOLOGIES, INC. 

 

 

Note B – Summary of Significant Accounting Policies (continued)

 

[14]Leases

Under ASC 842, the Company determines if an arrangement is a lease at inception. Right-of-Use (“ROU”) assets and related lease obligations are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. As the Company's lease does not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company's determined incremental borrowing rate is a hypothetical rate based on its understanding of what the Company's credit rating would be. The ROU asset also includes any lease payments made prior to commencement and is recorded net of any lease incentives received and net of the deferred rent balance on the date of implementation. The Company's lease terms may include options to extend or terminate the lease when it is reasonably certain that it will exercise such options. As permitted under ASC 842, the Company has elected to not recognize ROU assets and related lease obligations for leases with terms of twelve months or less.

 

[15]Dividend Policy

Cash dividends are recorded when declared by the Company’s Board of Directors. Common stock dividends are charged against retained earnings when declared or paid (see Note O hereof).

 

[16]Reclassifications

Stock-based compensation in the 2021 consolidated statements of operations and comprehensive income (loss) have been recast and reclassified to conform to the current year’s presentation. 

 

Note C – Patents

The Company’s intangible assets at December 31, 2022 include patents with estimated remaining economic useful lives ranging from 0.50 to 16.50 years. For all periods presented, all the Company’s patents were subject to amortization. The gross carrying amounts and accumulated amortization related to acquired intangible assets as of December 31, 2022 and 2021 were as follows:

          
  

2022

  

2021

 
Gross carrying amount  $8,473,000   $7,949,000 
Accumulated amortization   (6,881,000)   (6,565,000)
Patents, net  $1,592,000   $1,384,000 

 

Amortization expense for the years ended December 31, 2022 and 2021 was $316,000 and $295,000, respectively. Future amortization of current intangible assets, net is as follows:

      
For the years ended December 31,     
2023   $266,000 
2024    120,000 
2025    120,000 
2026    120,000 
2027    119,000 
Thereafter    847,000 
Total   $1,592,000 
       

 

Two patents within the Cox Patent Portfolio expire in July 2023 and November 2023, and the balance of the patents within such portfolio have expired. The expiration dates of patents within the Company’s M2M/IoT Patent Portfolio range from September 2033 to May 2034. The expiration dates within the Company’s HFT Patent Portfolio range from October 31, 2039 to November 1, 2039. All of the patents within the Company’s Mirror Worlds Patent Portfolio expired and the Remote Power Patent expired.

 

 

F-12

 

NETWORK-1 TECHNOLOGIES, INC.

 

 

 

 

Note D – Income (Loss) Per Share

Basic Income (Loss) per share is calculated by dividing the net income (loss) by the weighted average number of outstanding common shares during the period. Diluted per share data included the dilutive effects of stock options and restricted stock units. Potentially dilutive shares of 625,000 and 12,500 at December 31, 2022 and 2021, respectively, consist of restricted stock units. However, as the Company generated a net loss in 2022, all potentially dilutive shares were not reflected in diluted net loss per share because the impact of such instruments was anti-dilutive. Computations of basic and diluted weighted average common shares outstanding are as follows:

 Schedule of earnings per share          
   2022   2021 
         
Weighted-average common shares outstanding – basic   23,825,917    24,136,821 
           
Dilutive effect of restricted stock units and stock options  

—

   393,747 
           
Weighted-average common shares outstanding – diluted   23,825,917    24,530,568 
           
Restricted stock units excluded from the computation of diluted income per share because the effect of inclusion would have been anti-dilutive   625,000    12,500 

 

 

Note E – Income Taxes

Significant components of the income taxes were as follows for the years ended December 31, 2022 and 2021.

          
   2022   2021 

 

Current

    
State and local  $—   $144,000 
Federal   —    2,808,000 
Total Current Tax Expense (Benefit)  $—   $2,952,000 
           
Deferred          
State and local      56,000    83,000 
Federal   551,000    1,425,000 
Total Deferred Tax Expense   607,000    1,508,000 
           
Total Income Taxes  $607,000   $4,460,000 

 

Significant components of deferred tax assets (liability) as of December 31, 2022 and 2021 consisted of the following:

          
   2022   2021 
Deferred tax assets (liability):
         Net operating loss carryforward		  $477,000   $
—		 
         Capital loss carryforward   331,000    — 
         Stock options and RSU   30,000    — 
Valuation allowance (838,000) —
           
           
        Deferred Tax Liability(1)   (1,161,000)   (554,000)
Total deferred tax liability  $(1,161,000)  $(554,000)

_________________________

(1) Deferred tax liability primarily as a result of a temporary difference related to the Company’s equity method investment.

 

F-13

 

NETWORK-1 TECHNOLOGIES, INC.

 

 

 

 

Note E – Income Taxes (continued) 

As of December 31, 2022, the Company’s estimated aggregate total net operating loss carryforwards (NOLs) were $2,168,000 for U.S. federal tax purposes with an indefinite life.  At December 31, 2022, the Company had deferred tax assets of $838,000, which were offset by a valuation allowance of $838,000 as it was determined that it is more likely than not that the deferred tax assets would not be realized. At December 31, 2022, the Company had a deferred tax liability position of $1,161,000.

The reconciliation between the taxes as shown and the amount that would be computed by applying the statutory federal income tax rate to the net income before income taxes is as follows:

Schedule of reconciliation of income tax  
   Years Ended 
  

December 31,

 
  

2022

  

2021

 
 
Income tax - statutory rate   21.00%    21.00% 
Permanent differences   (8.40)%    1.69% 
Change in valuation allowance   (48.79)%    —% 
State   1.28%    1.11% 
Other   (0.43)%    —% 
  Total   (35.34)%    23.80% 

 

 

On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of Treasury has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. The excise tax applies in cases where the total value of the stock repurchased during the taxable year exceeds $1,000,000.

The personal holding company (“PHC”) rules under the Internal Revenue Code impose a 20% tax on a PHC’s undistributed personal holding company income (“UPHCI”), which means, in general, taxable income subject to certain adjustments. For a corporation to be classified as a PHC, it must satisfy two tests: (i) that more than 50% in value of its outstanding shares must be owned directly or indirectly by five or fewer individuals at any time during the second half of the year (after applying constructive ownership rules to attribute stock owned by entities to their beneficial owners and among certain family members and other related parties) (the “Ownership Test”) and (ii) at least 60% of its adjusted ordinary gross income for a taxable year consists of dividends, interest, royalties, annuities and rents (the “Income Test”). During the second half of 2022, based on available information concerning the Company’s shareholder ownership, the Company did not satisfy the Ownership Test and thus the Company was not a PHC for 2022. However, the Company may subsequently be determined to be a PHC in 2023 or in future years if it satisfies both the Ownership Test and the Income Test. If the Company were to become a PHC in any future year, it would be subject to an additional 20% tax on its UPHCI. In such event, the Company may issue a special cash dividend, to its shareholders in an amount equal to the UPHCI rather than incur the additional 20% tax.

 

 

F-14

 

NETWORK-1 TECHNOLOGIES, INC. 

 

 

 

 

Note F – Stockholders’ Equity

The Company adopted a new 2022 Stock Incentive Plan, (the “2022 Plan”), approved by its Board of Directors on July 25, 2022 and its stockholders on September 20, 2022. The 2022 Plan provides for the grant of any or all of the following types of awards: (a) stock options, (b) restricted stock, (c) deferred stock, (d) stock appreciation rights, and (e) other stock-based awards including restricted stock units. Awards under the 2022 Plan may be granted singly, in combination, or in tandem. Subject to standard anti-dilution adjustments as provided, the 2022 Plan provides for an aggregate of 2,300,000 shares of the Company’s common stock to be available for distribution. The Company’s Compensation Committee generally has the authority to administer the 2022 Plan, determine participants who will be granted awards, the size and types of awards, the terms and conditions of awards and the form and content of the award agreements representing awards. Awards under the 2022 Plan may be granted to employees, directors and consultants of the Company and its subsidiaries. As of December 31, 2022, there were 2,300,000 shares of common stock available for issuance under the 2022 Plan.

As of December 31, 2022, there were 625,000 shares of common stock subject to outstanding awards under the Company 2013 Stock Incentive Plan (“2013 Plan”). The Company discontinued issuing awards under its 2013 Plan as a result of the adoption of the 2022 Plan.

[1]Restricted Stock Units

A summary of restricted stock units granted during the years ended December 31, 2022 and December 31, 2021 is as follows (each restricted stock unit represents the contingent right to receive one share of the Company’s common stock):

Schedule of restricted stock units                    
   2022   2021 
   Number of
Shares		   Weighted-Average Grant
Date Fair Value		   Number of
Shares		   Weighted-Average Grant
Date Fair Value		 
Balance of restricted stock units outstanding at beginning of year   12,500   $3.36    162,500   $2.25 
Grants of restricted stock units   670,000    1.92    45,000    3.51 
Vested restricted stock units   (57,500)   (2.73)   (195,000)   (2.47)
Balance of restricted stock units outstanding at end of year   625,000   $1.87    12,500   $3.36 

 

 

Restricted stock unit compensation expense was $585,000 for the year ended December 31, 2022 and $238,000 for the year ended December 31, 2021.

The Company has an aggregate of $736,000 of unrecognized restricted stock unit compensation expense as of December 31, 2022 to be expensed over a weighted average period of 2.61 years.

The fair value of restricted stock units is determined based on the number of shares granted and the quoted market price of the Company’s common stock on the date of grant for time-based and performance-based awards and fair value at grant date using the Monte Carlo simulation model for market-based awards. The key inputs into the Monte Carlo simulation used to value the restricted stock units was a risk-free rate of 2.39%, expected term of 4 years, expected volatility of 40% and a stock price of $2.47.

All of the Company’s issued restricted stock units have dividend equivalent rights. As of December 31, 2022 and 2021, there was $37,000 and $72,000 accrued for dividend equivalent rights which were included in other accrued expenses.

F-15

 

NETWORK-1 TECHNOLOGIES, INC.

 

 

 

 

Note F – Stockholders’ Equity (continued)
[2]Stock Options

At December 31, 2022, there were no stock options outstanding. At December 31, 2021, one stock option to purchase 500,000 shares of common stock was outstanding, representing an option grant outside of the 2013 Plan (issued prior to the establishment of the 2013 Plan). The stock option had a weighted average exercise price of $1.19 and a weighted average remaining life of 0.84 years. There were no grants of stock options during the years ended December 31, 2022 and 2021.

The following table summarizes stock option activity for the years ended December 31:

 

                    
  

2022

  

2021

 
       Weighted       Weighted 
       Average       Average 
   Options   Exercise   Options   Exercise 
  

Outstanding

  

Price

  

Outstanding

  

Price

 
Options outstanding at beginning of year   500,000   $1.19    500,000   $1.19 
Granted   —    —    —    — 
Expired   —    —    —    — 
Exercised   500,000   $1.19    —   — 
Options outstanding at end of year   —   —    500,000   $1.19 
Options exercisable at end of year   —   —    500,000   $1.19 
                     

 

During the year ended December 31, 2022 and 2021, the Company did not recognize any stock-based compensation related to the vesting of prior issued stock options to employees. The Company at December 31, 2022 and 2021 had no remaining unrecognized expenses related to unvested stock options to employees and directors. The aggregate intrinsic value of all stock options exercisable at December 31, 2022 and 2021 was $-0- and $815,000, respectively.

On October 27, 2022, the Company’s Chairman and Chief Executive Officer exercised a stock option to purchase 500,000 shares of the Company’s common stock at an exercise price of $1.19 per share on a net exercise (or cashless) basis. In connection with the net exercise of the stock option, the Company’s Chairman and Chief Executive Officer delivered 334,459 shares of common stock (including 94,539 shares for withholding taxes) to the Company and received 165,541 net shares.

 

Note G – Marketable Securities

Marketable securities as of December 31, 2022 and 2021 were composed of: 

Schedule of marketable securities                    
   December 31, 2022 
  

Cost
Basis

  

Gross
Unrealized
Gains

  

Gross
Unrealized
Losses

  

Fair Value

 
Government Securities  $20,781,000   $67,000   $—   $20,848,000 
Fixed income mutual funds   11,904,000    —    (915,000)   10,989,000 
Certificates of Deposit   3,019,000    —    (43,000)   2,976,000 
Corporate bonds and notes   192,000    —    (14,000)   178,000 
Total marketable securities  $35,896,000   $67,000   $(972,000)  $34,991,000 
                     

 

   December 31, 2021 
  

Cost
Basis

  

Gross
Unrealized
Gains

  

Gross
Unrealized
Losses

  

Fair Value

 
Fixed income mutual funds  $14,462,000    —   $(137,000)  $14,325,000 
Corporate bonds and notes   813,000    —    (12,000)   801,000 
Total marketable securities  $15,275,000   $—   $(149,000)  $15,126,000 

 

 

 

F-16

 

NETWORK-1 TECHNOLOGIES, INC. 

 

Note H – Equity Investment

During the period December 2018 through December 2022, the Company made an aggregate investment of $7,000,000 in ILiAD, a privately held clinical stage biotechnology company dedicated to the prevention and treatment of human disease caused by Bordetella pertussis. ILiAD is focused on validating its proprietary intranasal vaccine, BPZE1, for the prevention of Pertussis (whooping cough). At December 31, 2022, the Company owned approximately 6.8% of the outstanding units of ILiAD on a non-fully diluted basis and 6.3% of the outstanding units on a fully diluted basis (after giving effect to the exercise of all outstanding options and warrants). In connection with its investment, the Company’s Chairman and Chief Executive Officer obtained a seat on ILiAD’s Board of Managers and receives the same compensation for service on the Board of Managers as other non-management Board members.

On August 24, 2022, ILiAD completed a private financing of $42,836,000 of its Class D units, of which a multi-national pharmaceutical company invested $30,000,000 (the “Financing”). As part of the Financing, the Company invested $1,000,000. This private financing represented an observable price transaction in accordance with ASC 323 and resulted in dilution in the Company’s ownership in the ILiAD. In accordance with ASC 323-10-40-1, the Company accounted for the dilution as if it had sold a portion of its investment and therefore recorded an unrealized gain of $3,883,000 and a corresponding increase in the carrying value of its investment in ILiAD. The Company determined the new carrying value of its equity investment using an observable transaction price since the Company determined the securities owned by the Company were not materially different than the securities sold by ILiAD in the Financing. The unrealized gain is reflected in the Company’s consolidated statements of operations and comprehensive income (loss) for the year ended December 31, 2022.

In addition, as part of the Financing, the Company converted its convertible note in the principal amount of $1,000,000 plus accrued interest of $86,000, in accordance with its terms, into equity of ILiAD and has accounted for this investment under the equity method of accounting. The Company recognized a gain on conversion of $271,000 which was recognized in its consolidated statements of operations and comprehensive income (loss) for the year ended December 31, 2022.

For the years ended December 31, 2022 and 2021, the Company recorded an allocated net loss from its equity method investment in ILiAD of $1,639,000 and $999,000, respectively.

The difference between the Company’s share of equity in ILiAD’s net assets and the purchase price of the investment is due to an excess amount paid over the book value of the investment of $4,130,000, which is accounted for as equity method goodwill.

The Company performed an assessment to determine significance of its equity investee using the investment, asset and income tests. The Company concluded the income test threshold was met for the year ended December 31, 2022. The following table provides certain summarized financial information for the Company’s equity method investee for the periods presented and has been compiled from the equity investee’s financial statement, reported on one quarter lag.

Schedule of equity method investments          
   Twelve Months Ended September 30, 
  

2022

  

2021

 
Loss from continuing operations  $15,246,000   $11,133,000 
Comprehensive loss  $17,913,000   $10,384,000 
           

 

 

 

 

F-17

 

NETWORK-1 TECHNOLOGIES, INC.

 

 

 

 

Note I – Commitments and Contingencies

[1]Legal fees:

Russ, August & Kabat provides legal services to the Company with respect to its pending patent litigation filed in May 2017 against Facebook, Inc. in the U.S. District Court for the Southern District of New York relating to several patents within the Company’s Mirror Worlds Patent Portfolio (see Note K[2] hereof). The terms of the Company’s agreement with Russ, August & Kabat provide for cash payments on a monthly basis subject to a cap plus a contingency fee ranging between 15% and 24% of the net recovery (after deduction of expenses) depending on the stage of the proceeding in which the result (settlement or judgment) is achieved. The Company is responsible for all expenses incurred with respect to this litigation.

Russ, August & Kabat also provides legal services to the Company with respect to its pending patent litigations filed in April 2014 and December 2014 against Google Inc. and YouTube, LLC in the U.S. District Court for the Southern District of New York relating to certain patents within the Cox Patent Portfolio acquired by the Company from Dr. Cox (see Note K[1] hereof). The terms of the Company’s agreement with Russ, August & Kabat provide for legal fees on a full contingency basis ranging from 15% to 30% of the net recovery (after deduction of expenses) depending on the stage of the proceeding in which the result (settlement or judgment) is achieved. The Company is responsible for all expenses incurred with respect to this litigation.

[2]Patent Acquisitions:

On March 25, 2022, the Company completed the acquisition of a new patent portfolio (HFT Patent Portfolio) currently consisting of nine U.S. patents and two pending U.S. patents covering certain advanced technologies relating to high frequency trading, which inventions specifically address technological problems associated with speed and latency and provide critical latency gains in trading systems where the difference between success and failure may be measured in nanoseconds. The Company paid the seller $500,000 at the closing and has an obligation to pay the seller an additional $500,000 in cash and $375,000 of the Company’s common stock (up to a maximum of 375,000 shares) upon achieving certain milestones with respect to the HFT Patent Portfolio. The Company also has an additional obligation to pay the seller 15% of the first $50 million of net proceeds (after deduction of expenses) generated by the patent portfolio and 17.5% of net proceeds greater than $50 million.

In connection with the Company’s acquisition of its Cox Patent Portfolio, the Company is obligated to pay Dr. Cox 12.5% of the net proceeds (after deduction of expenses) generated by the Company from licensing, sale or enforcement of the patent portfolio. As of the years ended December 31, 2022, and 2021, no expense was incurred with respect to the Cox Patent Portfolio. As of December 31, 2022 and 2021, no amounts were accrued with respect to the Cox Patent Portfolio.

As part of the acquisition of the Mirror Worlds Patent Portfolio, the Company also entered into an agreement with Recognition Interface, LLC (“Recognition”) pursuant to which Recognition received from the Company an interest in the net proceeds realized from the monetization of the Mirror Worlds Patent Portfolio, as follows: (i) 10% of the first $125 million of net proceeds; (ii) 15% of the next $125 million of net proceeds; and (iii) 20% of any portion of the net proceeds in excess of $250 million. Since entering into the agreement with Recognition in May 2013, the Company has paid Recognition an aggregate of $3,127,000 with respect to such net proceeds interest related to the Mirror Worlds Patent Portfolio. No such payments were made by the Company to Recognition during the year ended December 31, 2022 and 2021.

In connection with the Company’s acquisition of its M2M/IoT Patent Portfolio, the Company is obligated to pay M2M 14% of the first $100 million of net proceeds (after deduction of expenses) and 5% of net proceeds greater than $100 million from Monetization Activities (as defined in the acquisition agreement) related to the M2MIoT Patent Portfolio. In addition, M2M will be entitled to receive from the Company $250,000 of additional consideration upon the occurrence of certain future events related to the patent portfolio.

 

 

F-18

 

NETWORK-1 TECHNOLOGIES, INC.

 

 

 

 

Note I – Commitments and Contingencies (continued)
[3]Savings and investment plan:

 

The Company has a Savings and Investment Plan which allows participants to make contributions by salary reduction pursuant to Section 401(k) of the Internal Revenue Code of 1986. The Company also may make discretionary annual matching contributions and profit sharing in amounts determined by the Board of Directors, subject to statutory limits. The 401(k) Plan expense for the years ended December 31, 2022 and 2021 was $78,000 and $102,000, respectively, all of which was accrued as of December 31, 2022 and 2021 and is recorded within accrued expenses on the Company’s consolidated balance sheets.

[4]Leases:

 

The Company has one operating lease for its principal office space in New Canaan, Connecticut that will expire on April 30, 2025.

There are no material residual guarantees associated with the Company’s lease and there are no significant restrictions or covenants included in the Company’s lease.

The calculated incremental borrowing rate was approximately 4.2%, which was calculated based on remaining lease term of 3 years as of May 1, 2022. The remaining lease term as of December 31, 2022 was approximately 2.3 years.

There was no sublease rental income for the year ended December 31, 2022, and the Company is not the lessor in any lease arrangement, and there were no related-party lease agreements.

Right-of-use lease assets and related lease obligations for the Company’s operating leases were recorded in the consolidated balance sheet as follows:

           
   As of   As of 
   December 31, 2022   December 31, 2021 
Operating lease right-of-use assets  $161,000   $— 
           
Operating lease obligations – current   79,000    — 
Operating lease obligations – non-current   94,000    — 
Total lease obligations  $173,000   $— 

 

The table below presents certain information related to the Company’s lease costs for the year ended December 31, 2022 and 2021:

          
   For the Year Ended
December 31,		 
  

2022

  

2021

 
Operating lease cost  $48,000   $— 
Short-term lease cost   82,000    128,000 
Total lease cost  $130,000   $128,000 

 

Future lease payments included in the measurement of lease liabilities on the consolidated balance sheet as of December 31, 2022, were as follows:

       
    Operating Leases 
 2023    83,000 
 2024    73,000 
 2025    24,000 
 Total future minimum lease payments    180,000 
 Less imputed interest    (7,000)
 Total operating lease liability   $173,000 

 

F-19

 

NETWORK-1 TECHNOLOGIES, INC.

  

Note J - Employment Arrangements and Other Agreements

[1] On March 22, 2022, the Company entered into a new employment agreement (“Agreement”) with its Chairman and Chief Executive Officer, pursuant to which he continues to serve as the Company’s Chairman and Chief Executive Officer for a four-year term (“Term”), at an annual base salary of $535,000 which shall be increased by 3% per annum during the Term. The Agreement established an annual target bonus of $175,000 for the Chairman and Chief Executive Officer based upon performance. For the year ended December 31, 2022 and 2021, the Chairman and Chief Executive Officer received an annual discretionary bonus of $175,000.

In addition, pursuant to the Agreement, the Company granted the Chairman and Chief Executive Officer, under its 2013 Plan, 600,000 restricted stock units (the “RSUs”, each RSU awarded by the Company to its officers, directors and consultants represents a contingent right to receive one share of the Company’s common stock) which terms provided for vesting in four tranches, as follows: (1) 175,000 RSUs which shall vest 100,000 RSUs on March 22, 2023 and 75,000 RSUs on March 22, 2024, subject to the Chairman and Chief Executive Officer’s continued employment by the Company through each such vesting date (the “Employment Condition”) (“Tranche 1”); (2) 150,000 RSUs shall vest if at any time during the Term that the Company’s common stock achieves a closing price for twenty (20) consecutive trading days (“Closing Price”) of a minimum of $3.50 per share (subject to adjustment for stock splits) and the Employment Condition is satisfied through the date such minimum per share Closing Price is achieved (“Tranche 2”); (3) 150,000 RSUs shall vest if at any time during the Term that the common stock achieves a Closing Price of a minimum of $4.00 per share (subject to adjustment for stock splits) and the Employment Condition is satisfied through the date such minimum per share Closing Price is achieved (“Tranche 3”); and (4) 125,000 RSUs shall vest if at any time during the Term, that the common stock achieves a Closing Price of a minimum of $4.50 per share (subject to adjustment for stock splits) and the Employment Condition is satisfied through the date such minimum per share Closing Price is achieved (“Tranche 4”). In the event of a Change of Control (as defined), Termination Other Than for Cause (as defined) or a termination by the Chairman and Chief Executive Officer for Good Reason (as defined) in each case prior to the last day of the Term, the vesting of all RSUs (Tranches 1, 2, 3 and 4) shall accelerate (and not be subject to any conditions) and all RSUs shall become immediately fully vested. All RSUs granted by the Company to its officers, directors or consultants have dividend equivalent rights.

Under the terms of the Agreement, so long as the Chairman and Chief Executive Officer continues to serve as an executive officer of the Company, whether pursuant to the Agreement or otherwise, the Chairman and Chief Executive Officer shall also receive incentive compensation in an amount equal to 5% of the Company’s gross royalties or other payments from Licensing Activities (as defined) (without deduction of legal fees or any other expenses) with respect to the Remote Power Patent and a 10% net interest (gross royalties and other payments after deduction of all legal fees and litigation expenses related to licensing, enforcement and sale activities, but in no event shall he receive less than 6.25% of the gross recovery) of the Company’s royalties and other payments relating to Licensing Activities with respect to patents other than the Remote Power Patent (including all of the Company’s patent portfolios and its investment in ILiAD) (collectively, the “Incentive Compensation”). During the year ended December 31, 2022 and 2021, the Chairman and Chief Executive Officer earned Incentive Compensation of $-0- and $1,801,000, respectively.

The Incentive Compensation shall continue to be paid to the Chairman and Chief Executive Officer for the life of each of the Company’s patents with respect to licenses entered into with third parties during the term of his employment or at anytime thereafter, whether he is employed by the Company or not; provided, that, the employment of the Chairman and Chief Executive Officer has not been terminated by the Company “For Cause” (as defined) or terminated by him without “Good Reason” (as defined). In the event of a merger or sale of substantially all of the Company’s assets, the Company has the option to extinguish the right of the Chairman and Chief Executive Officer to receive future Incentive Compensation by payment to him of a lump sum payment, in an amount equal to the fair market value of such future interest as determined by an independent third party expert if the parties do not reach agreement as to such value. In the event that the Chairman and Chief Executive Officer’s employment is terminated by the Company “Other Than For Cause” (as defined) or by him for “Good Reason” (as defined), the Chairman and Chief Executive Officer shall also be entitled to (i) a lump sum severance payment of 12 months base salary, (ii) a pro-rated portion of the $175,000 target bonus provided bonus criteria have been satisfied on a pro-rated basis through the calendar quarter in which the termination occurs and (iii) accelerated vesting of all unvested options, RSUs or other awards.

 

F-20

 

NETWORK-1 TECHNOLOGIES, INC.

 

Note J - Employment Arrangements and Other Agreements (continued)

In connection with the Agreement, the Chairman and Chief Executive Officer has also agreed not to compete with the Company as follows: (i) during the Term of the Agreement and for a period of 12 months thereafter if his employment is terminated “Other Than For Cause” (as defined) provided he is paid his 12 months base salary severance amount and (ii) for a period of two years from the termination date, if terminated “For Cause” by the Company or “Without Good Reason” by the Chairman and Chief Executive Officer.

[2] The Company’s Executive Vice President serves on an at-will basis at an annual base salary of $200,000. The Executive Vice President received a discretionary annual bonus of $25,000 and $40,000 for the year ended December 31, 2022 and 2021, respectively. On January 18, 2022, the Company’s Executive Vice President was granted 15,000 RSUs under the 2013 Plan, 50% of such RSUs vested on the one year anniversary of the date of grant (January 18, 2023) and 50% of such RSUs vest on the two year anniversary of the grant (January 18, 2024), subject to continued employment. On January 24, 2023, the Company’s Executive Vice President was granted 15,000 RSUs under the 2022 Plan, 50% of such RSUs vest on the one year anniversary of the date of grant (January 24, 2024) and 50% of such RSUs vest on the two year anniversary of the date of grant (January 24, 2025), subject to continued employment.

[3] The Company’s former Chief Financial Officer served on an at-will basis at an annual base salary of $175,000 until his retirement in December 2022. In connection with his retirement, the Chief Financial Officer was granted severance of 6 months base salary and certain other benefits.

[4] In December 2022, the Company’s Board of Directors elected a new Chief Financial Officer who serves on a consulting basis at an annual base salary of $175,000.

Note K – Legal Proceedings

[1] On April 4, 2014 and December 3, 2014, the Company initiated litigation against Google Inc. (“Google”) and YouTube, LLC (“YouTube”) in the U.S. District Court for the Southern District of New York for infringement of several of its patents within its Cox Patent Portfolio acquired from Dr. Cox which relate to the identification of media content on the Internet. The lawsuit alleges that Google and YouTube have infringed and continue to infringe certain of the Company’s patents by making, using, selling and offering to sell unlicensed systems and related products and services, which include YouTube’s Content ID system. The litigations against Google and YouTube were subject to court ordered stays which were in effect from July 2, 2015 until January 2, 2019 as a result of proceedings at the Patent Trial and Appeal Board (PTAB) and the appeals of PTAB Final Written Decisions to the U.S. Court of Appeals for the Federal Circuit. Pursuant to a Joint Stipulation and Order Regarding Lifting of Stays, entered on January 2, 2019, the parties agreed, among other things, that the stays with respect to the litigations were lifted. In January 2019, the two litigations against Google and YouTube were consolidated. Discovery is complete and the parties have each submitted summary judgment motions. A trial date has not yet been set.

[2] On May 9, 2017, Mirror Worlds Technologies, LLC, the Company’s wholly-owned subsidiary, initiated litigation against Facebook, Inc. (“now Meta Platforms, Inc. (“Meta”)) in the U.S. District Court for the Southern District of New York, for infringement of U.S. Patent No. 6,006,227, U.S. Patent No. 7,865,538 and U.S. Patent No. 8,255,439 (among the patents within the Company’s Mirror Worlds Patent Portfolio). The lawsuit alleged that the asserted patents are infringed by Meta’s core technologies that enable Meta’s Newsfeed and Timeline features. On May 7, 2018, Meta filed a motion for summary judgment on non-infringement. On August 11, 2018, the Court issued an order granting Meta’s motion for summary judgment of non-infringement and dismissed the case. On August 17, 2018, the Company filed a Notice of Appeal to appeal the summary judgment decision to the U.S. Court of Appeals for the Federal Circuit. On January 23, 2020, the U.S. Court of Appeals for the Federal Circuit ruled in the Company’s favor and reversed the summary judgment finding on non-infringement of the District Court and remanded the litigation to the Southern District of New York for further proceedings.

 

 

F-21

 

NETWORK-1 TECHNOLOGIES, INC.

 

 

 

 

Note K – Legal Proceedings (continued)

On March 7, 2022, the District Court entered a ruling granting in part and denying in part a motion for summary judgment by Meta. In its ruling the Court (i) denied Meta’s motion that the asserted patents were invalid by concluding that all asserted claims were patent eligible under §101 of the Patent Act and (ii) granted summary judgment of non-infringement in favor of Facebook and dismissed the case. The Company strongly disagrees with the decision on non-infringement and on April 4, 2022, the Company filed an appeal to the U.S. Court of Appeals for the Federal Circuit, which is pending.

[3] On December 15, 2020, the Company filed a lawsuit against Netgear, Inc. (“Netgear”) in the Supreme Court of the State of New York, County of New York, for breach of a Settlement and License Agreement, dated May 22, 2009, with the Company for failure to make royalty payments, and provide corresponding royalty reports, to the Company based on sales of Netgear’s PoE products. On October 22, 2021, Netgear filed a Demand for Arbitration at the American Arbitration Association (AAA) seeking to arbitrate certain issues raised in the litigation. The Company objected to jurisdiction at the AAA. On April 22, 2022, Netgear filed a counterclaim in the N.Y. court action alleging that the Company breached the License Agreement by not offering Netgear lower royalties. On September 22, 2022, the arbitration brought by Netgear was dismissed by the AAA on jurisdiction grounds. The case remains pending in the Supreme Court of the State of New York, County of New York.

[4] In October and November 2022, the Company initiated separate litigation against ten defendants for infringement of its Remote Power Patent seeking monetary damages based upon reasonable royalties, as follows: (i) On October 6, 2022, the Company initiated such litigation against Arista Networks, Inc., Fortinet, Inc., Honeywell International Inc. and Ubiquiti Inc. in the United States District Court, District of Delaware; (ii) On October 27, 2022, and November 3, 2022, the Company initiated such litigation against TP-Link USA Corporation and Hikvision USA, Inc. in the United States District Court for the Central District of California; (iii) On November 4, 2022, the Company initiated such litigation against Panasonic Holdings Corporation and Panasonic Corporation of North America in the United States District Court for the Eastern District of Texas (Marshall Division); and (iv) On November 8, 2022 and November 16, 2022, the Company initiated such litigation against Antaira Technologies, LLC and Dahua Technology USA in the United States District Court for the Central District of California.

Note L - Concentrations

The Company had no revenue for the year ended December 31, 2022. Revenue from the Company’s Remote Power Patent constituted 100% of the Company’s revenue for the year ended December 31, 2021, of which two licensees constituted an aggregate of 99% of the Company’s revenue for such year.

Note M – Related Party Transaction

On June 1, 2022, the Company repurchased from a director of the Company 41,500 shares of its common stock at a purchase price of $2.42 per share or aggregate consideration of $100,430.

Note N – Stock Repurchase Program

On June 11, 2021, the Company’s Board of Directors authorized an extension and increase of the Share Repurchase Program to repurchase up to $5,000,000 of the Company’s common stock over the subsequent 24-month period. The common stock may be repurchased from time to time in open market transactions or privately negotiated transactions in the Company’s discretion. The timing and amount of the shares repurchased are determined by management based on its evaluation of market conditions and other factors. The repurchase program may be increased, suspended or discontinued at any time.

During the year ended December 31, 2022, the Company repurchased an aggregate of 228,530 shares of its common stock pursuant to the Share Repurchase Program at a cost of approximately $531,000 (exclusive of commissions) or an average price per share of $2.33.

Since inception of the Share Repurchase Program (August 2011) through December 31, 2022, the Company has repurchased an aggregate of 9,212,664 shares of its common stock at a cost of approximately $17,758,000 (exclusive of commissions) or an average per share price of $1.93.

 

 

 

F-22

 

NETWORK-1 TECHNOLOGIES, INC.

 

Note O – Dividend Policy

The Company’s dividend policy consists of a semi-annual cash dividend of $0.05 per common share ($0.10 per common share annually) which have been paid in March and September of each year. On February 23, 2022, the Board of Directors declared a semi-annual cash dividend of $0.05 per share with a payment date of March 24, 2022 to all common shareholders of record as of March 9, 2022. On September 9, 2022, the Board of Directors declared a semi-annual dividend of $0.05 per share with a payment date of September 30, 2022 to all common shareholders of record as of September 20, 2022. The Company’s dividend policy undergoes a periodic review by the Board of Directors and is subject to change at any time depending upon the Company’s earnings, financial requirements and other factors.

Note P – Subsequent Events

[1] On March 3, 2023, the Company’s Board of Directors declared a semi-annual cash dividend of $0.05 per share with a payment date of March 31, 2023 to all common shareholders of record as of March 15, 2023.

[2] On March 3, 2023, the Company’s Board of Directors approved the grant of 15,000 RSUs to each of the Company’s three non-management directors. The RSUs vest over a one year period in equal quarterly installments of 3,750 shares of common stock on each of March 15, 2023, June 15, 2023, September 15, 2023 and December 15, 2023.

[3] During the period January 24, 2023 through March 10, 2023, the Company entered into settlement agreements with Arista Networks, Inc., Antiara Technologies LLC, Panasonic Holdings Corporation and TP-Link USA Corporation with respect to patent infringement litigation involving its Remote Power Patent, resulting in aggregate settlement payments to the Company of $537,300 and a conditional payment of $150,000 (see Note K[4] hereof).

 

 

 

 

 

 

 

 

 

 

 

F-23

 

PART IV

ITEM 15.EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

(a)(1)       Financial Statements:

The following are included under Item 8 “Financial Statements and Supplementary Data”:

Report of Independent Registered Public Accounting Firm

Consolidated balance sheets as of December 31, 2022 and 2021

Consolidated statements of operations and comprehensive (loss) income for the years ended December 31, 2022 and 2021

Consolidated statements of changes in stockholders' equity for the years ended December 31, 2022 and 2021

Consolidated statements of cash flows for the years ended December 31, 2022 and 2021

Notes to consolidated financial statements

(a)(2)       Financial Statements Schedules:

Financial statement schedules are omitted because the information is not applicable.

 

 

 

 

 

 

-46-

 

 

(a)(3) Exhibits:

3(i)(a)Certificate of Incorporation, as amended. Previously filed as Exhibit 3.1 to the Company’s Registration Statement on Form SB-2 (Registration No. 333-59617), declared effective by the SEC on November 12, 1998 (the “1998 Registration Statement”), and incorporated herein by reference.
3(i)(b)Certificate of Amendment to the Certificate of Incorporation dated November 27, 2001. Previously filed as Exhibit 3.1.1 to the Company’s Registration Statement on Form S-3 (Registration No. 333-81344) declared effective by the SEC on February 12, 2002, and incorporated herein by reference (the “February 2002 Form S-3”)
3(i)(c)Certificate of Amendment to the Certificate of Incorporation dated October 9, 2013. Previously filed as Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on October 10, 2013, and incorporated herein by reference.
3(ii)Second Amended and Restated By-laws. Previously filed as Exhibit 3.1 to the Company’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2016 filed on November 14, 2016 and incorporated herein by reference.
4.1Description of Common Stock. Previously filed under the header “Common Stock” under the section captioned “Description of Securities” in the Company’s Registration Statement on Form S-1A (File No. 333-190719) filed on September 30, 2014 and incorporated herein by reference.
10.2+Employment Agreement, dated July 14, 2016, between the Company and Corey M. Horowitz, Chairman and Chief Executive Officer. Previously filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on July 19, 2016 and incorporated herein by reference.
10.3+Employment Agreement, dated March 22, 2022, between the Company and Corey M. Horowitz, Chairman and Chief Executive Officer. Previously filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on March 28, 2022 and incorporated herein by reference.
10.4+2013 Stock Incentive Plan. Previously filed as Appendix B to the Company’s Schedule 14A (Proxy Statement) filed on August 20, 2013 and incorporated herein by reference.
10.5+2022 Stock Incentive Plan Previously filed as Exhibit A to the Company's Schedule 14A (Proxy Statement) filed on July 27, 2022 and incorporated herein by reference.

 

 

 

 

 

-47-

 

 

 

10.6Form of Indemnification Agreement for directors and officers. Previously filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on December 13, 2019 and incorporated herein by reference.
14Code of Ethics. Previously filed as Exhibit 14 to the Company's Annual Report on Form 10-KSB for the year ended December 31, 2004 filed on April 14, 2004 and incorporated herein by reference.
16Letter, dated October 12, 2002, from Friedman LLP. Previously filed as Exhibit 16 to the Company’s Current Report on Form 8-K filed on October 12, 2022 and incorporated herein by reference.
21.1*List of Subsidiaries of Registrant.
23.1*Consent of Marcum LLP, independent registered public accounting firm.
23.2Consent of Friedman LLP, the Company’s former independent registered public accounting firm.
31.1*Section 302 Certification of Chief Executive Officer.
31.2*Section 302 Certification of Chief Financial Officer.
32.1*Section 906 Certification of Chief Executive Officer.
32.2*Section 906 Certification of Chief Financial Officer.

101* Interactive data files: *

101.INS       XBRL Instance Document.

101.SCH       XBRL Scheme Document.

101.CAL       XBRL Calculation Linkbase Document.

101.DEF       XBRL Definition Linkbase Document.

101.LAB       XBRL Label Linkbase Document.

101.PRE       XBRL Presentation Linkbase Document.

_________________________________________________________________ 

*  Filed herewith

+  Management contract or compensatory plan or arrangement

 

 

 

 

 

 

 

 

 

 

-48-

 

 

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

NETWORK-1 TECHNOLOGIES, INC.

 

 

By  /s/ Corey M. Horowitz                               

Corey M. Horowitz

Chairman and Chief Executive Officer

March 30, 2023

 

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated:

 

NAME   TITLE   DATE
         

 

/s/ Corey M. Horowitz

Corey M. Horowitz

  

 

Chairman and Chief Executive Officer, Chairman of the Board of Directors (principal executive officer)

  

 

March 30, 2023

 

/s/ Robert Mahan

Robert Mahan

  

 

Chief Financial Officer (principal financial officer and principal accounting officer)

  

 

March 30, 2023

 

/s/ Jonathan Greene

Jonathan Greene

  

 

Executive Vice President, Secretary and a Director

  

 

March 30, 2023

 

/s/ Emanuel Pearlman

Emanuel Pearlman

  

Director

  

 

 March 30, 2023

 

/s/ Niv Harizman

Niv Harizman

  

 

Director

  

 

 March 30, 2023

 

/s/ Allison Hoffman

Allison Hoffman

  

 

Director

  

 

 March 30, 2023

 

 

 

 

 

 

 

 

-49-

 

 

 EX-21.1 2 exh21-1_18704.htm LIST OF SUBSIDIARIES OF NETWORK-1 TECHNOLOGIES, INC.

 

EXHIBIT 21.1

 

 

 

List of Subsidiaries of Network-1 Technologies, Inc.

 

 

Name   Jurisdiction
     
Mirror Worlds Technologies, LLC   Delaware
     

HFT Solutions, LLC

   Delaware

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 EX-23.1 3 exh23-1_18704.htm CONSENT OF MARCUM LLP

 

EXHIBIT 23.1

 

 

 

 

Independent Registered Public Accounting Firm’s Consent

 

We consent to the incorporation by reference in the Registration Statements of Network-1 Technologies, Inc. on Form S-8 Nos. 333-192811, 333-186612 and 333-269142 of our report dated March 30, 2023, with respect to our audit of the consolidated financial statements of Network-1 Technologies, Inc. as of and for the year ended December 31, 2022, which report is included in this Annual Report on Form 10-K of Network-1 Technologies, Inc. for the year ended December 31, 2022.

 

/s/ Marcum llp

 

Marcum llp

New York, New York

March 30, 2023

 

 

 

 

 

 EX-23.2 4 exh23-2_18704.htm CONSENT OF FRIEDMAN, LLP

EXHIBIT 23.2

 

 

 

 

 

 

Independent Registered Public Accounting Firm’s Consent

 

 

We consent to the incorporation by reference in the Registration Statements of Network-1 Technologies, Inc. and Subsidiary on Form S-8 Nos. 333-192811, 333-186612, and 333-269142 of our report dated March 30, 2022, with respect to our audit of the consolidated financial statements of Network-1 Technologies, Inc. and Subsidiary as of December 31, 2021, which report is included in the Annual Report on Form 10-K of Network-1 Technologies, Inc. and Subsidiary for the year ended December 31, 2022.

 

We resigned as auditors on October 11, 2022, and, accordingly, we have not performed any audit or review procedures with respect to any financial statements for the periods after the date of our resignation.

 

 

/s/ Friedman LLP

 

New York, New York

March 30, 2023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 EX-31.1 5 exh31-1_18704.htm CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TOSECTION 302 OF THE SARBANES

EXHIBIT 31.1

 

 

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. §1350)

 

 

I, Corey M. Horowitz, Chairman and Chief Executive Officer of Network-1 Technologies, Inc. (the "Registrant"), certify that:

 

1. I have reviewed this report on Form 10-K for the year ended December 31, 2022 of the Registrant;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

 

4. The Registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the Registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the Registrant's internal control over financial reporting that occurred during the Registrant's most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting; and

 

5. The Registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant's auditors and the audit committee of the Registrant's board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant's ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant's internal control over financial reporting.

 

   
Date:   March 30, 2023 /s/ Corey M. Horowitz
    Corey M. Horowitz
Chairman and Chief Executive Officer

 

 

 

 EX-31.2 6 exh31-2_18704.htm CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TOSECTION 302 OF THE SARBANES

EXHIBIT 31.2

 

 

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. §1350)

 

 

I, Robert M. Mahan, Chief Financial Officer of Network-1 Technologies, Inc. (the "Registrant"), certify that:

 

1. I have reviewed this report on Form 10-K for the year ended December 31, 2022 of the Registrant;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

 

4. The Registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the Registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the Registrant's internal control over financial reporting that occurred during the Registrant's most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting; and

 

5. The Registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant's auditors and the audit committee of the Registrant's board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant's ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant's internal control over financial reporting.

 

   
Date:  March 30, 2023 /s/ Robert M. Mahan
    Robert M. Mahan
Chief Financial Officer

 

 

 

 EX-32.1 7 exh32-1_18704.htm CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TOSECTION 906 OF THE SARBANES

EXHIBIT 32.1

 

 

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. §1350,

as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

 

Pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, Corey M. Horowitz, Chairman and Chief Executive Officer of Network-1 Technologies, Inc., a Delaware corporation (the "Company"), does hereby certify that:

 

The Annual Report on Form 10-K for the year ended December 31, 2022 of the Company (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

 

/s/ Corey M. Horowitz                                     
Chief Executive Officer and Chairman

March 30, 2023

 

 

 

 

 

 

 

 

 

 

 

 

 EX-32.2 8 exh32-2_18704.htm CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TOSECTION 906 OF THE SARBANES

EXHIBIT 32.2

 

 

 

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. §1350,

as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

 

Pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, Robert M. Mahan, Chief Financial Officer of Network-1 Technologies, Inc., a Delaware corporation (the "Company"), does hereby certify that:

 

The Annual Report on Form 10-K for the year ended December 31, 2022 of the Company (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

 

 

/s/ Robert M. Mahan                                    
Chief Financial Officer

March 30, 2023

 

 

 

 

 

 

 

 

 

 EX-101.CAL 9 nssi-20221231_cal.xml XBRL CALCULATION FILE EX-101.DEF 10 nssi-20221231_def.xml XBRL DEFINITION FILE EX-101.LAB 11 nssi-20221231_lab.xml XBRL LABEL FILE Equity Components [Axis] Common Stock Additional Paid-in Capital Accumulated Deficit Accumulated Other Comprehensive (Loss) Total Stockholders’ Equity Legal Entity [Axis] I Li A D Biotechnologies L L C [Member] Product and Service [Axis] Fully Paid Licenses [Member] Royalty Bearing Licenses [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Plan Name [Axis] Stock Incentive Plan 2022 [Member] Stock Incentive Plan 2013 [Member] Award Type [Axis] Restricted Stock Units (RSUs) [Member] Title of Individual [Axis] Chairman And Chief Executive Officer [Member] Equity Option [Member] Other Investment Not Readily Marketable [Axis] Cost Basis [Member] Gross Unrealized Gains [Member] Gross Unrealized Losses [Member] Concentration Risk Benchmark [Axis] Fair Value [Member] Investment, Name [Axis] Iliad [Member] Derivative Instrument [Axis] Class C Units [Member] Related Party Transaction [Axis] Business Acquisition [Axis] Cox Patent Portfolio [Member] Chief Executive Officer [Member] New Employment Agreement [Member] Vesting [Axis] Share-Based Payment Arrangement, Tranche One [Member] Share-Based Payment Arrangement, Tranche Two [Member] Share-Based Payment Arrangement, Tranche Three [Member] Share Based Compensation Award Tranche Four [Member] Vice President [Member] Chief Financial Officer [Member] Google [Member] Facebook [Member] Netgear [Member] Arista Networks [Member] Concentration Risk Type [Axis] Remote Power Patent [Member] Licensees Two [Member] Board Of Directors [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Settlement Agreements [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Auditor Firm ID Auditor Name Auditor Location Statement of Financial Position [Abstract] ASSETS: CURRENT ASSETS: Cash and cash equivalents Marketable securities, at fair value Prepaid taxes Other current assets Total Current Assets OTHER ASSETS: Patents, net of accumulated amortization Equity investment Convertible note investment Operating leases right of use asset Security deposits Total Other Assets TOTAL ASSETS LIABILITIES AND STOCKHOLDERS’ EQUITY: CURRENT LIABILITIES: Accounts payable Income taxes payable Accrued contingency fees and related costs Accrued payroll Other accrued expenses Operating lease obligations, current Total Current Liabilities LONG TERM LIABILITIES: Deferred tax liability Operating lease obligation, non-current TOTAL LIABILITIES COMMITMENTS AND CONTINGENCIES (See Note I) STOCKHOLDERS' EQUITY Preferred stock, $0.01 par value; authorized 10,000,000 shares; none issued and outstanding at December 31, 2022 and December 31, 2021 Common stock, $0.01 par value; authorized 50,000,000 shares; 23,863,639 and 23,792,212 shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively Additional paid-in capital Accumulated deficit Accumulated other comprehensive loss TOTAL STOCKHOLDERS’ EQUITY   TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY Preferred Stock, Par or Stated Value Per Share Preferred Stock, Shares Authorized Preferred Stock, Shares Issued Preferred Stock, Shares Outstanding Common Stock, Par or Stated Value Per Share Common Stock, Shares Authorized Common Stock, Shares, Issued Common Stock, Shares, Outstanding Income Statement [Abstract] REVENUE OPERATING EXPENSES: Costs of revenue Professional fees and related costs General and administrative Amortization of patents TOTAL OPERATING EXPENSES OPERATING INCOME (LOSS)   OTHER INCOME Interest and dividend income, net Gain on conversion of note Gain on equity method investment Net realized and unrealized loss on marketable securities Total other income, net (LOSS) INCOME BEFORE INCOME TAXES AND SHARE OF NET LOSSES OF EQUITY METHOD INVESTEE INCOME TAXES PROVISION: Current Deferred taxes, net Total income taxes expense (LOSS) INCOME BEFORE SHARE OF NET LOSSES OF EQUITY METHOD INVESTEE: SHARE OF NET LOSSES OF EQUITY METHOD INVESTEE NET (LOSS) INCOME Net (Loss) Income Per Share: Basic Diluted Weighted average common shares outstanding: Basic Diluted Cash dividends declared per share OTHER COMPREHENSIVE LOSS Net unrealized holding loss on corporate bonds and notes arising during the year, net of tax COMPREHENSIVE (LOSS) INCOME Statement [Table] Statement [Line Items] Balance – December 31, 2021 Beginning Balance, Shares Dividends and dividend equivalents declared Stock-based compensation Vesting of restricted stock units Vesting of restricted stock units, shares Cashless exercise of stock options Cashless exercise of options, Shares Value of shares delivered to pay exercise price and withholding taxes Value of shares delivered to pay withholding taxes, Shares Treasury stock purchased and retired Treasury stock purchased and retired, shares Net unrealized loss on corporate bonds and notes Net loss Balance – December 31, 2022 Ending Balance, Shares Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Net (loss) income Adjustments to reconcile net (loss) income to net cash used in operating activities: Stock-based compensation Loss allocated from equity investment Deferred tax expense Amortization of right of use asset, net Gain on equity method investment Accrued interest on convertible note Gain on conversion of note Unrealized loss on marketable securities Changes in operating assets and liabilities: Other current assets Prepaid taxes Accounts payable Income taxes payable Security deposit Operating lease obligations Accrued expenses NET CASH (USED IN) PROVIDED BY OPERATING ACTIVITIES CASH FLOWS FROM INVESTING ACTIVITIES: Sales of marketable securities Purchases of marketable securities Development of patents Equity Investment Convertible note investment NET CASH (USED IN) PROVIDED BY INVESTING ACTIVITIES CASH FLOWS FROM FINANCING ACTIVITIES: Cash dividends paid Value of shares delivered to fund withholding taxes Repurchases of common stock, inclusive of commissions NET CASH USED IN FINANCING ACTIVITIES NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS CASH AND CASH EQUIVALENTS, beginning of year CASH AND CASH EQUIVALENTS, end of year SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: Cash paid during the years for: Interest Income taxes NON-CASH FINANCING ACTIVITY Accrued dividend rights on restricted stock units Right of use asset obtained in exchange for lease liability Conversion of note receivable Accounting Policies [Abstract] Business Summary of Significant Accounting Policies Patents Patents Earnings Per Share [Abstract] Income (Loss) Per Share Income Tax Disclosure [Abstract] Income Taxes Equity [Abstract] Stockholders’ Equity Marketable Securities Marketable Securities Equity Method Investments and Joint Ventures [Abstract] Equity Investment Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Employment Arrangements And Other Agreements Employment Arrangements and Other Agreements Legal Proceedings Risks and Uncertainties [Abstract] Concentrations Related Party Transactions [Abstract] Related Party Transaction Other Liabilities Disclosure [Abstract] Stock Repurchase Program Dividend Policy Subsequent Events [Abstract] Subsequent Events Principles of Consolidation Use of Estimates and Assumptions Cash and Cash Equivalents Marketable Securities Revenue Recognition Equity Method Investments Patents Costs of Revenue and Related Costs Income Taxes Stock-Based Compensation Earnings Per Share Fair Value Measurements Carrying Value, Recoverability and Impairment of Long-Lived Assets Leases Dividend Policy Reclassifications Schedule of disaggregation of revenue Schedule of patent Schedule of future amortization of current intangible Schedule of earnings per share Schedule of components of the income taxes Schedule of components of deferred tax assets and liability Schedule of reconciliation of income tax Schedule of restricted stock units Schedule of stock option activity Schedule of marketable securities Schedule of equity method investments Schedule of operating leases obligations Schedule of leases cost Schedule of future minimum leases payments Patents owned by the company Expired patents Foreign patents owned by the company Aggregate investment amount Schedule of Product Information [Table] Product Information [Line Items] Total Revenue FDIC insured limit Cash in excess of FDIC insured limit Certificates of deposit Increase in net losses of equity method investee Decrease in basic and diluted earnings Uncertain tax positions Company impairment patents and equity investment Gross carrying amount Accumulated amortization Patents, net 2023 2024 2025 2026 2027 Thereafter Total Estimated remaining economic useful of patents Amortization expense Expiration dates of the patents within the Cox patent portfolio Expiration dates of the patents within the Company's M2M/IoT Patent Portfolio Expiration dates within companys HFT patent portfolio Weighted-average common shares outstanding – basic Dilutive effect of restricted stock units and stock options Weighted-average common shares outstanding – diluted Restricted stock units excluded from the computation of diluted income per share because the effect of inclusion would have been anti-dilutive Potentially dilutive shares   Current State and local Federal Total Current Tax Expense (Benefit) Deferred State and local Federal Total Deferred Tax Expense Total Income Taxes Net operating loss carry forwards Capital loss carryforward Stock options and RSU Valuation allowance Deferred Tax Liability Total deferred tax assets (liability) Income tax - statutory rate Permanent difference Change in valuation allowance State Other Total Operating Loss Carryforwards Deferred Tax Assets, Gross Deferred Tax Assets, Valuation Allowance Deferred Tax Liabilities, Net Restricted stock units, outstanding number of units, beginning balance Restricted stock units, weighted average grant date fair value, beginning balance Grants of restricted stock units Grants of restricted stock units, weighted average grant date fair value Vested restricted stock units Vested restricted stock units, weighted average grant date fair value Resricted stock units, Outstanding Number of units, Ending Balance Restricted stock units, weighted average grant date fair value, ending balance Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Options outstanding, beginning, at beginning of year Weighted average exercise price, options outstanding, at beginning of year Options Granted Weighted average exercise price, Options Granted Options Expired Weighted average exercise price, Options Expired Options Exercised Weighted average exercise price, Options Exercised Weighted average exercise price, Options outstanding, at end of year Weighted average exercise price, options outstanding, at end of year Option exercisable at end of year Option exercise price at end of year Common stock available for issuance under 2022 Plan Common stock subject to outstanding awards Restricted stock unit compensation expense Unrecognized restricted stock unit compensation expense Weighted average amortized period Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Share Price Accrued dividend rights on restricted stock unit Aggregate intrinsic value of options exercisable Common stock shares purchased option exercise Exercise price Aggregate common stock shares delivered to company Common stock shares delivered to company - withholding taxes Net shares received OtherInvestmentReadilyMarketablesTable [Table] OtherInvestmentsReadilyMarketableLineItems [Line Items] Government securities Fixed income mutual funds Certificates of deposit Corporate bonds and notes Total marketable securities Loss from continuing operations Comprehensive loss Schedule of Equity Method Investments [Table] Schedule of Equity Method Investments [Line Items] Aggregrate investment Ownership percentage not fully diluted Ownership percentage fully diluted Private financing - D units Invested amount - multi-national pharma Additional invested amount - D units Unrealized gain securities Principal amount - convertible note Accrued interest - convertible note Unrealized gain on conversion - convertible note Equity investment net loss Book value of investment Operating lease right-of-use assets Operating lease obligations – current Operating lease obligations – non-current Total lease obligations Operating lease cost Short-term lease cost Total lease cost 2023 2024 2025 Total future minimum lease payments Less imputed interest Total operating lease liability Schedule of Restructuring and Related Costs [Table] PatentsAcquisition [Line Items] HFT patent acqusition - cash at closing Obligation to pay HFT seller additional cash based on achieving certain milestones Contingent common stock issued upon achieving certain milestones First $50 million of HFT net proceeds Greater than $50 million of HFT net proceeds Obligated to pay Cox, net proceeds percentage Accrued expenses Obligated to pay Recognition, net proceeds First $125 Million Next $125 Million Over $250 Million Recognition net proceeds payment related to Mirror Worlds patents Obligated to pay MTM First $100 Million Next $100 Million Additional consideration payable upon occurrence of certain future events Plan expense Borrowing rate - incremental Remaining lease term Annual base salary Annual Target Bonus Annual discretionary bonus Restricted stock units granted Restricted stock units Tranche 1 Restricted Stock Units to vest (Tranche 1) Restricted stock units to vest (Tranche 2) Minimum stock price for vesting Restricted stock units to vest (Tranche 3) Restricted stock units to vest (Tranche 4) CEO Incentive Compensation Prorated target bonus Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table] Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items] Litigation pending, description Concentration Risk [Table] Concentration Risk [Line Items] Percentage revenue Number of shares, common stock repurchased Price per share, common stock repurchased Aggregate cost of common stock Stock repurchase program, dollar amount Number of shares, common stock repurchased since inception Aggregate cost of common stock repurchased since inception Average price per share, common stock repurchased since inception Dividends, per share - semi-annual Dividends, per share - annual Semi-annual cash dividend payment date Semi-annual cash dividend record date Subsequent Event [Table] Subsequent Event [Line Items] Semi-annual cash dividend per common share Dividend payment date Restricted stock units granted to directors Aggregate settlement payments Conditional payment The member represent board of directors. Weighted average price per share common stock subject to repurchase. Semi-annual cash dividend record date Obligated to pay Cox, net proceeds percentage. Represent percentage of first $125 million. Represent next $125 Million. Over $250 Million Represent percentage of first $100 million. Represent percentage of next $100 million. Additional consideration payable upon occurrence of certain future events The member represent new employment agreement. The amount of Target annual bonus paid Chairman and CEO. Litigation pending, description. The member represent facebook. Assets, Current Other Assets Assets Liabilities, Current Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity Operating Expenses Operating Income (Loss) Nonoperating Income (Expense) Income (Loss) from Continuing Operations before Interest Expense, Interest Income, Income Taxes, Noncontrolling Interests, Net LossIncomeBeforeShareOfNetLossesOfEquityMethodInvestee Net Income (Loss) Attributable to Parent Weighted Average Number of Shares Outstanding, Diluted Shares, Outstanding Net Income (Loss) Available to Common Stockholders, Basic Share-Based Payment Arrangement, Noncash Expense Equity Method Investment, Realized Gain (Loss) on Disposal AccruedInterestOnConvertibleNote Marketable Securities, Unrealized Gain (Loss) Increase (Decrease) in Other Current Assets Increase (Decrease) in Prepaid Taxes Increase (Decrease) in Accounts Payable Increase (Decrease) in Income Taxes Payable Net Cash Provided by (Used in) Operating Activities Marketable Securities, Gain (Loss) Payments to Acquire Marketable Securities Payments to Acquire Intangible Assets Payments to Acquire Equity Method Investments ConvertibleNoteInvestment Net Cash Provided by (Used in) Investing Activities Payments of Ordinary Dividends, Common Stock ValueOfSharesDeliveredToFundWithholdingTaxes Payments for Repurchase of Common Stock Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents PatentsTextBlock MarketableSecuritiesDisclosureTextBlock Marketable Securities, Policy [Policy Text Block] PatentsPolicyTextBlock Income Tax, Policy [Policy Text Block] Policyholders' Dividend [Policy Text Block] Finite-Lived Intangible Assets, Accumulated Amortization Finite-Lived Intangible Assets, Net Deferred State and Local Income Tax Expense (Benefit) Deferred Federal Income Tax Expense (Benefit) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price CertificatesOfDeposit Lease, Cost Lessee, Operating Lease, Liability, to be Paid, Year One Lessee, Operating Lease, Liability, to be Paid, Year Two Lessee, Operating Lease, Liability, to be Paid, Year Three Accrued Liabilities and Other Liabilities EX-101.PRE 12 nssi-20221231_pre.xml XBRL PRESENTATION FILE EX-101.SCH 13 nssi-20221231.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Business link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Patents link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Income (Loss) Per Share link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Stockholders’ Equity link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Marketable Securities link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Equity Investment link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Employment Arrangements and Other Agreements link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Legal Proceedings link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Concentrations link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Related Party Transaction link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Stock Repurchase Program link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Dividend Policy link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Patents (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Income (Loss) Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Stockholders’ Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Marketable Securities (Tables) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Equity Investment (Tables) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Business (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Summary Of Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Patents (Details) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Patents (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Patents (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Disclosure -Income (Loss) Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - Income (Loss) Per Share (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - Income Taxes (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - Income Taxes (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - Income Taxes (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - Stockholders' Equity (Details) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - Stockholders' Equity (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - Stockholders’ Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - Marketable Securities (Details) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - Equity Investment (Details) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - Equity Investment (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - Commitments And Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - Commitments And Contingencies (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000053 - Disclosure - Commitments And Contingencies (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000054 - Disclosure - Commitments and Contingencies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000055 - Disclosure - Employment Arrangements and Other Agreements (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000056 - Disclosure - Legal Proceedings (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000057 - Disclosure - Concentrations (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000058 - Disclosure - Related Party Transaction (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000059 - Disclosure - Stock Repurchase Program (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000060 - Disclosure - Dividend Policy (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000061 - Disclosure - Subsequent Events (Details Narrative) link:presentationLink link:calculationLink link:definitionLink XML 14 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover - USD ($)
 12 Months Ended
Dec. 31, 2022
Mar. 23, 2023
Jun. 30, 2022
Cover [Abstract]      
Document Type 10-K    
Amendment Flag false    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Dec. 31, 2022    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2022    
Current Fiscal Year End Date --12-31    
Entity File Number 1-15288    
Entity Registrant Name NETWORK-1 TECHNOLOGIES, INC.    
Entity Central Index Key 0001065078    
Entity Tax Identification Number 11-3027591    
Entity Incorporation, State or Country Code DE    
Entity Address, Address Line One 65 Locust Avenue    
Entity Address, Address Line Two Third Floor    
Entity Address, City or Town New Canaan    
Entity Address, State or Province CT    
Entity Address, Postal Zip Code 06840    
City Area Code (203)    
Local Phone Number 920-1055    
Title of 12(b) Security Common Stock $.01 par value    
Trading Symbol NTIP    
Security Exchange Name NYSEAMER    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
Entity Shell Company false    
Entity Public Float     $ 39,885,677
Entity Common Stock, Shares Outstanding   23,817,505  
Auditor Firm ID 688    
Auditor Name Marcum LLP    
Auditor Location New York, New York    
XML 15 R2.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED BALANCE SHEETS - USD ($)
Dec. 31, 2022
Dec. 31, 2021
CURRENT ASSETS:    
Cash and cash equivalents $ 13,448,000 $ 44,497,000
Marketable securities, at fair value 34,991,000 15,126,000
Prepaid taxes 177,000
Other current assets 348,000 150,000
Total Current Assets 48,964,000 59,773,000
OTHER ASSETS:    
Patents, net of accumulated amortization 1,592,000 1,384,000
Equity investment 7,252,000 2,651,000
Convertible note investment 1,000,000
Operating leases right of use asset 161,000
Security deposits 13,000
Total Other Assets 9,005,000 5,048,000
TOTAL ASSETS 57,969,000 64,821,000
CURRENT LIABILITIES:    
Accounts payable 507,000 459,000
Income taxes payable 115,000 2,952,000
Accrued contingency fees and related costs 137,000
Accrued payroll 317,000 380,000
Other accrued expenses 587,000 180,000
Operating lease obligations, current 79,000
Total Current Liabilities 1,605,000 4,108,000
LONG TERM LIABILITIES:    
Deferred tax liability 1,161,000 554,000
Operating lease obligation, non-current 94,000
TOTAL LIABILITIES 2,860,000 4,662,000
STOCKHOLDERS' EQUITY    
Preferred stock, $0.01 par value; authorized 10,000,000 shares; none issued and outstanding at December 31, 2022 and December 31, 2021
Common stock, $0.01 par value; authorized 50,000,000 shares; 23,863,639 and 23,792,212 shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively 239,000 238,000
Additional paid-in capital 66,939,000 66,361,000
Accumulated deficit (12,055,000) (6,428,000)
Accumulated other comprehensive loss (14,000) (12,000)
TOTAL STOCKHOLDERS’ EQUITY 55,109,000 60,159,000
  TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 57,969,000 $ 64,821,000
XML 16 R3.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
Dec. 31, 2022
Dec. 31, 2021
Statement of Financial Position [Abstract]    
Preferred Stock, Par or Stated Value Per Share $ 0.01 $ 0.01
Preferred Stock, Shares Authorized 10,000,000 10,000,000
Preferred Stock, Shares Issued 0 0
Preferred Stock, Shares Outstanding 0 0
Common Stock, Par or Stated Value Per Share $ 0.01 $ 0.01
Common Stock, Shares Authorized 50,000,000 50,000,000
Common Stock, Shares, Issued 23,863,639 23,792,212
Common Stock, Shares, Outstanding 23,863,639 23,792,212
XML 17 R4.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]    
REVENUE $ 36,029,000
OPERATING EXPENSES:    
Costs of revenue 12,147,000
Professional fees and related costs 809,000 1,500,000
General and administrative 2,778,000 2,501,000
Amortization of patents 316,000 295,000
TOTAL OPERATING EXPENSES 3,903,000 16,443,000
OPERATING INCOME (LOSS) (3,903,000) 19,586,000
  OTHER INCOME    
Interest and dividend income, net 1,020,000 327,000
Gain on conversion of note 271,000
Gain on equity method investment 3,883,000
Net realized and unrealized loss on marketable securities (1,351,000) (173,000)
Total other income, net 3,823,000 154,000
(LOSS) INCOME BEFORE INCOME TAXES AND SHARE OF NET LOSSES OF EQUITY METHOD INVESTEE (80,000) 19,740,000
INCOME TAXES PROVISION:    
Current 2,952,000
Deferred taxes, net 607,000 1,508,000
Total income taxes expense 607,000 4,460,000
(LOSS) INCOME BEFORE SHARE OF NET LOSSES OF EQUITY METHOD INVESTEE: (687,000) 15,280,000
SHARE OF NET LOSSES OF EQUITY METHOD INVESTEE (1,639,000) (999,000)
NET (LOSS) INCOME $ (2,326,000) $ 14,281,000
Basic $ (0.10) $ 0.59
Diluted $ (0.10) $ 0.58
Weighted average common shares outstanding:    
Basic 23,825,917 24,136,821
Diluted 23,825,917 24,530,568
Cash dividends declared per share $ 0.10 $ 0.10
OTHER COMPREHENSIVE LOSS    
Net unrealized holding loss on corporate bonds and notes arising during the year, net of tax $ (2,000) $ (2,000)
COMPREHENSIVE (LOSS) INCOME $ (2,328,000) $ 14,279,000
XML 18 R5.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive (Loss)
Total Stockholders’ Equity
Balance – December 31, 2021 at Dec. 31, 2020 $ 241,000 $ 66,124,000 $ (17,193,000) $ (10,000) $ 49,162,000
Beginning Balance, Shares at Dec. 31, 2020 24,105,879        
Dividends and dividend equivalents declared (2,429,000) (2,429,000)
Stock-based compensation 238,000 238,000
Vesting of restricted stock units $ 1,000 (1,000)
Vesting of restricted stock units, shares 70,000        
Value of shares delivered to pay exercise price and withholding taxes (14,000) (14,000)
Value of shares delivered to pay withholding taxes, Shares (5,192)        
Treasury stock purchased and retired $ (4,000) (1,073,000) (1,077,000)
Treasury stock purchased and retired, shares (378,475)        
Net unrealized loss on corporate bonds and notes (2,000) (2,000)
Net loss 14,281,000 14,281,000
Balance – December 31, 2022 at Dec. 31, 2021 $ 238,000 66,361,000 (6,428,000) (12,000) 60,159,000
Ending Balance, Shares at Dec. 31, 2021 23,792,212        
Dividends and dividend equivalents declared (2,418,000) (2,418,000)
Stock-based compensation 585,000 585,000
Vesting of restricted stock units $ 2,000 (2,000)
Vesting of restricted stock units, shares 182,500        
Cashless exercise of stock options $ 5,000 (5,000)
Cashless exercise of options, Shares 500,000        
Value of shares delivered to pay exercise price and withholding taxes $ (3,000) (352,000) (355,000)
Value of shares delivered to pay withholding taxes, Shares (382,543)        
Treasury stock purchased and retired $ (3,000) (531,000) (534,000)
Treasury stock purchased and retired, shares (228,530)        
Net unrealized loss on corporate bonds and notes (2,000) (2,000)
Net loss (2,326,000) (2,326,000)
Balance – December 31, 2022 at Dec. 31, 2022 $ 239,000 $ 66,939,000 $ (12,055,000) $ (14,000) $ 55,109,000
Ending Balance, Shares at Dec. 31, 2022 23,863,639        
XML 19 R6.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net (loss) income $ (2,326,000) $ 14,281,000
Adjustments to reconcile net (loss) income to net cash used in operating activities:    
Amortization of patents 316,000 295,000
Stock-based compensation 585,000 238,000
Loss allocated from equity investment 1,639,000 999,000
Deferred tax expense 607,000 1,508,000
Amortization of right of use asset, net 43,000
Gain on equity method investment (3,883,000)
Accrued interest on convertible note (86,000)
Gain on conversion of note (271,000)
Unrealized loss on marketable securities 880,000 148,000
Changes in operating assets and liabilities:    
Other current assets (208,000) (30,000)
Prepaid taxes (167,000)
Accounts payable 48,000 (142,000)
Income taxes payable (2,837,000) 2,952,000
Security deposit 13,000 8,000
Operating lease obligations (31,000)
Accrued expenses 242,000 (758,000)
NET CASH (USED IN) PROVIDED BY OPERATING ACTIVITIES (5,436,000) 19,499,000
CASH FLOWS FROM INVESTING ACTIVITIES:    
Sales of marketable securities 13,156,000 17,154,000
Purchases of marketable securities (33,903,000) (13,059,000)
Development of patents (524,000) (101,000)
Equity Investment (1,000,000)
Convertible note investment (1,000,000)
NET CASH (USED IN) PROVIDED BY INVESTING ACTIVITIES (22,271,000) 2,994,000
CASH FLOWS FROM FINANCING ACTIVITIES:    
Cash dividends paid (2,453,000) (2,410,000)
Value of shares delivered to fund withholding taxes (355,000) (14,000)
Repurchases of common stock, inclusive of commissions (534,000) (1,077,000)
NET CASH USED IN FINANCING ACTIVITIES (3,342,000) (3,501,000)
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS (31,049,000) 18,992,000
CASH AND CASH EQUIVALENTS, beginning of year 44,497,000 25,505,000
CASH AND CASH EQUIVALENTS, end of year 13,448,000 44,497,000
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:    
Interest
Income taxes 3,004,000
NON-CASH FINANCING ACTIVITY    
Accrued dividend rights on restricted stock units 37,000 20,000
Right of use asset obtained in exchange for lease liability 204,000
Conversion of note receivable $ 1,086,000
XML 20 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Business
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Business

Note A – Business

 

Network-1 Technologies, Inc. (the “Company”) is engaged in the development, licensing and protection of its intellectual property assets. The Company presently owns ninety-seven (97) U.S. patents, fifty-two (52) of such patents have expired, and eight (8) foreign patents related to (i) the Cox patent portfolio (the “Cox Patent Portfolio) relating to enabling technology for identifying media content on the Internet and taking further actions to be performed after such identification; (ii) the M2M/IoT patent portfolio (the “M2M/IoT Patent Portfolio”) relating to, among other things, enabling technology for authenticating, provisioning and using embedded SIM (Subscriber Identification Module)technology in next generation IoT, Machine-to-Machine, and other mobile devices, including smartphones, tablets and computers; (iii) the HFT patent portfolio (the “HFT Patent Portfolio”) covering certain advanced technologies relating to high frequency trading, which inventions specifically address technological problems associated with speed and latency and provide critical latency gains in trading systems where the difference between success and failure may be measured in nanoseconds; (iv) the Mirror Worlds patent portfolio (the “Mirror Worlds Patent Portfolio”) relating to foundational technologies that enable unified search and indexing, displaying and archiving of documents in a computer system; and (v) the remote power patent (the “Remote Power Patent”) covering delivery of Power over Ethernet (PoE) cables for the purpose of remotely powering network devices, such as wireless access ports, IP phones and network based cameras.

The Company’s current strategy includes continuing to pursue licensing opportunities for its intellectual property assets. In addition, the Company continually reviews opportunities to acquire or license additional intellectual property as well as other strategic alternatives. The Company’s patent acquisition and development strategy is to focus on acquiring high quality patents which management believes have the potential to generate significant licensing opportunities as the Company has achieved with respect to its Remote Power Patent and Mirror Worlds Patent Portfolio. In addition, the Company may also enter into strategic relationships with third parties to develop, commercialize, license or otherwise monetize their intellectual property.

The Company has made equity investments totaling $7,000,000 in ILiAD Biotechnologies, LLC (“ILiAD”), a clinical stage biotechnology company (see Note H hereof).

XML 21 R8.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

Note B – Summary of Significant Accounting Policies

 

[1]Principles of Consolidation

The Company’s consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The accompanying financial statements include the accounts of the Company and its wholly-owned subsidiaries, Mirror Worlds Technologies, LLC and HFT Solutions, LLC. All intercompany transactions and balances are eliminated in consolidation.

 

[2]Use of Estimates and Assumptions

The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods. The significant estimates and assumptions made in the preparation of the Company’s consolidated financial statements primarily include costs related to the Company’s assertion of litigation, the valuation of the Company’s patent portfolios, stock-based compensation, the recoverability of deferred tax assets and carrying value of the Company’s equity method investments. Actual results could be materially different from those estimates, upon which the carrying values were based.

Certain amounts recorded to reflect the Company’s share of income or losses of its equity method investee, accounted for under the equity method, are based on estimates and the unaudited results of operations of the equity method investee and may require adjustment in the future when the audit is complete. The Company reports its share of the results of its equity method investee on a one quarter lag basis.

 

[3]Cash and Cash Equivalents

The Company maintains cash deposits in high quality financial institutions insured by the Federal Deposit Insurance Corporation ("FDIC"). Accounts at each institution are insured by the FDIC up to $250,000. At December 31, 2022 and 2021, the Company had $1,715,000 and $8,109,000, respectively, in excess of the FDIC insured limit.

 

The Company considers all highly liquid short-term investments, including certificates of deposit and money market funds, that are purchased with an original maturity of three months or less to be cash equivalents.

 

[4]Marketable Securities

 

The Company’s marketable securities are comprised of certificates of deposit with original maturity greater than three months from date of purchase, government securities, fixed income mutual funds, and a corporate bond (see Note G). At December 31, 2022 and December 31, 2021, included in marketable securities, the Company had aggregate certificates of deposit of $2,976,000 and $0, respectively. The Company’s marketable securities are measured at fair value and are accounted for in accordance with ASU 2016-01. Unrealized holding gains and losses on certificates of deposit, government securities, and fixed income mutual funds are recorded in net realized and unrealized gain (loss) from investments on the consolidated statements of operations and comprehensive income (loss). Unrealized holding gains and losses, net of the related tax effect, on corporate bonds and notes are excluded from earnings and are reported as a separate component of stockholders’ equity until realized. Dividend and interest income are recognized when earned. Realized gains and losses are included in earnings and are derived using the specific identification method for determining the cost of the marketable securities.

 

[5]Revenue Recognition

 

Under ASC 606, revenue is recognized when the Company completes the licensing of its intellectual property to its licensees, in an amount that reflects the consideration the Company expects to be entitled to in exchange for licensing its intellectual property.

 

The Company determines revenue recognition through the follow steps:

 

•identification of the license agreement;
•identification of the performance obligations in the license agreement;
•determination of the consideration for the license;
•allocation of the transaction price to the performance obligations in the contract; and
•recognition of revenue when the Company satisfies its performance obligations.

Revenue disaggregated by source is as follows (the Company had no revenue for the year ended December 31, 2022):

          
   Years Ended December 31, 
   2022   2021 
Fully-Paid Licenses  $—   $17,000,000(1)
Royalty Bearing Licenses   —    19,029,000(2)
Total Revenue  $—   $36,029,000 

__________________________

(1)Includes $17,000,000 received from Hewlett-Packard related to settlement of a patent litigation (see Note K[1] hereof).
(2)Includes (1) $18,691,890 of royalty revenue from Cisco Systems, Inc. from resolution of a dispute under its license agreement with the Company and (2) $337,000 of royalty revenue received from Plantronics, Inc.

 

Revenue from the Company’s patent licensing business is typically generated from negotiated license agreements. The timing and amount of revenue recognized from each licensee depends upon a variety of factors, including the terms of each agreement and the nature of the obligations of the parties. These agreements may include, but not be limited to, elements related to past infringement liabilities, non-refundable upfront license fees, and ongoing royalties on licensed products sold by the licensee. Generally, in the event of settlement of litigation related to the Company’s assertion of patent infringement involving its intellectual property, defendants will either pay (i) a non-refundable lump sum payment for a non-exclusive fully-paid license, or (ii) a non-refundable lump sum payment (license initiation fee) together with an ongoing obligation to pay quarterly or monthly royalties to the Company for the life of the licensed patent.

 

[6]Equity Method Investments

Equity method investments are equity securities in entities the Company does not control but over which it has the ability to exercise significant influence. These investments are accounted for under the equity method of accounting in accordance with ASC 323, Investments — Equity Method and Joint Ventures (see Note H hereof). Equity method investments are measured at cost minus impairment, if any, plus or minus the Company’s share of an investee’s income or loss. The Company’s proportionate share of the income or loss from equity method investments is recognized on a one-quarter lag. When the Company’s carrying value in an equity method investment is reduced to zero, no further losses are recorded in the Company’s financial statements unless the Company guaranteed obligations of the investee company or has committed additional funding. When the investee company subsequently reports income, the Company will not record its share of such income until it equals the amount of its share of losses not previously recognized.

Upon a sale of an equity method investment by the Company, the difference between sales proceeds and the carrying amount of the equity investment is recognized in profit or loss. Upon the issuance of securities in an observable price transaction, the Company will account for the share issuance by the equity method investee as if the Company had sold a proportionate share of its investment in the observable price transaction. The Company will record a gain or loss associated with the dilution of its investment to reflect third party investments in the investee and will increase or decrease its basis in the equity method investee accordingly. The gain or loss is recorded within other income or expense in the Company’s consolidated statements of operations and comprehensive income (loss).

During the year ended December 31, 2022, the Company recorded a change in its share of net losses of the equity method investee as a result of the Company receiving new information from the equity method investee during the fourth quarter of 2022. The effect of this change was an increase in the Company’s share of the net losses of the equity method investee of $398,000 and a corresponding decrease in the Company’s net income, and a decrease in basic and diluted earnings of $0.02 per share.

The Company performed an assessment to determine significance of the equity method investee under the investment, asset and income tests utilizing the 20% threshold. The Company determined that the equity method investee satisfied the income test and has included summarized financial data of the equity method investee in Note H hereof.

 

[7]Patents

The Company owns patents that relate to various technologies. The Company capitalizes the costs associated with acquisition, registration and maintenance of its acquired patents and amortizes these assets over their remaining useful lives on a straight-line basis. Any further payments made to maintain or develop the patents would be capitalized and amortized over the balance of the useful life for the patents.

[8]Costs of Revenue and Related Costs

The Company includes in costs of revenue for the year ended December 31, 2022 and 2021 contingent legal fees payable to patent litigation counsel, any other contractual payments to third parties related to net proceeds from monetization of patents (see Note I[1] hereof) and incentive bonus compensation payable to its Chairman and Chief Executive Officer (see Note J[1] hereof).

 

[9]Income Taxes

The Company accounts for income taxes in accordance with Financial Accounting Standards Board (FASB) ASC Topic 740, Income Taxes (ASC 740), which requires the Company to use the assets and liability method of accounting for income taxes. Under the assets and liability method, deferred income taxes are recognized for the tax consequences of temporary (timing) differences by applying enacted statutory tax rates applicable to future years to differences between financial statement carrying amounts and the tax bases of existing assets and liabilities and operating loss and tax credit carry forwards. Under this accounting standard, the effect on deferred income taxes of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recognized if it is more likely than not that some portion, or all, of a deferred tax asset will not be realized.

ASC 740-10, Accounting for Uncertainty in Income Taxes, defines uncertainty in income taxes and the evaluation of a tax position as a two-step process. The first step is to determine whether it is more likely than not that a tax position will be sustained upon examination, including the resolution of any related appeals or litigation based on the technical merits of that position. The second step is to measure a tax position that meets the more-likely-than-not threshold to determine the amount of benefit to be recognized in the financial statements. A tax position is measured at the largest amount of benefit that is greater than 50 percent likelihood of being realized upon ultimate settlement. Tax positions that previously failed to meet the more-likely-than-not recognition threshold should be recognized in the first subsequent period in which the threshold is met. Previously recognized tax positions that no longer meet the more-likely-than-not criteria should be de-recognized in the first subsequent financial reporting period in which the threshold is no longer met. The Company had no uncertain tax positions as of December 31, 2022 and 2021.

U.S. federal, state and local income tax returns prior to 2019 are not subject to examination by any applicable tax authorities, except that tax authorities could challenge returns (only under certain circumstances) for earlier years to the extent they generated loss carry-forwards that are available for those future years.

 

[10]Stock-Based Compensation

The Company accounts for its stock-based compensation awards to employees and directors in accordance with FASB ASC Topic 718, Compensation — Stock Compensation (“ASC 718”). ASC 718 requires all stock-based compensation to employees, including grants of employee stock options and restricted stock units, to be recognized in the consolidated statements of operations and comprehensive income (loss) based on their grant date fair values.

Compensation expense related to awards to employees is recognized on a straight-line basis based on the grant date fair value over the associated service period of the award, which is generally the vesting term. The Company uses the Black-Scholes option pricing model to determine the grant date fair value of options granted. The fair value of restricted stock units is determined based on the number of shares underlying the grant and either the quoted market price of the Company’s common stock on the date of grant for time-based and performance-based awards, or the fair value on the date of grant using the Monte Carlo Simulation model for market-based awards.

 

[11]Earnings Per Share

The Company reports earnings per share in accordance with U.S. GAAP, which requires presentation of basic and diluted earnings per share in conjunction with the disclosure of the methodology used in computing such earnings per share. Basic earnings per share excludes dilution and is computed by dividing income available to common shareholders by the weighted average common shares outstanding during the period. Diluted earnings per share takes into account the potential dilution that could occur if securities or other contracts, such as warrants and options to purchase common stock were exercised and shares were issued pursuant to outstanding restricted stock units. Common stock equivalents having an anti-dilutive effect on earnings per share are excluded from the calculation of diluted earnings per share.

 

[12]Fair Value Measurements

ASC Topic 820, Fair Value Measurement and Disclosures, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. This topic also establishes a fair value hierarchy which requires classification based on observable and unobservable inputs when measuring fair value.

There are three levels of inputs that may be used to measure fair value:

Level 1: Observable inputs such as quoted prices (unadjusted) in an active market for identical assets or liabilities.

Level 2: Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.

Level 3: Unobservable inputs that are supported by little or no market activity; therefore, the inputs are developed by the Company using estimates and assumptions that the Company expects a market participant would use, including pricing models, discounted cash flow methodologies, or similar techniques.

The carrying value of the Company’s financial instruments, including cash and cash equivalents and accounts payable, approximates fair value because of the short-term nature of these financial instruments.

The Company’s marketable securities are classified within Level 1 because they are valued using quoted market prices in an active market.

The Company’s equity method investment is measured on a non-recurring basis and is classified within Level 2 as it is valued using an observable price transaction for similar assets in a market that is not active (see Note B[6] and Note H hereof).

 

[13]Carrying Value, Recoverability and Impairment of Long-Lived Assets

An impairment loss shall be recognized only if the carrying amount of a long-lived asset (asset group) is not recoverable and exceeds its fair value. The carrying amount of a long-lived asset (asset group) is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset (asset group). That assessment shall be based on the carrying amount of the asset (asset group) at the date it is tested for recoverability. An impairment loss shall be measured as the amount by which the carrying amount of a long-lived asset (asset group) exceeds its fair value. If an impairment loss is recognized, the adjusted carrying amount of a long-lived asset shall be its new cost basis. For a depreciable long-lived asset, the new cost basis shall be depreciated (amortized) over the remaining useful life of that asset. Restoration of a previously recognized impairment loss is prohibited. At December 31, 2022 and 2021, there was no impairment to the Company’s patents and equity investment.

The Company’s equity investment in ILiAD is evaluated on a non-recurring basis for impairment, when and if a triggering event occurs.

 

[14]Leases

Under ASC 842, the Company determines if an arrangement is a lease at inception. Right-of-Use (“ROU”) assets and related lease obligations are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. As the Company's lease does not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company's determined incremental borrowing rate is a hypothetical rate based on its understanding of what the Company's credit rating would be. The ROU asset also includes any lease payments made prior to commencement and is recorded net of any lease incentives received and net of the deferred rent balance on the date of implementation. The Company's lease terms may include options to extend or terminate the lease when it is reasonably certain that it will exercise such options. As permitted under ASC 842, the Company has elected to not recognize ROU assets and related lease obligations for leases with terms of twelve months or less.

 

[15]Dividend Policy

Cash dividends are recorded when declared by the Company’s Board of Directors. Common stock dividends are charged against retained earnings when declared or paid (see Note O hereof).

 

[16]Reclassifications

Stock-based compensation in the 2021 consolidated statements of operations and comprehensive income (loss) have been recast and reclassified to conform to the current year’s presentation. 

 
XML 22 R9.htm IDEA: XBRL DOCUMENT v3.23.1
Patents
 12 Months Ended
Dec. 31, 2022
Patents  
Patents

Note C – Patents

The Company’s intangible assets at December 31, 2022 include patents with estimated remaining economic useful lives ranging from 0.50 to 16.50 years. For all periods presented, all the Company’s patents were subject to amortization. The gross carrying amounts and accumulated amortization related to acquired intangible assets as of December 31, 2022 and 2021 were as follows:

          
  

2022

  

2021

 
Gross carrying amount  $8,473,000   $7,949,000 
Accumulated amortization   (6,881,000)   (6,565,000)
Patents, net  $1,592,000   $1,384,000 

 

Amortization expense for the years ended December 31, 2022 and 2021 was $316,000 and $295,000, respectively. Future amortization of current intangible assets, net is as follows:

      
For the years ended December 31,     
2023   $266,000 
2024    120,000 
2025    120,000 
2026    120,000 
2027    119,000 
Thereafter    847,000 
Total   $1,592,000 
       

 

Two patents within the Cox Patent Portfolio expire in July 2023 and November 2023, and the balance of the patents within such portfolio have expired. The expiration dates of patents within the Company’s M2M/IoT Patent Portfolio range from September 2033 to May 2034. The expiration dates within the Company’s HFT Patent Portfolio range from October 31, 2039 to November 1, 2039. All of the patents within the Company’s Mirror Worlds Patent Portfolio expired and the Remote Power Patent expired.
XML 23 R10.htm IDEA: XBRL DOCUMENT v3.23.1
Income (Loss) Per Share
 12 Months Ended
Dec. 31, 2022
Earnings Per Share [Abstract]  
Income (Loss) Per Share

Note D – Income (Loss) Per Share

Basic Income (Loss) per share is calculated by dividing the net income (loss) by the weighted average number of outstanding common shares during the period. Diluted per share data included the dilutive effects of stock options and restricted stock units. Potentially dilutive shares of 625,000 and 12,500 at December 31, 2022 and 2021, respectively, consist of restricted stock units. However, as the Company generated a net loss in 2022, all potentially dilutive shares were not reflected in diluted net loss per share because the impact of such instruments was anti-dilutive. Computations of basic and diluted weighted average common shares outstanding are as follows:

 Schedule of earnings per share          
   2022   2021 
         
Weighted-average common shares outstanding – basic   23,825,917    24,136,821 
           
Dilutive effect of restricted stock units and stock options  

—

   393,747 
           
Weighted-average common shares outstanding – diluted   23,825,917    24,530,568 
           
Restricted stock units excluded from the computation of diluted income per share because the effect of inclusion would have been anti-dilutive   625,000    12,500 

 

 
XML 24 R11.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes
 12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Income Taxes

Note E – Income Taxes

Significant components of the income taxes were as follows for the years ended December 31, 2022 and 2021.

          
   2022   2021 

 

Current

    
State and local  $—   $144,000 
Federal   —    2,808,000 
Total Current Tax Expense (Benefit)  $—   $2,952,000 
           
Deferred          
State and local      56,000    83,000 
Federal   551,000    1,425,000 
Total Deferred Tax Expense   607,000    1,508,000 
           
Total Income Taxes  $607,000   $4,460,000 

 

Significant components of deferred tax assets (liability) as of December 31, 2022 and 2021 consisted of the following:

          
   2022   2021 
Deferred tax assets (liability):
         Net operating loss carryforward		  $477,000   $
—		 
         Capital loss carryforward   331,000    — 
         Stock options and RSU   30,000    — 
Valuation allowance (838,000) —
           
           
        Deferred Tax Liability(1)   (1,161,000)   (554,000)
Total deferred tax liability  $(1,161,000)  $(554,000)

_________________________

(1) Deferred tax liability primarily as a result of a temporary difference related to the Company’s equity method investment.

 

As of December 31, 2022, the Company’s estimated aggregate total net operating loss carryforwards (NOLs) were $2,168,000 for U.S. federal tax purposes with an indefinite life.  At December 31, 2022, the Company had deferred tax assets of $838,000, which were offset by a valuation allowance of $838,000 as it was determined that it is more likely than not that the deferred tax assets would not be realized. At December 31, 2022, the Company had a deferred tax liability position of $1,161,000.

The reconciliation between the taxes as shown and the amount that would be computed by applying the statutory federal income tax rate to the net income before income taxes is as follows:

Schedule of reconciliation of income tax  
   Years Ended 
  

December 31,

 
  

2022

  

2021

 
 
Income tax - statutory rate   21.00%    21.00% 
Permanent differences   (8.40)%    1.69% 
Change in valuation allowance   (48.79)%    —% 
State   1.28%    1.11% 
Other   (0.43)%    —% 
  Total   (35.34)%    23.80% 

 

 

On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of Treasury has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. The excise tax applies in cases where the total value of the stock repurchased during the taxable year exceeds $1,000,000.

The personal holding company (“PHC”) rules under the Internal Revenue Code impose a 20% tax on a PHC’s undistributed personal holding company income (“UPHCI”), which means, in general, taxable income subject to certain adjustments. For a corporation to be classified as a PHC, it must satisfy two tests: (i) that more than 50% in value of its outstanding shares must be owned directly or indirectly by five or fewer individuals at any time during the second half of the year (after applying constructive ownership rules to attribute stock owned by entities to their beneficial owners and among certain family members and other related parties) (the “Ownership Test”) and (ii) at least 60% of its adjusted ordinary gross income for a taxable year consists of dividends, interest, royalties, annuities and rents (the “Income Test”). During the second half of 2022, based on available information concerning the Company’s shareholder ownership, the Company did not satisfy the Ownership Test and thus the Company was not a PHC for 2022. However, the Company may subsequently be determined to be a PHC in 2023 or in future years if it satisfies both the Ownership Test and the Income Test. If the Company were to become a PHC in any future year, it would be subject to an additional 20% tax on its UPHCI. In such event, the Company may issue a special cash dividend, to its shareholders in an amount equal to the UPHCI rather than incur the additional 20% tax.
XML 25 R12.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders’ Equity
 12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
Stockholders’ Equity

Note F – Stockholders’ Equity

The Company adopted a new 2022 Stock Incentive Plan, (the “2022 Plan”), approved by its Board of Directors on July 25, 2022 and its stockholders on September 20, 2022. The 2022 Plan provides for the grant of any or all of the following types of awards: (a) stock options, (b) restricted stock, (c) deferred stock, (d) stock appreciation rights, and (e) other stock-based awards including restricted stock units. Awards under the 2022 Plan may be granted singly, in combination, or in tandem. Subject to standard anti-dilution adjustments as provided, the 2022 Plan provides for an aggregate of 2,300,000 shares of the Company’s common stock to be available for distribution. The Company’s Compensation Committee generally has the authority to administer the 2022 Plan, determine participants who will be granted awards, the size and types of awards, the terms and conditions of awards and the form and content of the award agreements representing awards. Awards under the 2022 Plan may be granted to employees, directors and consultants of the Company and its subsidiaries. As of December 31, 2022, there were 2,300,000 shares of common stock available for issuance under the 2022 Plan.

As of December 31, 2022, there were 625,000 shares of common stock subject to outstanding awards under the Company 2013 Stock Incentive Plan (“2013 Plan”). The Company discontinued issuing awards under its 2013 Plan as a result of the adoption of the 2022 Plan.

[1]Restricted Stock Units

A summary of restricted stock units granted during the years ended December 31, 2022 and December 31, 2021 is as follows (each restricted stock unit represents the contingent right to receive one share of the Company’s common stock):

Schedule of restricted stock units                    
   2022   2021 
   Number of
Shares		   Weighted-Average Grant
Date Fair Value		   Number of
Shares		   Weighted-Average Grant
Date Fair Value		 
Balance of restricted stock units outstanding at beginning of year   12,500   $3.36    162,500   $2.25 
Grants of restricted stock units   670,000    1.92    45,000    3.51 
Vested restricted stock units   (57,500)   (2.73)   (195,000)   (2.47)
Balance of restricted stock units outstanding at end of year   625,000   $1.87    12,500   $3.36 

 

 

Restricted stock unit compensation expense was $585,000 for the year ended December 31, 2022 and $238,000 for the year ended December 31, 2021.

The Company has an aggregate of $736,000 of unrecognized restricted stock unit compensation expense as of December 31, 2022 to be expensed over a weighted average period of 2.61 years.

The fair value of restricted stock units is determined based on the number of shares granted and the quoted market price of the Company’s common stock on the date of grant for time-based and performance-based awards and fair value at grant date using the Monte Carlo simulation model for market-based awards. The key inputs into the Monte Carlo simulation used to value the restricted stock units was a risk-free rate of 2.39%, expected term of 4 years, expected volatility of 40% and a stock price of $2.47.

All of the Company’s issued restricted stock units have dividend equivalent rights. As of December 31, 2022 and 2021, there was $37,000 and $72,000 accrued for dividend equivalent rights which were included in other accrued expenses.

[2]Stock Options

At December 31, 2022, there were no stock options outstanding. At December 31, 2021, one stock option to purchase 500,000 shares of common stock was outstanding, representing an option grant outside of the 2013 Plan (issued prior to the establishment of the 2013 Plan). The stock option had a weighted average exercise price of $1.19 and a weighted average remaining life of 0.84 years. There were no grants of stock options during the years ended December 31, 2022 and 2021.

The following table summarizes stock option activity for the years ended December 31:

 

                    
  

2022

  

2021

 
       Weighted       Weighted 
       Average       Average 
   Options   Exercise   Options   Exercise 
  

Outstanding

  

Price

  

Outstanding

  

Price

 
Options outstanding at beginning of year   500,000   $1.19    500,000   $1.19 
Granted   —    —    —    — 
Expired   —    —    —    — 
Exercised   500,000   $1.19    —   — 
Options outstanding at end of year   —   —    500,000   $1.19 
Options exercisable at end of year   —   —    500,000   $1.19 
                     

 

During the year ended December 31, 2022 and 2021, the Company did not recognize any stock-based compensation related to the vesting of prior issued stock options to employees. The Company at December 31, 2022 and 2021 had no remaining unrecognized expenses related to unvested stock options to employees and directors. The aggregate intrinsic value of all stock options exercisable at December 31, 2022 and 2021 was $-0- and $815,000, respectively.

On October 27, 2022, the Company’s Chairman and Chief Executive Officer exercised a stock option to purchase 500,000 shares of the Company’s common stock at an exercise price of $1.19 per share on a net exercise (or cashless) basis. In connection with the net exercise of the stock option, the Company’s Chairman and Chief Executive Officer delivered 334,459 shares of common stock (including 94,539 shares for withholding taxes) to the Company and received 165,541 net shares.

 
XML 26 R13.htm IDEA: XBRL DOCUMENT v3.23.1
Marketable Securities
 12 Months Ended
Dec. 31, 2022
Marketable Securities  
Marketable Securities

Note G – Marketable Securities

Marketable securities as of December 31, 2022 and 2021 were composed of: 

Schedule of marketable securities                    
   December 31, 2022 
  

Cost
Basis

  

Gross
Unrealized
Gains

  

Gross
Unrealized
Losses

  

Fair Value

 
Government Securities  $20,781,000   $67,000   $—   $20,848,000 
Fixed income mutual funds   11,904,000    —    (915,000)   10,989,000 
Certificates of Deposit   3,019,000    —    (43,000)   2,976,000 
Corporate bonds and notes   192,000    —    (14,000)   178,000 
Total marketable securities  $35,896,000   $67,000   $(972,000)  $34,991,000 
                     

 

   December 31, 2021 
  

Cost
Basis

  

Gross
Unrealized
Gains

  

Gross
Unrealized
Losses

  

Fair Value

 
Fixed income mutual funds  $14,462,000    —   $(137,000)  $14,325,000 
Corporate bonds and notes   813,000    —    (12,000)   801,000 
Total marketable securities  $15,275,000   $—   $(149,000)  $15,126,000 

 
XML 27 R14.htm IDEA: XBRL DOCUMENT v3.23.1
Equity Investment
 12 Months Ended
Dec. 31, 2022
Equity Method Investments and Joint Ventures [Abstract]  
Equity Investment

Note H – Equity Investment

During the period December 2018 through December 2022, the Company made an aggregate investment of $7,000,000 in ILiAD, a privately held clinical stage biotechnology company dedicated to the prevention and treatment of human disease caused by Bordetella pertussis. ILiAD is focused on validating its proprietary intranasal vaccine, BPZE1, for the prevention of Pertussis (whooping cough). At December 31, 2022, the Company owned approximately 6.8% of the outstanding units of ILiAD on a non-fully diluted basis and 6.3% of the outstanding units on a fully diluted basis (after giving effect to the exercise of all outstanding options and warrants). In connection with its investment, the Company’s Chairman and Chief Executive Officer obtained a seat on ILiAD’s Board of Managers and receives the same compensation for service on the Board of Managers as other non-management Board members.

On August 24, 2022, ILiAD completed a private financing of $42,836,000 of its Class D units, of which a multi-national pharmaceutical company invested $30,000,000 (the “Financing”). As part of the Financing, the Company invested $1,000,000. This private financing represented an observable price transaction in accordance with ASC 323 and resulted in dilution in the Company’s ownership in the ILiAD. In accordance with ASC 323-10-40-1, the Company accounted for the dilution as if it had sold a portion of its investment and therefore recorded an unrealized gain of $3,883,000 and a corresponding increase in the carrying value of its investment in ILiAD. The Company determined the new carrying value of its equity investment using an observable transaction price since the Company determined the securities owned by the Company were not materially different than the securities sold by ILiAD in the Financing. The unrealized gain is reflected in the Company’s consolidated statements of operations and comprehensive income (loss) for the year ended December 31, 2022.

In addition, as part of the Financing, the Company converted its convertible note in the principal amount of $1,000,000 plus accrued interest of $86,000, in accordance with its terms, into equity of ILiAD and has accounted for this investment under the equity method of accounting. The Company recognized a gain on conversion of $271,000 which was recognized in its consolidated statements of operations and comprehensive income (loss) for the year ended December 31, 2022.

For the years ended December 31, 2022 and 2021, the Company recorded an allocated net loss from its equity method investment in ILiAD of $1,639,000 and $999,000, respectively.

The difference between the Company’s share of equity in ILiAD’s net assets and the purchase price of the investment is due to an excess amount paid over the book value of the investment of $4,130,000, which is accounted for as equity method goodwill.

The Company performed an assessment to determine significance of its equity investee using the investment, asset and income tests. The Company concluded the income test threshold was met for the year ended December 31, 2022. The following table provides certain summarized financial information for the Company’s equity method investee for the periods presented and has been compiled from the equity investee’s financial statement, reported on one quarter lag.

Schedule of equity method investments          
   Twelve Months Ended September 30, 
  

2022

  

2021

 
Loss from continuing operations  $15,246,000   $11,133,000 
Comprehensive loss  $17,913,000   $10,384,000 
           

 
XML 28 R15.htm IDEA: XBRL DOCUMENT v3.23.1
Commitments and Contingencies
 12 Months Ended
Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

Note I – Commitments and Contingencies

[1]Legal fees:

Russ, August & Kabat provides legal services to the Company with respect to its pending patent litigation filed in May 2017 against Facebook, Inc. in the U.S. District Court for the Southern District of New York relating to several patents within the Company’s Mirror Worlds Patent Portfolio (see Note K[2] hereof). The terms of the Company’s agreement with Russ, August & Kabat provide for cash payments on a monthly basis subject to a cap plus a contingency fee ranging between 15% and 24% of the net recovery (after deduction of expenses) depending on the stage of the proceeding in which the result (settlement or judgment) is achieved. The Company is responsible for all expenses incurred with respect to this litigation.

Russ, August & Kabat also provides legal services to the Company with respect to its pending patent litigations filed in April 2014 and December 2014 against Google Inc. and YouTube, LLC in the U.S. District Court for the Southern District of New York relating to certain patents within the Cox Patent Portfolio acquired by the Company from Dr. Cox (see Note K[1] hereof). The terms of the Company’s agreement with Russ, August & Kabat provide for legal fees on a full contingency basis ranging from 15% to 30% of the net recovery (after deduction of expenses) depending on the stage of the proceeding in which the result (settlement or judgment) is achieved. The Company is responsible for all expenses incurred with respect to this litigation.

[2]Patent Acquisitions:

On March 25, 2022, the Company completed the acquisition of a new patent portfolio (HFT Patent Portfolio) currently consisting of nine U.S. patents and two pending U.S. patents covering certain advanced technologies relating to high frequency trading, which inventions specifically address technological problems associated with speed and latency and provide critical latency gains in trading systems where the difference between success and failure may be measured in nanoseconds. The Company paid the seller $500,000 at the closing and has an obligation to pay the seller an additional $500,000 in cash and $375,000 of the Company’s common stock (up to a maximum of 375,000 shares) upon achieving certain milestones with respect to the HFT Patent Portfolio. The Company also has an additional obligation to pay the seller 15% of the first $50 million of net proceeds (after deduction of expenses) generated by the patent portfolio and 17.5% of net proceeds greater than $50 million.

In connection with the Company’s acquisition of its Cox Patent Portfolio, the Company is obligated to pay Dr. Cox 12.5% of the net proceeds (after deduction of expenses) generated by the Company from licensing, sale or enforcement of the patent portfolio. As of the years ended December 31, 2022, and 2021, no expense was incurred with respect to the Cox Patent Portfolio. As of December 31, 2022 and 2021, no amounts were accrued with respect to the Cox Patent Portfolio.

As part of the acquisition of the Mirror Worlds Patent Portfolio, the Company also entered into an agreement with Recognition Interface, LLC (“Recognition”) pursuant to which Recognition received from the Company an interest in the net proceeds realized from the monetization of the Mirror Worlds Patent Portfolio, as follows: (i) 10% of the first $125 million of net proceeds; (ii) 15% of the next $125 million of net proceeds; and (iii) 20% of any portion of the net proceeds in excess of $250 million. Since entering into the agreement with Recognition in May 2013, the Company has paid Recognition an aggregate of $3,127,000 with respect to such net proceeds interest related to the Mirror Worlds Patent Portfolio. No such payments were made by the Company to Recognition during the year ended December 31, 2022 and 2021.

In connection with the Company’s acquisition of its M2M/IoT Patent Portfolio, the Company is obligated to pay M2M 14% of the first $100 million of net proceeds (after deduction of expenses) and 5% of net proceeds greater than $100 million from Monetization Activities (as defined in the acquisition agreement) related to the M2MIoT Patent Portfolio. In addition, M2M will be entitled to receive from the Company $250,000 of additional consideration upon the occurrence of certain future events related to the patent portfolio.

[3]Savings and investment plan:

 

The Company has a Savings and Investment Plan which allows participants to make contributions by salary reduction pursuant to Section 401(k) of the Internal Revenue Code of 1986. The Company also may make discretionary annual matching contributions and profit sharing in amounts determined by the Board of Directors, subject to statutory limits. The 401(k) Plan expense for the years ended December 31, 2022 and 2021 was $78,000 and $102,000, respectively, all of which was accrued as of December 31, 2022 and 2021 and is recorded within accrued expenses on the Company’s consolidated balance sheets.

[4]Leases:

 

The Company has one operating lease for its principal office space in New Canaan, Connecticut that will expire on April 30, 2025.

There are no material residual guarantees associated with the Company’s lease and there are no significant restrictions or covenants included in the Company’s lease.

The calculated incremental borrowing rate was approximately 4.2%, which was calculated based on remaining lease term of 3 years as of May 1, 2022. The remaining lease term as of December 31, 2022 was approximately 2.3 years.

There was no sublease rental income for the year ended December 31, 2022, and the Company is not the lessor in any lease arrangement, and there were no related-party lease agreements.

Right-of-use lease assets and related lease obligations for the Company’s operating leases were recorded in the consolidated balance sheet as follows:

           
   As of   As of 
   December 31, 2022   December 31, 2021 
Operating lease right-of-use assets  $161,000   $— 
           
Operating lease obligations – current   79,000    — 
Operating lease obligations – non-current   94,000    — 
Total lease obligations  $173,000   $— 

 

The table below presents certain information related to the Company’s lease costs for the year ended December 31, 2022 and 2021:

          
   For the Year Ended
December 31,		 
  

2022

  

2021

 
Operating lease cost  $48,000   $— 
Short-term lease cost   82,000    128,000 
Total lease cost  $130,000   $128,000 

 

Future lease payments included in the measurement of lease liabilities on the consolidated balance sheet as of December 31, 2022, were as follows:

       
    Operating Leases 
 2023    83,000 
 2024    73,000 
 2025    24,000 
 Total future minimum lease payments    180,000 
 Less imputed interest    (7,000)
 Total operating lease liability   $173,000 

 
XML 29 R16.htm IDEA: XBRL DOCUMENT v3.23.1
Employment Arrangements and Other Agreements
 12 Months Ended
Dec. 31, 2022
Employment Arrangements And Other Agreements  
Employment Arrangements and Other Agreements

Note J - Employment Arrangements and Other Agreements

[1] On March 22, 2022, the Company entered into a new employment agreement (“Agreement”) with its Chairman and Chief Executive Officer, pursuant to which he continues to serve as the Company’s Chairman and Chief Executive Officer for a four-year term (“Term”), at an annual base salary of $535,000 which shall be increased by 3% per annum during the Term. The Agreement established an annual target bonus of $175,000 for the Chairman and Chief Executive Officer based upon performance. For the year ended December 31, 2022 and 2021, the Chairman and Chief Executive Officer received an annual discretionary bonus of $175,000.

In addition, pursuant to the Agreement, the Company granted the Chairman and Chief Executive Officer, under its 2013 Plan, 600,000 restricted stock units (the “RSUs”, each RSU awarded by the Company to its officers, directors and consultants represents a contingent right to receive one share of the Company’s common stock) which terms provided for vesting in four tranches, as follows: (1) 175,000 RSUs which shall vest 100,000 RSUs on March 22, 2023 and 75,000 RSUs on March 22, 2024, subject to the Chairman and Chief Executive Officer’s continued employment by the Company through each such vesting date (the “Employment Condition”) (“Tranche 1”); (2) 150,000 RSUs shall vest if at any time during the Term that the Company’s common stock achieves a closing price for twenty (20) consecutive trading days (“Closing Price”) of a minimum of $3.50 per share (subject to adjustment for stock splits) and the Employment Condition is satisfied through the date such minimum per share Closing Price is achieved (“Tranche 2”); (3) 150,000 RSUs shall vest if at any time during the Term that the common stock achieves a Closing Price of a minimum of $4.00 per share (subject to adjustment for stock splits) and the Employment Condition is satisfied through the date such minimum per share Closing Price is achieved (“Tranche 3”); and (4) 125,000 RSUs shall vest if at any time during the Term, that the common stock achieves a Closing Price of a minimum of $4.50 per share (subject to adjustment for stock splits) and the Employment Condition is satisfied through the date such minimum per share Closing Price is achieved (“Tranche 4”). In the event of a Change of Control (as defined), Termination Other Than for Cause (as defined) or a termination by the Chairman and Chief Executive Officer for Good Reason (as defined) in each case prior to the last day of the Term, the vesting of all RSUs (Tranches 1, 2, 3 and 4) shall accelerate (and not be subject to any conditions) and all RSUs shall become immediately fully vested. All RSUs granted by the Company to its officers, directors or consultants have dividend equivalent rights.

Under the terms of the Agreement, so long as the Chairman and Chief Executive Officer continues to serve as an executive officer of the Company, whether pursuant to the Agreement or otherwise, the Chairman and Chief Executive Officer shall also receive incentive compensation in an amount equal to 5% of the Company’s gross royalties or other payments from Licensing Activities (as defined) (without deduction of legal fees or any other expenses) with respect to the Remote Power Patent and a 10% net interest (gross royalties and other payments after deduction of all legal fees and litigation expenses related to licensing, enforcement and sale activities, but in no event shall he receive less than 6.25% of the gross recovery) of the Company’s royalties and other payments relating to Licensing Activities with respect to patents other than the Remote Power Patent (including all of the Company’s patent portfolios and its investment in ILiAD) (collectively, the “Incentive Compensation”). During the year ended December 31, 2022 and 2021, the Chairman and Chief Executive Officer earned Incentive Compensation of $-0- and $1,801,000, respectively.

The Incentive Compensation shall continue to be paid to the Chairman and Chief Executive Officer for the life of each of the Company’s patents with respect to licenses entered into with third parties during the term of his employment or at anytime thereafter, whether he is employed by the Company or not; provided, that, the employment of the Chairman and Chief Executive Officer has not been terminated by the Company “For Cause” (as defined) or terminated by him without “Good Reason” (as defined). In the event of a merger or sale of substantially all of the Company’s assets, the Company has the option to extinguish the right of the Chairman and Chief Executive Officer to receive future Incentive Compensation by payment to him of a lump sum payment, in an amount equal to the fair market value of such future interest as determined by an independent third party expert if the parties do not reach agreement as to such value. In the event that the Chairman and Chief Executive Officer’s employment is terminated by the Company “Other Than For Cause” (as defined) or by him for “Good Reason” (as defined), the Chairman and Chief Executive Officer shall also be entitled to (i) a lump sum severance payment of 12 months base salary, (ii) a pro-rated portion of the $175,000 target bonus provided bonus criteria have been satisfied on a pro-rated basis through the calendar quarter in which the termination occurs and (iii) accelerated vesting of all unvested options, RSUs or other awards.

In connection with the Agreement, the Chairman and Chief Executive Officer has also agreed not to compete with the Company as follows: (i) during the Term of the Agreement and for a period of 12 months thereafter if his employment is terminated “Other Than For Cause” (as defined) provided he is paid his 12 months base salary severance amount and (ii) for a period of two years from the termination date, if terminated “For Cause” by the Company or “Without Good Reason” by the Chairman and Chief Executive Officer.

[2] The Company’s Executive Vice President serves on an at-will basis at an annual base salary of $200,000. The Executive Vice President received a discretionary annual bonus of $25,000 and $40,000 for the year ended December 31, 2022 and 2021, respectively. On January 18, 2022, the Company’s Executive Vice President was granted 15,000 RSUs under the 2013 Plan, 50% of such RSUs vested on the one year anniversary of the date of grant (January 18, 2023) and 50% of such RSUs vest on the two year anniversary of the grant (January 18, 2024), subject to continued employment. On January 24, 2023, the Company’s Executive Vice President was granted 15,000 RSUs under the 2022 Plan, 50% of such RSUs vest on the one year anniversary of the date of grant (January 24, 2024) and 50% of such RSUs vest on the two year anniversary of the date of grant (January 24, 2025), subject to continued employment.

[3] The Company’s former Chief Financial Officer served on an at-will basis at an annual base salary of $175,000 until his retirement in December 2022. In connection with his retirement, the Chief Financial Officer was granted severance of 6 months base salary and certain other benefits.

[4] In December 2022, the Company’s Board of Directors elected a new Chief Financial Officer who serves on a consulting basis at an annual base salary of $175,000.
XML 30 R17.htm IDEA: XBRL DOCUMENT v3.23.1
Legal Proceedings
 12 Months Ended
Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
Legal Proceedings

Note K – Legal Proceedings

[1] On April 4, 2014 and December 3, 2014, the Company initiated litigation against Google Inc. (“Google”) and YouTube, LLC (“YouTube”) in the U.S. District Court for the Southern District of New York for infringement of several of its patents within its Cox Patent Portfolio acquired from Dr. Cox which relate to the identification of media content on the Internet. The lawsuit alleges that Google and YouTube have infringed and continue to infringe certain of the Company’s patents by making, using, selling and offering to sell unlicensed systems and related products and services, which include YouTube’s Content ID system. The litigations against Google and YouTube were subject to court ordered stays which were in effect from July 2, 2015 until January 2, 2019 as a result of proceedings at the Patent Trial and Appeal Board (PTAB) and the appeals of PTAB Final Written Decisions to the U.S. Court of Appeals for the Federal Circuit. Pursuant to a Joint Stipulation and Order Regarding Lifting of Stays, entered on January 2, 2019, the parties agreed, among other things, that the stays with respect to the litigations were lifted. In January 2019, the two litigations against Google and YouTube were consolidated. Discovery is complete and the parties have each submitted summary judgment motions. A trial date has not yet been set.

[2] On May 9, 2017, Mirror Worlds Technologies, LLC, the Company’s wholly-owned subsidiary, initiated litigation against Facebook, Inc. (“now Meta Platforms, Inc. (“Meta”)) in the U.S. District Court for the Southern District of New York, for infringement of U.S. Patent No. 6,006,227, U.S. Patent No. 7,865,538 and U.S. Patent No. 8,255,439 (among the patents within the Company’s Mirror Worlds Patent Portfolio). The lawsuit alleged that the asserted patents are infringed by Meta’s core technologies that enable Meta’s Newsfeed and Timeline features. On May 7, 2018, Meta filed a motion for summary judgment on non-infringement. On August 11, 2018, the Court issued an order granting Meta’s motion for summary judgment of non-infringement and dismissed the case. On August 17, 2018, the Company filed a Notice of Appeal to appeal the summary judgment decision to the U.S. Court of Appeals for the Federal Circuit. On January 23, 2020, the U.S. Court of Appeals for the Federal Circuit ruled in the Company’s favor and reversed the summary judgment finding on non-infringement of the District Court and remanded the litigation to the Southern District of New York for further proceedings.

On March 7, 2022, the District Court entered a ruling granting in part and denying in part a motion for summary judgment by Meta. In its ruling the Court (i) denied Meta’s motion that the asserted patents were invalid by concluding that all asserted claims were patent eligible under §101 of the Patent Act and (ii) granted summary judgment of non-infringement in favor of Facebook and dismissed the case. The Company strongly disagrees with the decision on non-infringement and on April 4, 2022, the Company filed an appeal to the U.S. Court of Appeals for the Federal Circuit, which is pending.

[3] On December 15, 2020, the Company filed a lawsuit against Netgear, Inc. (“Netgear”) in the Supreme Court of the State of New York, County of New York, for breach of a Settlement and License Agreement, dated May 22, 2009, with the Company for failure to make royalty payments, and provide corresponding royalty reports, to the Company based on sales of Netgear’s PoE products. On October 22, 2021, Netgear filed a Demand for Arbitration at the American Arbitration Association (AAA) seeking to arbitrate certain issues raised in the litigation. The Company objected to jurisdiction at the AAA. On April 22, 2022, Netgear filed a counterclaim in the N.Y. court action alleging that the Company breached the License Agreement by not offering Netgear lower royalties. On September 22, 2022, the arbitration brought by Netgear was dismissed by the AAA on jurisdiction grounds. The case remains pending in the Supreme Court of the State of New York, County of New York.

[4] In October and November 2022, the Company initiated separate litigation against ten defendants for infringement of its Remote Power Patent seeking monetary damages based upon reasonable royalties, as follows: (i) On October 6, 2022, the Company initiated such litigation against Arista Networks, Inc., Fortinet, Inc., Honeywell International Inc. and Ubiquiti Inc. in the United States District Court, District of Delaware; (ii) On October 27, 2022, and November 3, 2022, the Company initiated such litigation against TP-Link USA Corporation and Hikvision USA, Inc. in the United States District Court for the Central District of California; (iii) On November 4, 2022, the Company initiated such litigation against Panasonic Holdings Corporation and Panasonic Corporation of North America in the United States District Court for the Eastern District of Texas (Marshall Division); and (iv) On November 8, 2022 and November 16, 2022, the Company initiated such litigation against Antaira Technologies, LLC and Dahua Technology USA in the United States District Court for the Central District of California.
XML 31 R18.htm IDEA: XBRL DOCUMENT v3.23.1
Concentrations
 12 Months Ended
Dec. 31, 2022
Risks and Uncertainties [Abstract]  
Concentrations

Note L - Concentrations

The Company had no revenue for the year ended December 31, 2022. Revenue from the Company’s Remote Power Patent constituted 100% of the Company’s revenue for the year ended December 31, 2021, of which two licensees constituted an aggregate of 99% of the Company’s revenue for such year.
XML 32 R19.htm IDEA: XBRL DOCUMENT v3.23.1
Related Party Transaction
 12 Months Ended
Dec. 31, 2022
Related Party Transactions [Abstract]  
Related Party Transaction

Note M – Related Party Transaction

On June 1, 2022, the Company repurchased from a director of the Company 41,500 shares of its common stock at a purchase price of $2.42 per share or aggregate consideration of $100,430.
XML 33 R20.htm IDEA: XBRL DOCUMENT v3.23.1
Stock Repurchase Program
 12 Months Ended
Dec. 31, 2022
Other Liabilities Disclosure [Abstract]  
Stock Repurchase Program

Note N – Stock Repurchase Program

On June 11, 2021, the Company’s Board of Directors authorized an extension and increase of the Share Repurchase Program to repurchase up to $5,000,000 of the Company’s common stock over the subsequent 24-month period. The common stock may be repurchased from time to time in open market transactions or privately negotiated transactions in the Company’s discretion. The timing and amount of the shares repurchased are determined by management based on its evaluation of market conditions and other factors. The repurchase program may be increased, suspended or discontinued at any time.

During the year ended December 31, 2022, the Company repurchased an aggregate of 228,530 shares of its common stock pursuant to the Share Repurchase Program at a cost of approximately $531,000 (exclusive of commissions) or an average price per share of $2.33.

Since inception of the Share Repurchase Program (August 2011) through December 31, 2022, the Company has repurchased an aggregate of 9,212,664 shares of its common stock at a cost of approximately $17,758,000 (exclusive of commissions) or an average per share price of $1.93.
XML 34 R21.htm IDEA: XBRL DOCUMENT v3.23.1
Dividend Policy
 12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
Dividend Policy

Note O – Dividend Policy

The Company’s dividend policy consists of a semi-annual cash dividend of $0.05 per common share ($0.10 per common share annually) which have been paid in March and September of each year. On February 23, 2022, the Board of Directors declared a semi-annual cash dividend of $0.05 per share with a payment date of March 24, 2022 to all common shareholders of record as of March 9, 2022. On September 9, 2022, the Board of Directors declared a semi-annual dividend of $0.05 per share with a payment date of September 30, 2022 to all common shareholders of record as of September 20, 2022. The Company’s dividend policy undergoes a periodic review by the Board of Directors and is subject to change at any time depending upon the Company’s earnings, financial requirements and other factors.
XML 35 R22.htm IDEA: XBRL DOCUMENT v3.23.1
Subsequent Events
 12 Months Ended
Dec. 31, 2022
Subsequent Events [Abstract]  
Subsequent Events

Note P – Subsequent Events

[1] On March 3, 2023, the Company’s Board of Directors declared a semi-annual cash dividend of $0.05 per share with a payment date of March 31, 2023 to all common shareholders of record as of March 15, 2023.

[2] On March 3, 2023, the Company’s Board of Directors approved the grant of 15,000 RSUs to each of the Company’s three non-management directors. The RSUs vest over a one year period in equal quarterly installments of 3,750 shares of common stock on each of March 15, 2023, June 15, 2023, September 15, 2023 and December 15, 2023.

[3] During the period January 24, 2023 through March 10, 2023, the Company entered into settlement agreements with Arista Networks, Inc., Antiara Technologies LLC, Panasonic Holdings Corporation and TP-Link USA Corporation with respect to patent infringement litigation involving its Remote Power Patent, resulting in aggregate settlement payments to the Company of $537,300 and a conditional payment of $150,000 (see Note K[4] hereof).
XML 36 R23.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies (Policies)
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Principles of Consolidation

 

[1]Principles of Consolidation

The Company’s consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The accompanying financial statements include the accounts of the Company and its wholly-owned subsidiaries, Mirror Worlds Technologies, LLC and HFT Solutions, LLC. All intercompany transactions and balances are eliminated in consolidation.
Use of Estimates and Assumptions

 

[2]Use of Estimates and Assumptions

The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods. The significant estimates and assumptions made in the preparation of the Company’s consolidated financial statements primarily include costs related to the Company’s assertion of litigation, the valuation of the Company’s patent portfolios, stock-based compensation, the recoverability of deferred tax assets and carrying value of the Company’s equity method investments. Actual results could be materially different from those estimates, upon which the carrying values were based.

Certain amounts recorded to reflect the Company’s share of income or losses of its equity method investee, accounted for under the equity method, are based on estimates and the unaudited results of operations of the equity method investee and may require adjustment in the future when the audit is complete. The Company reports its share of the results of its equity method investee on a one quarter lag basis.
Cash and Cash Equivalents

 

[3]Cash and Cash Equivalents

The Company maintains cash deposits in high quality financial institutions insured by the Federal Deposit Insurance Corporation ("FDIC"). Accounts at each institution are insured by the FDIC up to $250,000. At December 31, 2022 and 2021, the Company had $1,715,000 and $8,109,000, respectively, in excess of the FDIC insured limit.

 

The Company considers all highly liquid short-term investments, including certificates of deposit and money market funds, that are purchased with an original maturity of three months or less to be cash equivalents.
Marketable Securities

 

[4]Marketable Securities

 

The Company’s marketable securities are comprised of certificates of deposit with original maturity greater than three months from date of purchase, government securities, fixed income mutual funds, and a corporate bond (see Note G). At December 31, 2022 and December 31, 2021, included in marketable securities, the Company had aggregate certificates of deposit of $2,976,000 and $0, respectively. The Company’s marketable securities are measured at fair value and are accounted for in accordance with ASU 2016-01. Unrealized holding gains and losses on certificates of deposit, government securities, and fixed income mutual funds are recorded in net realized and unrealized gain (loss) from investments on the consolidated statements of operations and comprehensive income (loss). Unrealized holding gains and losses, net of the related tax effect, on corporate bonds and notes are excluded from earnings and are reported as a separate component of stockholders’ equity until realized. Dividend and interest income are recognized when earned. Realized gains and losses are included in earnings and are derived using the specific identification method for determining the cost of the marketable securities.
Revenue Recognition

 

[5]Revenue Recognition

 

Under ASC 606, revenue is recognized when the Company completes the licensing of its intellectual property to its licensees, in an amount that reflects the consideration the Company expects to be entitled to in exchange for licensing its intellectual property.

 

The Company determines revenue recognition through the follow steps:

 

•identification of the license agreement;
•identification of the performance obligations in the license agreement;
•determination of the consideration for the license;
•allocation of the transaction price to the performance obligations in the contract; and
•recognition of revenue when the Company satisfies its performance obligations.

Revenue disaggregated by source is as follows (the Company had no revenue for the year ended December 31, 2022):

          
   Years Ended December 31, 
   2022   2021 
Fully-Paid Licenses  $—   $17,000,000(1)
Royalty Bearing Licenses   —    19,029,000(2)
Total Revenue  $—   $36,029,000 

__________________________

(1)Includes $17,000,000 received from Hewlett-Packard related to settlement of a patent litigation (see Note K[1] hereof).
(2)Includes (1) $18,691,890 of royalty revenue from Cisco Systems, Inc. from resolution of a dispute under its license agreement with the Company and (2) $337,000 of royalty revenue received from Plantronics, Inc.

 

Revenue from the Company’s patent licensing business is typically generated from negotiated license agreements. The timing and amount of revenue recognized from each licensee depends upon a variety of factors, including the terms of each agreement and the nature of the obligations of the parties. These agreements may include, but not be limited to, elements related to past infringement liabilities, non-refundable upfront license fees, and ongoing royalties on licensed products sold by the licensee. Generally, in the event of settlement of litigation related to the Company’s assertion of patent infringement involving its intellectual property, defendants will either pay (i) a non-refundable lump sum payment for a non-exclusive fully-paid license, or (ii) a non-refundable lump sum payment (license initiation fee) together with an ongoing obligation to pay quarterly or monthly royalties to the Company for the life of the licensed patent.
Equity Method Investments

 

[6]Equity Method Investments

Equity method investments are equity securities in entities the Company does not control but over which it has the ability to exercise significant influence. These investments are accounted for under the equity method of accounting in accordance with ASC 323, Investments — Equity Method and Joint Ventures (see Note H hereof). Equity method investments are measured at cost minus impairment, if any, plus or minus the Company’s share of an investee’s income or loss. The Company’s proportionate share of the income or loss from equity method investments is recognized on a one-quarter lag. When the Company’s carrying value in an equity method investment is reduced to zero, no further losses are recorded in the Company’s financial statements unless the Company guaranteed obligations of the investee company or has committed additional funding. When the investee company subsequently reports income, the Company will not record its share of such income until it equals the amount of its share of losses not previously recognized.

Upon a sale of an equity method investment by the Company, the difference between sales proceeds and the carrying amount of the equity investment is recognized in profit or loss. Upon the issuance of securities in an observable price transaction, the Company will account for the share issuance by the equity method investee as if the Company had sold a proportionate share of its investment in the observable price transaction. The Company will record a gain or loss associated with the dilution of its investment to reflect third party investments in the investee and will increase or decrease its basis in the equity method investee accordingly. The gain or loss is recorded within other income or expense in the Company’s consolidated statements of operations and comprehensive income (loss).

During the year ended December 31, 2022, the Company recorded a change in its share of net losses of the equity method investee as a result of the Company receiving new information from the equity method investee during the fourth quarter of 2022. The effect of this change was an increase in the Company’s share of the net losses of the equity method investee of $398,000 and a corresponding decrease in the Company’s net income, and a decrease in basic and diluted earnings of $0.02 per share.

The Company performed an assessment to determine significance of the equity method investee under the investment, asset and income tests utilizing the 20% threshold. The Company determined that the equity method investee satisfied the income test and has included summarized financial data of the equity method investee in Note H hereof.
Patents

 

[7]Patents

The Company owns patents that relate to various technologies. The Company capitalizes the costs associated with acquisition, registration and maintenance of its acquired patents and amortizes these assets over their remaining useful lives on a straight-line basis. Any further payments made to maintain or develop the patents would be capitalized and amortized over the balance of the useful life for the patents.
Costs of Revenue and Related Costs

[8]Costs of Revenue and Related Costs

The Company includes in costs of revenue for the year ended December 31, 2022 and 2021 contingent legal fees payable to patent litigation counsel, any other contractual payments to third parties related to net proceeds from monetization of patents (see Note I[1] hereof) and incentive bonus compensation payable to its Chairman and Chief Executive Officer (see Note J[1] hereof).
Income Taxes

 

[9]Income Taxes

The Company accounts for income taxes in accordance with Financial Accounting Standards Board (FASB) ASC Topic 740, Income Taxes (ASC 740), which requires the Company to use the assets and liability method of accounting for income taxes. Under the assets and liability method, deferred income taxes are recognized for the tax consequences of temporary (timing) differences by applying enacted statutory tax rates applicable to future years to differences between financial statement carrying amounts and the tax bases of existing assets and liabilities and operating loss and tax credit carry forwards. Under this accounting standard, the effect on deferred income taxes of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recognized if it is more likely than not that some portion, or all, of a deferred tax asset will not be realized.

ASC 740-10, Accounting for Uncertainty in Income Taxes, defines uncertainty in income taxes and the evaluation of a tax position as a two-step process. The first step is to determine whether it is more likely than not that a tax position will be sustained upon examination, including the resolution of any related appeals or litigation based on the technical merits of that position. The second step is to measure a tax position that meets the more-likely-than-not threshold to determine the amount of benefit to be recognized in the financial statements. A tax position is measured at the largest amount of benefit that is greater than 50 percent likelihood of being realized upon ultimate settlement. Tax positions that previously failed to meet the more-likely-than-not recognition threshold should be recognized in the first subsequent period in which the threshold is met. Previously recognized tax positions that no longer meet the more-likely-than-not criteria should be de-recognized in the first subsequent financial reporting period in which the threshold is no longer met. The Company had no uncertain tax positions as of December 31, 2022 and 2021.

U.S. federal, state and local income tax returns prior to 2019 are not subject to examination by any applicable tax authorities, except that tax authorities could challenge returns (only under certain circumstances) for earlier years to the extent they generated loss carry-forwards that are available for those future years.
Stock-Based Compensation

 

[10]Stock-Based Compensation

The Company accounts for its stock-based compensation awards to employees and directors in accordance with FASB ASC Topic 718, Compensation — Stock Compensation (“ASC 718”). ASC 718 requires all stock-based compensation to employees, including grants of employee stock options and restricted stock units, to be recognized in the consolidated statements of operations and comprehensive income (loss) based on their grant date fair values.

Compensation expense related to awards to employees is recognized on a straight-line basis based on the grant date fair value over the associated service period of the award, which is generally the vesting term. The Company uses the Black-Scholes option pricing model to determine the grant date fair value of options granted. The fair value of restricted stock units is determined based on the number of shares underlying the grant and either the quoted market price of the Company’s common stock on the date of grant for time-based and performance-based awards, or the fair value on the date of grant using the Monte Carlo Simulation model for market-based awards.
Earnings Per Share

 

[11]Earnings Per Share

The Company reports earnings per share in accordance with U.S. GAAP, which requires presentation of basic and diluted earnings per share in conjunction with the disclosure of the methodology used in computing such earnings per share. Basic earnings per share excludes dilution and is computed by dividing income available to common shareholders by the weighted average common shares outstanding during the period. Diluted earnings per share takes into account the potential dilution that could occur if securities or other contracts, such as warrants and options to purchase common stock were exercised and shares were issued pursuant to outstanding restricted stock units. Common stock equivalents having an anti-dilutive effect on earnings per share are excluded from the calculation of diluted earnings per share.
Fair Value Measurements

 

[12]Fair Value Measurements

ASC Topic 820, Fair Value Measurement and Disclosures, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. This topic also establishes a fair value hierarchy which requires classification based on observable and unobservable inputs when measuring fair value.

There are three levels of inputs that may be used to measure fair value:

Level 1: Observable inputs such as quoted prices (unadjusted) in an active market for identical assets or liabilities.

Level 2: Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.

Level 3: Unobservable inputs that are supported by little or no market activity; therefore, the inputs are developed by the Company using estimates and assumptions that the Company expects a market participant would use, including pricing models, discounted cash flow methodologies, or similar techniques.

The carrying value of the Company’s financial instruments, including cash and cash equivalents and accounts payable, approximates fair value because of the short-term nature of these financial instruments.

The Company’s marketable securities are classified within Level 1 because they are valued using quoted market prices in an active market.

The Company’s equity method investment is measured on a non-recurring basis and is classified within Level 2 as it is valued using an observable price transaction for similar assets in a market that is not active (see Note B[6] and Note H hereof).
Carrying Value, Recoverability and Impairment of Long-Lived Assets

 

[13]Carrying Value, Recoverability and Impairment of Long-Lived Assets

An impairment loss shall be recognized only if the carrying amount of a long-lived asset (asset group) is not recoverable and exceeds its fair value. The carrying amount of a long-lived asset (asset group) is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset (asset group). That assessment shall be based on the carrying amount of the asset (asset group) at the date it is tested for recoverability. An impairment loss shall be measured as the amount by which the carrying amount of a long-lived asset (asset group) exceeds its fair value. If an impairment loss is recognized, the adjusted carrying amount of a long-lived asset shall be its new cost basis. For a depreciable long-lived asset, the new cost basis shall be depreciated (amortized) over the remaining useful life of that asset. Restoration of a previously recognized impairment loss is prohibited. At December 31, 2022 and 2021, there was no impairment to the Company’s patents and equity investment.

The Company’s equity investment in ILiAD is evaluated on a non-recurring basis for impairment, when and if a triggering event occurs.
Leases

 

[14]Leases

Under ASC 842, the Company determines if an arrangement is a lease at inception. Right-of-Use (“ROU”) assets and related lease obligations are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. As the Company's lease does not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company's determined incremental borrowing rate is a hypothetical rate based on its understanding of what the Company's credit rating would be. The ROU asset also includes any lease payments made prior to commencement and is recorded net of any lease incentives received and net of the deferred rent balance on the date of implementation. The Company's lease terms may include options to extend or terminate the lease when it is reasonably certain that it will exercise such options. As permitted under ASC 842, the Company has elected to not recognize ROU assets and related lease obligations for leases with terms of twelve months or less.
Dividend Policy

 

[15]Dividend Policy

Cash dividends are recorded when declared by the Company’s Board of Directors. Common stock dividends are charged against retained earnings when declared or paid (see Note O hereof).
Reclassifications

 

[16]Reclassifications

Stock-based compensation in the 2021 consolidated statements of operations and comprehensive income (loss) have been recast and reclassified to conform to the current year’s presentation. 

 
XML 37 R24.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies (Tables)
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Schedule of disaggregation of revenue
          
   Years Ended December 31, 
   2022   2021 
Fully-Paid Licenses  $—   $17,000,000(1)
Royalty Bearing Licenses   —    19,029,000(2)
Total Revenue  $—   $36,029,000 
XML 38 R25.htm IDEA: XBRL DOCUMENT v3.23.1
Patents (Tables)
 12 Months Ended
Dec. 31, 2022
Patents  
Schedule of patent
          
  

2022

  

2021

 
Gross carrying amount  $8,473,000   $7,949,000 
Accumulated amortization   (6,881,000)   (6,565,000)
Patents, net  $1,592,000   $1,384,000 
Schedule of future amortization of current intangible
      
For the years ended December 31,     
2023   $266,000 
2024    120,000 
2025    120,000 
2026    120,000 
2027    119,000 
Thereafter    847,000 
Total   $1,592,000 
       
XML 39 R26.htm IDEA: XBRL DOCUMENT v3.23.1
Income (Loss) Per Share (Tables)
 12 Months Ended
Dec. 31, 2022
Earnings Per Share [Abstract]  
Schedule of earnings per share
 Schedule of earnings per share          
   2022   2021 
         
Weighted-average common shares outstanding – basic   23,825,917    24,136,821 
           
Dilutive effect of restricted stock units and stock options  

—

   393,747 
           
Weighted-average common shares outstanding – diluted   23,825,917    24,530,568 
           
Restricted stock units excluded from the computation of diluted income per share because the effect of inclusion would have been anti-dilutive   625,000    12,500 
XML 40 R27.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes (Tables)
 12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Schedule of components of the income taxes
          
   2022   2021 

 

Current

    
State and local  $—   $144,000 
Federal   —    2,808,000 
Total Current Tax Expense (Benefit)  $—   $2,952,000 
           
Deferred          
State and local      56,000    83,000 
Federal   551,000    1,425,000 
Total Deferred Tax Expense   607,000    1,508,000 
           
Total Income Taxes  $607,000   $4,460,000 
Schedule of components of deferred tax assets and liability
          
   2022   2021 
Deferred tax assets (liability):
         Net operating loss carryforward		  $477,000   $
—		 
         Capital loss carryforward   331,000    — 
         Stock options and RSU   30,000    — 
Valuation allowance (838,000) —
           
           
        Deferred Tax Liability(1)   (1,161,000)   (554,000)
Total deferred tax liability  $(1,161,000)  $(554,000)

_________________________

(1) Deferred tax liability primarily as a result of a temporary difference related to the Company’s equity method investment.
Schedule of reconciliation of income tax
Schedule of reconciliation of income tax  
   Years Ended 
  

December 31,

 
  

2022

  

2021

 
 
Income tax - statutory rate   21.00%    21.00% 
Permanent differences   (8.40)%    1.69% 
Change in valuation allowance   (48.79)%    —% 
State   1.28%    1.11% 
Other   (0.43)%    —% 
  Total   (35.34)%    23.80% 
XML 41 R28.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders’ Equity (Tables)
 12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
Schedule of restricted stock units
Schedule of restricted stock units                    
   2022   2021 
   Number of
Shares		   Weighted-Average Grant
Date Fair Value		   Number of
Shares		   Weighted-Average Grant
Date Fair Value		 
Balance of restricted stock units outstanding at beginning of year   12,500   $3.36    162,500   $2.25 
Grants of restricted stock units   670,000    1.92    45,000    3.51 
Vested restricted stock units   (57,500)   (2.73)   (195,000)   (2.47)
Balance of restricted stock units outstanding at end of year   625,000   $1.87    12,500   $3.36 
Schedule of stock option activity
                    
  

2022

  

2021

 
       Weighted       Weighted 
       Average       Average 
   Options   Exercise   Options   Exercise 
  

Outstanding

  

Price

  

Outstanding

  

Price

 
Options outstanding at beginning of year   500,000   $1.19    500,000   $1.19 
Granted   —    —    —    — 
Expired   —    —    —    — 
Exercised   500,000   $1.19    —   — 
Options outstanding at end of year   —   —    500,000   $1.19 
Options exercisable at end of year   —   —    500,000   $1.19 
                     
XML 42 R29.htm IDEA: XBRL DOCUMENT v3.23.1
Marketable Securities (Tables)
 12 Months Ended
Dec. 31, 2022
Marketable Securities  
Schedule of marketable securities
Schedule of marketable securities                    
   December 31, 2022 
  

Cost
Basis

  

Gross
Unrealized
Gains

  

Gross
Unrealized
Losses

  

Fair Value

 
Government Securities  $20,781,000   $67,000   $—   $20,848,000 
Fixed income mutual funds   11,904,000    —    (915,000)   10,989,000 
Certificates of Deposit   3,019,000    —    (43,000)   2,976,000 
Corporate bonds and notes   192,000    —    (14,000)   178,000 
Total marketable securities  $35,896,000   $67,000   $(972,000)  $34,991,000 
                     

 

   December 31, 2021 
  

Cost
Basis

  

Gross
Unrealized
Gains

  

Gross
Unrealized
Losses

  

Fair Value

 
Fixed income mutual funds  $14,462,000    —   $(137,000)  $14,325,000 
Corporate bonds and notes   813,000    —    (12,000)   801,000 
Total marketable securities  $15,275,000   $—   $(149,000)  $15,126,000 
XML 43 R30.htm IDEA: XBRL DOCUMENT v3.23.1
Equity Investment (Tables)
 12 Months Ended
Dec. 31, 2022
Equity Method Investments and Joint Ventures [Abstract]  
Schedule of equity method investments
Schedule of equity method investments          
   Twelve Months Ended September 30, 
  

2022

  

2021

 
Loss from continuing operations  $15,246,000   $11,133,000 
Comprehensive loss  $17,913,000   $10,384,000 
           
XML 44 R31.htm IDEA: XBRL DOCUMENT v3.23.1
Commitments and Contingencies (Tables)
 12 Months Ended
Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
Schedule of operating leases obligations
           
   As of   As of 
   December 31, 2022   December 31, 2021 
Operating lease right-of-use assets  $161,000   $— 
           
Operating lease obligations – current   79,000    — 
Operating lease obligations – non-current   94,000    — 
Total lease obligations  $173,000   $— 
Schedule of leases cost
          
   For the Year Ended
December 31,		 
  

2022

  

2021

 
Operating lease cost  $48,000   $— 
Short-term lease cost   82,000    128,000 
Total lease cost  $130,000   $128,000 
Schedule of future minimum leases payments
       
    Operating Leases 
 2023    83,000 
 2024    73,000 
 2025    24,000 
 Total future minimum lease payments    180,000 
 Less imputed interest    (7,000)
 Total operating lease liability   $173,000 
XML 45 R32.htm IDEA: XBRL DOCUMENT v3.23.1
Business (Details Narrative)
 12 Months Ended
Dec. 31, 2022
USD ($)
Integer
Patents owned by the company 97
Expired patents 52
Foreign patents owned by the company 8
I Li A D Biotechnologies L L C [Member]  
Aggregate investment amount | $ $ 7,000,000
XML 46 R33.htm IDEA: XBRL DOCUMENT v3.23.1
Summary Of Significant Accounting Policies (Details) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Product Information [Line Items]    
Total Revenue $ 36,029,000
Fully Paid Licenses [Member]    
Product Information [Line Items]    
Total Revenue 17,000,000 [1]
Royalty Bearing Licenses [Member]    
Product Information [Line Items]    
Total Revenue $ 19,029,000 [2]
[1] Includes $17,000,000 received from Hewlett-Packard related to settlement of a patent litigation (see Note K[1] hereof).
[2] Includes (1) $18,691,890 of royalty revenue from Cisco Systems, Inc. from resolution of a dispute under its license agreement with the Company and (2) $337,000 of royalty revenue received from Plantronics, Inc.
XML 47 R34.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Accounting Policies [Abstract]    
FDIC insured limit $ 250,000 $ 250,000
Cash in excess of FDIC insured limit 1,715,000 8,109,000
Certificates of deposit 2,976,000 0
Increase in net losses of equity method investee $ 398,000  
Decrease in basic and diluted earnings $ 0.02  
Uncertain tax positions $ 0 0
Company impairment patents and equity investment   $ 0
XML 48 R35.htm IDEA: XBRL DOCUMENT v3.23.1
Patents (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Patents    
Gross carrying amount $ 8,473,000 $ 7,949,000
Accumulated amortization (6,881,000) (6,565,000)
Patents, net $ 1,592,000 $ 1,384,000
XML 49 R36.htm IDEA: XBRL DOCUMENT v3.23.1
Patents (Details 1)
Dec. 31, 2022
USD ($)
Patents  
2023 $ 266,000
2024 120,000
2025 120,000
2026 120,000
2027 119,000
Thereafter 847,000
Total $ 1,592,000
XML 50 R37.htm IDEA: XBRL DOCUMENT v3.23.1
Patents (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Amortization expense $ 316,000 $ 295,000
Minimum [Member]    
Estimated remaining economic useful of patents 6 months  
Expiration dates of the patents within the Cox patent portfolio July 2023  
Expiration dates of the patents within the Company's M2M/IoT Patent Portfolio September 2033  
Expiration dates within companys HFT patent portfolio October 31, 2039  
Maximum [Member]    
Estimated remaining economic useful of patents 16 years 6 months  
Expiration dates of the patents within the Cox patent portfolio November 2023  
Expiration dates of the patents within the Company's M2M/IoT Patent Portfolio May 2034  
Expiration dates within companys HFT patent portfolio November 1, 2039  
XML 51 R38.htm IDEA: XBRL DOCUMENT v3.23.1
Disclosure -Income (Loss) Per Share (Details) - shares
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Earnings Per Share [Abstract]    
Weighted-average common shares outstanding – basic 23,825,917 24,136,821
Dilutive effect of restricted stock units and stock options 393,747
Weighted-average common shares outstanding – diluted 23,825,917 24,530,568
Restricted stock units excluded from the computation of diluted income per share because the effect of inclusion would have been anti-dilutive 625,000 12,500
XML 52 R39.htm IDEA: XBRL DOCUMENT v3.23.1
Income (Loss) Per Share (Details Narrative) - shares
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Earnings Per Share [Abstract]    
Potentially dilutive shares 625,000 12,500
XML 53 R40.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes (Details) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
  Current    
State and local $ 144,000
Federal 2,808,000
Total Current Tax Expense (Benefit) 2,952,000
Deferred    
State and local 56,000 83,000
Federal 551,000 1,425,000
Total Deferred Tax Expense 607,000 1,508,000
Total Income Taxes $ 607,000 $ 4,460,000
XML 54 R41.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes (Details 1) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]    
Net operating loss carry forwards $ 477,000
Capital loss carryforward 331,000
Stock options and RSU 30,000
Valuation allowance 838,000 0
Deferred Tax Liability (1,161,000) (554,000)
Total deferred tax assets (liability) $ (1,161,000) $ (554,000)
XML 55 R42.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes (Details 2)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]    
Income tax - statutory rate 21.00% 21.00%
Permanent difference (8.40%) 1.69%
Change in valuation allowance (48.79%) 0.00%
State 1.28% 1.11%
Other (0.43%) 0.00%
Total (35.34%) 23.80%
XML 56 R43.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes (Details Narrative) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]    
Operating Loss Carryforwards $ 2,168,000  
Deferred Tax Assets, Gross 838,000  
Deferred Tax Assets, Valuation Allowance 838,000 $ 0
Deferred Tax Liabilities, Net $ 1,161,000  
XML 57 R44.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders' Equity (Details) - $ / shares
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Equity [Abstract]    
Restricted stock units, outstanding number of units, beginning balance 12,500 162,500
Restricted stock units, weighted average grant date fair value, beginning balance $ 3.36 $ 2.25
Grants of restricted stock units 670,000 45,000
Grants of restricted stock units, weighted average grant date fair value $ 1.92 $ 3.51
Vested restricted stock units (57,500) (195,000)
Vested restricted stock units, weighted average grant date fair value $ (2.73) $ (2.47)
Resricted stock units, Outstanding Number of units, Ending Balance 625,000 12,500
Restricted stock units, weighted average grant date fair value, ending balance $ 1.87 $ 3.36
XML 58 R45.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders' Equity (Details 1) - Equity Option [Member] - $ / shares
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Options outstanding, beginning, at beginning of year 500,000 500,000
Weighted average exercise price, options outstanding, at beginning of year $ 1.19 $ 1.19
Options Granted
Weighted average exercise price, Options Granted
Options Expired
Weighted average exercise price, Options Expired
Options Exercised 500,000
Weighted average exercise price, Options Exercised $ 1.19
Weighted average exercise price, Options outstanding, at end of year 500,000
Weighted average exercise price, options outstanding, at end of year $ 1.19
Option exercisable at end of year 500,000
Option exercise price at end of year $ 1.19
XML 59 R46.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders’ Equity (Details Narrative) - USD ($)
 1 Months Ended 12 Months Ended
Oct. 27, 2022
Dec. 31, 2022
Dec. 31, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Aggregate intrinsic value of options exercisable   $ 0 $ 815,000
Chairman And Chief Executive Officer [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Common stock shares purchased option exercise 500,000    
Exercise price $ 1.19    
Aggregate common stock shares delivered to company 334,459    
Common stock shares delivered to company - withholding taxes 94,539    
Net shares received 165,541    
Restricted Stock Units (RSUs) [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Restricted stock unit compensation expense   585,000 238,000
Unrecognized restricted stock unit compensation expense   $ 736,000  
Weighted average amortized period   2 years 7 months 9 days  
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate   2.39%  
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term   4 years  
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate   40.00%  
Share Price   $ 2.47  
Accrued dividend rights on restricted stock unit   $ 37,000 $ 72,000
Stock Incentive Plan 2022 [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Common stock available for issuance under 2022 Plan   2,300,000  
Stock Incentive Plan 2013 [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Common stock subject to outstanding awards   625,000  
XML 60 R47.htm IDEA: XBRL DOCUMENT v3.23.1
Marketable Securities (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Fair Value [Member]    
OtherInvestmentsReadilyMarketableLineItems [Line Items]    
Government securities $ 20,848,000  
Fixed income mutual funds 10,989,000 $ 14,325,000
Certificates of deposit 2,976,000  
Corporate bonds and notes 178,000 801,000
Total marketable securities 34,991,000 15,126,000
Cost Basis [Member]    
OtherInvestmentsReadilyMarketableLineItems [Line Items]    
Government securities 20,781,000  
Fixed income mutual funds 11,904,000 14,462,000
Certificates of deposit 3,019,000  
Corporate bonds and notes 192,000 813,000
Total marketable securities 35,896,000 15,275,000
Gross Unrealized Gains [Member]    
OtherInvestmentsReadilyMarketableLineItems [Line Items]    
Government securities 67,000  
Fixed income mutual funds
Certificates of deposit  
Corporate bonds and notes
Total marketable securities 67,000
Gross Unrealized Losses [Member]    
OtherInvestmentsReadilyMarketableLineItems [Line Items]    
Government securities  
Fixed income mutual funds (915,000) (137,000)
Certificates of deposit (43,000)  
Corporate bonds and notes (14,000) (12,000)
Total marketable securities $ (972,000) $ (149,000)
XML 61 R48.htm IDEA: XBRL DOCUMENT v3.23.1
Equity Investment (Details) - USD ($)
 12 Months Ended
Dec. 31, 2022
Sep. 30, 2022
Dec. 31, 2021
Sep. 30, 2021
Equity Method Investments and Joint Ventures [Abstract]        
Loss from continuing operations   $ 15,246,000   $ 11,133,000
Comprehensive loss $ (2,328,000) $ 17,913,000 $ 14,279,000 $ 10,384,000
XML 62 R49.htm IDEA: XBRL DOCUMENT v3.23.1
Equity Investment (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Aug. 24, 2022
Schedule of Equity Method Investments [Line Items]      
Unrealized gain securities $ 3,883,000    
Principal amount - convertible note 1,000,000    
Accrued interest - convertible note 86,000    
Unrealized gain on conversion - convertible note $ 271,000  
Iliad [Member]      
Schedule of Equity Method Investments [Line Items]      
Ownership percentage fully diluted 6.30%    
Equity investment net loss $ 1,639,000 $ 999,000  
Book value of investment $ 4,130,000    
Iliad [Member] | Class C Units [Member]      
Schedule of Equity Method Investments [Line Items]      
Ownership percentage not fully diluted 6.80%    
I Li A D Biotechnologies L L C [Member]      
Schedule of Equity Method Investments [Line Items]      
Aggregrate investment $ 7,000,000    
Private financing - D units     $ 42,836,000
Invested amount - multi-national pharma     30,000,000
Additional invested amount - D units     $ 1,000,000
XML 63 R50.htm IDEA: XBRL DOCUMENT v3.23.1
Commitments And Contingencies (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]    
Operating lease right-of-use assets $ 161,000
Operating lease obligations – current 79,000
Operating lease obligations – non-current 94,000
Total lease obligations $ 173,000
XML 64 R51.htm IDEA: XBRL DOCUMENT v3.23.1
Commitments And Contingencies (Details 1) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]    
Operating lease cost $ 48,000
Short-term lease cost 82,000 128,000
Total lease cost $ 130,000 $ 128,000
XML 65 R52.htm IDEA: XBRL DOCUMENT v3.23.1
Commitments And Contingencies (Details 2) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]    
2023 $ 83,000  
2024 73,000  
2025 24,000  
Total future minimum lease payments 180,000  
Less imputed interest (7,000)  
Total operating lease liability $ 173,000
XML 66 R53.htm IDEA: XBRL DOCUMENT v3.23.1
Commitments and Contingencies (Details Narrative) - USD ($)
 1 Months Ended 12 Months Ended 104 Months Ended
Mar. 25, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2021
May 01, 2022
PatentsAcquisition [Line Items]          
HFT patent acqusition - cash at closing $ 500,000        
Obligation to pay HFT seller additional cash based on achieving certain milestones 500,000        
Contingent common stock issued upon achieving certain milestones $ 375,000        
First $50 million of HFT net proceeds 15.00%        
Greater than $50 million of HFT net proceeds 17.50%        
Obligated to pay Cox, net proceeds percentage   12.50%      
Obligated to pay Recognition, net proceeds          
First $125 Million   10.00%      
Next $125 Million   15.00%      
Over $250 Million   20.00%      
Recognition net proceeds payment related to Mirror Worlds patents       $ 3,127,000  
Obligated to pay MTM          
First $100 Million   14.00%      
Next $100 Million   5.00%      
Additional consideration payable upon occurrence of certain future events   $ 250,000      
Plan expense   $ 78,000 $ 102,000    
Borrowing rate - incremental         4.20%
Remaining lease term   2 years 3 months 18 days     3 years
Cox Patent Portfolio [Member]          
PatentsAcquisition [Line Items]          
Accrued expenses   $ 0 $ 0 $ 0  
XML 67 R54.htm IDEA: XBRL DOCUMENT v3.23.1
Employment Arrangements and Other Agreements (Details Narrative) - USD ($)
 1 Months Ended 12 Months Ended
Mar. 22, 2024
Mar. 22, 2023
Mar. 22, 2022
Dec. 31, 2022
Dec. 31, 2021
Chief Executive Officer [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Annual discretionary bonus       $ 175,000 $ 175,000
CEO Incentive Compensation       0 1,801,000
Chief Executive Officer [Member] | Restricted Stock Units (RSUs) [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Restricted stock units granted     600,000    
Chief Executive Officer [Member] | Restricted Stock Units (RSUs) [Member] | Share-Based Payment Arrangement, Tranche One [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Restricted stock units Tranche 1     175,000    
Restricted Stock Units to vest (Tranche 1) 75,000 100,000      
Chief Executive Officer [Member] | Restricted Stock Units (RSUs) [Member] | Share-Based Payment Arrangement, Tranche Two [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Restricted stock units to vest (Tranche 2)     150,000    
Minimum stock price for vesting     $ 3.50    
Chief Executive Officer [Member] | Restricted Stock Units (RSUs) [Member] | Share-Based Payment Arrangement, Tranche Three [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Minimum stock price for vesting     $ 4.00    
Restricted stock units to vest (Tranche 3)     150,000    
Chief Executive Officer [Member] | Restricted Stock Units (RSUs) [Member] | Share Based Compensation Award Tranche Four [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Minimum stock price for vesting     $ 4.50    
Restricted stock units to vest (Tranche 4)     125,000    
Chief Executive Officer [Member] | New Employment Agreement [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Annual base salary     $ 535,000    
Annual Target Bonus     175,000    
Prorated target bonus     $ 175,000    
Vice President [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Annual discretionary bonus       25,000 $ 40,000
Chief Financial Officer [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Annual base salary       $ 175,000  
XML 68 R55.htm IDEA: XBRL DOCUMENT v3.23.1
Legal Proceedings (Details Narrative)
May 09, 2017
Google [Member]  
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]  
Litigation pending, description Company initiated litigation against Google Inc. (“Google”) and YouTube, LLC (“YouTube”) in the U.S. District Court for the Southern District of New York for infringement of several of its patents within its Cox Patent Portfolio acquired from Dr. Cox which relate to the identification of media content on the Internet. The lawsuit alleges that Google and YouTube have infringed and continue to infringe certain of the Company’s patents by making, using, selling and offering to sell unlicensed systems and related products and services, which include YouTube’s Content ID system. The litigations against Google and YouTube were subject to court ordered stays which were in effect from July 2, 2015 until January 2, 2019 as a result of proceedings at the Patent Trial and Appeal Board (PTAB) and the appeals of PTAB Final Written Decisions to the U.S. Court of Appeals for the Federal Circuit. Pursuant to a Joint Stipulation and Order Regarding Lifting of Stays, entered on January 2, 2019, the parties agreed, among other things, that the stays with respect to the litigations were lifted. In January 2019, the two litigations against Google and YouTube were consolidated. Discovery is complete and the parties have each submitted summary judgment motions. A trial date has not yet been set.
Facebook [Member]  
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]  
Litigation pending, description Company’s wholly-owned subsidiary, initiated litigation against Facebook, Inc. (“now Meta Platforms, Inc. (“Meta”)) in the U.S. District Court for the Southern District of New York, for infringement of U.S. Patent No. 6,006,227, U.S. Patent No. 7,865,538 and U.S. Patent No. 8,255,439 (among the patents within the Company’s Mirror Worlds Patent Portfolio). The lawsuit alleged that the asserted patents are infringed by Meta’s core technologies that enable Meta’s Newsfeed and Timeline features.
Netgear [Member]  
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]  
Litigation pending, description Company filed a lawsuit against Netgear, Inc. (“Netgear”) in the Supreme Court of the State of New York, County of New York, for breach of a Settlement and License Agreement, dated May 22, 2009, with the Company for failure to make royalty payments, and provide corresponding royalty reports, to the Company based on sales of Netgear’s PoE products. On October 22, 2021, Netgear filed a Demand for Arbitration at the American Arbitration Association (AAA) seeking to arbitrate certain issues raised in the litigation. The Company objected to jurisdiction at the AAA. On April 22, 2022, Netgear filed a counterclaim in the N.Y. court action alleging that the Company breached the License Agreement by not offering Netgear lower royalties. On September 22, 2022, the arbitration brought by Netgear was dismissed by the AAA on jurisdiction grounds. The case remains pending in the Supreme Court of the State of New York, County of New York.
Arista Networks [Member]  
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]  
Litigation pending, description Company initiated separate litigation against ten defendants for infringement of its Remote Power Patent seeking monetary damages based upon reasonable royalties, as follows: (i) On October 6, 2022, the Company initiated such litigation against Arista Networks, Inc., Fortinet, Inc., Honeywell International Inc. and Ubiquiti Inc. in the United States District Court, District of Delaware; (ii) On October 27, 2022, and November 3, 2022, the Company initiated such litigation against TP-Link USA Corporation and Hikvision USA, Inc. in the United States District Court for the Central District of California; (iii) On November 4, 2022, the Company initiated such litigation against Panasonic Holdings Corporation and Panasonic Corporation of North America in the United States District Court for the Eastern District of Texas (Marshall Division); and (iv) On November 8, 2022 and November 16, 2022, the Company initiated such litigation against Antaira Technologies, LLC and Dahua Technology USA in the United States District Court for the Central District of California.
XML 69 R56.htm IDEA: XBRL DOCUMENT v3.23.1
Concentrations (Details Narrative)
 12 Months Ended
Dec. 31, 2021
Remote Power Patent [Member]  
Concentration Risk [Line Items]  
Percentage revenue 100.00%
Licensees Two [Member]  
Concentration Risk [Line Items]  
Percentage revenue 99.00%
XML 70 R57.htm IDEA: XBRL DOCUMENT v3.23.1
Related Party Transaction (Details Narrative) - Board Of Directors [Member]
Jun. 01, 2022
USD ($)
$ / shares
shares
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]  
Number of shares, common stock repurchased | shares 41,500
Price per share, common stock repurchased | $ / shares $ 2.42
Aggregate cost of common stock | $ $ 100,430
XML 71 R58.htm IDEA: XBRL DOCUMENT v3.23.1
Stock Repurchase Program (Details Narrative) - USD ($)
 12 Months Ended 137 Months Ended
Dec. 31, 2022
Dec. 31, 2022
Jun. 11, 2021
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]      
Number of shares, common stock repurchased since inception 228,530 9,212,664  
Aggregate cost of common stock repurchased since inception $ 531,000 $ 17,758,000  
Average price per share, common stock repurchased since inception $ 2.33 $ 1.93  
Board Of Directors [Member]      
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]      
Stock repurchase program, dollar amount     5,000,000
XML 72 R59.htm IDEA: XBRL DOCUMENT v3.23.1
Dividend Policy (Details Narrative) - $ / shares
 1 Months Ended 12 Months Ended
Sep. 09, 2021
Feb. 23, 2022
Dec. 31, 2022
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]      
Dividends, per share - semi-annual     $ 0.05
Dividends, per share - annual     $ 0.10
Board Of Directors [Member]      
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]      
Dividends, per share - semi-annual $ 0.05 $ 0.05  
Semi-annual cash dividend payment date Sep. 30, 2022 Mar. 24, 2022  
Semi-annual cash dividend record date Sep. 20, 2022 Mar. 09, 2022  
XML 73 R60.htm IDEA: XBRL DOCUMENT v3.23.1
Subsequent Events (Details Narrative) - USD ($)
 1 Months Ended 2 Months Ended 12 Months Ended
Mar. 03, 2023
Sep. 09, 2021
Feb. 23, 2022
Mar. 10, 2023
Dec. 31, 2022
Dec. 31, 2021
Subsequent Event [Line Items]            
Semi-annual cash dividend per common share         $ 0.10 $ 0.10
Board Of Directors [Member]            
Subsequent Event [Line Items]            
Dividend payment date   Sep. 30, 2022 Mar. 24, 2022      
Semi-annual cash dividend record date   Sep. 20, 2022 Mar. 09, 2022      
Subsequent Event [Member] | Settlement Agreements [Member]            
Subsequent Event [Line Items]            
Aggregate settlement payments       $ 537,300    
Conditional payment       $ 150,000    
Subsequent Event [Member] | Restricted Stock Units (RSUs) [Member]            
Subsequent Event [Line Items]            
Restricted stock units granted to directors 15,000          
Subsequent Event [Member] | Board Of Directors [Member]            
Subsequent Event [Line Items]            
Semi-annual cash dividend per common share $ 0.05          
Dividend payment date Mar. 31, 2023          
Semi-annual cash dividend record date Mar. 15, 2023          
XML 74 network1_10k-123122_htm.xml IDEA: XBRL DOCUMENT 0001065078 2022-01-01 2022-12-31 0001065078 2022-06-30 0001065078 2023-03-23 0001065078 2022-12-31 0001065078 2021-12-31 0001065078 2021-01-01 2021-12-31 0001065078 us-gaap:CommonStockMember 2020-12-31 0001065078 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001065078 us-gaap:RetainedEarningsMember 2020-12-31 0001065078 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001065078 nssi:TotalStockholdersEquityMember 2020-12-31 0001065078 us-gaap:CommonStockMember 2021-12-31 0001065078 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001065078 us-gaap:RetainedEarningsMember 2021-12-31 0001065078 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001065078 nssi:TotalStockholdersEquityMember 2021-12-31 0001065078 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001065078 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001065078 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001065078 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001065078 nssi:TotalStockholdersEquityMember 2021-01-01 2021-12-31 0001065078 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001065078 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001065078 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001065078 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001065078 nssi:TotalStockholdersEquityMember 2022-01-01 2022-12-31 0001065078 us-gaap:CommonStockMember 2022-12-31 0001065078 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001065078 us-gaap:RetainedEarningsMember 2022-12-31 0001065078 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001065078 nssi:TotalStockholdersEquityMember 2022-12-31 0001065078 2020-12-31 0001065078 nssi:ILiADBiotechnologiesLLCMember 2022-12-31 0001065078 nssi:FullyPaidLicensesMember 2022-01-01 2022-12-31 0001065078 nssi:FullyPaidLicensesMember 2021-01-01 2021-12-31 0001065078 nssi:RoyaltyBearingLicensesMember 2022-01-01 2022-12-31 0001065078 nssi:RoyaltyBearingLicensesMember 2021-01-01 2021-12-31 0001065078 srt:MinimumMember 2022-01-01 2022-12-31 0001065078 srt:MaximumMember 2022-01-01 2022-12-31 0001065078 nssi:StockIncentivePlan2022Member 2022-12-31 0001065078 nssi:StockIncentivePlan2013Member 2022-12-31 0001065078 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001065078 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-12-31 0001065078 us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001065078 us-gaap:RestrictedStockUnitsRSUMember 2021-12-31 0001065078 nssi:ChairmanAndChiefExecutiveOfficerMember 2022-10-01 2022-10-27 0001065078 nssi:ChairmanAndChiefExecutiveOfficerMember 2022-10-27 0001065078 us-gaap:StockOptionMember 2021-12-31 0001065078 us-gaap:StockOptionMember 2020-12-31 0001065078 us-gaap:StockOptionMember 2022-01-01 2022-12-31 0001065078 us-gaap:StockOptionMember 2021-01-01 2021-12-31 0001065078 us-gaap:StockOptionMember 2022-12-31 0001065078 nssi:CostBasisMember 2022-12-31 0001065078 nssi:GrossUnrealizedGainsMember 2022-12-31 0001065078 nssi:GrossUnrealizedLossesMember 2022-12-31 0001065078 nssi:FairValueMember 2022-12-31 0001065078 nssi:CostBasisMember 2021-12-31 0001065078 nssi:GrossUnrealizedGainsMember 2021-12-31 0001065078 nssi:GrossUnrealizedLossesMember 2021-12-31 0001065078 nssi:FairValueMember 2021-12-31 0001065078 nssi:IliadMember nssi:ClassCUnitsMember 2022-12-31 0001065078 nssi:IliadMember 2022-01-01 2022-12-31 0001065078 nssi:ILiADBiotechnologiesLLCMember 2022-08-24 0001065078 nssi:IliadMember 2021-01-01 2021-12-31 0001065078 nssi:IliadMember 2022-12-31 0001065078 2021-10-01 2022-09-30 0001065078 2020-10-01 2021-09-30 0001065078 2022-03-01 2022-03-25 0001065078 nssi:CoxPatentPortfolioMember 2022-12-31 0001065078 nssi:CoxPatentPortfolioMember 2021-12-31 0001065078 2013-05-01 2021-12-31 0001065078 2022-05-01 0001065078 srt:ChiefExecutiveOfficerMember nssi:NewEmploymentAgreementMember 2022-03-01 2022-03-22 0001065078 srt:ChiefExecutiveOfficerMember 2022-01-01 2022-12-31 0001065078 srt:ChiefExecutiveOfficerMember 2021-01-01 2021-12-31 0001065078 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockUnitsRSUMember 2022-03-01 2022-03-22 0001065078 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockUnitsRSUMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2022-03-01 2022-03-22 0001065078 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockUnitsRSUMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2023-03-01 2023-03-22 0001065078 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockUnitsRSUMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2024-03-01 2024-03-22 0001065078 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockUnitsRSUMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2022-03-01 2022-03-22 0001065078 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockUnitsRSUMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2022-03-01 2022-03-22 0001065078 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockUnitsRSUMember nssi:ShareBasedCompensationAwardTrancheFourMember 2022-03-01 2022-03-22 0001065078 srt:VicePresidentMember 2022-01-01 2022-12-31 0001065078 srt:VicePresidentMember 2021-01-01 2021-12-31 0001065078 srt:ChiefFinancialOfficerMember 2022-01-01 2022-12-31 0001065078 nssi:GoogleMember 2017-05-08 2017-05-09 0001065078 nssi:FacebookMember 2017-05-08 2017-05-09 0001065078 nssi:NetgearMember 2017-05-08 2017-05-09 0001065078 nssi:AristaNetworksMember 2017-05-08 2017-05-09 0001065078 nssi:RemotePowerPatentMember 2021-01-01 2021-12-31 0001065078 nssi:LicenseesTwoMember 2021-01-01 2021-12-31 0001065078 nssi:BoardOfDirectorsMember 2022-05-29 2022-06-01 0001065078 nssi:BoardOfDirectorsMember 2021-06-11 0001065078 2011-08-01 2022-12-31 0001065078 nssi:BoardOfDirectorsMember 2022-02-01 2022-02-23 0001065078 nssi:BoardOfDirectorsMember 2021-09-01 2021-09-09 0001065078 nssi:BoardOfDirectorsMember us-gaap:SubsequentEventMember 2023-03-01 2023-03-03 0001065078 us-gaap:RestrictedStockUnitsRSUMember us-gaap:SubsequentEventMember 2023-03-01 2023-03-03 0001065078 us-gaap:SubsequentEventMember nssi:SettlementAgreementsMember 2023-01-24 2023-03-10 iso4217:USD shares iso4217:USD shares pure nssi:Integer 0001065078 false 2022 FY 10-K true 2022-12-31 --12-31 false 1-15288 NETWORK-1 TECHNOLOGIES, INC. DE 11-3027591 65 Locust Avenue Third Floor New Canaan CT 06840 (203) 920-1055 Common Stock $.01 par value NTIP NYSEAMER No No Yes Yes Non-accelerated Filer true false false 39885677 23817505 688 Marcum LLP New York, New York 13448000 44497000 34991000 15126000 177000 348000 150000 48964000 59773000 1592000 1384000 7252000 2651000 1000000 161000 13000 9005000 5048000 57969000 64821000 507000 459000 115000 2952000 137000 317000 380000 587000 180000 79000 1605000 4108000 1161000 554000 94000 2860000 4662000 0.01 0.01 10000000 10000000 0 0 0 0 0.01 0.01 50000000 50000000 23863639 23863639 23792212 23792212 239000 238000 66939000 66361000 -12055000 -6428000 -14000 -12000 55109000 60159000 57969000 64821000 36029000 12147000 809000 1500000 2778000 2501000 316000 295000 3903000 16443000 -3903000 19586000 1020000 327000 271000 3883000 -1351000 -173000 3823000 154000 -80000 19740000 2952000 607000 1508000 607000 4460000 -687000 15280000 -1639000 -999000 -2326000 14281000 -0.10 0.59 -0.10 0.58 23825917 24136821 23825917 24530568 0.10 0.10 -2326000 14281000 -2000 -2000 -2328000 14279000 24105879 241000 66124000 -17193000 -10000 49162000 -2429000 -2429000 238000 238000 70000 1000 -1000 -5192 -14000 -14000 -378475 -4000 -1073000 -1077000 -2000 -2000 14281000 14281000 23792212 238000 66361000 -6428000 -12000 60159000 -2418000 -2418000 585000 585000 182500 2000 -2000 500000 5000 -5000 -382543 -3000 -352000 -355000 -228530 -3000 -531000 -534000 -2000 -2000 -2326000 -2326000 23863639 239000 66939000 -12055000 -14000 55109000 2326000 -14281000 316000 295000 585000 238000 -1639000 -999000 607000 1508000 43000 3883000 86000 271000 -880000 -148000 208000 30000 167000 48000 -142000 -2837000 2952000 13000 8000 -31000 242000 -758000 -5436000 19499000 -13156000 -17154000 33903000 13059000 524000 101000 1000000 1000000 -22271000 2994000 2453000 2410000 355000 14000 534000 1077000 -3342000 -3501000 -31049000 18992000 44497000 25505000 13448000 44497000 3004000 37000 20000 204000 1086000 <p id="xdx_80B_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zVY9tAT5VkLc" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-variant: small-caps; color: Black"><b>Note A – <span id="xdx_828_zLz19vFSOm13">Business</span></b></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; color: Black"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">Network-1 Technologies, Inc. (the “Company”) is engaged in the development, licensing and protection of its intellectual property assets. The Company presently owns ninety-seven (<span id="xdx_905_eus-gaap--GainContingencyPatentsFoundInfringedUponNumber_uInteger_c20220101__20221231_z5TZOIa1LrUc" title="Patents owned by the company">97</span>) U.S. patents, fifty-two (<span id="xdx_906_ecustom--ExpiredPatents_uInteger_c20220101__20221231_zlNRw86V09ca" title="Expired patents">52</span>) of such patents have expired, and eight (<span id="xdx_90F_ecustom--ForeignPatentsOwnedByCompany_uInteger_c20220101__20221231_z4XIStVRddke" title="Foreign patents owned by the company">8</span>) foreign patents related to (i) the Cox patent portfolio (the “Cox Patent Portfolio) relating to enabling technology for identifying media content on the Internet and taking further actions to be performed after such identification; (ii) the M2M/IoT patent portfolio (the “M2M/IoT Patent Portfolio”) relating to, among other things, enabling technology for authenticating, provisioning and using embedded SIM (Subscriber Identification Module)technology in next generation IoT, Machine-to-Machine, and other mobile devices, including smartphones, tablets and computers; (iii) the HFT patent portfolio (the “HFT Patent Portfolio”) covering certain advanced technologies relating to high frequency trading, which inventions specifically address technological problems associated with speed and latency and provide critical latency gains in trading systems where the difference between success and failure may be measured in nanoseconds; (iv) the Mirror Worlds patent portfolio (the “Mirror Worlds Patent Portfolio”) relating to foundational technologies that enable unified search and indexing, displaying and archiving of documents in a computer system; and (v) the remote power patent (the “Remote Power Patent”) covering delivery of Power over Ethernet (PoE) cables for the purpose of remotely powering network devices, such as wireless access ports, IP phones and network based cameras.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">The Company’s current strategy includes continuing to pursue licensing opportunities for its intellectual property assets. In addition, the Company continually reviews opportunities to acquire or license additional intellectual property as well as other strategic alternatives. The Company’s patent acquisition and development strategy is to focus on acquiring high quality patents which management believes have the potential to generate significant licensing opportunities as the Company has achieved with respect to its Remote Power Patent and Mirror Worlds Patent Portfolio. In addition, the Company may also enter into strategic relationships with third parties to develop, commercialize, license or otherwise monetize their intellectual property.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">The Company has made equity investments totaling $<span id="xdx_907_eus-gaap--Investments_iI_pp0p0_c20221231__dei--LegalEntityAxis__custom--ILiADBiotechnologiesLLCMember_z6rFQDXnd0xh" title="Aggregate investment amount">7,000,000</span> in ILiAD Biotechnologies, LLC (“ILiAD”), a clinical stage biotechnology company (see Note H hereof). </span></p> 97 52 8 7000000 <p id="xdx_807_eus-gaap--BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_zkL7Kutv7hX3" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt"><span style="font-family: Times New Roman, Times, Serif; font-variant: small-caps; color: Black"><b>Note </b></span><b><span style="font-family: Times New Roman, Times, Serif; color: Black">B – <span style="font-variant: small-caps"><span id="xdx_828_zjI88BEQ1tHf">Summary of Significant Accounting Policies</span></span></span></b></p> <p id="xdx_84C_eus-gaap--ConsolidationPolicyTextBlock_zU0XAKZ0DJWe" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt"><b><span style="font-family: Times New Roman, Times, Serif; color: Black"><span style="font-variant: small-caps"><span> </span> </span></span></b></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>[1]</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_864_zb8RucttfVP">Principles of Consolidation</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt 27.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">The Company’s consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The accompanying financial statements include the accounts of the Company and its wholly-owned subsidiaries, Mirror Worlds Technologies, LLC and HFT Solutions, LLC. All intercompany transactions and balances are eliminated in consolidation.</span></p> <p id="xdx_842_eus-gaap--UseOfEstimates_zT2pw0Eh4lY1" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt 27.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>[2]</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_866_zZt5VJJORZJ">Use of Estimates and Assumptions</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods. The significant estimates and assumptions made in the preparation of the Company’s consolidated financial statements primarily include costs related to the Company’s assertion of litigation, the valuation of the Company’s patent portfolios, stock-based compensation, the recoverability of deferred tax assets and carrying value of the Company’s equity method investments. Actual results could be materially different from those estimates, upon which the carrying values were based. </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">Certain amounts recorded to reflect the Company’s share of income or losses of its equity method investee, accounted for under the equity method, are based on estimates and the unaudited results of operations of the equity method investee and may require adjustment in the future when the audit is complete. The Company reports its share of the results of its equity method investee on a one quarter lag basis.</span></p> <p id="xdx_84D_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z6IcCdmaNNy" style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; color: Black"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>[3]</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_865_zK5no9Mn5Kkl">Cash and Cash Equivalents</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">The Company maintains cash deposits in high quality financial institutions insured by the Federal Deposit Insurance Corporation ("FDIC"). Accounts at each institution are insured by the FDIC up to $<span id="xdx_90B_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20221231_z9w1DmjjqWaj" title="FDIC insured limit"><span id="xdx_905_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20211231_zmoVZaZhL847" title="FDIC insured limit">250,000</span></span>. At December 31, 2022 and 2021, the Company had $<span id="xdx_900_eus-gaap--CashUninsuredAmount_c20221231_pp0p0" title="Cash in excess of FDIC insured limit">1,715,000</span> and $<span id="xdx_907_eus-gaap--CashUninsuredAmount_c20211231_pp0p0" title="Cash in excess of FDIC insured limit">8,109,000</span>, respectively, in excess of the FDIC insured limit.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">The Company considers all highly liquid short-term investments, including certificates of deposit and money market funds, that are purchased with an original maturity of three months or less to be cash equivalents.</span></p> <p id="xdx_844_eus-gaap--MarketableSecuritiesPolicy_zYKl9nUsxQq8" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>[4]</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_86E_zvzMkV2bZYZ6">Marketable Securities</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">The Company’s marketable securities are comprised of certificates of deposit with original maturity greater than three months from date of purchase, government securities, fixed income mutual funds, and a corporate bond (see Note G). At December 31, 2022 and December 31, 2021, included in marketable securities, the Company had aggregate certificates of deposit of $<span id="xdx_901_eus-gaap--CertificatesOfDepositAtCarryingValue_c20221231_pp0p0" title="Certificates of deposit">2,976,000</span> and $<span id="xdx_90E_eus-gaap--CertificatesOfDepositAtCarryingValue_c20211231_pp0p0" title="Certificates of deposit">0</span>, respectively. The Company’s marketable securities are measured at fair value and are accounted for in accordance with ASU 2016-01. Unrealized holding gains and losses on certificates of deposit, government securities, and fixed income mutual funds are recorded in net realized and unrealized gain (loss) from investments on the consolidated statements of operations and comprehensive income (loss). Unrealized holding gains and losses, net of the related tax effect, on corporate bonds and notes are excluded from earnings and are reported as a separate component of stockholders’ equity until realized. Dividend and interest income are recognized when earned. Realized gains and losses are included in earnings and are derived using the specific identification method for determining the cost of the marketable securities.</span></p> <p id="xdx_842_eus-gaap--RevenueRecognitionPolicyTextBlock_z2YYs8o2uRN8" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>[5]</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_86E_zD0G3drxLHv9">Revenue Recognition</span></b></span></td></tr></table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; color: Black"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">Under ASC 606, revenue is recognized when the Company completes the licensing of its intellectual property to its licensees, in an amount that reflects the consideration the Company expects to be entitled to in exchange for licensing its intellectual property.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">The Company determines revenue recognition through the follow steps:</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.6in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">•</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">identification of the license agreement;</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.6in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">•</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">identification of the performance obligations in the license agreement;</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.6in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">•</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">determination of the consideration for the license;</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.6in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">•</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">allocation of the transaction price to the performance obligations in the contract; and</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 0.6in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">•</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">recognition of revenue when the Company satisfies its performance obligations.</span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">Revenue disaggregated by source is as follows (the Company had no revenue for the year ended December 31, 2022):</span></p> <table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--DisaggregationOfRevenueTableTextBlock_zEsPMiFU6n0c" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary Of Significant Accounting Policies (Details)"> <tr style="vertical-align: bottom"> <td style="text-indent: 20pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span id="xdx_8B9_zM9l7nIwA6sg" style="display: none">Schedule of disaggregation of revenue</span></td><td style="font-size: 9pt; padding-bottom: 1pt"> </td> <td style="font-size: 9pt; text-align: left"> </td><td style="font-size: 9pt; text-align: right"> </td><td style="padding-bottom: 1pt; font-size: 9pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Years Ended December 31,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><sup> </sup></span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><sup> </sup></span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: 20pt; width: 56%; text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Fully-Paid Licenses</span></td><td style="width: 8%; font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="width: 1%; font-size: 12pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">$</span></td><td id="xdx_98C_eus-gaap--Revenues_c20220101__20221231__srt--ProductOrServiceAxis__custom--FullyPaidLicensesMember_pp0p0" style="width: 12%; font-size: 12pt; text-align: right" title="Total Revenue"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0599">—</span></span></td><td style="width: 1%; font-size: 12pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">$</span></td><td id="xdx_98F_eus-gaap--Revenues_pp0p0_c20210101__20211231__srt--ProductOrServiceAxis__custom--FullyPaidLicensesMember_fKDEp_zZ7m85ZQj411" style="width: 12%; text-align: right" title="Total Revenue"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">17,000,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><sup>(1)</sup></span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: 20pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Royalty Bearing Licenses</span></td><td style="font-size: 9pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 9pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td><td id="xdx_982_eus-gaap--Revenues_c20220101__20221231__srt--ProductOrServiceAxis__custom--RoyaltyBearingLicensesMember_pp0p0" style="border-bottom: Black 1pt solid; font-size: 9pt; text-align: right" title="Total Revenue"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0603">—</span></span></td><td style="padding-bottom: 1pt; font-size: 9pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td><td id="xdx_98D_eus-gaap--Revenues_pp0p0_c20210101__20211231__srt--ProductOrServiceAxis__custom--RoyaltyBearingLicensesMember_fKDIp_zlutUasnAC2j" style="border-bottom: Black 1pt solid; text-align: right" title="Total Revenue"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">19,029,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><sup>(2)</sup></span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: 20pt; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Total Revenue</span></td><td style="font-size: 12pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 12pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">$</span></td><td id="xdx_98B_eus-gaap--Revenues_c20220101__20221231_pp0p0" style="border-bottom: Black 2.5pt double; font-size: 12pt; text-align: right" title="Total Revenue"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0607">—</span></span></td><td style="padding-bottom: 2.5pt; font-size: 12pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">$</span></td><td id="xdx_989_eus-gaap--Revenues_c20210101__20211231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Revenue"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">36,029,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><sup> </sup></span></td></tr> </table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">__________________________</span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top"> <td style="width: 0.35in"/><td style="width: 0.25in"><span id="xdx_F06_zyY4SKDbFCS7" style="font-family: Times New Roman, Times, Serif; font-size: 9pt; color: Black">(1)</span></td><td style="text-align: justify"><span id="xdx_F1F_zOzuuRXaedh2" style="font-family: Times New Roman, Times, Serif; font-size: 9pt; color: Black">Includes $17,000,000 received from Hewlett-Packard related to settlement of a patent litigation (see Note K[1] hereof).</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top"> <td style="width: 0.35in"/><td style="width: 0.25in"><span id="xdx_F0F_zlRWkfkChUCl" style="font-family: Times New Roman, Times, Serif; font-size: 9pt; color: Black">(2)</span></td><td style="text-align: justify"><span id="xdx_F1A_zrgSGrDRVGc3" style="font-family: Times New Roman, Times, Serif; font-size: 9pt; color: Black">Includes (1) $18,691,890 of royalty revenue from Cisco Systems, Inc. from resolution of a dispute under its license agreement with the Company and (2) $337,000 of royalty revenue received from Plantronics, Inc.</span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">Revenue from the Company’s patent licensing business is typically generated from negotiated license agreements. The timing and amount of revenue recognized from each licensee depends upon a variety of factors, including the terms of each agreement and the nature of the obligations of the parties. These agreements may include, but not be limited to, elements related to past infringement liabilities, non-refundable upfront license fees, and ongoing royalties on licensed products sold by the licensee. Generally, in the event of settlement of litigation related to the Company’s assertion of patent infringement involving its intellectual property, defendants will either pay (i) a non-refundable lump sum payment for a non-exclusive fully-paid license, or (ii) a non-refundable lump sum payment (license initiation fee) together with an ongoing obligation to pay quarterly or monthly royalties to the Company for the life of the licensed patent.</span></p> <p id="xdx_84A_eus-gaap--EquityMethodInvestmentsPolicy_ztManH9gY1Bk" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>[6]</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_862_z4lJ0c8zSkB2">Equity Method Investments</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">Equity method investments are equity securities in entities the Company does not control but over which it has the ability to exercise significant influence. These investments are accounted for under the equity method of accounting in accordance with ASC 323, <i>Investments — Equity Method and Joint Ventures</i> (see Note H hereof). Equity method investments are measured at cost minus impairment, if any, plus or minus the Company’s share of an investee’s income or loss. The Company’s proportionate share of the income or loss from equity method investments is recognized on a one-quarter lag. When the Company’s carrying value in an equity method investment is reduced to zero, no further losses are recorded in the Company’s financial statements unless the Company guaranteed obligations of the investee company or has committed additional funding. When the investee company subsequently reports income, the Company will not record its share of such income until it equals the amount of its share of losses not previously recognized.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">Upon a sale of an equity method investment by the Company, the difference between sales proceeds and the carrying amount of the equity investment is recognized in profit or loss. Upon the issuance of securities in an observable price transaction, the Company will account for the share issuance by the equity method investee as if the Company had sold a proportionate share of its investment in the observable price transaction. The Company will record a gain or loss associated with the dilution of its investment to reflect third party investments in the investee and will increase or decrease its basis in the equity method investee accordingly. The gain or loss is recorded within other income or expense in the Company’s consolidated statements of operations and comprehensive income (loss).</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">During the year ended December 31, 2022, the Company recorded a change in its share of net losses of the equity method investee as a result of the Company receiving new information from the equity method investee during the fourth quarter of 2022. The effect of this change was an increase in the Company’s share of the net losses of the equity method investee of $<span id="xdx_90B_ecustom--IncreaseInNetLossesOfEquityMethodInvestee_c20220101__20221231_pp0p0" title="Increase in net losses of equity method investee">398,000</span> and a corresponding decrease in the Company’s net income, and a decrease in basic and diluted earnings of $<span id="xdx_905_ecustom--DecreaseInBasicAndDilutedEarnings_c20220101__20221231_pdd" title="Decrease in basic and diluted earnings">0.02</span> per share.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">The Company performed an assessment to determine significance of the equity method investee under the investment, asset and income tests utilizing the 20% threshold. The Company determined that the equity method investee satisfied the income test and has included summarized financial data of the equity method investee in Note H hereof.</span></p> <p id="xdx_841_ecustom--PatentsPolicyTextBlock_zutOXt36UYwd" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>[7]</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_865_zeCQ8tbsHDpi">Patents</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">The Company owns patents that relate to various technologies. The Company capitalizes the costs associated with acquisition, registration and maintenance of its acquired patents and amortizes these assets over their remaining useful lives on a straight-line basis. Any further payments made to maintain or develop the patents would be capitalized and amortized over the balance of the useful life for the patents.</span></p> <p id="xdx_848_ecustom--CostsofRevenueandRelatedCostsPolicyTextBlock_zfvpOIRg1ulk" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"/></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>[8]</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_860_zRemIh08DNQa">Costs of Revenue and Related Costs</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">The Company includes in costs of revenue for the year ended December 31, 2022 and 2021 contingent legal fees payable to patent litigation counsel, any other contractual payments to third parties related to net proceeds from monetization of patents (see Note I[1] hereof) and incentive bonus compensation payable to its Chairman and Chief Executive Officer (see Note J[1] hereof).</span></p> <p id="xdx_847_eus-gaap--IncomeTaxPolicyTextBlock_zAUIyj5LX212" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt"><b><span style="font-family: Times New Roman, Times, Serif; color: Black"><span style="font-variant: small-caps"> </span></span></b></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>[9]</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_86A_zCrRi72uJ4ha">Income Taxes</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">The Company accounts for income taxes in accordance with Financial Accounting Standards Board (FASB) ASC Topic 740, Income Taxes (ASC 740), which requires the Company to use the assets and liability method of accounting for income taxes. Under the assets and liability method, deferred income taxes are recognized for the tax consequences of temporary (timing) differences by applying enacted statutory tax rates applicable to future years to differences between financial statement carrying amounts and the tax bases of existing assets and liabilities and operating loss and tax credit carry forwards. Under this accounting standard, the effect on deferred income taxes of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recognized if it is more likely than not that some portion, or all, of a deferred tax asset will not be realized.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">ASC 740-10, <i>Accounting for Uncertainty in Income Taxes</i>, defines uncertainty in income taxes and the evaluation of a tax position as a two-step process. The first step is to determine whether it is more likely than not that a tax position will be sustained upon examination, including the resolution of any related appeals or litigation based on the technical merits of that position. The second step is to measure a tax position that meets the more-likely-than-not threshold to determine the amount of benefit to be recognized in the financial statements. A tax position is measured at the largest amount of benefit that is greater than 50 percent likelihood of being realized upon ultimate settlement. Tax positions that previously failed to meet the more-likely-than-not recognition threshold should be recognized in the first subsequent period in which the threshold is met. Previously recognized tax positions that no longer meet the more-likely-than-not criteria should be de-recognized in the first subsequent financial reporting period in which the threshold is no longer met. The Company had <span id="xdx_907_eus-gaap--LiabilityForUncertainTaxPositionsCurrent_iI_pp0p0_do_c20221231_zMxbHkX2Lcwa" title="Uncertain tax positions"><span id="xdx_906_eus-gaap--LiabilityForUncertainTaxPositionsCurrent_iI_pp0p0_do_c20211231_zmqcZNdy783h" title="Uncertain tax positions">no</span></span> uncertain tax positions as of December 31, 2022 and 2021.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">U.S. federal, state and local income tax returns prior to 2019 are not subject to examination by any applicable tax authorities, except that tax authorities could challenge returns (only under certain circumstances) for earlier years to the extent they generated loss carry-forwards that are available for those future years.</span></p> <p id="xdx_84B_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zgfzVW4vVh8l" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>[10]</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_860_zq0QKsnsdb8">Stock-Based Compensation</span></b></span></td></tr></table> <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The Company accounts for its stock-based compensation awards to employees and directors in accordance with FASB ASC Topic 718, <i>Compensation </i></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt; color: Black"><b>—</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><i>Stock Compensation </i>(“ASC 718”). ASC 718 requires all stock-based compensation to employees, including grants of employee stock options and restricted stock units, to be recognized in the consolidated statements of operations and comprehensive income (loss) based on their grant date fair values. </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">Compensation expense related to awards to employees is recognized on a straight-line basis based on the grant date fair value over the associated service period of the award, which is generally the vesting term. The Company uses the Black-Scholes option pricing model to determine the grant date fair value of options granted. The fair value of restricted stock units is determined based on the number of shares underlying the grant and either the quoted market price of the Company’s common stock on the date of grant for time-based and performance-based awards, or the fair value on the date of grant using the Monte Carlo Simulation model for market-based awards.</span></p> <p id="xdx_84C_eus-gaap--EarningsPerSharePolicyTextBlock_zM6kqnYRCw12" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>[11]</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_861_ztdd3JEpppx3">Earnings Per Share</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">The Company reports earnings per share in accordance with U.S. GAAP, which requires presentation of basic and diluted earnings per share in conjunction with the disclosure of the methodology used in computing such earnings per share. Basic earnings per share excludes dilution and is computed by dividing income available to common shareholders by the weighted average common shares outstanding during the period. Diluted earnings per share takes into account the potential dilution that could occur if securities or other contracts, such as warrants and options to purchase common stock were exercised and shares were issued pursuant to outstanding restricted stock units. Common stock equivalents having an anti-dilutive effect on earnings per share are excluded from the calculation of diluted earnings per share.</span></p> <p id="xdx_842_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_z2iwDUTMjPI5" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt"><b><span style="font-family: Times New Roman, Times, Serif; color: Black"><span style="font-variant: small-caps"> </span></span></b></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>[12]</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_86B_zO2SpbxQvcUf">Fair Value Measurements</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">ASC Topic 820, Fair Value Measurement and Disclosures, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. This topic also establishes a fair value hierarchy which requires classification based on observable and unobservable inputs when measuring fair value.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">There are three levels of inputs that may be used to measure fair value:</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">Level 1: Observable inputs such as quoted prices (unadjusted) in an active market for identical assets or liabilities.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">Level 2: Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">Level 3: Unobservable inputs that are supported by little or no market activity; therefore, the inputs are developed by the Company using estimates and assumptions that the Company expects a market participant would use, including pricing models, discounted cash flow methodologies, or similar techniques.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">The carrying value of the Company’s financial instruments, including cash and cash equivalents and accounts payable, approximates fair value because of the short-term nature of these financial instruments.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">The Company’s marketable securities are classified within Level 1 because they are valued using quoted market prices in an active market.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">The Company’s equity method investment is measured on a non-recurring basis and is classified within Level 2 as it is valued using an observable price transaction for similar assets in a market that is not active (see Note B[6] and Note H hereof).</span></p> <p id="xdx_845_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zqnCViCp1Ya" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>[13]</b></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_862_zdMA4YET40oe">Carrying Value, Recoverability and Impairment of Long-Lived Assets</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">An impairment loss shall be recognized only if the carrying amount of a long-lived asset (asset group) is not recoverable and exceeds its fair value. The carrying amount of a long-lived asset (asset group) is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset (asset group). That assessment shall be based on the carrying amount of the asset (asset group) at the date it is tested for recoverability. An impairment loss shall be measured as the amount by which the carrying amount of a long-lived asset (asset group) exceeds its fair value. If an impairment loss is recognized, the adjusted carrying amount of a long-lived asset shall be its new cost basis. For a depreciable long-lived asset, the new cost basis shall be depreciated (amortized) over the remaining useful life of that asset. Restoration of a previously recognized impairment loss is prohibited. At December 31, 2022 and 2021, there was <span id="xdx_90B_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_pp0p0_do_c20210101__20211231_zCsshb6gh96a" title="Company impairment patents and equity investment"><span id="xdx_901_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_pp0p0_do_c20210101__20211231_zURxNo4CeRN3" title="Company impairment patents and equity investment">no</span></span> impairment to the Company’s patents and equity investment.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">The Company’s equity investment in ILiAD is evaluated on a non-recurring basis for impairment, when and if a triggering event occurs.</span></p> <p id="xdx_841_eus-gaap--LesseeLeasesPolicyTextBlock_zTVqmTrHl7Hj" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt"><b><span style="font-family: Times New Roman, Times, Serif; color: Black"><span style="font-variant: small-caps"> </span></span></b></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>[14]</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_866_zKksL6I4fOB5">Leases</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">Under ASC 842, the Company determines if an arrangement is a lease at inception. Right-of-Use (“ROU”) assets and related lease obligations are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. As the Company's lease does not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company's determined incremental borrowing rate is a hypothetical rate based on its understanding of what the Company's credit rating would be. The ROU asset also includes any lease payments made prior to commencement and is recorded net of any lease incentives received and net of the deferred rent balance on the date of implementation. The Company's lease terms may include options to extend or terminate the lease when it is reasonably certain that it will exercise such options. As permitted under ASC 842, the Company has elected to not recognize ROU assets and related lease obligations for leases with terms of twelve months or less.</span></p> <p id="xdx_849_eus-gaap--PolicyholdersDividendPolicy_znpmQ1PrdM0d" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font: small-caps 10pt Times New Roman, Times, Serif; color: Black"><b>[15]</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_865_zoB5h3EgRDUl">Dividend Policy</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">Cash dividends are recorded when declared by the Company’s Board of Directors. Common stock dividends are charged against retained earnings when declared or paid (see Note O hereof).</span></p> <p id="xdx_84F_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zS8qU84IDvg5" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"/> </p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"> <tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font: small-caps 10pt Times New Roman, Times, Serif; color: Black"><b>[16]</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_86C_zbwgUCXoG8C2">Reclassifications</span></b></span></td></tr> </table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; color: Black"/></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">Stock-based compensation in the 2021 consolidated statements of operations and comprehensive income (loss) have been recast and reclassified to conform to the current year’s presentation. </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; color: Black"> </span></p> <p id="xdx_84C_eus-gaap--ConsolidationPolicyTextBlock_zU0XAKZ0DJWe" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt"><b><span style="font-family: Times New Roman, Times, Serif; color: Black"><span style="font-variant: small-caps"><span> </span> </span></span></b></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>[1]</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_864_zb8RucttfVP">Principles of Consolidation</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt 27.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">The Company’s consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The accompanying financial statements include the accounts of the Company and its wholly-owned subsidiaries, Mirror Worlds Technologies, LLC and HFT Solutions, LLC. All intercompany transactions and balances are eliminated in consolidation.</span></p> <p id="xdx_842_eus-gaap--UseOfEstimates_zT2pw0Eh4lY1" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt 27.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>[2]</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_866_zZt5VJJORZJ">Use of Estimates and Assumptions</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods. The significant estimates and assumptions made in the preparation of the Company’s consolidated financial statements primarily include costs related to the Company’s assertion of litigation, the valuation of the Company’s patent portfolios, stock-based compensation, the recoverability of deferred tax assets and carrying value of the Company’s equity method investments. Actual results could be materially different from those estimates, upon which the carrying values were based. </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">Certain amounts recorded to reflect the Company’s share of income or losses of its equity method investee, accounted for under the equity method, are based on estimates and the unaudited results of operations of the equity method investee and may require adjustment in the future when the audit is complete. The Company reports its share of the results of its equity method investee on a one quarter lag basis.</span></p> <p id="xdx_84D_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z6IcCdmaNNy" style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; color: Black"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>[3]</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_865_zK5no9Mn5Kkl">Cash and Cash Equivalents</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">The Company maintains cash deposits in high quality financial institutions insured by the Federal Deposit Insurance Corporation ("FDIC"). Accounts at each institution are insured by the FDIC up to $<span id="xdx_90B_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20221231_z9w1DmjjqWaj" title="FDIC insured limit"><span id="xdx_905_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20211231_zmoVZaZhL847" title="FDIC insured limit">250,000</span></span>. At December 31, 2022 and 2021, the Company had $<span id="xdx_900_eus-gaap--CashUninsuredAmount_c20221231_pp0p0" title="Cash in excess of FDIC insured limit">1,715,000</span> and $<span id="xdx_907_eus-gaap--CashUninsuredAmount_c20211231_pp0p0" title="Cash in excess of FDIC insured limit">8,109,000</span>, respectively, in excess of the FDIC insured limit.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">The Company considers all highly liquid short-term investments, including certificates of deposit and money market funds, that are purchased with an original maturity of three months or less to be cash equivalents.</span></p> 250000 250000 1715000 8109000 <p id="xdx_844_eus-gaap--MarketableSecuritiesPolicy_zYKl9nUsxQq8" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>[4]</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_86E_zvzMkV2bZYZ6">Marketable Securities</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">The Company’s marketable securities are comprised of certificates of deposit with original maturity greater than three months from date of purchase, government securities, fixed income mutual funds, and a corporate bond (see Note G). At December 31, 2022 and December 31, 2021, included in marketable securities, the Company had aggregate certificates of deposit of $<span id="xdx_901_eus-gaap--CertificatesOfDepositAtCarryingValue_c20221231_pp0p0" title="Certificates of deposit">2,976,000</span> and $<span id="xdx_90E_eus-gaap--CertificatesOfDepositAtCarryingValue_c20211231_pp0p0" title="Certificates of deposit">0</span>, respectively. The Company’s marketable securities are measured at fair value and are accounted for in accordance with ASU 2016-01. Unrealized holding gains and losses on certificates of deposit, government securities, and fixed income mutual funds are recorded in net realized and unrealized gain (loss) from investments on the consolidated statements of operations and comprehensive income (loss). Unrealized holding gains and losses, net of the related tax effect, on corporate bonds and notes are excluded from earnings and are reported as a separate component of stockholders’ equity until realized. Dividend and interest income are recognized when earned. Realized gains and losses are included in earnings and are derived using the specific identification method for determining the cost of the marketable securities.</span></p> 2976000 0 <p id="xdx_842_eus-gaap--RevenueRecognitionPolicyTextBlock_z2YYs8o2uRN8" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>[5]</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_86E_zD0G3drxLHv9">Revenue Recognition</span></b></span></td></tr></table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; color: Black"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">Under ASC 606, revenue is recognized when the Company completes the licensing of its intellectual property to its licensees, in an amount that reflects the consideration the Company expects to be entitled to in exchange for licensing its intellectual property.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">The Company determines revenue recognition through the follow steps:</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.6in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">•</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">identification of the license agreement;</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.6in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">•</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">identification of the performance obligations in the license agreement;</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.6in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">•</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">determination of the consideration for the license;</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.6in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">•</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">allocation of the transaction price to the performance obligations in the contract; and</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 0.6in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">•</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">recognition of revenue when the Company satisfies its performance obligations.</span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">Revenue disaggregated by source is as follows (the Company had no revenue for the year ended December 31, 2022):</span></p> <table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--DisaggregationOfRevenueTableTextBlock_zEsPMiFU6n0c" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary Of Significant Accounting Policies (Details)"> <tr style="vertical-align: bottom"> <td style="text-indent: 20pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span id="xdx_8B9_zM9l7nIwA6sg" style="display: none">Schedule of disaggregation of revenue</span></td><td style="font-size: 9pt; padding-bottom: 1pt"> </td> <td style="font-size: 9pt; text-align: left"> </td><td style="font-size: 9pt; text-align: right"> </td><td style="padding-bottom: 1pt; font-size: 9pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Years Ended December 31,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><sup> </sup></span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><sup> </sup></span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: 20pt; width: 56%; text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Fully-Paid Licenses</span></td><td style="width: 8%; font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="width: 1%; font-size: 12pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">$</span></td><td id="xdx_98C_eus-gaap--Revenues_c20220101__20221231__srt--ProductOrServiceAxis__custom--FullyPaidLicensesMember_pp0p0" style="width: 12%; font-size: 12pt; text-align: right" title="Total Revenue"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0599">—</span></span></td><td style="width: 1%; font-size: 12pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">$</span></td><td id="xdx_98F_eus-gaap--Revenues_pp0p0_c20210101__20211231__srt--ProductOrServiceAxis__custom--FullyPaidLicensesMember_fKDEp_zZ7m85ZQj411" style="width: 12%; text-align: right" title="Total Revenue"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">17,000,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><sup>(1)</sup></span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: 20pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Royalty Bearing Licenses</span></td><td style="font-size: 9pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 9pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td><td id="xdx_982_eus-gaap--Revenues_c20220101__20221231__srt--ProductOrServiceAxis__custom--RoyaltyBearingLicensesMember_pp0p0" style="border-bottom: Black 1pt solid; font-size: 9pt; text-align: right" title="Total Revenue"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0603">—</span></span></td><td style="padding-bottom: 1pt; font-size: 9pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td><td id="xdx_98D_eus-gaap--Revenues_pp0p0_c20210101__20211231__srt--ProductOrServiceAxis__custom--RoyaltyBearingLicensesMember_fKDIp_zlutUasnAC2j" style="border-bottom: Black 1pt solid; text-align: right" title="Total Revenue"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">19,029,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><sup>(2)</sup></span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: 20pt; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Total Revenue</span></td><td style="font-size: 12pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 12pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">$</span></td><td id="xdx_98B_eus-gaap--Revenues_c20220101__20221231_pp0p0" style="border-bottom: Black 2.5pt double; font-size: 12pt; text-align: right" title="Total Revenue"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0607">—</span></span></td><td style="padding-bottom: 2.5pt; font-size: 12pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">$</span></td><td id="xdx_989_eus-gaap--Revenues_c20210101__20211231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Revenue"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">36,029,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><sup> </sup></span></td></tr> </table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">__________________________</span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top"> <td style="width: 0.35in"/><td style="width: 0.25in"><span id="xdx_F06_zyY4SKDbFCS7" style="font-family: Times New Roman, Times, Serif; font-size: 9pt; color: Black">(1)</span></td><td style="text-align: justify"><span id="xdx_F1F_zOzuuRXaedh2" style="font-family: Times New Roman, Times, Serif; font-size: 9pt; color: Black">Includes $17,000,000 received from Hewlett-Packard related to settlement of a patent litigation (see Note K[1] hereof).</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top"> <td style="width: 0.35in"/><td style="width: 0.25in"><span id="xdx_F0F_zlRWkfkChUCl" style="font-family: Times New Roman, Times, Serif; font-size: 9pt; color: Black">(2)</span></td><td style="text-align: justify"><span id="xdx_F1A_zrgSGrDRVGc3" style="font-family: Times New Roman, Times, Serif; font-size: 9pt; color: Black">Includes (1) $18,691,890 of royalty revenue from Cisco Systems, Inc. from resolution of a dispute under its license agreement with the Company and (2) $337,000 of royalty revenue received from Plantronics, Inc.</span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">Revenue from the Company’s patent licensing business is typically generated from negotiated license agreements. The timing and amount of revenue recognized from each licensee depends upon a variety of factors, including the terms of each agreement and the nature of the obligations of the parties. These agreements may include, but not be limited to, elements related to past infringement liabilities, non-refundable upfront license fees, and ongoing royalties on licensed products sold by the licensee. Generally, in the event of settlement of litigation related to the Company’s assertion of patent infringement involving its intellectual property, defendants will either pay (i) a non-refundable lump sum payment for a non-exclusive fully-paid license, or (ii) a non-refundable lump sum payment (license initiation fee) together with an ongoing obligation to pay quarterly or monthly royalties to the Company for the life of the licensed patent.</span></p> <table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--DisaggregationOfRevenueTableTextBlock_zEsPMiFU6n0c" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary Of Significant Accounting Policies (Details)"> <tr style="vertical-align: bottom"> <td style="text-indent: 20pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span id="xdx_8B9_zM9l7nIwA6sg" style="display: none">Schedule of disaggregation of revenue</span></td><td style="font-size: 9pt; padding-bottom: 1pt"> </td> <td style="font-size: 9pt; text-align: left"> </td><td style="font-size: 9pt; text-align: right"> </td><td style="padding-bottom: 1pt; font-size: 9pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Years Ended December 31,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><sup> </sup></span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><sup> </sup></span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: 20pt; width: 56%; text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Fully-Paid Licenses</span></td><td style="width: 8%; font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="width: 1%; font-size: 12pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">$</span></td><td id="xdx_98C_eus-gaap--Revenues_c20220101__20221231__srt--ProductOrServiceAxis__custom--FullyPaidLicensesMember_pp0p0" style="width: 12%; font-size: 12pt; text-align: right" title="Total Revenue"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0599">—</span></span></td><td style="width: 1%; font-size: 12pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">$</span></td><td id="xdx_98F_eus-gaap--Revenues_pp0p0_c20210101__20211231__srt--ProductOrServiceAxis__custom--FullyPaidLicensesMember_fKDEp_zZ7m85ZQj411" style="width: 12%; text-align: right" title="Total Revenue"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">17,000,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><sup>(1)</sup></span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: 20pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Royalty Bearing Licenses</span></td><td style="font-size: 9pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 9pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td><td id="xdx_982_eus-gaap--Revenues_c20220101__20221231__srt--ProductOrServiceAxis__custom--RoyaltyBearingLicensesMember_pp0p0" style="border-bottom: Black 1pt solid; font-size: 9pt; text-align: right" title="Total Revenue"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0603">—</span></span></td><td style="padding-bottom: 1pt; font-size: 9pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td><td id="xdx_98D_eus-gaap--Revenues_pp0p0_c20210101__20211231__srt--ProductOrServiceAxis__custom--RoyaltyBearingLicensesMember_fKDIp_zlutUasnAC2j" style="border-bottom: Black 1pt solid; text-align: right" title="Total Revenue"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">19,029,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><sup>(2)</sup></span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: 20pt; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Total Revenue</span></td><td style="font-size: 12pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 12pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">$</span></td><td id="xdx_98B_eus-gaap--Revenues_c20220101__20221231_pp0p0" style="border-bottom: Black 2.5pt double; font-size: 12pt; text-align: right" title="Total Revenue"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0607">—</span></span></td><td style="padding-bottom: 2.5pt; font-size: 12pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">$</span></td><td id="xdx_989_eus-gaap--Revenues_c20210101__20211231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Revenue"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">36,029,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><sup> </sup></span></td></tr> </table> 17000000 19029000 36029000 <p id="xdx_84A_eus-gaap--EquityMethodInvestmentsPolicy_ztManH9gY1Bk" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>[6]</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_862_z4lJ0c8zSkB2">Equity Method Investments</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">Equity method investments are equity securities in entities the Company does not control but over which it has the ability to exercise significant influence. These investments are accounted for under the equity method of accounting in accordance with ASC 323, <i>Investments — Equity Method and Joint Ventures</i> (see Note H hereof). Equity method investments are measured at cost minus impairment, if any, plus or minus the Company’s share of an investee’s income or loss. The Company’s proportionate share of the income or loss from equity method investments is recognized on a one-quarter lag. When the Company’s carrying value in an equity method investment is reduced to zero, no further losses are recorded in the Company’s financial statements unless the Company guaranteed obligations of the investee company or has committed additional funding. When the investee company subsequently reports income, the Company will not record its share of such income until it equals the amount of its share of losses not previously recognized.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">Upon a sale of an equity method investment by the Company, the difference between sales proceeds and the carrying amount of the equity investment is recognized in profit or loss. Upon the issuance of securities in an observable price transaction, the Company will account for the share issuance by the equity method investee as if the Company had sold a proportionate share of its investment in the observable price transaction. The Company will record a gain or loss associated with the dilution of its investment to reflect third party investments in the investee and will increase or decrease its basis in the equity method investee accordingly. The gain or loss is recorded within other income or expense in the Company’s consolidated statements of operations and comprehensive income (loss).</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">During the year ended December 31, 2022, the Company recorded a change in its share of net losses of the equity method investee as a result of the Company receiving new information from the equity method investee during the fourth quarter of 2022. The effect of this change was an increase in the Company’s share of the net losses of the equity method investee of $<span id="xdx_90B_ecustom--IncreaseInNetLossesOfEquityMethodInvestee_c20220101__20221231_pp0p0" title="Increase in net losses of equity method investee">398,000</span> and a corresponding decrease in the Company’s net income, and a decrease in basic and diluted earnings of $<span id="xdx_905_ecustom--DecreaseInBasicAndDilutedEarnings_c20220101__20221231_pdd" title="Decrease in basic and diluted earnings">0.02</span> per share.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">The Company performed an assessment to determine significance of the equity method investee under the investment, asset and income tests utilizing the 20% threshold. The Company determined that the equity method investee satisfied the income test and has included summarized financial data of the equity method investee in Note H hereof.</span></p> 398000 0.02 <p id="xdx_841_ecustom--PatentsPolicyTextBlock_zutOXt36UYwd" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>[7]</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_865_zeCQ8tbsHDpi">Patents</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">The Company owns patents that relate to various technologies. The Company capitalizes the costs associated with acquisition, registration and maintenance of its acquired patents and amortizes these assets over their remaining useful lives on a straight-line basis. Any further payments made to maintain or develop the patents would be capitalized and amortized over the balance of the useful life for the patents.</span></p> <p id="xdx_848_ecustom--CostsofRevenueandRelatedCostsPolicyTextBlock_zfvpOIRg1ulk" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"/></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>[8]</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_860_zRemIh08DNQa">Costs of Revenue and Related Costs</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">The Company includes in costs of revenue for the year ended December 31, 2022 and 2021 contingent legal fees payable to patent litigation counsel, any other contractual payments to third parties related to net proceeds from monetization of patents (see Note I[1] hereof) and incentive bonus compensation payable to its Chairman and Chief Executive Officer (see Note J[1] hereof).</span></p> <p id="xdx_847_eus-gaap--IncomeTaxPolicyTextBlock_zAUIyj5LX212" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt"><b><span style="font-family: Times New Roman, Times, Serif; color: Black"><span style="font-variant: small-caps"> </span></span></b></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>[9]</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_86A_zCrRi72uJ4ha">Income Taxes</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">The Company accounts for income taxes in accordance with Financial Accounting Standards Board (FASB) ASC Topic 740, Income Taxes (ASC 740), which requires the Company to use the assets and liability method of accounting for income taxes. Under the assets and liability method, deferred income taxes are recognized for the tax consequences of temporary (timing) differences by applying enacted statutory tax rates applicable to future years to differences between financial statement carrying amounts and the tax bases of existing assets and liabilities and operating loss and tax credit carry forwards. Under this accounting standard, the effect on deferred income taxes of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recognized if it is more likely than not that some portion, or all, of a deferred tax asset will not be realized.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">ASC 740-10, <i>Accounting for Uncertainty in Income Taxes</i>, defines uncertainty in income taxes and the evaluation of a tax position as a two-step process. The first step is to determine whether it is more likely than not that a tax position will be sustained upon examination, including the resolution of any related appeals or litigation based on the technical merits of that position. The second step is to measure a tax position that meets the more-likely-than-not threshold to determine the amount of benefit to be recognized in the financial statements. A tax position is measured at the largest amount of benefit that is greater than 50 percent likelihood of being realized upon ultimate settlement. Tax positions that previously failed to meet the more-likely-than-not recognition threshold should be recognized in the first subsequent period in which the threshold is met. Previously recognized tax positions that no longer meet the more-likely-than-not criteria should be de-recognized in the first subsequent financial reporting period in which the threshold is no longer met. The Company had <span id="xdx_907_eus-gaap--LiabilityForUncertainTaxPositionsCurrent_iI_pp0p0_do_c20221231_zMxbHkX2Lcwa" title="Uncertain tax positions"><span id="xdx_906_eus-gaap--LiabilityForUncertainTaxPositionsCurrent_iI_pp0p0_do_c20211231_zmqcZNdy783h" title="Uncertain tax positions">no</span></span> uncertain tax positions as of December 31, 2022 and 2021.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">U.S. federal, state and local income tax returns prior to 2019 are not subject to examination by any applicable tax authorities, except that tax authorities could challenge returns (only under certain circumstances) for earlier years to the extent they generated loss carry-forwards that are available for those future years.</span></p> 0 0 <p id="xdx_84B_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zgfzVW4vVh8l" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>[10]</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_860_zq0QKsnsdb8">Stock-Based Compensation</span></b></span></td></tr></table> <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The Company accounts for its stock-based compensation awards to employees and directors in accordance with FASB ASC Topic 718, <i>Compensation </i></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt; color: Black"><b>—</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><i>Stock Compensation </i>(“ASC 718”). ASC 718 requires all stock-based compensation to employees, including grants of employee stock options and restricted stock units, to be recognized in the consolidated statements of operations and comprehensive income (loss) based on their grant date fair values. </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">Compensation expense related to awards to employees is recognized on a straight-line basis based on the grant date fair value over the associated service period of the award, which is generally the vesting term. The Company uses the Black-Scholes option pricing model to determine the grant date fair value of options granted. The fair value of restricted stock units is determined based on the number of shares underlying the grant and either the quoted market price of the Company’s common stock on the date of grant for time-based and performance-based awards, or the fair value on the date of grant using the Monte Carlo Simulation model for market-based awards.</span></p> <p id="xdx_84C_eus-gaap--EarningsPerSharePolicyTextBlock_zM6kqnYRCw12" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>[11]</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_861_ztdd3JEpppx3">Earnings Per Share</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">The Company reports earnings per share in accordance with U.S. GAAP, which requires presentation of basic and diluted earnings per share in conjunction with the disclosure of the methodology used in computing such earnings per share. Basic earnings per share excludes dilution and is computed by dividing income available to common shareholders by the weighted average common shares outstanding during the period. Diluted earnings per share takes into account the potential dilution that could occur if securities or other contracts, such as warrants and options to purchase common stock were exercised and shares were issued pursuant to outstanding restricted stock units. Common stock equivalents having an anti-dilutive effect on earnings per share are excluded from the calculation of diluted earnings per share.</span></p> <p id="xdx_842_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_z2iwDUTMjPI5" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt"><b><span style="font-family: Times New Roman, Times, Serif; color: Black"><span style="font-variant: small-caps"> </span></span></b></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>[12]</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_86B_zO2SpbxQvcUf">Fair Value Measurements</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">ASC Topic 820, Fair Value Measurement and Disclosures, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. This topic also establishes a fair value hierarchy which requires classification based on observable and unobservable inputs when measuring fair value.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">There are three levels of inputs that may be used to measure fair value:</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">Level 1: Observable inputs such as quoted prices (unadjusted) in an active market for identical assets or liabilities.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">Level 2: Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">Level 3: Unobservable inputs that are supported by little or no market activity; therefore, the inputs are developed by the Company using estimates and assumptions that the Company expects a market participant would use, including pricing models, discounted cash flow methodologies, or similar techniques.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">The carrying value of the Company’s financial instruments, including cash and cash equivalents and accounts payable, approximates fair value because of the short-term nature of these financial instruments.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">The Company’s marketable securities are classified within Level 1 because they are valued using quoted market prices in an active market.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">The Company’s equity method investment is measured on a non-recurring basis and is classified within Level 2 as it is valued using an observable price transaction for similar assets in a market that is not active (see Note B[6] and Note H hereof).</span></p> <p id="xdx_845_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zqnCViCp1Ya" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>[13]</b></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_862_zdMA4YET40oe">Carrying Value, Recoverability and Impairment of Long-Lived Assets</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">An impairment loss shall be recognized only if the carrying amount of a long-lived asset (asset group) is not recoverable and exceeds its fair value. The carrying amount of a long-lived asset (asset group) is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset (asset group). That assessment shall be based on the carrying amount of the asset (asset group) at the date it is tested for recoverability. An impairment loss shall be measured as the amount by which the carrying amount of a long-lived asset (asset group) exceeds its fair value. If an impairment loss is recognized, the adjusted carrying amount of a long-lived asset shall be its new cost basis. For a depreciable long-lived asset, the new cost basis shall be depreciated (amortized) over the remaining useful life of that asset. Restoration of a previously recognized impairment loss is prohibited. At December 31, 2022 and 2021, there was <span id="xdx_90B_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_pp0p0_do_c20210101__20211231_zCsshb6gh96a" title="Company impairment patents and equity investment"><span id="xdx_901_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_pp0p0_do_c20210101__20211231_zURxNo4CeRN3" title="Company impairment patents and equity investment">no</span></span> impairment to the Company’s patents and equity investment.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">The Company’s equity investment in ILiAD is evaluated on a non-recurring basis for impairment, when and if a triggering event occurs.</span></p> 0 0 <p id="xdx_841_eus-gaap--LesseeLeasesPolicyTextBlock_zTVqmTrHl7Hj" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt"><b><span style="font-family: Times New Roman, Times, Serif; color: Black"><span style="font-variant: small-caps"> </span></span></b></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>[14]</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_866_zKksL6I4fOB5">Leases</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">Under ASC 842, the Company determines if an arrangement is a lease at inception. Right-of-Use (“ROU”) assets and related lease obligations are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. As the Company's lease does not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company's determined incremental borrowing rate is a hypothetical rate based on its understanding of what the Company's credit rating would be. The ROU asset also includes any lease payments made prior to commencement and is recorded net of any lease incentives received and net of the deferred rent balance on the date of implementation. The Company's lease terms may include options to extend or terminate the lease when it is reasonably certain that it will exercise such options. As permitted under ASC 842, the Company has elected to not recognize ROU assets and related lease obligations for leases with terms of twelve months or less.</span></p> <p id="xdx_849_eus-gaap--PolicyholdersDividendPolicy_znpmQ1PrdM0d" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font: small-caps 10pt Times New Roman, Times, Serif; color: Black"><b>[15]</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_865_zoB5h3EgRDUl">Dividend Policy</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">Cash dividends are recorded when declared by the Company’s Board of Directors. Common stock dividends are charged against retained earnings when declared or paid (see Note O hereof).</span></p> <p id="xdx_84F_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zS8qU84IDvg5" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"/> </p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"> <tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font: small-caps 10pt Times New Roman, Times, Serif; color: Black"><b>[16]</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_86C_zbwgUCXoG8C2">Reclassifications</span></b></span></td></tr> </table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; color: Black"/></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">Stock-based compensation in the 2021 consolidated statements of operations and comprehensive income (loss) have been recast and reclassified to conform to the current year’s presentation. </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; color: Black"> </span></p> <p id="xdx_801_ecustom--PatentsTextBlock_zogNm62ak682" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt"><span style="font-family: Times New Roman, Times, Serif; font-variant: small-caps; color: Black"><b>Note C – <span id="xdx_826_zmdpFWbS9Ef8">Patents</span></b></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">The Company’s intangible assets at December 31, 2022 include patents with estimated remaining economic useful lives ranging from <span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_dtY_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zwlvL3tAEtFj" title="Estimated remaining economic useful of patents">0.50</span> to <span id="xdx_900_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_dtY_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zsUklthLioV2" title="Estimated remaining economic useful of patents">16.50</span> years. For all periods presented, all the Company’s patents were subject to amortization. The gross carrying amounts and accumulated amortization related to acquired intangible assets as of December 31, 2022 and 2021 were as follows:</span></p> <table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zGW8AbqXGFek" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - Patents (Details)"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: left; padding-left: 27pt"><span id="xdx_8B6_z64aS8Ot3sUg" style="display: none">Schedule of patent</span></td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_490_20221231_zyxehxrGjHD9" style="text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_49F_20211231_z2GEZsSmF1Qe" style="text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>2022</b></span></p></td><td style="font-weight: bold"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>2021</b></span></p></td><td style="font-weight: bold"><span style="color: Black"> </span></td></tr> <tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_zZhK3Kal3hBi" style="vertical-align: bottom"> <td style="width: 50%; text-align: left; padding-left: 27pt"><span style="color: Black">Gross carrying amount</span></td><td style="width: 8%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td style="width: 15%; text-align: right"><span style="color: Black">8,473,000</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td style="width: 8%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td style="width: 15%; text-align: right"><span style="color: Black">7,949,000</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td></tr> <tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_zhe0jz0Z8O1d" style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: left; padding-left: 27pt"><span style="color: Black">Accumulated amortization</span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="color: Black">(6,881,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">)</span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="color: Black">(6,565,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">)</span></td></tr> <tr id="xdx_400_eus-gaap--FiniteLivedPatentsGross_iI_pp0p0_z4oEjOrI1dU7" style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 27pt"><span style="color: Black">Patents, net</span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="color: Black">1,592,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="color: Black">1,384,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td></tr> </table> <p id="xdx_8A2_zT4f48J97FI" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">Amortization expense for the years ended December 31, 2022 and 2021 was $<span id="xdx_905_eus-gaap--AmortizationOfFinancingCosts_c20220101__20221231_pp0p0" title="Amortization expense">316,000</span> and $<span id="xdx_90B_eus-gaap--AmortizationOfFinancingCosts_c20210101__20211231_pp0p0" title="Amortization expense">295,000</span>, respectively. Future amortization of current intangible assets, net is as follows:</span></p> <table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zEgScjMiEuy8" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto" summary="xdx: Disclosure - Patents (Details 1)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8BF_zSZAXmnCow76" style="display: none">Schedule of future amortization of current intangible</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_491_20221231_z4m195m97ldb" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black">For the years ended December 31,</span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td><td style="font-size: 12pt; padding-bottom: 1pt"><span style="color: Black"> </span></td> <td colspan="2" style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt; font-size: 12pt"><span style="color: Black"> </span></td></tr> <tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_maFLIANz69q_zQXOrurSiuzb" style="vertical-align: bottom"> <td style="width: 48%; text-align: left"><span style="color: Black">2023</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td style="width: 25%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td style="width: 24%; text-align: right"><span style="color: Black">266,000</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td></tr> <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_maFLIANz69q_zJRyfDg0CZ09" style="vertical-align: bottom"> <td style="text-align: left"><span style="color: Black">2024</span></td><td style="text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td style="text-align: right"><span style="color: Black">120,000</span></td><td style="text-align: left"><span style="color: Black"> </span></td></tr> <tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_maFLIANz69q_z84GA7fUsWXd" style="vertical-align: bottom"> <td style="text-align: left"><span style="color: Black">2025</span></td><td style="text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td style="text-align: right"><span style="color: Black">120,000</span></td><td style="text-align: left"><span style="color: Black"> </span></td></tr> <tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_maFLIANz69q_zlVPJwlG6fk1" style="vertical-align: bottom"> <td style="text-align: left"><span style="color: Black">2026</span></td><td style="text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td style="text-align: right"><span style="color: Black">120,000</span></td><td style="text-align: left"><span style="color: Black"> </span></td></tr> <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_maFLIANz69q_zI70dCx5suh9" style="vertical-align: bottom"> <td style="text-align: left"><span style="color: Black">2027</span></td><td style="text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td style="text-align: right"><span style="color: Black">119,000</span></td><td style="text-align: left"><span style="color: Black"> </span></td></tr> <tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_pp0p0_maFLIANz69q_zBt4BjloXNl5" style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Thereafter</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="color: Black">847,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr id="xdx_408_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pp0p0_mtFLIANz69q_zlvI9MF1dN5k" style="vertical-align: bottom"> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Total</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="color: Black">1,592,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td></tr> </table> <p id="xdx_8AC_zWfcpoWIc4Wl" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">Two patents within the Cox Patent Portfolio expire in <span id="xdx_90E_ecustom--ExpirationDatesOfPatentsWithinCoxPatentPortfolio_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zJE44LkePXQ9" title="Expiration dates of the patents within the Cox patent portfolio">July 2023</span> and <span id="xdx_906_ecustom--ExpirationDatesOfPatentsWithinCoxPatentPortfolio_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zA58bOoIkRo4" title="Expiration dates of the patents within the Cox patent portfolio">November 2023</span>, and the balance of the patents within such portfolio have expired. The expiration dates of patents within the Company’s M2M/IoT Patent Portfolio range from <span id="xdx_900_ecustom--ExpirationDatesOfPatentsWithinCompanysM2miotPatentPortfolio_c20220101__20221231__srt--RangeAxis__srt--MinimumMember" title="Expiration dates of the patents within the Company's M2M/IoT Patent Portfolio">September 2033</span> to <span id="xdx_90E_ecustom--ExpirationDatesOfPatentsWithinCompanysM2miotPatentPortfolio_c20220101__20221231__srt--RangeAxis__srt--MaximumMember" title="Expiration dates of the patents within the Company's M2M/IoT Patent Portfolio">May 2034</span>. The expiration dates within the Company’s HFT Patent Portfolio range from <span id="xdx_90D_ecustom--ExpirationDatesWithinCompanysHftPatentPortfolio_c20220101__20221231__srt--RangeAxis__srt--MinimumMember" title="Expiration dates within companys HFT patent portfolio">October 31, 2039</span> to <span id="xdx_90F_ecustom--ExpirationDatesWithinCompanysHftPatentPortfolio_c20220101__20221231__srt--RangeAxis__srt--MaximumMember" title="Expiration dates within companys HFT patent portfolio">November 1, 2039</span>. All of the patents within the Company’s Mirror Worlds Patent Portfolio expired and the Remote Power Patent expired.</span></p> P0Y6M P16Y6M <table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zGW8AbqXGFek" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - Patents (Details)"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: left; padding-left: 27pt"><span id="xdx_8B6_z64aS8Ot3sUg" style="display: none">Schedule of patent</span></td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_490_20221231_zyxehxrGjHD9" style="text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_49F_20211231_z2GEZsSmF1Qe" style="text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>2022</b></span></p></td><td style="font-weight: bold"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>2021</b></span></p></td><td style="font-weight: bold"><span style="color: Black"> </span></td></tr> <tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_zZhK3Kal3hBi" style="vertical-align: bottom"> <td style="width: 50%; text-align: left; padding-left: 27pt"><span style="color: Black">Gross carrying amount</span></td><td style="width: 8%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td style="width: 15%; text-align: right"><span style="color: Black">8,473,000</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td style="width: 8%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td style="width: 15%; text-align: right"><span style="color: Black">7,949,000</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td></tr> <tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_zhe0jz0Z8O1d" style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: left; padding-left: 27pt"><span style="color: Black">Accumulated amortization</span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="color: Black">(6,881,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">)</span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="color: Black">(6,565,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">)</span></td></tr> <tr id="xdx_400_eus-gaap--FiniteLivedPatentsGross_iI_pp0p0_z4oEjOrI1dU7" style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 27pt"><span style="color: Black">Patents, net</span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="color: Black">1,592,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="color: Black">1,384,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td></tr> </table> 8473000 7949000 6881000 6565000 1592000 1384000 316000 295000 <table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zEgScjMiEuy8" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto" summary="xdx: Disclosure - Patents (Details 1)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8BF_zSZAXmnCow76" style="display: none">Schedule of future amortization of current intangible</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_491_20221231_z4m195m97ldb" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black">For the years ended December 31,</span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td><td style="font-size: 12pt; padding-bottom: 1pt"><span style="color: Black"> </span></td> <td colspan="2" style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt; font-size: 12pt"><span style="color: Black"> </span></td></tr> <tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_maFLIANz69q_zQXOrurSiuzb" style="vertical-align: bottom"> <td style="width: 48%; text-align: left"><span style="color: Black">2023</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td style="width: 25%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td style="width: 24%; text-align: right"><span style="color: Black">266,000</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td></tr> <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_maFLIANz69q_zJRyfDg0CZ09" style="vertical-align: bottom"> <td style="text-align: left"><span style="color: Black">2024</span></td><td style="text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td style="text-align: right"><span style="color: Black">120,000</span></td><td style="text-align: left"><span style="color: Black"> </span></td></tr> <tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_maFLIANz69q_z84GA7fUsWXd" style="vertical-align: bottom"> <td style="text-align: left"><span style="color: Black">2025</span></td><td style="text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td style="text-align: right"><span style="color: Black">120,000</span></td><td style="text-align: left"><span style="color: Black"> </span></td></tr> <tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_maFLIANz69q_zlVPJwlG6fk1" style="vertical-align: bottom"> <td style="text-align: left"><span style="color: Black">2026</span></td><td style="text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td style="text-align: right"><span style="color: Black">120,000</span></td><td style="text-align: left"><span style="color: Black"> </span></td></tr> <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_maFLIANz69q_zI70dCx5suh9" style="vertical-align: bottom"> <td style="text-align: left"><span style="color: Black">2027</span></td><td style="text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td style="text-align: right"><span style="color: Black">119,000</span></td><td style="text-align: left"><span style="color: Black"> </span></td></tr> <tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_pp0p0_maFLIANz69q_zBt4BjloXNl5" style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Thereafter</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="color: Black">847,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr id="xdx_408_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pp0p0_mtFLIANz69q_zlvI9MF1dN5k" style="vertical-align: bottom"> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Total</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="color: Black">1,592,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td></tr> </table> 266000 120000 120000 120000 119000 847000 1592000 July 2023 November 2023 September 2033 May 2034 October 31, 2039 November 1, 2039 <p id="xdx_804_eus-gaap--EarningsPerShareTextBlock_zG1maRUPSlzi" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-variant: small-caps; color: Black"><b>Note D – <span id="xdx_826_zQJt2miFXH75">Income (Loss) Per Share</span></b></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">Basic Income (Loss) per share is calculated by dividing the net income (loss) by the weighted average number of outstanding common shares during the period. Diluted per share data included the dilutive effects of stock options and restricted stock units. Potentially dilutive shares of <span id="xdx_900_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_c20220101__20221231_zIQxzeUgmF2i" title="Potentially dilutive shares">625,000</span> and <span id="xdx_909_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_c20210101__20211231_pdd" title="Potentially dilutive shares">12,500</span> at December 31, 2022 and 2021, respectively, consist of restricted stock units. However, as the Company generated a net loss in 2022, all potentially dilutive shares were not reflected in diluted net loss per share because the impact of such instruments was anti-dilutive. Computations of basic and diluted weighted average common shares outstanding are as follows:</span></p> <table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z37CslNhNQlk" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - Disclosure -Income (Loss) Per Share (Details)"> <tr style="vertical-align: bottom"> <td style="font-size: 12pt; padding-left: 5.4pt"><span style="color: Black"> <span style="display: none"><span id="xdx_8BE_z5HWIVDwd5i2">Schedule of earnings per share</span></span></span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td id="xdx_493_20220101__20221231_zoiNz3Dyk2Ah" style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td id="xdx_491_20210101__20211231_zfwsmg2Kv2X5" style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"><span style="color: Black"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="color: Black"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="color: Black"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td colspan="2" style="font-size: 12pt; text-align: center"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td colspan="2" style="font-size: 12pt; text-align: center"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td></tr> <tr id="xdx_403_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i_pdd" style="vertical-align: bottom"> <td style="width: 56%; text-align: left; padding-left: 5.4pt"><span style="color: Black">Weighted-average common shares outstanding – basic</span></td><td style="width: 8%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td style="width: 12%; text-align: right"><span style="color: Black">23,825,917</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td style="width: 8%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td style="width: 12%; text-align: right"><span style="color: Black">24,136,821</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt; padding-left: 5.4pt"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr id="xdx_401_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_i_pdd" style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="color: Black">Dilutive effect of restricted stock units and stock options</span></td><td style="padding-bottom: 1pt"/> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"/><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"/><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0743">—</span></span></p></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"/> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="color: Black">393,747</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt; padding-left: 5.4pt"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr id="xdx_406_ecustom--WeightedaverageCommonSharesOutstandingDiluted_i_pdd" style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"><span style="color: Black">Weighted-average common shares outstanding – diluted</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="color: Black"> </span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-style: normal; font-weight: normal; color: Black">23,825,917</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="color: Black"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="color: Black">24,530,568</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt; padding-left: 5.4pt"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td style="text-align: right"><span style="color: Black"> </span></td><td style="text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td style="text-align: right"><span style="color: Black"> </span></td><td style="text-align: left"><span style="color: Black"> </span></td></tr> <tr id="xdx_40C_ecustom--RestrictedStockUnitsExcludedFromComputationOfDilutedIncomePerShareBecauseEffectOfInclusionWouldHaveBeenAntidilutive_i_pdd" style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"><span style="color: Black">Restricted stock units excluded from the computation of diluted income per share because the effect of inclusion would have been anti-dilutive</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="color: Black"> </span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-style: normal; font-weight: normal; color: Black">625,000</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="color: Black"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="color: Black">12,500</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td></tr> </table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-variant: small-caps; color: Black"><b> </b></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify"><span style="color: Black"> </span></p> 625000 12500 <table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z37CslNhNQlk" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - Disclosure -Income (Loss) Per Share (Details)"> <tr style="vertical-align: bottom"> <td style="font-size: 12pt; padding-left: 5.4pt"><span style="color: Black"> <span style="display: none"><span id="xdx_8BE_z5HWIVDwd5i2">Schedule of earnings per share</span></span></span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td id="xdx_493_20220101__20221231_zoiNz3Dyk2Ah" style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td id="xdx_491_20210101__20211231_zfwsmg2Kv2X5" style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"><span style="color: Black"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="color: Black"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="color: Black"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td colspan="2" style="font-size: 12pt; text-align: center"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td colspan="2" style="font-size: 12pt; text-align: center"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td></tr> <tr id="xdx_403_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i_pdd" style="vertical-align: bottom"> <td style="width: 56%; text-align: left; padding-left: 5.4pt"><span style="color: Black">Weighted-average common shares outstanding – basic</span></td><td style="width: 8%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td style="width: 12%; text-align: right"><span style="color: Black">23,825,917</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td style="width: 8%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td style="width: 12%; text-align: right"><span style="color: Black">24,136,821</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt; padding-left: 5.4pt"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr id="xdx_401_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_i_pdd" style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="color: Black">Dilutive effect of restricted stock units and stock options</span></td><td style="padding-bottom: 1pt"/> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"/><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"/><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0743">—</span></span></p></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"/> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="color: Black">393,747</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt; padding-left: 5.4pt"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr id="xdx_406_ecustom--WeightedaverageCommonSharesOutstandingDiluted_i_pdd" style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"><span style="color: Black">Weighted-average common shares outstanding – diluted</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="color: Black"> </span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-style: normal; font-weight: normal; color: Black">23,825,917</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="color: Black"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="color: Black">24,530,568</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt; padding-left: 5.4pt"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td style="text-align: right"><span style="color: Black"> </span></td><td style="text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td style="text-align: right"><span style="color: Black"> </span></td><td style="text-align: left"><span style="color: Black"> </span></td></tr> <tr id="xdx_40C_ecustom--RestrictedStockUnitsExcludedFromComputationOfDilutedIncomePerShareBecauseEffectOfInclusionWouldHaveBeenAntidilutive_i_pdd" style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"><span style="color: Black">Restricted stock units excluded from the computation of diluted income per share because the effect of inclusion would have been anti-dilutive</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="color: Black"> </span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-style: normal; font-weight: normal; color: Black">625,000</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="color: Black"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="color: Black">12,500</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td></tr> </table> 23825917 24136821 393747 23825917 24530568 625000 12500 <p id="xdx_80D_eus-gaap--IncomeTaxDisclosureTextBlock_zS4HJ6aXBlh4" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-variant: small-caps; color: Black"><b>Note E – <span id="xdx_82B_zpNekp4cJx9f">Income Taxes</span> </b></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">Significant components of the income taxes were as follows for the years ended December 31, 2022 and 2021.</span></p> <table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zxZECpiSceZi" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - Income Taxes (Details)"> <tr style="vertical-align: bottom"> <td style="text-indent: 20pt; text-align: left"><span id="xdx_8BB_zola7sNie5Fi" style="display: none">Schedule of components of the income taxes</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_493_20220101__20221231_zgQjITGDANia" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_497_20210101__20211231_z69GJMUs5kFj" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"><span style="color: Black"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="color: Black"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="color: Black"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black"> </span></td></tr> <tr id="xdx_403_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_iB" style="vertical-align: bottom"> <td><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; color: Black"> </span></p><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; color: Black">Current</span></p></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td colspan="6" style="font-size: 12pt"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td></tr> <tr id="xdx_400_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_i01_pp0p0_maCITEBz4Q6_zkPNYUPMsRXi" style="vertical-align: bottom"> <td style="text-indent: 20pt; width: 56%; text-align: left"><span style="color: Black">State and local</span></td><td style="width: 8%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td style="width: 12%; text-align: right"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0759">—</span></span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td style="width: 8%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td style="width: 12%; text-align: right"><span style="color: Black">144,000</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td></tr> <tr id="xdx_407_eus-gaap--CurrentFederalTaxExpenseBenefit_i01_pp0p0_maCITEBz4Q6_zGS6ZrRENLv2" style="vertical-align: bottom"> <td style="text-indent: 20pt"><span style="color: Black">Federal</span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0762">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="color: Black">2,808,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr id="xdx_403_eus-gaap--CurrentIncomeTaxExpenseBenefit_i01T_pp0p0_mtCITEBz4Q6_maITEBzLGv_zx0MXnp9kuvj" style="vertical-align: bottom"> <td style="text-align: left"><span style="color: Black">Total Current Tax Expense (Benefit)</span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0765">—</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="color: Black">2,952,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr id="xdx_40A_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_iB" style="vertical-align: bottom"> <td><span style="color: Black">Deferred</span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr id="xdx_408_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_i01_pp0p0_maDITEBza7G_z1ABkECzdaO7" style="vertical-align: bottom"> <td style="text-indent: 20pt; text-align: left"><span style="color: Black">State and local</span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">   56,000</span></td><td style="text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td style="text-align: right"><span style="color: Black">83,000</span></td><td style="text-align: left"><span style="color: Black"> </span></td></tr> <tr id="xdx_402_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_i01_pp0p0_maDITEBza7G_z2SMQAtpVhPi" style="vertical-align: bottom"> <td style="text-indent: 20pt"><span style="color: Black">Federal</span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right">551,000</td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="color: Black">1,425,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr id="xdx_40A_eus-gaap--DeferredIncomeTaxExpenseBenefit_i01T_pp0p0_mtDITEBza7G_maITEBzLGv_ztJxbwRi94o2" style="vertical-align: bottom"> <td style="text-align: left"><span style="color: Black">Total Deferred Tax Expense</span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="color: Black">607,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="color: Black">1,508,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr id="xdx_40B_eus-gaap--IncomeTaxExpenseBenefit_i01_pp0p0_zyRzM3jwdHA6" style="vertical-align: bottom"> <td style="text-align: left"><span style="color: Black">Total Income Taxes</span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="color: Black">607,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="color: Black">4,460,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td></tr> </table> <p id="xdx_8AF_z0R2rERh1Q15" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="color: Black"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">Significant components of deferred tax assets (liability) as of December 31, 2022 and 2021 consisted of the following:</span></p> <table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zzmPeOzEcUbg" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - Income Taxes (Details 1)"> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"><span id="xdx_8BE_z3frulvNktE8" style="display: none; color: Black">Schedule of components of deferred tax assets and liability</span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"><span style="color: Black"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="color: Black"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="color: Black"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="width: 56%; text-align: left"><span style="color: Black">Deferred tax assets (liability):<br/>          Net operating loss carryforward</span></td><td style="width: 8%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td id="xdx_989_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_c20221231_pp0p0" style="width: 12%; text-align: right" title="Net operating loss carry forwards"><span style="color: Black">477,000</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td style="width: 8%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><br/><span id="xdx_909_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_c20211231_pp0p0" title="Net operating loss carry forwards"><span style="-sec-ix-hidden: xdx2ixbrl0787">—</span></span></span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="color: Black">         Capital loss carryforward</span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td id="xdx_98A_eus-gaap--DeferredTaxAssetsCapitalLossCarryforwards_c20221231_pp0p0" style="text-align: right" title="Capital loss carryforward"><span style="color: Black">331,000</span></td><td style="text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span id="xdx_902_eus-gaap--DeferredTaxAssetsCapitalLossCarryforwards_c20211231_pp0p0" title="Capital loss carryforward"><span style="-sec-ix-hidden: xdx2ixbrl0791">—</span></span></span></td><td style="text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">         Stock options and RSU</span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td id="xdx_985_ecustom--DeferredTaxAssetsStockOptionsAndRsu_c20221231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Stock options and RSU"><span style="color: Black">30,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span id="xdx_90D_ecustom--DeferredTaxAssetsStockOptionsAndRsu_c20211231_pp0p0" title="Stock options and RSU"><span style="-sec-ix-hidden: xdx2ixbrl0795">—</span></span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">Valuation allowance</span></td><td style="padding-bottom: 1pt"/> <td style="border-bottom: Black 1pt solid; text-align: left"/><td style="border-bottom: Black 1pt solid; text-align: right"><span style="color: Black">(<span id="xdx_90B_eus-gaap--DeferredTaxAssetsValuationAllowance_c20221231_pp0p0" title="Valuation allowance">838,000</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">)</span></td><td style="padding-bottom: 1pt; font-size: 12pt"/> <td style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: left"/><td style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: right"><span style="font-size: 10pt; color: Black"><span id="xdx_90D_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_pp0p0_d0_c20211231_zNE6vu2YUtGl" title="Valuation allowance">—</span></span></td><td style="padding-bottom: 1pt; font-size: 12pt; text-align: left"/></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="color: Black">        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred Tax Liability<sup>(1)</sup></span></span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td id="xdx_983_ecustom--DeferredTaxLiability_c20221231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Deferred Tax Liability"><span style="color: Black">(1,161,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">)</span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td id="xdx_980_ecustom--DeferredTaxLiability_c20211231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Deferred Tax Liability"><span style="color: Black">(554,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">)</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="color: Black">Total deferred tax liability</span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="color: Black">$</span></td><td id="xdx_988_ecustom--DeferredTaxAssetsLiability_c20221231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total deferred tax assets (liability)"><span style="color: Black">(1,161,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black">)</span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="color: Black">$</span></td><td id="xdx_989_ecustom--DeferredTaxAssetsLiability_c20211231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total deferred tax assets (liability)"><span style="color: Black">(554,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black">)</span></td></tr> </table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 6pt 0 0 27.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">_________________________</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">(1) Deferred tax liability primarily as a result of a temporary difference related to the Company’s equity method investment.</span></p> <p id="xdx_8A9_zkVRnxYvczh2" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">As of December 31, 2022, the Company’s estimated aggregate total net operating loss carryforwards (NOLs) were $<span id="xdx_904_eus-gaap--OperatingLossCarryforwards_c20221231_pp0p0">2,168,000 </span></span><span style="font-family: Times New Roman, Times, Serif; color: Black">for U.S. federal tax purposes with an indefinite life.  At December 31, 2022, the Company had deferred tax assets of $<span id="xdx_908_eus-gaap--DeferredTaxAssetsGross_c20221231_pp0p0">838,000</span></span><span style="font-family: Times New Roman, Times, Serif; color: Black">, which were offset by a valuation allowance of $<span id="xdx_90A_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_pp0p0_c20221231_zg9gEGpLoQHc">838,000 </span></span><span style="font-family: Times New Roman, Times, Serif; color: Black">as it was determined that it is more likely than not that the deferred tax assets would not be realized. At December 31, 2022, the Company had a deferred tax liability position of $<span id="xdx_908_eus-gaap--DeferredTaxLiabilities_c20221231_pp0p0">1,161,000</span></span><span style="font-family: Times New Roman, Times, Serif; color: Black">.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">The reconciliation between the taxes as shown and the amount that would be computed by applying the statutory federal income tax rate to the net income before income taxes is as follows:</span></p> <table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zbapG1AjSOB8" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - Income Taxes (Details 2)"> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"><span style="display: none"><span id="xdx_8B8_zMVGWFocpW65">Schedule of reconciliation of income tax</span></span></td><td style="font-size: 12pt"/> <td colspan="2" style="font-size: 12pt; text-align: center"/><td style="font-size: 12pt"/><td style="font-size: 12pt"/> <td colspan="2" style="font-size: 12pt; text-align: center"><span style="font-size: 10pt; color: Black"> </span></td><td style="font-size: 12pt"/></tr> <tr style="vertical-align: bottom"> <td><span style="font-size: 10pt; color: Black"> </span></td><td style="font-weight: bold"><span style="font-size: 10pt; color: Black"> </span></td> <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-size: 10pt; color: Black">Years Ended</span></td><td style="font-weight: bold"><span style="font-size: 10pt; color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"><span style="font-size: 10pt; color: Black"> </span></td><td style="font-weight: bold"><span style="font-size: 10pt; color: Black"> </span></td> <td colspan="6" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>December 31,</b></span></p></td><td style="font-weight: bold"><span style="font-size: 10pt; color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-size: 10pt; color: Black"> </span></td><td style="font-weight: bold"><span style="font-size: 10pt; color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>2022</b></span></p></td><td style="font-weight: bold"><span style="font-size: 10pt; color: Black"> </span></td><td style="font-weight: bold"><span style="font-size: 10pt; color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>2021</b></span></p></td><td style="font-weight: bold"><span style="font-size: 10pt; color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"/><td style="font-size: 12pt"/> <td colspan="2" style="font-size: 12pt; text-align: center"/><td style="font-size: 12pt"/><td style="font-size: 12pt"/> <td colspan="2" style="font-size: 12pt; text-align: center"><span style="font-size: 10pt; color: Black"> </span></td><td style="font-size: 12pt"/></tr> <tr style="vertical-align: bottom"> <td style="width: 56%; text-align: left"><span style="font-size: 10pt; color: Black">Income tax - statutory rate</span></td><td style="width: 8%"><span style="font-size: 10pt; color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td style="width: 12%; text-align: right"><span style="font-size: 10pt; color: Black"><span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20220101__20221231_z6M71iHbNlh1" title="Income tax - statutory rate">21.00</span>%</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td style="width: 8%"><span style="font-size: 10pt; color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td style="width: 12%; text-align: right"><span style="font-size: 10pt; color: Black"><span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20210101__20211231_ziUgpp6A2Baa" title="Income tax - statutory rate">21.00</span>%</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-size: 10pt; color: Black">Permanent differences</span></td><td style="font-weight: bold"><span style="font-size: 10pt; color: Black"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td id="xdx_981_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_c20220101__20221231_pdd" style="font-weight: bold; text-align: right" title="Permanent difference"><span style="font-style: normal; font-weight: normal">(8.40<span style="font: normal 10pt Times New Roman, Times, Serif; color: Black">)%</span></span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td><span style="font-size: 10pt; color: Black"> </span></td> <td style="text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td style="text-align: right"><span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_dp_c20210101__20211231_zt2aX6DZUXUb" style="font-size: 10pt; color: Black">1.69</span><span style="font-size: 10pt; color: Black">%</span></td><td style="text-align: left"><span style="font-size: 10pt; color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left">Change in valuation allowance</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td id="xdx_98F_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_c20220101__20221231_pdd" style="font-weight: bold; text-align: right" title="Change in valuation allowance"><span style="font-style: normal; font-weight: normal">(48.79)%</span></td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_d0_c20210101__20211231_zhJgFbqPh5va" style="text-align: right" title="Change in valuation allowance">—%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-size: 10pt; color: Black">State</span></td><td style="font-weight: bold"><span style="font-size: 10pt; color: Black"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td id="xdx_982_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_c20220101__20221231_pdd" style="font-weight: bold; text-align: right" title="State"><span style="font-style: normal; font-weight: normal">1.28%</span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td><span style="font-size: 10pt; color: Black"> </span></td> <td style="text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td id="xdx_983_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_d0_c20210101__20211231_zaE4chOwHJMl" style="text-align: right" title="State">1.11<span style="font-size: 10pt; color: Black">%</span></td><td style="text-align: left"><span style="font-size: 10pt; color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: left">Other</td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td id="xdx_98D_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_c20220101__20221231_pdd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Other"><span style="font-style: normal; font-weight: normal">(0.43)%</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_c20210101__20211231_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Other">—<span style="font-size: 10pt; color: Black">%</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: 20pt; padding-bottom: 2.5pt"><span style="font-size: 10pt; color: Black">  Total</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 10pt; color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td id="xdx_983_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_c20220101__20221231_pdd" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total"><span style="font-style: normal; font-weight: normal">(35.34<span style="font: normal 10pt Times New Roman, Times, Serif; color: Black">)%</span></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp_c20210101__20211231_ztU7boe91WXe" style="font-size: 10pt; color: Black">23.80</span><span style="font-size: 10pt; color: Black">%</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td></tr> </table> <p id="xdx_8A5_zF176KuJqUib" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; color: Black"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; color: Black"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of Treasury has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. The excise tax applies in cases where the total value of the stock repurchased during the taxable year exceeds $1,000,000.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">The personal holding company (“PHC”) rules under the Internal Revenue Code impose a 20% tax on a PHC’s undistributed personal holding company income (“UPHCI”), which means, in general, taxable income subject to certain adjustments. For a corporation to be classified as a PHC, it must satisfy two tests: (i) that more than 50% in value of its outstanding shares must be owned directly or indirectly by five or fewer individuals at any time during the second half of the year (after applying constructive ownership rules to attribute stock owned by entities to their beneficial owners and among certain family members and other related parties) (the “Ownership Test”) and (ii) at least 60% of its adjusted ordinary gross income for a taxable year consists of dividends, interest, royalties, annuities and rents (the “Income Test”). During the second half of 2022, based on available information concerning the Company’s shareholder ownership, the Company did not satisfy the Ownership Test and thus the Company was not a PHC for 2022. However, the Company may subsequently be determined to be a PHC in 2023 or in future years if it satisfies both the Ownership Test and the Income Test. If the Company were to become a PHC in any future year, it would be subject to an additional 20% tax on its UPHCI. In such event, the Company may issue a special cash dividend, to its shareholders in an amount equal to the UPHCI rather than incur the additional 20% tax.</span></p> <table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zxZECpiSceZi" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - Income Taxes (Details)"> <tr style="vertical-align: bottom"> <td style="text-indent: 20pt; text-align: left"><span id="xdx_8BB_zola7sNie5Fi" style="display: none">Schedule of components of the income taxes</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_493_20220101__20221231_zgQjITGDANia" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_497_20210101__20211231_z69GJMUs5kFj" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"><span style="color: Black"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="color: Black"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="color: Black"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black"> </span></td></tr> <tr id="xdx_403_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_iB" style="vertical-align: bottom"> <td><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; color: Black"> </span></p><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; color: Black">Current</span></p></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td colspan="6" style="font-size: 12pt"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td></tr> <tr id="xdx_400_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_i01_pp0p0_maCITEBz4Q6_zkPNYUPMsRXi" style="vertical-align: bottom"> <td style="text-indent: 20pt; width: 56%; text-align: left"><span style="color: Black">State and local</span></td><td style="width: 8%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td style="width: 12%; text-align: right"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0759">—</span></span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td style="width: 8%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td style="width: 12%; text-align: right"><span style="color: Black">144,000</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td></tr> <tr id="xdx_407_eus-gaap--CurrentFederalTaxExpenseBenefit_i01_pp0p0_maCITEBz4Q6_zGS6ZrRENLv2" style="vertical-align: bottom"> <td style="text-indent: 20pt"><span style="color: Black">Federal</span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0762">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="color: Black">2,808,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr id="xdx_403_eus-gaap--CurrentIncomeTaxExpenseBenefit_i01T_pp0p0_mtCITEBz4Q6_maITEBzLGv_zx0MXnp9kuvj" style="vertical-align: bottom"> <td style="text-align: left"><span style="color: Black">Total Current Tax Expense (Benefit)</span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0765">—</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="color: Black">2,952,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr id="xdx_40A_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_iB" style="vertical-align: bottom"> <td><span style="color: Black">Deferred</span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr id="xdx_408_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_i01_pp0p0_maDITEBza7G_z1ABkECzdaO7" style="vertical-align: bottom"> <td style="text-indent: 20pt; text-align: left"><span style="color: Black">State and local</span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">   56,000</span></td><td style="text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td style="text-align: right"><span style="color: Black">83,000</span></td><td style="text-align: left"><span style="color: Black"> </span></td></tr> <tr id="xdx_402_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_i01_pp0p0_maDITEBza7G_z2SMQAtpVhPi" style="vertical-align: bottom"> <td style="text-indent: 20pt"><span style="color: Black">Federal</span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right">551,000</td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="color: Black">1,425,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr id="xdx_40A_eus-gaap--DeferredIncomeTaxExpenseBenefit_i01T_pp0p0_mtDITEBza7G_maITEBzLGv_ztJxbwRi94o2" style="vertical-align: bottom"> <td style="text-align: left"><span style="color: Black">Total Deferred Tax Expense</span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="color: Black">607,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="color: Black">1,508,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr id="xdx_40B_eus-gaap--IncomeTaxExpenseBenefit_i01_pp0p0_zyRzM3jwdHA6" style="vertical-align: bottom"> <td style="text-align: left"><span style="color: Black">Total Income Taxes</span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="color: Black">607,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="color: Black">4,460,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td></tr> </table> 144000 2808000 2952000 56000 83000 551000 1425000 607000 1508000 607000 4460000 <table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zzmPeOzEcUbg" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - Income Taxes (Details 1)"> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"><span id="xdx_8BE_z3frulvNktE8" style="display: none; color: Black">Schedule of components of deferred tax assets and liability</span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"><span style="color: Black"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="color: Black"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="color: Black"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="width: 56%; text-align: left"><span style="color: Black">Deferred tax assets (liability):<br/>          Net operating loss carryforward</span></td><td style="width: 8%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td id="xdx_989_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_c20221231_pp0p0" style="width: 12%; text-align: right" title="Net operating loss carry forwards"><span style="color: Black">477,000</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td style="width: 8%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><br/><span id="xdx_909_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_c20211231_pp0p0" title="Net operating loss carry forwards"><span style="-sec-ix-hidden: xdx2ixbrl0787">—</span></span></span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="color: Black">         Capital loss carryforward</span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td id="xdx_98A_eus-gaap--DeferredTaxAssetsCapitalLossCarryforwards_c20221231_pp0p0" style="text-align: right" title="Capital loss carryforward"><span style="color: Black">331,000</span></td><td style="text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span id="xdx_902_eus-gaap--DeferredTaxAssetsCapitalLossCarryforwards_c20211231_pp0p0" title="Capital loss carryforward"><span style="-sec-ix-hidden: xdx2ixbrl0791">—</span></span></span></td><td style="text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">         Stock options and RSU</span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td id="xdx_985_ecustom--DeferredTaxAssetsStockOptionsAndRsu_c20221231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Stock options and RSU"><span style="color: Black">30,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span id="xdx_90D_ecustom--DeferredTaxAssetsStockOptionsAndRsu_c20211231_pp0p0" title="Stock options and RSU"><span style="-sec-ix-hidden: xdx2ixbrl0795">—</span></span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">Valuation allowance</span></td><td style="padding-bottom: 1pt"/> <td style="border-bottom: Black 1pt solid; text-align: left"/><td style="border-bottom: Black 1pt solid; text-align: right"><span style="color: Black">(<span id="xdx_90B_eus-gaap--DeferredTaxAssetsValuationAllowance_c20221231_pp0p0" title="Valuation allowance">838,000</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">)</span></td><td style="padding-bottom: 1pt; font-size: 12pt"/> <td style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: left"/><td style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: right"><span style="font-size: 10pt; color: Black"><span id="xdx_90D_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_pp0p0_d0_c20211231_zNE6vu2YUtGl" title="Valuation allowance">—</span></span></td><td style="padding-bottom: 1pt; font-size: 12pt; text-align: left"/></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="color: Black">        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred Tax Liability<sup>(1)</sup></span></span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td id="xdx_983_ecustom--DeferredTaxLiability_c20221231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Deferred Tax Liability"><span style="color: Black">(1,161,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">)</span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td id="xdx_980_ecustom--DeferredTaxLiability_c20211231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Deferred Tax Liability"><span style="color: Black">(554,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">)</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="color: Black">Total deferred tax liability</span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="color: Black">$</span></td><td id="xdx_988_ecustom--DeferredTaxAssetsLiability_c20221231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total deferred tax assets (liability)"><span style="color: Black">(1,161,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black">)</span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="color: Black">$</span></td><td id="xdx_989_ecustom--DeferredTaxAssetsLiability_c20211231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total deferred tax assets (liability)"><span style="color: Black">(554,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black">)</span></td></tr> </table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 6pt 0 0 27.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">_________________________</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">(1) Deferred tax liability primarily as a result of a temporary difference related to the Company’s equity method investment.</span></p> 477000 331000 30000 838000 0 -1161000 -554000 -1161000 -554000 2168000 838000 838000 1161000 <table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zbapG1AjSOB8" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - Income Taxes (Details 2)"> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"><span style="display: none"><span id="xdx_8B8_zMVGWFocpW65">Schedule of reconciliation of income tax</span></span></td><td style="font-size: 12pt"/> <td colspan="2" style="font-size: 12pt; text-align: center"/><td style="font-size: 12pt"/><td style="font-size: 12pt"/> <td colspan="2" style="font-size: 12pt; text-align: center"><span style="font-size: 10pt; color: Black"> </span></td><td style="font-size: 12pt"/></tr> <tr style="vertical-align: bottom"> <td><span style="font-size: 10pt; color: Black"> </span></td><td style="font-weight: bold"><span style="font-size: 10pt; color: Black"> </span></td> <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-size: 10pt; color: Black">Years Ended</span></td><td style="font-weight: bold"><span style="font-size: 10pt; color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"><span style="font-size: 10pt; color: Black"> </span></td><td style="font-weight: bold"><span style="font-size: 10pt; color: Black"> </span></td> <td colspan="6" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>December 31,</b></span></p></td><td style="font-weight: bold"><span style="font-size: 10pt; color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-size: 10pt; color: Black"> </span></td><td style="font-weight: bold"><span style="font-size: 10pt; color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>2022</b></span></p></td><td style="font-weight: bold"><span style="font-size: 10pt; color: Black"> </span></td><td style="font-weight: bold"><span style="font-size: 10pt; color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>2021</b></span></p></td><td style="font-weight: bold"><span style="font-size: 10pt; color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"/><td style="font-size: 12pt"/> <td colspan="2" style="font-size: 12pt; text-align: center"/><td style="font-size: 12pt"/><td style="font-size: 12pt"/> <td colspan="2" style="font-size: 12pt; text-align: center"><span style="font-size: 10pt; color: Black"> </span></td><td style="font-size: 12pt"/></tr> <tr style="vertical-align: bottom"> <td style="width: 56%; text-align: left"><span style="font-size: 10pt; color: Black">Income tax - statutory rate</span></td><td style="width: 8%"><span style="font-size: 10pt; color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td style="width: 12%; text-align: right"><span style="font-size: 10pt; color: Black"><span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20220101__20221231_z6M71iHbNlh1" title="Income tax - statutory rate">21.00</span>%</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td style="width: 8%"><span style="font-size: 10pt; color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td style="width: 12%; text-align: right"><span style="font-size: 10pt; color: Black"><span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20210101__20211231_ziUgpp6A2Baa" title="Income tax - statutory rate">21.00</span>%</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-size: 10pt; color: Black">Permanent differences</span></td><td style="font-weight: bold"><span style="font-size: 10pt; color: Black"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td id="xdx_981_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_c20220101__20221231_pdd" style="font-weight: bold; text-align: right" title="Permanent difference"><span style="font-style: normal; font-weight: normal">(8.40<span style="font: normal 10pt Times New Roman, Times, Serif; color: Black">)%</span></span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td><span style="font-size: 10pt; color: Black"> </span></td> <td style="text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td style="text-align: right"><span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_dp_c20210101__20211231_zt2aX6DZUXUb" style="font-size: 10pt; color: Black">1.69</span><span style="font-size: 10pt; color: Black">%</span></td><td style="text-align: left"><span style="font-size: 10pt; color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left">Change in valuation allowance</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td id="xdx_98F_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_c20220101__20221231_pdd" style="font-weight: bold; text-align: right" title="Change in valuation allowance"><span style="font-style: normal; font-weight: normal">(48.79)%</span></td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_d0_c20210101__20211231_zhJgFbqPh5va" style="text-align: right" title="Change in valuation allowance">—%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-size: 10pt; color: Black">State</span></td><td style="font-weight: bold"><span style="font-size: 10pt; color: Black"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td id="xdx_982_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_c20220101__20221231_pdd" style="font-weight: bold; text-align: right" title="State"><span style="font-style: normal; font-weight: normal">1.28%</span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td><span style="font-size: 10pt; color: Black"> </span></td> <td style="text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td id="xdx_983_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_d0_c20210101__20211231_zaE4chOwHJMl" style="text-align: right" title="State">1.11<span style="font-size: 10pt; color: Black">%</span></td><td style="text-align: left"><span style="font-size: 10pt; color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: left">Other</td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td id="xdx_98D_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_c20220101__20221231_pdd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Other"><span style="font-style: normal; font-weight: normal">(0.43)%</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_c20210101__20211231_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Other">—<span style="font-size: 10pt; color: Black">%</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: 20pt; padding-bottom: 2.5pt"><span style="font-size: 10pt; color: Black">  Total</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 10pt; color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td id="xdx_983_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_c20220101__20221231_pdd" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total"><span style="font-style: normal; font-weight: normal">(35.34<span style="font: normal 10pt Times New Roman, Times, Serif; color: Black">)%</span></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp_c20210101__20211231_ztU7boe91WXe" style="font-size: 10pt; color: Black">23.80</span><span style="font-size: 10pt; color: Black">%</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td></tr> </table> 0.2100 0.2100 -0.0840 0.0169 -0.4879 0 0.0128 0.0111 -0.0043 0 -0.3534 0.2380 <p id="xdx_806_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zVi2gWkPcj43" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>N<span style="font-variant: small-caps">ote </span>F – <span style="font-variant: small-caps"><span id="xdx_82B_zCO7Kfelou36">Stockholders’ Equity</span></span></b></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">The Company adopted a new 2022 Stock Incentive Plan, (the “2022 Plan”), approved by its Board of Directors on July 25, 2022 and its stockholders on September 20, 2022. The 2022 Plan provides for the grant of any or all of the following types of awards: (a) stock options, (b) restricted stock, (c) deferred stock, (d) stock appreciation rights, and (e) other stock-based awards including restricted stock units. Awards under the 2022 Plan may be granted singly, in combination, or in tandem. Subject to standard anti-dilution adjustments as provided, the 2022 Plan provides for an aggregate of 2,300,000 shares of the Company’s common stock to be available for distribution. The Company’s Compensation Committee generally has the authority to administer the 2022 Plan, determine participants who will be granted awards, the size and types of awards, the terms and conditions of awards and the form and content of the award agreements representing awards. Awards under the 2022 Plan may be granted to employees, directors and consultants of the Company and its subsidiaries. As of December 31, 2022, there were <span id="xdx_907_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_c20221231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_pdd" title="Common stock available for issuance under 2022 Plan">2,300,000</span> shares of common stock available for issuance under the 2022 Plan.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">As of December 31, 2022, there were <span id="xdx_90A_ecustom--CommonStockSubjectToOutstandingAwards_iI_c20221231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2013Member_zFwiW42I25Yc" title="Common stock subject to outstanding awards">625,000</span> shares of common stock subject to outstanding awards under the Company 2013 Stock Incentive Plan (“2013 Plan”). The Company discontinued issuing awards under its 2013 Plan as a result of the adoption of the 2022 Plan.</span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>[1]</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Restricted Stock Units</b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">A summary of restricted stock units granted during the years ended December 31, 2022 and December 31, 2021 is as follows (each restricted stock unit represents the contingent right to receive one share of the Company’s common stock):</span></p> <table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_zk8NziO0j1r4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stockholders' Equity (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="display: none"><span id="xdx_8B5_zTa2pihpUVki">Schedule of restricted stock units</span></span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; font-size: 12pt; text-align: center"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt; text-align: center"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Number of<br/> Shares</span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Weighted-Average Grant<br/> Date Fair Value</span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="color: Black">Number of<br/> Shares</span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Weighted-Average Grant<br/> Date Fair Value</span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="width: 40%; text-align: left"><span style="color: Black">Balance of restricted stock units outstanding at beginning of year</span></td><td style="width: 3%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_c20220101__20221231_zp2tRdQ7ZRr4" style="width: 10%; text-align: right" title="Restricted stock units, outstanding number of units, beginning balance"><span style="color: Black">12,500</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td style="width: 3%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20220101__20221231_zRTQTrK4bYAe" style="width: 10%; text-align: right" title="Restricted stock units, weighted average grant date fair value, beginning balance"><span style="color: Black">3.36</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td style="width: 3%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_c20210101__20211231_z7nOq6tK2g" style="width: 10%; text-align: right" title="Restricted stock units, outstanding number of units, beginning balance"><span style="color: Black">162,500</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td style="width: 3%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20210101__20211231_zIogphnyJQv8" style="width: 10%; text-align: right" title="Restricted stock units, weighted average grant date fair value, beginning balance"><span style="color: Black">2.25</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="color: Black">Grants of restricted stock units</span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20220101__20221231_pdd" style="text-align: right" title="Grants of restricted stock units"><span style="color: Black">670,000</span></td><td style="text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td id="xdx_980_ecustom--IssuanceWeightedaverageGrantDateFairValue_c20220101__20221231_zm1RRQ0BgXX6" style="text-align: right" title="Grants of restricted stock units, weighted average grant date fair value"><span style="color: Black">1.92</span></td><td style="text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20210101__20211231_pdd" style="text-align: right" title="Grants of restricted stock units"><span style="color: Black">45,000</span></td><td style="text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td id="xdx_986_ecustom--IssuanceWeightedaverageGrantDateFairValue_c20210101__20211231_zE1uhnVz4Ny1" style="text-align: right" title="Grants of restricted stock units, weighted average grant date fair value"><span style="color: Black">3.51</span></td><td style="text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="color: Black">Vested restricted stock units</span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20220101__20221231_z19pvdJWdxUb" style="border-bottom: Black 1pt solid; text-align: right" title="Vested restricted stock units"><span style="color: Black">(57,500</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">)</span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_iN_di_c20220101__20221231_zwenylVFQsZ6" style="padding-bottom: 1pt; text-align: right" title="Vested restricted stock units, weighted average grant date fair value"><span style="color: Black">(2.73</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">)</span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20210101__20211231_zKQqbVJ3A7Ll" style="border-bottom: Black 1pt solid; text-align: right" title="Vested restricted stock units"><span style="color: Black">(195,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">)</span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_iN_di_c20210101__20211231_z8PTBcQmfBR5" style="padding-bottom: 1pt; text-align: right" title="Vested restricted stock units, weighted average grant date fair value"><span style="color: Black">(2.47</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">)</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="color: Black">Balance of restricted stock units outstanding at end of year</span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_c20220101__20221231_zXxmB97sIpb5" style="border-bottom: Black 1pt solid; text-align: right" title="Resricted stock units, Outstanding Number of units, Ending Balance"><span style="color: Black">625,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20220101__20221231_zmydD2n20LTi" style="padding-bottom: 1pt; text-align: right" title="Restricted stock units, weighted average grant date fair value, ending balance"><span style="color: Black">1.87</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_c20210101__20211231_zsKfxNn73RL" style="border-bottom: Black 1pt solid; text-align: right" title="Resricted stock units, Outstanding Number of units, Ending Balance"><span style="color: Black">12,500</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">$</span></td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20210101__20211231_z6TvyjfeFrE4" style="padding-bottom: 1pt; text-align: right" title="Restricted stock units, weighted average grant date fair value, ending balance"><span style="color: Black">3.36</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td></tr> </table> <p id="xdx_8AE_zOKRIaO2Vdo4" style="margin-top: 0; margin-bottom: 0"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 45pt; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; color: Black"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 12pt 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">Restricted stock unit compensation expense was $<span id="xdx_900_eus-gaap--AllocatedShareBasedCompensationExpense_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pp0p0" title="Restricted stock unit compensation expense">585,000</span> for the year ended December 31, 2022 and $<span id="xdx_90D_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pp0p0" title="Restricted stock unit compensation expense">238,000</span> for the year ended December 31, 2021.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">The Company has an aggregate of $<span id="xdx_90E_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_c20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pp0p0" title="Unrecognized restricted stock unit compensation expense">736,000</span> of unrecognized restricted stock unit compensation expense as of December 31, 2022 to be expensed over a weighted average period of <span id="xdx_90A_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zFzeRYOMITx2" title="Weighted average amortized period">2.61</span> years.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">The fair value of restricted stock units is determined based on the number of shares granted and the quoted market price of the Company’s common stock on the date of grant for time-based and performance-based awards and fair value at grant date using the Monte Carlo simulation model for market-based awards. The key inputs into the Monte Carlo simulation used to value the restricted stock units was a risk-free rate of <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zOySP0RZuLw5">2.39%</span></span><span style="font-family: Times New Roman, Times, Serif; color: Black">, expected term of <span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z2XSqCaULWvd">4 </span></span><span style="font-family: Times New Roman, Times, Serif; color: Black">years, expected volatility of <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zYkVmRyCVyt1">40% </span></span><span style="font-family: Times New Roman, Times, Serif; color: Black">and a stock price of $<span id="xdx_902_eus-gaap--SharePrice_iI_dtY_c20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zmiz4jvYzNse">2.47</span></span><span style="font-family: Times New Roman, Times, Serif; color: Black">.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">All of the Company’s issued restricted stock units have dividend equivalent rights. As of December 31, 2022 and 2021, there was $<span id="xdx_904_ecustom--AccruedDividendRightsOnRestrictedStockUnit_c20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pp0p0" title="Accrued dividend rights on restricted stock unit">37,000</span> and $<span id="xdx_907_ecustom--AccruedDividendRightsOnRestrictedStockUnit_c20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pp0p0" title="Accrued dividend rights on restricted stock unit">72,000</span> accrued for dividend equivalent rights which were included in other accrued expenses.</span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>[2]</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Stock Options</b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">At December 31, 2022, there were no stock options outstanding. At December 31, 2021, one stock option to purchase 500,000 shares of common stock was outstanding, representing an option grant outside of the 2013 Plan (issued prior to the establishment of the 2013 Plan). The stock option had a weighted average exercise price of $1.19 and a weighted average remaining life of 0.84 years. There were no grants of stock options during the years ended December 31, 2022 and 2021.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">The following table summarizes stock option activity for the years ended December 31:</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"> </span></p> <table cellpadding="0" cellspacing="3" id="xdx_89F_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zLsnFXShGfAl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stockholders' Equity (Details 1)"> <tr style="vertical-align: bottom"> <td style="text-indent: 20pt; padding-left: 5.4pt"><span id="xdx_8B6_zylvdb71LQ" style="display: none">Schedule of stock option activity</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: 20pt"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="6" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>2022</b></span></p></td><td style="font-weight: bold"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="6" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>2021</b></span></p></td><td style="font-weight: bold"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: 20pt; font-size: 12pt"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td colspan="2" style="font-size: 12pt; text-align: center"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="color: Black">Weighted</span></td><td style="font-weight: bold"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td colspan="2" style="font-size: 12pt; text-align: center"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="color: Black">Weighted</span></td><td style="font-weight: bold"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: 20pt; font-size: 12pt"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td colspan="2" style="font-size: 12pt; text-align: center"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="color: Black">Average</span></td><td style="font-weight: bold"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td colspan="2" style="font-size: 12pt; text-align: center"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="color: Black">Average</span></td><td style="font-weight: bold"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: 20pt; font-size: 12pt"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="color: Black">Options</span></td><td style="font-weight: bold"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="color: Black">Exercise</span></td><td style="font-weight: bold"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="color: Black">Options</span></td><td style="font-weight: bold"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="color: Black">Exercise</span></td><td style="font-weight: bold"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: 20pt; font-size: 12pt"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>Outstanding</b></span></p></td><td style="font-weight: bold"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>Price</b></span></p></td><td style="font-weight: bold"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>Outstanding</b></span></p></td><td style="font-weight: bold"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>Price</b></span></p></td><td style="font-weight: bold"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: 20pt; width: 40%; text-align: left; padding-left: 5.4pt"><span style="color: Black">Options outstanding at beginning of year</span></td><td style="width: 3%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20220131__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zaN2thf25fw4" style="width: 10%; text-align: right" title="Options outstanding, beginning, at beginning of year"><span style="color: Black">500,000</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td style="width: 3%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zaskmt8bIlL9" style="width: 10%; text-align: right" title="Weighted average exercise price, options outstanding, at beginning of year"><span style="color: Black">1.19</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td style="width: 3%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zLhWViII6WF7" style="width: 10%; text-align: right" title="Options outstanding, beginning, at beginning of year"><span style="color: Black">500,000</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td style="width: 3%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zn8GLFY2YME1" style="width: 10%; text-align: right" title="Weighted average exercise price, options outstanding, at beginning of year"><span style="color: Black">1.19</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: 20pt; padding-left: 5.4pt"><span style="color: Black">Granted</span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd" style="text-align: right" title="Options Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0922">—</span></span></td><td style="text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd" style="text-align: right" title="Weighted average exercise price, Options Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0924">—</span></span></td><td style="text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd" style="text-align: right" title="Options Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0926">—</span></span></td><td style="text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd" style="text-align: right" title="Weighted average exercise price, Options Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0928">—</span></span></td><td style="text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: 20pt; padding-left: 5.4pt"><span style="color: Black">Expired</span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd" style="text-align: right" title="Options Expired"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0930">—</span></span></td><td style="text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd" style="text-align: right" title="Weighted average exercise price, Options Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0932">—</span></span></td><td style="text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd" style="text-align: right" title="Options Expired"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0934">—</span></span></td><td style="text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd" style="text-align: right" title="Weighted average exercise price, Options Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0936">—</span></span></td><td style="text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: 20pt; padding-bottom: 1pt; padding-left: 5.4pt"><span style="color: Black">Exercised</span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Options Exercised"><span style="color: Black">500,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd" style="padding-bottom: 1pt; text-align: right" title="Weighted average exercise price, Options Exercised"><span style="color: Black">1.19</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Options Exercised"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0942">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"/></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd" style="padding-bottom: 1pt; text-align: right" title="Weighted average exercise price, Options Exercised"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0944">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: 20pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="color: Black">Options outstanding at end of year</span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zvL83L1MFTKh" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, Options outstanding, at end of year"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0946">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"/></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zrBI96xKgGT4" style="padding-bottom: 1pt; text-align: right" title="Weighted average exercise price, options outstanding, at end of year"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0948">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zhvMhrGrEdN5" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, Options outstanding, at end of year"><span style="color: Black">500,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zy06V1LkQMmg" style="padding-bottom: 1pt; text-align: right" title="Weighted average exercise price, options outstanding, at end of year"><span style="color: Black">1.19</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: 20pt; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"><span style="color: Black">Options exercisable at end of year</span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="color: Black"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20221231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd" style="border-bottom: Black 2.5pt double; text-align: right" title="Option exercisable at end of year"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0954">—</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"/></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20221231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd" style="padding-bottom: 2.5pt; text-align: right" title="Option exercise price at end of year"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0956">—</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="color: Black"> </span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd" style="border-bottom: Black 2.5pt double; text-align: right" title="Option exercisable at end of year"><span style="color: Black">500,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd" style="padding-bottom: 2.5pt; text-align: right" title="Option exercise price at end of year"><span style="color: Black">1.19</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: 20pt; font-size: 12pt; padding-left: 5.4pt"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td style="text-align: right"><span style="color: Black"> </span></td><td style="text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td style="text-align: right"><span style="color: Black"> </span></td><td style="text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td style="text-align: right"><span style="color: Black"> </span></td><td style="text-align: left"><span style="color: Black"> </span></td></tr> </table> <p id="xdx_8A1_zA5kGe43NOB9" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">During the year ended December 31, 2022 and 2021, the Company did not recognize any stock-based compensation related to the vesting of prior issued stock options to employees. The Company at December 31, 2022 and 2021 had no remaining unrecognized expenses related to unvested stock options to employees and directors. The aggregate intrinsic value of all stock options exercisable at December 31, 2022 and 2021 was $-<span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_c20221231_pp0p0" title="Aggregate intrinsic value of options exercisable">0</span>- and $<span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_c20211231_pp0p0" title="Aggregate intrinsic value of options exercisable">815,000</span>, respectively.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">On October 27, 2022, the Company’s Chairman and Chief Executive Officer exercised a stock option to purchase <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20221001__20221027__srt--TitleOfIndividualAxis__custom--ChairmanAndChiefExecutiveOfficerMember_zFGEHWe7psC8" title="Common stock shares purchased option exercise">500,000</span> shares of the Company’s common stock at an exercise price of $<span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221027__srt--TitleOfIndividualAxis__custom--ChairmanAndChiefExecutiveOfficerMember_zxfIpqKXPsoh" title="Exercise price">1.19</span> per share on a net exercise (or cashless) basis. In connection with the net exercise of the stock option, the Company’s Chairman and Chief Executive Officer delivered <span id="xdx_904_eus-gaap--TemporaryEquitySharesIssued_iI_c20221027__srt--TitleOfIndividualAxis__custom--ChairmanAndChiefExecutiveOfficerMember_zFGAfNqUrwxj" title="Aggregate common stock shares delivered to company">334,459</span> shares of common stock (including <span id="xdx_902_ecustom--CommonStockSharesDeliveredToCompanyWithholdingTaxes_c20221001__20221027__srt--TitleOfIndividualAxis__custom--ChairmanAndChiefExecutiveOfficerMember_zgL2STRStHxj" title="Common stock shares delivered to company - withholding taxes">94,539</span> shares for withholding taxes) to the Company and received <span id="xdx_901_ecustom--NetSharesReceived_iI_c20221027__srt--TitleOfIndividualAxis__custom--ChairmanAndChiefExecutiveOfficerMember_zVKti5pdYxTe" title="Net shares received">165,541</span> net shares.</span></p> <p style="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-variant: small-caps; color: Black"> </span></p> 2300000 625000 <table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_zk8NziO0j1r4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stockholders' Equity (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="display: none"><span id="xdx_8B5_zTa2pihpUVki">Schedule of restricted stock units</span></span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; font-size: 12pt; text-align: center"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt; text-align: center"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Number of<br/> Shares</span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Weighted-Average Grant<br/> Date Fair Value</span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="color: Black">Number of<br/> Shares</span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Weighted-Average Grant<br/> Date Fair Value</span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="width: 40%; text-align: left"><span style="color: Black">Balance of restricted stock units outstanding at beginning of year</span></td><td style="width: 3%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_c20220101__20221231_zp2tRdQ7ZRr4" style="width: 10%; text-align: right" title="Restricted stock units, outstanding number of units, beginning balance"><span style="color: Black">12,500</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td style="width: 3%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20220101__20221231_zRTQTrK4bYAe" style="width: 10%; text-align: right" title="Restricted stock units, weighted average grant date fair value, beginning balance"><span style="color: Black">3.36</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td style="width: 3%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_c20210101__20211231_z7nOq6tK2g" style="width: 10%; text-align: right" title="Restricted stock units, outstanding number of units, beginning balance"><span style="color: Black">162,500</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td style="width: 3%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20210101__20211231_zIogphnyJQv8" style="width: 10%; text-align: right" title="Restricted stock units, weighted average grant date fair value, beginning balance"><span style="color: Black">2.25</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="color: Black">Grants of restricted stock units</span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20220101__20221231_pdd" style="text-align: right" title="Grants of restricted stock units"><span style="color: Black">670,000</span></td><td style="text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td id="xdx_980_ecustom--IssuanceWeightedaverageGrantDateFairValue_c20220101__20221231_zm1RRQ0BgXX6" style="text-align: right" title="Grants of restricted stock units, weighted average grant date fair value"><span style="color: Black">1.92</span></td><td style="text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20210101__20211231_pdd" style="text-align: right" title="Grants of restricted stock units"><span style="color: Black">45,000</span></td><td style="text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td id="xdx_986_ecustom--IssuanceWeightedaverageGrantDateFairValue_c20210101__20211231_zE1uhnVz4Ny1" style="text-align: right" title="Grants of restricted stock units, weighted average grant date fair value"><span style="color: Black">3.51</span></td><td style="text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="color: Black">Vested restricted stock units</span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20220101__20221231_z19pvdJWdxUb" style="border-bottom: Black 1pt solid; text-align: right" title="Vested restricted stock units"><span style="color: Black">(57,500</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">)</span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_iN_di_c20220101__20221231_zwenylVFQsZ6" style="padding-bottom: 1pt; text-align: right" title="Vested restricted stock units, weighted average grant date fair value"><span style="color: Black">(2.73</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">)</span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20210101__20211231_zKQqbVJ3A7Ll" style="border-bottom: Black 1pt solid; text-align: right" title="Vested restricted stock units"><span style="color: Black">(195,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">)</span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_iN_di_c20210101__20211231_z8PTBcQmfBR5" style="padding-bottom: 1pt; text-align: right" title="Vested restricted stock units, weighted average grant date fair value"><span style="color: Black">(2.47</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">)</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="color: Black">Balance of restricted stock units outstanding at end of year</span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_c20220101__20221231_zXxmB97sIpb5" style="border-bottom: Black 1pt solid; text-align: right" title="Resricted stock units, Outstanding Number of units, Ending Balance"><span style="color: Black">625,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20220101__20221231_zmydD2n20LTi" style="padding-bottom: 1pt; text-align: right" title="Restricted stock units, weighted average grant date fair value, ending balance"><span style="color: Black">1.87</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_c20210101__20211231_zsKfxNn73RL" style="border-bottom: Black 1pt solid; text-align: right" title="Resricted stock units, Outstanding Number of units, Ending Balance"><span style="color: Black">12,500</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">$</span></td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20210101__20211231_z6TvyjfeFrE4" style="padding-bottom: 1pt; text-align: right" title="Restricted stock units, weighted average grant date fair value, ending balance"><span style="color: Black">3.36</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td></tr> </table> 12500 3.36 162500 2.25 670000 1.92 45000 3.51 57500 2.73 195000 2.47 625000 1.87 12500 3.36 585000 238000 736000 P2Y7M9D 0.0239 P4Y 0.40 2.47 37000 72000 <table cellpadding="0" cellspacing="3" id="xdx_89F_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zLsnFXShGfAl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stockholders' Equity (Details 1)"> <tr style="vertical-align: bottom"> <td style="text-indent: 20pt; padding-left: 5.4pt"><span id="xdx_8B6_zylvdb71LQ" style="display: none">Schedule of stock option activity</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: 20pt"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="6" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>2022</b></span></p></td><td style="font-weight: bold"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="6" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>2021</b></span></p></td><td style="font-weight: bold"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: 20pt; font-size: 12pt"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td colspan="2" style="font-size: 12pt; text-align: center"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="color: Black">Weighted</span></td><td style="font-weight: bold"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td colspan="2" style="font-size: 12pt; text-align: center"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="color: Black">Weighted</span></td><td style="font-weight: bold"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: 20pt; font-size: 12pt"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td colspan="2" style="font-size: 12pt; text-align: center"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="color: Black">Average</span></td><td style="font-weight: bold"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td colspan="2" style="font-size: 12pt; text-align: center"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="color: Black">Average</span></td><td style="font-weight: bold"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: 20pt; font-size: 12pt"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="color: Black">Options</span></td><td style="font-weight: bold"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="color: Black">Exercise</span></td><td style="font-weight: bold"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="color: Black">Options</span></td><td style="font-weight: bold"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="color: Black">Exercise</span></td><td style="font-weight: bold"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: 20pt; font-size: 12pt"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>Outstanding</b></span></p></td><td style="font-weight: bold"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>Price</b></span></p></td><td style="font-weight: bold"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>Outstanding</b></span></p></td><td style="font-weight: bold"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>Price</b></span></p></td><td style="font-weight: bold"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: 20pt; width: 40%; text-align: left; padding-left: 5.4pt"><span style="color: Black">Options outstanding at beginning of year</span></td><td style="width: 3%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20220131__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zaN2thf25fw4" style="width: 10%; text-align: right" title="Options outstanding, beginning, at beginning of year"><span style="color: Black">500,000</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td style="width: 3%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zaskmt8bIlL9" style="width: 10%; text-align: right" title="Weighted average exercise price, options outstanding, at beginning of year"><span style="color: Black">1.19</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td style="width: 3%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zLhWViII6WF7" style="width: 10%; text-align: right" title="Options outstanding, beginning, at beginning of year"><span style="color: Black">500,000</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td style="width: 3%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zn8GLFY2YME1" style="width: 10%; text-align: right" title="Weighted average exercise price, options outstanding, at beginning of year"><span style="color: Black">1.19</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: 20pt; padding-left: 5.4pt"><span style="color: Black">Granted</span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd" style="text-align: right" title="Options Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0922">—</span></span></td><td style="text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd" style="text-align: right" title="Weighted average exercise price, Options Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0924">—</span></span></td><td style="text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd" style="text-align: right" title="Options Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0926">—</span></span></td><td style="text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd" style="text-align: right" title="Weighted average exercise price, Options Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0928">—</span></span></td><td style="text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: 20pt; padding-left: 5.4pt"><span style="color: Black">Expired</span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd" style="text-align: right" title="Options Expired"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0930">—</span></span></td><td style="text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd" style="text-align: right" title="Weighted average exercise price, Options Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0932">—</span></span></td><td style="text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd" style="text-align: right" title="Options Expired"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0934">—</span></span></td><td style="text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd" style="text-align: right" title="Weighted average exercise price, Options Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0936">—</span></span></td><td style="text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: 20pt; padding-bottom: 1pt; padding-left: 5.4pt"><span style="color: Black">Exercised</span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Options Exercised"><span style="color: Black">500,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd" style="padding-bottom: 1pt; text-align: right" title="Weighted average exercise price, Options Exercised"><span style="color: Black">1.19</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Options Exercised"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0942">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"/></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd" style="padding-bottom: 1pt; text-align: right" title="Weighted average exercise price, Options Exercised"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0944">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: 20pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="color: Black">Options outstanding at end of year</span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zvL83L1MFTKh" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, Options outstanding, at end of year"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0946">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"/></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zrBI96xKgGT4" style="padding-bottom: 1pt; text-align: right" title="Weighted average exercise price, options outstanding, at end of year"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0948">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zhvMhrGrEdN5" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, Options outstanding, at end of year"><span style="color: Black">500,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zy06V1LkQMmg" style="padding-bottom: 1pt; text-align: right" title="Weighted average exercise price, options outstanding, at end of year"><span style="color: Black">1.19</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: 20pt; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"><span style="color: Black">Options exercisable at end of year</span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="color: Black"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20221231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd" style="border-bottom: Black 2.5pt double; text-align: right" title="Option exercisable at end of year"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0954">—</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"/></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20221231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd" style="padding-bottom: 2.5pt; text-align: right" title="Option exercise price at end of year"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0956">—</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="color: Black"> </span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd" style="border-bottom: Black 2.5pt double; text-align: right" title="Option exercisable at end of year"><span style="color: Black">500,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd" style="padding-bottom: 2.5pt; text-align: right" title="Option exercise price at end of year"><span style="color: Black">1.19</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: 20pt; font-size: 12pt; padding-left: 5.4pt"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td style="text-align: right"><span style="color: Black"> </span></td><td style="text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td style="text-align: right"><span style="color: Black"> </span></td><td style="text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td style="text-align: right"><span style="color: Black"> </span></td><td style="text-align: left"><span style="color: Black"> </span></td></tr> </table> 500000 1.19 500000 1.19 500000 1.19 500000 1.19 500000 1.19 0 815000 500000 1.19 334459 94539 165541 <p id="xdx_801_ecustom--MarketableSecuritiesDisclosureTextBlock_zLKT2kzENpF1" style="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-variant: small-caps; color: Black">Note G – <span id="xdx_82F_zvNSgSPWyUM4">Marketable Securities</span></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">Marketable securities as of December 31, 2022 and 2021 were composed of: </span></p> <table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--MarketableSecuritiesTextBlock_zmra6HxgjtD5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Marketable Securities (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-indent: 20pt; text-align: left; padding-left: 5.4pt"><span style="display: none"><span id="xdx_8BB_zP2ar2mabBch">Schedule of marketable securities</span></span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-bottom: 1pt; text-indent: 20pt; font-size: 12pt; text-align: justify"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black"> </span></td> <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">December 31, 2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-indent: 20pt; font-size: 12pt; text-align: justify"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 0.5pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>Cost<br/> Basis</b></span></p></td><td style="font-weight: bold"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 0.5pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>Gross<br/> Unrealized<br/> Gains</b></span></p></td><td style="font-weight: bold"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 0.5pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>Gross<br/> Unrealized<br/> Losses</b></span></p></td><td style="font-weight: bold"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 0.5pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>Fair Value</b></span></p></td><td style="font-weight: bold"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-indent: 20pt; width: 40%; text-align: left; padding-left: 5.4pt"><span style="color: Black">Government Securities</span></td><td style="width: 3%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td id="xdx_983_ecustom--GovernmentSecurities_c20221231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--CostBasisMember_pp0p0" style="width: 10%; text-align: right" title="Government securities"><span style="color: Black">20,781,000</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td style="width: 3%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td id="xdx_987_ecustom--GovernmentSecurities_c20221231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedGainsMember_pp0p0" style="width: 10%; text-align: right" title="Government securities"><span style="color: Black">67,000</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td style="width: 3%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td id="xdx_984_ecustom--GovernmentSecurities_c20221231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedLossesMember_pp0p0" style="width: 10%; text-align: right" title="Government securities"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0984">—</span></span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td style="width: 3%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td id="xdx_987_ecustom--GovernmentSecurities_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--FairValueMember_pp0p0" style="width: 10%; text-align: right" title="Government securities"><span style="color: Black">20,848,000</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-indent: 20pt; text-align: left; padding-left: 5.4pt"><span style="color: Black">Fixed income mutual funds</span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td id="xdx_984_ecustom--ShortTermBondFunds_c20221231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--CostBasisMember_pp0p0" style="text-align: right" title="Fixed income mutual funds"><span style="color: Black">11,904,000</span></td><td style="text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td id="xdx_988_ecustom--ShortTermBondFunds_c20221231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedGainsMember_pp0p0" style="text-align: right" title="Fixed income mutual funds"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0990">—</span></span></td><td style="text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td id="xdx_981_ecustom--ShortTermBondFunds_c20221231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedLossesMember_pp0p0" style="text-align: right" title="Fixed income mutual funds"><span style="color: Black">(915,000</span></td><td style="text-align: left"><span style="color: Black">)</span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td id="xdx_989_ecustom--ShortTermBondFunds_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--FairValueMember_pp0p0" style="text-align: right" title="Fixed income mutual funds"><span style="color: Black">10,989,000</span></td><td style="text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-indent: 20pt; padding-left: 5.4pt"><span style="color: Black">Certificates of Deposit</span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td id="xdx_98E_ecustom--CertificatesOfDeposit_c20221231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--CostBasisMember_pp0p0" style="text-align: right" title="Certificates of deposit"><span style="color: Black">3,019,000</span></td><td style="text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td id="xdx_98B_ecustom--CertificatesOfDeposit_c20221231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedGainsMember_pp0p0" style="text-align: right" title="Certificates of deposit"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0998">—</span></span></td><td style="text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td id="xdx_98B_ecustom--CertificatesOfDeposit_c20221231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedLossesMember_pp0p0" style="text-align: right" title="Certificates of deposit"><span style="color: Black">(43,000</span></td><td style="text-align: left"><span style="color: Black">)</span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td id="xdx_98B_ecustom--CertificatesOfDeposit_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--FairValueMember_pp0p0" style="text-align: right" title="Certificates of deposit"><span style="color: Black">2,976,000</span></td><td style="text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-indent: 20pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="color: Black">Corporate bonds and notes</span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td id="xdx_989_ecustom--CorporateBonds_c20221231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--CostBasisMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Corporate bonds and notes"><span style="color: Black">192,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td id="xdx_984_ecustom--CorporateBonds_c20221231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedGainsMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Corporate bonds and notes"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl1006">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td id="xdx_989_ecustom--CorporateBonds_c20221231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedLossesMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Corporate bonds and notes"><span style="color: Black">(14,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">)</span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td id="xdx_986_ecustom--CorporateBonds_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--FairValueMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Corporate bonds and notes"><span style="color: Black">178,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-indent: 20pt; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"><span style="color: Black">Total marketable securities</span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98B_ecustom--OtherInvestment_c20221231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--CostBasisMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total marketable securities"><span style="color: Black">35,896,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98A_ecustom--OtherInvestment_c20221231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedGainsMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total marketable securities"><span style="color: Black">67,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98A_ecustom--OtherInvestment_c20221231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedLossesMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total marketable securities"><span style="color: Black">(972,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black">)</span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98A_ecustom--OtherInvestment_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--FairValueMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total marketable securities"><span style="color: Black">34,991,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-indent: 20pt; font-size: 12pt; padding-left: 5.4pt"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td></tr> </table> <p style="margin: 0"><span style="color: Black"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-bottom: 1pt; text-indent: 20pt; font-size: 12pt; text-align: justify"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black"> </span></td> <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">December 31, 2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-indent: 20pt; font-size: 12pt; text-align: justify"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 0.5pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>Cost<br/> Basis</b></span></p></td><td style="font-weight: bold"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 0.5pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>Gross<br/> Unrealized<br/> Gains</b></span></p></td><td style="font-weight: bold"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 0.5pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>Gross<br/> Unrealized<br/> Losses</b></span></p></td><td style="font-weight: bold"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 0.5pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>Fair Value</b></span></p></td><td style="font-weight: bold"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-indent: 20pt; width: 40%; text-align: left; padding-left: 5.4pt"><span style="color: Black">Fixed income mutual funds</span></td><td style="width: 3%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td id="xdx_985_ecustom--ShortTermBondFunds_c20211231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--CostBasisMember_pp0p0" style="width: 10%; text-align: right" title="Fixed income mutual funds"><span style="color: Black">14,462,000</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td style="width: 3%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td id="xdx_989_ecustom--ShortTermBondFunds_c20211231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedGainsMember_pp0p0" style="width: 10%; text-align: right" title="Fixed income mutual funds"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl1022">—</span></span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td style="width: 3%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td id="xdx_982_ecustom--ShortTermBondFunds_c20211231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedLossesMember_pp0p0" style="width: 10%; text-align: right" title="Fixed income mutual funds"><span style="color: Black">(137,000</span></td><td style="width: 1%; text-align: left"><span style="color: Black">)</span></td><td style="width: 3%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td id="xdx_988_ecustom--ShortTermBondFunds_c20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--FairValueMember_pp0p0" style="width: 10%; text-align: right" title="Fixed income mutual funds"><span style="color: Black">14,325,000</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-indent: 20pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="color: Black">Corporate bonds and notes</span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td id="xdx_988_ecustom--CorporateBonds_c20211231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--CostBasisMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Corporate bonds and notes"><span style="color: Black">813,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td id="xdx_985_ecustom--CorporateBonds_c20211231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedGainsMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Corporate bonds and notes"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl1030">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td id="xdx_989_ecustom--CorporateBonds_c20211231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedLossesMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Corporate bonds and notes"><span style="color: Black">(12,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">)</span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td id="xdx_987_ecustom--CorporateBonds_c20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--FairValueMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Corporate bonds and notes"><span style="color: Black">801,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-indent: 20pt; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"><span style="color: Black">Total marketable securities</span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98A_ecustom--OtherInvestment_c20211231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--CostBasisMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total marketable securities"><span style="color: Black">15,275,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98B_ecustom--OtherInvestment_c20211231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedGainsMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total marketable securities"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl1038">—</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="color: Black">$</span></td><td id="xdx_989_ecustom--OtherInvestment_c20211231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedLossesMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total marketable securities"><span style="color: Black">(149,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black">)</span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98B_ecustom--OtherInvestment_c20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--FairValueMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total marketable securities"><span style="color: Black">15,126,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td></tr> </table> <p id="xdx_8A7_ztCOdewZgHvb" style="margin-top: 0; margin-bottom: 0"><span style="color: Black"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--MarketableSecuritiesTextBlock_zmra6HxgjtD5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Marketable Securities (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-indent: 20pt; text-align: left; padding-left: 5.4pt"><span style="display: none"><span id="xdx_8BB_zP2ar2mabBch">Schedule of marketable securities</span></span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-bottom: 1pt; text-indent: 20pt; font-size: 12pt; text-align: justify"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black"> </span></td> <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">December 31, 2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-indent: 20pt; font-size: 12pt; text-align: justify"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 0.5pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>Cost<br/> Basis</b></span></p></td><td style="font-weight: bold"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 0.5pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>Gross<br/> Unrealized<br/> Gains</b></span></p></td><td style="font-weight: bold"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 0.5pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>Gross<br/> Unrealized<br/> Losses</b></span></p></td><td style="font-weight: bold"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 0.5pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>Fair Value</b></span></p></td><td style="font-weight: bold"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-indent: 20pt; width: 40%; text-align: left; padding-left: 5.4pt"><span style="color: Black">Government Securities</span></td><td style="width: 3%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td id="xdx_983_ecustom--GovernmentSecurities_c20221231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--CostBasisMember_pp0p0" style="width: 10%; text-align: right" title="Government securities"><span style="color: Black">20,781,000</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td style="width: 3%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td id="xdx_987_ecustom--GovernmentSecurities_c20221231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedGainsMember_pp0p0" style="width: 10%; text-align: right" title="Government securities"><span style="color: Black">67,000</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td style="width: 3%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td id="xdx_984_ecustom--GovernmentSecurities_c20221231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedLossesMember_pp0p0" style="width: 10%; text-align: right" title="Government securities"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0984">—</span></span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td style="width: 3%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td id="xdx_987_ecustom--GovernmentSecurities_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--FairValueMember_pp0p0" style="width: 10%; text-align: right" title="Government securities"><span style="color: Black">20,848,000</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-indent: 20pt; text-align: left; padding-left: 5.4pt"><span style="color: Black">Fixed income mutual funds</span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td id="xdx_984_ecustom--ShortTermBondFunds_c20221231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--CostBasisMember_pp0p0" style="text-align: right" title="Fixed income mutual funds"><span style="color: Black">11,904,000</span></td><td style="text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td id="xdx_988_ecustom--ShortTermBondFunds_c20221231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedGainsMember_pp0p0" style="text-align: right" title="Fixed income mutual funds"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0990">—</span></span></td><td style="text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td id="xdx_981_ecustom--ShortTermBondFunds_c20221231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedLossesMember_pp0p0" style="text-align: right" title="Fixed income mutual funds"><span style="color: Black">(915,000</span></td><td style="text-align: left"><span style="color: Black">)</span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td id="xdx_989_ecustom--ShortTermBondFunds_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--FairValueMember_pp0p0" style="text-align: right" title="Fixed income mutual funds"><span style="color: Black">10,989,000</span></td><td style="text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-indent: 20pt; padding-left: 5.4pt"><span style="color: Black">Certificates of Deposit</span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td id="xdx_98E_ecustom--CertificatesOfDeposit_c20221231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--CostBasisMember_pp0p0" style="text-align: right" title="Certificates of deposit"><span style="color: Black">3,019,000</span></td><td style="text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td id="xdx_98B_ecustom--CertificatesOfDeposit_c20221231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedGainsMember_pp0p0" style="text-align: right" title="Certificates of deposit"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0998">—</span></span></td><td style="text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td id="xdx_98B_ecustom--CertificatesOfDeposit_c20221231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedLossesMember_pp0p0" style="text-align: right" title="Certificates of deposit"><span style="color: Black">(43,000</span></td><td style="text-align: left"><span style="color: Black">)</span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td id="xdx_98B_ecustom--CertificatesOfDeposit_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--FairValueMember_pp0p0" style="text-align: right" title="Certificates of deposit"><span style="color: Black">2,976,000</span></td><td style="text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-indent: 20pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="color: Black">Corporate bonds and notes</span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td id="xdx_989_ecustom--CorporateBonds_c20221231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--CostBasisMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Corporate bonds and notes"><span style="color: Black">192,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td id="xdx_984_ecustom--CorporateBonds_c20221231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedGainsMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Corporate bonds and notes"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl1006">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td id="xdx_989_ecustom--CorporateBonds_c20221231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedLossesMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Corporate bonds and notes"><span style="color: Black">(14,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">)</span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td id="xdx_986_ecustom--CorporateBonds_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--FairValueMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Corporate bonds and notes"><span style="color: Black">178,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-indent: 20pt; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"><span style="color: Black">Total marketable securities</span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98B_ecustom--OtherInvestment_c20221231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--CostBasisMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total marketable securities"><span style="color: Black">35,896,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98A_ecustom--OtherInvestment_c20221231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedGainsMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total marketable securities"><span style="color: Black">67,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98A_ecustom--OtherInvestment_c20221231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedLossesMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total marketable securities"><span style="color: Black">(972,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black">)</span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98A_ecustom--OtherInvestment_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--FairValueMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total marketable securities"><span style="color: Black">34,991,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-indent: 20pt; font-size: 12pt; padding-left: 5.4pt"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td></tr> </table> <p style="margin: 0"><span style="color: Black"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-bottom: 1pt; text-indent: 20pt; font-size: 12pt; text-align: justify"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black"> </span></td> <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">December 31, 2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-indent: 20pt; font-size: 12pt; text-align: justify"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 0.5pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>Cost<br/> Basis</b></span></p></td><td style="font-weight: bold"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 0.5pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>Gross<br/> Unrealized<br/> Gains</b></span></p></td><td style="font-weight: bold"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 0.5pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>Gross<br/> Unrealized<br/> Losses</b></span></p></td><td style="font-weight: bold"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 0.5pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>Fair Value</b></span></p></td><td style="font-weight: bold"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-indent: 20pt; width: 40%; text-align: left; padding-left: 5.4pt"><span style="color: Black">Fixed income mutual funds</span></td><td style="width: 3%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td id="xdx_985_ecustom--ShortTermBondFunds_c20211231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--CostBasisMember_pp0p0" style="width: 10%; text-align: right" title="Fixed income mutual funds"><span style="color: Black">14,462,000</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td style="width: 3%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td id="xdx_989_ecustom--ShortTermBondFunds_c20211231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedGainsMember_pp0p0" style="width: 10%; text-align: right" title="Fixed income mutual funds"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl1022">—</span></span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td style="width: 3%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td id="xdx_982_ecustom--ShortTermBondFunds_c20211231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedLossesMember_pp0p0" style="width: 10%; text-align: right" title="Fixed income mutual funds"><span style="color: Black">(137,000</span></td><td style="width: 1%; text-align: left"><span style="color: Black">)</span></td><td style="width: 3%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td id="xdx_988_ecustom--ShortTermBondFunds_c20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--FairValueMember_pp0p0" style="width: 10%; text-align: right" title="Fixed income mutual funds"><span style="color: Black">14,325,000</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-indent: 20pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="color: Black">Corporate bonds and notes</span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td id="xdx_988_ecustom--CorporateBonds_c20211231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--CostBasisMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Corporate bonds and notes"><span style="color: Black">813,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td id="xdx_985_ecustom--CorporateBonds_c20211231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedGainsMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Corporate bonds and notes"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl1030">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td id="xdx_989_ecustom--CorporateBonds_c20211231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedLossesMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Corporate bonds and notes"><span style="color: Black">(12,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">)</span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td id="xdx_987_ecustom--CorporateBonds_c20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--FairValueMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Corporate bonds and notes"><span style="color: Black">801,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-indent: 20pt; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"><span style="color: Black">Total marketable securities</span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98A_ecustom--OtherInvestment_c20211231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--CostBasisMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total marketable securities"><span style="color: Black">15,275,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98B_ecustom--OtherInvestment_c20211231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedGainsMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total marketable securities"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl1038">—</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="color: Black">$</span></td><td id="xdx_989_ecustom--OtherInvestment_c20211231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedLossesMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total marketable securities"><span style="color: Black">(149,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black">)</span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98B_ecustom--OtherInvestment_c20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--FairValueMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total marketable securities"><span style="color: Black">15,126,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td></tr> </table> 20781000 67000 20848000 11904000 -915000 10989000 3019000 -43000 2976000 192000 -14000 178000 35896000 67000 -972000 34991000 14462000 -137000 14325000 813000 -12000 801000 15275000 -149000 15126000 <p id="xdx_808_eus-gaap--EquityMethodInvestmentsDisclosureTextBlock_zhvDLyrtcBy5" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-variant: small-caps; color: Black"><b>Note H – <span id="xdx_820_ziSqf4q7KUa2">Equity Investment</span></b></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">During the period December 2018 through December 2022, the Company made an aggregate investment of $<span id="xdx_90D_eus-gaap--Investments_iI_pp0p0_c20221231__dei--LegalEntityAxis__custom--ILiADBiotechnologiesLLCMember_zi5icM6ZJPRe" title="Aggregrate investment">7,000,000</span> in ILiAD, a privately held clinical stage biotechnology company dedicated to the prevention and treatment of human disease caused by Bordetella pertussis. ILiAD is focused on validating its proprietary intranasal vaccine, BPZE1, for the prevention of Pertussis (whooping cough). At December 31, 2022, the Company owned approximately <span id="xdx_901_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20221231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--IliadMember__us-gaap--DerivativeInstrumentRiskAxis__custom--ClassCUnitsMember_zEnWEwOzuFPj" title="Ownership percentage not fully diluted">6.8</span>% of the outstanding units of ILiAD on a non-fully diluted basis and <span id="xdx_90C_ecustom--OwnershipPercentageFullyDiluted_dp_c20220101__20221231__us-gaap--RelatedPartyTransactionAxis__custom--IliadMember_z9o8S2zTVkJk" title="Ownership percentage fully diluted">6.3</span>% of the outstanding units on a fully diluted basis (after giving effect to the exercise of all outstanding options and warrants). In connection with its investment, the Company’s Chairman and Chief Executive Officer obtained a seat on ILiAD’s Board of Managers and receives the same compensation for service on the Board of Managers as other non-management Board members.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">On August 24, 2022, ILiAD completed a private financing of $<span id="xdx_90D_eus-gaap--LineOfCredit_c20220824__dei--LegalEntityAxis__custom--ILiADBiotechnologiesLLCMember_pp0p0" title="Private financing - D units">42,836,000</span> of its Class D units, of which a multi-national pharmaceutical company invested $<span id="xdx_900_ecustom--InvestedAmount_c20220824__dei--LegalEntityAxis__custom--ILiADBiotechnologiesLLCMember_pp0p0" title="Invested amount - multi-national pharma">30,000,000</span> (the “Financing”). As part of the Financing, the Company invested $<span id="xdx_904_ecustom--AdditionalInvestedAmount_c20220824__dei--LegalEntityAxis__custom--ILiADBiotechnologiesLLCMember_pp0p0" title="Additional invested amount - D units">1,000,000</span>. This private financing represented an observable price transaction in accordance with ASC 323 and resulted in dilution in the Company’s ownership in the ILiAD. In accordance with ASC 323-10-40-1, the Company accounted for the dilution as if it had sold a portion of its investment and therefore recorded an unrealized gain of $<span id="xdx_909_eus-gaap--DebtSecuritiesUnrealizedGainLoss_c20220101__20221231_pp0p0" title="Unrealized gain securities">3,883,000</span> and a corresponding increase in the carrying value of its investment in ILiAD. The Company determined the new carrying value of its equity investment using an observable transaction price since the Company determined the securities owned by the Company were not materially different than the securities sold by ILiAD in the Financing. The unrealized gain is reflected in the Company’s consolidated statements of operations and comprehensive income (loss) for the year ended December 31, 2022.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">In addition, as part of the Financing, the Company converted its convertible note in the principal amount of $<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_c20221231_pp0p0" title="Principal amount - convertible note">1,000,000</span> plus accrued interest of $<span id="xdx_90A_eus-gaap--InterestPayableCurrent_c20221231_pp0p0" title="Accrued interest - convertible note">86,000</span>, in accordance with its terms, into equity of ILiAD and has accounted for this investment under the equity method of accounting. The Company recognized a gain on conversion of $<span id="xdx_90D_eus-gaap--GainsLossesOnExtinguishmentOfDebt_c20220101__20221231_pp0p0" title="Unrealized gain on conversion - convertible note">271,000</span> which was recognized in its consolidated statements of operations and comprehensive income (loss) for the year ended December 31, 2022.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">For the years ended December 31, 2022 and 2021, the Company recorded an allocated net loss from its equity method investment in ILiAD of $<span id="xdx_902_ecustom--EquityInvestmentNetLoss_c20220101__20221231__us-gaap--RelatedPartyTransactionAxis__custom--IliadMember_pp0p0" title="Equity investment net loss">1,639,000</span> and $<span id="xdx_900_ecustom--EquityInvestmentNetLoss_pp0p0_c20210101__20211231__us-gaap--RelatedPartyTransactionAxis__custom--IliadMember_z2eywZMAST7" title="Equity investment net loss">999,000</span>, respectively.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">The difference between the Company’s share of equity in ILiAD’s net assets and the purchase price of the investment is due to an excess amount paid over the book value of the investment of $<span id="xdx_90C_ecustom--BookValueOfInvestment_iI_pp0p0_c20221231__us-gaap--RelatedPartyTransactionAxis__custom--IliadMember_zHfpW3mR8uZc" title="Book value of investment">4,130,000</span>, which is accounted for as equity method goodwill.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">The Company performed an assessment to determine significance of its equity investee using the investment, asset and income tests. The Company concluded the income test threshold was met for the year ended December 31, 2022. The following table provides certain summarized financial information for the Company’s equity method investee for the periods presented and has been compiled from the equity investee’s financial statement, reported on one quarter lag.</span></p> <table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--EquityMethodInvestmentsTextBlock_zIgoVYCQfLJ7" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - Equity Investment (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 5.4pt"><span style="display: none"><span id="xdx_8BE_zQJd2vWhBRHe">Schedule of equity method investments</span></span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_499_20211001__20220930_zSY9IdAk6Kya" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49F_20201001__20210930_zluR9d3RJZAl" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; font-size: 12pt; text-align: justify"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">Twelve Months Ended September 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt; text-align: justify"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 0.5pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>2022</b></span></p></td><td style="font-weight: bold"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 0.5pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>2021</b></span></p></td><td style="font-weight: bold"><span style="color: Black"> </span></td></tr> <tr id="xdx_407_eus-gaap--IncomeLossFromEquityMethodInvestments_i_pp0p0" style="vertical-align: bottom"> <td style="width: 56%; text-align: left; padding-left: 5.4pt"><span style="color: Black">Loss from continuing operations</span></td><td style="width: 8%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td style="width: 12%; text-align: right"><span style="color: Black">15,246,000</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td style="width: 8%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td style="width: 12%; text-align: right"><span style="color: Black">11,133,000</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td></tr> <tr id="xdx_409_eus-gaap--ComprehensiveIncomeNetOfTax_i_pp0p0" style="vertical-align: bottom"> <td style="text-align: left; padding-left: 5.4pt"><span style="color: Black">Comprehensive loss</span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black">$</span></td><td style="text-align: right"><span style="color: Black">17,913,000</span></td><td style="text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black">$</span></td><td style="text-align: right"><span style="color: Black">10,384,000</span></td><td style="text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt; padding-left: 5.4pt"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td></tr> </table> <p id="xdx_8A3_zwMAZgVfzhJ1" style="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-variant: small-caps; color: Black"> </span></p> 7000000 0.068 0.063 42836000 30000000 1000000 3883000 1000000 86000 271000 1639000 999000 4130000 <table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--EquityMethodInvestmentsTextBlock_zIgoVYCQfLJ7" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - Equity Investment (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 5.4pt"><span style="display: none"><span id="xdx_8BE_zQJd2vWhBRHe">Schedule of equity method investments</span></span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_499_20211001__20220930_zSY9IdAk6Kya" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49F_20201001__20210930_zluR9d3RJZAl" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; font-size: 12pt; text-align: justify"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">Twelve Months Ended September 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt; text-align: justify"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 0.5pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>2022</b></span></p></td><td style="font-weight: bold"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 0.5pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>2021</b></span></p></td><td style="font-weight: bold"><span style="color: Black"> </span></td></tr> <tr id="xdx_407_eus-gaap--IncomeLossFromEquityMethodInvestments_i_pp0p0" style="vertical-align: bottom"> <td style="width: 56%; text-align: left; padding-left: 5.4pt"><span style="color: Black">Loss from continuing operations</span></td><td style="width: 8%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td style="width: 12%; text-align: right"><span style="color: Black">15,246,000</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td style="width: 8%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td style="width: 12%; text-align: right"><span style="color: Black">11,133,000</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td></tr> <tr id="xdx_409_eus-gaap--ComprehensiveIncomeNetOfTax_i_pp0p0" style="vertical-align: bottom"> <td style="text-align: left; padding-left: 5.4pt"><span style="color: Black">Comprehensive loss</span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black">$</span></td><td style="text-align: right"><span style="color: Black">17,913,000</span></td><td style="text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black">$</span></td><td style="text-align: right"><span style="color: Black">10,384,000</span></td><td style="text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt; padding-left: 5.4pt"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt"><span style="color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td></tr> </table> 15246000 11133000 17913000 10384000 <p id="xdx_803_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zvNPHbU1PKNe" style="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-variant: small-caps; color: Black">Note I – <span id="xdx_82D_ziaCcLAR1Jhd">Commitments and Contingencies</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>[1]</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Legal fees:</b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">Russ, August &amp; Kabat provides legal services to the Company with respect to its pending patent litigation filed in May 2017 against Facebook, Inc. in the U.S. District Court for the Southern District of New York relating to several patents within the Company’s Mirror Worlds Patent Portfolio (see Note K[2] hereof). The terms of the Company’s agreement with Russ, August &amp; Kabat provide for cash payments on a monthly basis subject to a cap plus a contingency fee ranging between 15% and 24% of the net recovery (after deduction of expenses) depending on the stage of the proceeding in which the result (settlement or judgment) is achieved. The Company is responsible for all expenses incurred with respect to this litigation.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">Russ, August &amp; Kabat also provides legal services to the Company with respect to its pending patent litigations filed in April 2014 and December 2014 against Google Inc. and YouTube, LLC in the U.S. District Court for the Southern District of New York relating to certain patents within the Cox Patent Portfolio acquired by the Company from Dr. Cox (see Note K[1] hereof). The terms of the Company’s agreement with Russ, August &amp; Kabat provide for legal fees on a full contingency basis ranging from 15% to 30% of the net recovery (after deduction of expenses) depending on the stage of the proceeding in which the result (settlement or judgment) is achieved. The Company is responsible for all expenses incurred with respect to this litigation.</span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>[2]</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Patent Acquisitions:</b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">On March 25, 2022, the Company completed the acquisition of a new patent portfolio (HFT Patent Portfolio) currently consisting of nine U.S. patents and two pending U.S. patents covering certain advanced technologies relating to high frequency trading, which inventions specifically address technological problems associated with speed and latency and provide critical latency gains in trading systems where the difference between success and failure may be measured in nanoseconds. The Company paid the seller $<span id="xdx_90F_ecustom--HftPatentAcqusitionCashAtClosing_c20220301__20220325_pp0p0" title="HFT patent acqusition - cash at closing">500,000</span> at the closing and has an obligation to pay the seller an additional $<span id="xdx_90E_ecustom--ObligationToPayHftSellerAdditionalCashBasedOnAchievingCertainMilestones_c20220301__20220325_pp0p0" title="Obligation to pay HFT seller additional cash based on achieving certain milestones">500,000</span> in cash and $<span id="xdx_90E_ecustom--ContingentCommonStockIssuedUponAchievingCertainMilestones_c20220301__20220325_pp0p0" title="Contingent common stock issued upon achieving certain milestones">375,000</span> of the Company’s common stock (up to a maximum of 375,000 shares) upon achieving certain milestones with respect to the HFT Patent Portfolio. The Company also has an additional obligation to pay the seller <span id="xdx_908_ecustom--First50Million_dp_c20220301__20220325_zWCu5IqXrofe" title="First $50 million of HFT net proceeds">15</span>% of the first $50 million of net proceeds (after deduction of expenses) generated by the patent portfolio and <span id="xdx_908_ecustom--GreaterThan50Million_dp_c20220301__20220325_zDClGBYQkw11" title="Greater than $50 million of HFT net proceeds">17.5</span>% of net proceeds greater than $50 million.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">In connection with the Company’s acquisition of its Cox Patent Portfolio, the Company is obligated to pay Dr. Cox <span id="xdx_90C_ecustom--ObligatedToPaySellerNetProceedPercentage_iI_dp_c20221231_zN9pPbnbPZP9" title="Obligated to pay Cox, net proceeds percentage">12.5</span>% of the net proceeds (after deduction of expenses) generated by the Company from licensing, sale or enforcement of the patent portfolio. As of the years ended December 31, 2022, and 2021, <span id="xdx_903_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_pp0p0_do_c20221231__us-gaap--BusinessAcquisitionAxis__custom--CoxPatentPortfolioMember_zPACc9R5qkQ7" title="Accrued expenses"><span id="xdx_903_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_pp0p0_do_c20211231__us-gaap--BusinessAcquisitionAxis__custom--CoxPatentPortfolioMember_zSOPPC9hZAe6" title="Accrued expenses">no</span></span> expense was incurred with respect to the Cox Patent Portfolio. As of December 31, 2022 and 2021, no amounts were accrued with respect to the Cox Patent Portfolio.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">As part of the acquisition of the Mirror Worlds Patent Portfolio, the Company also entered into an agreement with Recognition Interface, LLC (“Recognition”) pursuant to which Recognition received from the Company an interest in the net proceeds realized from the monetization of the Mirror Worlds Patent Portfolio, as follows: <span id="xdx_907_ecustom--ObligatedToPayRecognitionNetProceedsAbstract_iB_c20220101__20221231_zHkyi6Lb4tZe" style="display: none" title="Obligated to pay Recognition, net proceeds">Obligated to pay recognition, net proceeds</span> (i) <span id="xdx_909_ecustom--First125Million_iI_dp_c20221231_ziEsxXFyPCkh" title="First $125 Million">10</span>% of the first $125 million of net proceeds; (ii) <span id="xdx_906_ecustom--Next125Million_iI_dp_c20221231_z2LO3zgmhFpd" title="Next $125 Million">15</span>% of the next $125 million of net proceeds; and (iii) <span id="xdx_90F_ecustom--Over250Million_iI_dp_c20221231_ztE0m3xsGGO7" title="Over $250 Million">20</span>% of any portion of the net proceeds in excess of $250 million. Since entering into the agreement with Recognition in May 2013, the Company has paid Recognition an aggregate of $<span id="xdx_907_ecustom--RecognitionNetProceedsPaymentRelatedToMirrorWorldsPatents_pp0p0_c20130501__20211231_zjbYjumsCjo6" title="Recognition net proceeds payment related to Mirror Worlds patents">3,127,000</span> with respect to such net proceeds interest related to the Mirror Worlds Patent Portfolio. No such payments were made by the Company to Recognition during the year ended December 31, 2022 and 2021.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">In connection with the Company’s acquisition of its M2M/IoT Patent Portfolio, the Company is <span id="xdx_900_ecustom--ObligatedToPayMtmAbstract_iB_c20220101__20221231_zXKUJi9Qkk3l" title="Obligated to pay MTM">obligated to pay M2M</span> <span id="xdx_902_ecustom--First100_iI_dp_c20221231_zJsuTfrVEAo1" title="First $100 Million">14</span>% of the first $100 million of net proceeds (after deduction of expenses) and <span id="xdx_90C_ecustom--Next100_iI_dp_c20221231_z4REyKl2ZwEc" title="Next $100 Million">5</span>% of net proceeds greater than $100 million from Monetization Activities (as defined in the acquisition agreement) related to the M2MIoT Patent Portfolio. In addition, M2M will be entitled to receive from the Company $<span id="xdx_90D_ecustom--AadditionalConsideration_c20221231_pp0p0" title="Additional consideration payable upon occurrence of certain future events">250,000</span> of additional consideration upon the occurrence of certain future events related to the patent portfolio.</span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>[3]</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Savings and investment plan:</b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">The Company has a Savings and Investment Plan which allows participants to make contributions by salary reduction pursuant to Section 401(k) of the Internal Revenue Code of 1986. The Company also may make discretionary annual matching contributions and profit sharing in amounts determined by the Board of Directors, subject to statutory limits. The 401(k) Plan expense for the years ended December 31, 2022 and 2021 was $<span id="xdx_900_eus-gaap--StockOptionPlanExpense_c20220101__20221231_pp0p0" title="Plan expense">78,000</span> and $<span id="xdx_902_eus-gaap--StockOptionPlanExpense_c20210101__20211231_pp0p0" title="Plan expense">102,000</span>, respectively, all of which was accrued as of December 31, 2022 and 2021 and is recorded within accrued expenses on the Company’s consolidated balance sheets.</span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0; text-align: left"><span style="font: small-caps 10pt Times New Roman, Times, Serif; color: Black"><b>[4]</b></span></td><td style="width: 14pt"/><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Leases:</b></span></td> </tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.35in"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in"><span style="font-family: Times New Roman, Times, Serif; color: Black">The Company has one operating lease for its principal office space in New Canaan, Connecticut that will expire on April 30, 2025.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in"><span style="font-family: Times New Roman, Times, Serif; color: Black">There are no material residual guarantees associated with the Company’s lease and there are no significant restrictions or covenants included in the Company’s lease.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in"><span style="font-family: Times New Roman, Times, Serif; color: Black">The calculated incremental borrowing rate was approximately <span id="xdx_902_eus-gaap--LesseeOperatingLeaseDiscountRate_iI_dp_c20220501_zlNcBNRDqaG7" title="Borrowing rate - incremental">4.2</span>%, which was calculated based on remaining lease term of <span id="xdx_906_eus-gaap--LesseeOperatingLeaseRemainingLeaseTerm_iI_dtY_c20220501_zsBzD1rFfrOi" title="Remaining lease term">3</span> years as of May 1, 2022. The remaining lease term as of December 31, 2022 was approximately <span id="xdx_906_eus-gaap--LesseeOperatingLeaseRemainingLeaseTerm_iI_dtY_c20221231_zt8YcqFHP8ue" title="Remaining lease term">2.3</span> years.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in"><span style="font-family: Times New Roman, Times, Serif; color: Black">There was no sublease rental income for the year ended December 31, 2022, and the Company is not the lessor in any lease arrangement, and there were no related-party lease agreements.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in"><span style="font-family: Times New Roman, Times, Serif; color: Black">Right-of-use lease assets and related lease obligations for the Company’s operating leases were recorded in the consolidated balance sheet as follows: </span></p> <table cellpadding="0" cellspacing="2" id="xdx_895_ecustom--OperatingLeasesTableTextBlock_zC8t3In6vK0a" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto" summary="xdx: Disclosure - Commitments And Contingencies (Details)"> <tr style="vertical-align: bottom"> <td style="font-size: 12pt; text-align: justify; padding-left: 0.35in"><span style="font-size: 10pt; color: Black"> <span id="xdx_8B1_zfto4vPi0shd" style="display: none">Schedule of operating leases obligations</span></span></td><td style="font-size: 12pt"><span style="font-size: 10pt; color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td id="xdx_495_20221231_zLiIufVqGNw9" style="font-size: 12pt; text-align: right"><span style="font-size: 10pt; color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td style="font-size: 12pt"><span style="font-size: 10pt; color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td id="xdx_49B_20211231_zEZVsQ3VP4r" style="font-size: 12pt; text-align: right"><span style="font-size: 10pt; color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt; text-align: justify"><span style="font-size: 10pt; color: Black"> </span></td><td style="font-weight: bold"><span style="font-size: 10pt; color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-size: 10pt; color: Black">As of</span></td><td style="font-weight: bold"><span style="font-size: 10pt; color: Black"> </span></td><td style="font-weight: bold"><span style="font-size: 10pt; color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-size: 10pt; color: Black">As of</span></td><td style="font-weight: bold"><span style="font-size: 10pt; color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt; text-align: justify"><span style="font-size: 10pt; color: Black"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt; color: Black"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt; color: Black">December 31, 2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 10pt; color: Black"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt; color: Black"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt; color: Black">December 31, 2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 10pt; color: Black"> </span></td></tr> <tr id="xdx_40E_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0" style="vertical-align: bottom"> <td style="width: 56%; text-align: justify; padding-left: 0.35in"><span style="font-size: 10pt; color: Black">Operating lease right-of-use assets</span></td><td style="width: 8%"><span style="font-size: 10pt; color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt; color: Black">$</span></td><td style="width: 12%; text-align: right"><span style="font-size: 10pt; color: Black">161,000</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td style="width: 8%"><span style="font-size: 10pt; color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt; color: Black">$</span></td><td style="width: 12%; text-align: right"><span style="font-size: 10pt; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl1149">—</span></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt; text-align: justify; padding-left: 0.35in"><span style="font-size: 10pt; color: Black"> </span></td><td style="font-size: 12pt"><span style="font-size: 10pt; color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="font-size: 10pt; color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td style="font-size: 12pt"><span style="font-size: 10pt; color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="font-size: 10pt; color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td></tr> <tr id="xdx_405_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pp0p0_maOLLzQnk_z6IbrXAmByUb" style="vertical-align: bottom"> <td style="text-align: justify; padding-left: 0.35in"><span style="font-size: 10pt; color: Black">Operating lease obligations – current</span></td><td><span style="font-size: 10pt; color: Black"> </span></td> <td style="text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td style="text-align: right"><span style="font-size: 10pt; color: Black">79,000</span></td><td style="text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td><span style="font-size: 10pt; color: Black"> </span></td> <td style="text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td style="text-align: right"><span style="font-size: 10pt; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl1152">—</span></span></td><td style="text-align: left"><span style="font-size: 10pt; color: Black"> </span></td></tr> <tr id="xdx_40D_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0_maOLLzQnk_zuvjMnWDJYp1" style="vertical-align: bottom"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.35in"><span style="font-size: 10pt; color: Black">Operating lease obligations – non-current</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; color: Black">94,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl1155">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td></tr> <tr id="xdx_407_eus-gaap--OperatingLeaseLiability_iTI_pp0p0_mtOLLzQnk_zxIysIMEAbdi" style="vertical-align: bottom"> <td style="text-align: justify; padding-bottom: 2.5pt; padding-left: 0.35in"><span style="font-size: 10pt; color: Black">Total lease obligations</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; color: Black">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; color: Black">173,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; color: Black">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl1158">—</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td></tr> </table> <p id="xdx_8AC_zlO1rhtemFxc" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; color: Black"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in"><span style="font-family: Times New Roman, Times, Serif; color: Black">The table below presents certain information related to the Company’s lease costs for the year ended December 31, 2022 and 2021:</span></p> <table cellpadding="0" cellspacing="2" id="xdx_896_eus-gaap--LeaseCostTableTextBlock_z4DRZqpw5gC" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto" summary="xdx: Disclosure - Commitments And Contingencies (Details 1)"> <tr style="vertical-align: bottom"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.35in"><span id="xdx_8BF_z9ZY4p8NfWkh" style="display: none">Schedule of leases cost</span></td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_490_20220101_20221231" style="text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_49F_20210101_20211231" style="text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"><span style="color: Black"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="color: Black"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">For the Year Ended<br/> December 31,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 0.5pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>2022</b></span></p></td><td style="font-weight: bold"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 0.5pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>2021</b></span></p></td><td style="font-weight: bold"><span style="color: Black"> </span></td></tr> <tr id="xdx_407_eus-gaap--OperatingLeaseCost_maLCzI14_z5BaqCVGLQc5" style="vertical-align: bottom"> <td style="width: 56%; text-align: justify; padding-left: 0.35in"><span style="color: Black">Operating lease cost</span></td><td style="width: 8%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td style="width: 12%; text-align: right"><span style="color: Black">48,000</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td style="width: 8%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td style="width: 12%; text-align: right"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl1163">—</span></span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td></tr> <tr id="xdx_402_eus-gaap--ShortTermLeaseCost_maLCzI14_z3zeixQ1WzNe" style="vertical-align: bottom"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.35in"><span style="color: Black">Short-term lease cost</span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="color: Black">82,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="color: Black">128,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr id="xdx_405_eus-gaap--LeaseCost_iT_pp0p0_mtLCzI14_zxWyITMp3oBg" style="vertical-align: bottom"> <td style="text-align: justify; padding-bottom: 2.5pt; padding-left: 0.35in"><span style="color: Black">Total lease cost</span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="color: Black">130,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="color: Black">128,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td></tr> </table> <p id="xdx_8A0_zd1iY06m7r7l" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in"><span style="font-family: Times New Roman, Times, Serif; color: Black">Future lease payments included in the measurement of lease liabilities on the consolidated balance sheet as of December 31, 2022, were as follows:</span></p> <table cellpadding="0" cellspacing="3" id="xdx_891_eus-gaap--LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock_zj86gvOOiwK2" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto" summary="xdx: Disclosure - Commitments And Contingencies (Details 2)"> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="text-align: left"><span id="xdx_8BE_zFXZaefiqoik" style="display: none">Schedule of future minimum leases payments</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt; font-size: 12pt"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="color: Black"><b>Operating Leases</b></span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td style="width: 43%; text-align: left"><span style="color: Black">2023</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td style="width: 19%"><span style="color: Black"> </span></td> <td style="width: 2%; text-align: left"><span style="color: Black"> </span></td><td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_c20221231_z186ayeh6l2b" style="width: 33%; text-align: right" title="2023"><span style="color: Black">83,000</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="color: Black"> </span></td><td style="text-align: left"><span style="color: Black">2024</span></td><td style="text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td id="xdx_981_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_c20221231_zDYUCd0w3mq9" style="text-align: right" title="2024"><span style="color: Black">73,000</span></td><td style="text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">2025</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td id="xdx_983_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_c20221231_z3r4uizqIQVh" style="border-bottom: Black 1pt solid; text-align: right" title="2025"><span style="color: Black">24,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="color: Black"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Total future minimum lease payments</span></td><td style="text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td id="xdx_987_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_c20221231_zBDbwyaXlGPa" style="text-align: right" title="Total future minimum lease payments"><span style="color: Black">180,000</span></td><td style="text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Less imputed interest</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td id="xdx_981_ecustom--OperatingLeasesImputedInterest_iI_c20221231_zJsaR4kiUam8" style="border-bottom: Black 1pt solid; text-align: right" title="Less imputed interest"><span style="color: Black">(7,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Total operating lease liability</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98F_eus-gaap--OperatingLeaseLiability_iI_c20221231_zfb5OLuGIYr9" style="border-bottom: Black 2.5pt double; text-align: right" title="Total operating lease liability"><span style="color: Black">173,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td></tr> </table> <p id="xdx_8AB_zvZIMx6YPVv" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"> </span></p> 500000 500000 375000 0.15 0.175 0.125 0 0 0.10 0.15 0.20 3127000 0.14 0.05 250000 78000 102000 0.042 P3Y P2Y3M18D <table cellpadding="0" cellspacing="2" id="xdx_895_ecustom--OperatingLeasesTableTextBlock_zC8t3In6vK0a" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto" summary="xdx: Disclosure - Commitments And Contingencies (Details)"> <tr style="vertical-align: bottom"> <td style="font-size: 12pt; text-align: justify; padding-left: 0.35in"><span style="font-size: 10pt; color: Black"> <span id="xdx_8B1_zfto4vPi0shd" style="display: none">Schedule of operating leases obligations</span></span></td><td style="font-size: 12pt"><span style="font-size: 10pt; color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td id="xdx_495_20221231_zLiIufVqGNw9" style="font-size: 12pt; text-align: right"><span style="font-size: 10pt; color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td style="font-size: 12pt"><span style="font-size: 10pt; color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td id="xdx_49B_20211231_zEZVsQ3VP4r" style="font-size: 12pt; text-align: right"><span style="font-size: 10pt; color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt; text-align: justify"><span style="font-size: 10pt; color: Black"> </span></td><td style="font-weight: bold"><span style="font-size: 10pt; color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-size: 10pt; color: Black">As of</span></td><td style="font-weight: bold"><span style="font-size: 10pt; color: Black"> </span></td><td style="font-weight: bold"><span style="font-size: 10pt; color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-size: 10pt; color: Black">As of</span></td><td style="font-weight: bold"><span style="font-size: 10pt; color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt; text-align: justify"><span style="font-size: 10pt; color: Black"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt; color: Black"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt; color: Black">December 31, 2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 10pt; color: Black"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt; color: Black"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt; color: Black">December 31, 2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 10pt; color: Black"> </span></td></tr> <tr id="xdx_40E_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0" style="vertical-align: bottom"> <td style="width: 56%; text-align: justify; padding-left: 0.35in"><span style="font-size: 10pt; color: Black">Operating lease right-of-use assets</span></td><td style="width: 8%"><span style="font-size: 10pt; color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt; color: Black">$</span></td><td style="width: 12%; text-align: right"><span style="font-size: 10pt; color: Black">161,000</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td style="width: 8%"><span style="font-size: 10pt; color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt; color: Black">$</span></td><td style="width: 12%; text-align: right"><span style="font-size: 10pt; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl1149">—</span></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt; text-align: justify; padding-left: 0.35in"><span style="font-size: 10pt; color: Black"> </span></td><td style="font-size: 12pt"><span style="font-size: 10pt; color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="font-size: 10pt; color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td style="font-size: 12pt"><span style="font-size: 10pt; color: Black"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td style="font-size: 12pt; text-align: right"><span style="font-size: 10pt; color: Black"> </span></td><td style="font-size: 12pt; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td></tr> <tr id="xdx_405_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pp0p0_maOLLzQnk_z6IbrXAmByUb" style="vertical-align: bottom"> <td style="text-align: justify; padding-left: 0.35in"><span style="font-size: 10pt; color: Black">Operating lease obligations – current</span></td><td><span style="font-size: 10pt; color: Black"> </span></td> <td style="text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td style="text-align: right"><span style="font-size: 10pt; color: Black">79,000</span></td><td style="text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td><span style="font-size: 10pt; color: Black"> </span></td> <td style="text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td style="text-align: right"><span style="font-size: 10pt; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl1152">—</span></span></td><td style="text-align: left"><span style="font-size: 10pt; color: Black"> </span></td></tr> <tr id="xdx_40D_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0_maOLLzQnk_zuvjMnWDJYp1" style="vertical-align: bottom"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.35in"><span style="font-size: 10pt; color: Black">Operating lease obligations – non-current</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; color: Black">94,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt; color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl1155">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td></tr> <tr id="xdx_407_eus-gaap--OperatingLeaseLiability_iTI_pp0p0_mtOLLzQnk_zxIysIMEAbdi" style="vertical-align: bottom"> <td style="text-align: justify; padding-bottom: 2.5pt; padding-left: 0.35in"><span style="font-size: 10pt; color: Black">Total lease obligations</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; color: Black">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; color: Black">173,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt; color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt; color: Black">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl1158">—</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt; color: Black"> </span></td></tr> </table> 161000 79000 94000 173000 <table cellpadding="0" cellspacing="2" id="xdx_896_eus-gaap--LeaseCostTableTextBlock_z4DRZqpw5gC" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto" summary="xdx: Disclosure - Commitments And Contingencies (Details 1)"> <tr style="vertical-align: bottom"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.35in"><span id="xdx_8BF_z9ZY4p8NfWkh" style="display: none">Schedule of leases cost</span></td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_490_20220101_20221231" style="text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_49F_20210101_20211231" style="text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"><span style="color: Black"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="color: Black"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="color: Black">For the Year Ended<br/> December 31,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 0.5pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>2022</b></span></p></td><td style="font-weight: bold"><span style="color: Black"> </span></td><td style="font-weight: bold"><span style="color: Black"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 0.5pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>2021</b></span></p></td><td style="font-weight: bold"><span style="color: Black"> </span></td></tr> <tr id="xdx_407_eus-gaap--OperatingLeaseCost_maLCzI14_z5BaqCVGLQc5" style="vertical-align: bottom"> <td style="width: 56%; text-align: justify; padding-left: 0.35in"><span style="color: Black">Operating lease cost</span></td><td style="width: 8%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td style="width: 12%; text-align: right"><span style="color: Black">48,000</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td style="width: 8%"><span style="color: Black"> </span></td> <td style="width: 1%; text-align: left"><span style="color: Black">$</span></td><td style="width: 12%; text-align: right"><span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl1163">—</span></span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td></tr> <tr id="xdx_402_eus-gaap--ShortTermLeaseCost_maLCzI14_z3zeixQ1WzNe" style="vertical-align: bottom"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.35in"><span style="color: Black">Short-term lease cost</span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="color: Black">82,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="color: Black">128,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr id="xdx_405_eus-gaap--LeaseCost_iT_pp0p0_mtLCzI14_zxWyITMp3oBg" style="vertical-align: bottom"> <td style="text-align: justify; padding-bottom: 2.5pt; padding-left: 0.35in"><span style="color: Black">Total lease cost</span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="color: Black">130,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="color: Black">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="color: Black">128,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td></tr> </table> 48000 82000 128000 130000 128000 <table cellpadding="0" cellspacing="3" id="xdx_891_eus-gaap--LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock_zj86gvOOiwK2" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto" summary="xdx: Disclosure - Commitments And Contingencies (Details 2)"> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="text-align: left"><span id="xdx_8BE_zFXZaefiqoik" style="display: none">Schedule of future minimum leases payments</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-size: 12pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt; font-size: 12pt"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="color: Black"><b>Operating Leases</b></span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td style="width: 43%; text-align: left"><span style="color: Black">2023</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td><td style="width: 19%"><span style="color: Black"> </span></td> <td style="width: 2%; text-align: left"><span style="color: Black"> </span></td><td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_c20221231_z186ayeh6l2b" style="width: 33%; text-align: right" title="2023"><span style="color: Black">83,000</span></td><td style="width: 1%; text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="color: Black"> </span></td><td style="text-align: left"><span style="color: Black">2024</span></td><td style="text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td id="xdx_981_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_c20221231_zDYUCd0w3mq9" style="text-align: right" title="2024"><span style="color: Black">73,000</span></td><td style="text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">2025</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td id="xdx_983_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_c20221231_z3r4uizqIQVh" style="border-bottom: Black 1pt solid; text-align: right" title="2025"><span style="color: Black">24,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="color: Black"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Total future minimum lease payments</span></td><td style="text-align: left"><span style="color: Black"> </span></td><td><span style="color: Black"> </span></td> <td style="text-align: left"><span style="color: Black"> </span></td><td id="xdx_987_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_c20221231_zBDbwyaXlGPa" style="text-align: right" title="Total future minimum lease payments"><span style="color: Black">180,000</span></td><td style="text-align: left"><span style="color: Black"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Less imputed interest</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 1pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="color: Black"> </span></td><td id="xdx_981_ecustom--OperatingLeasesImputedInterest_iI_c20221231_zJsaR4kiUam8" style="border-bottom: Black 1pt solid; text-align: right" title="Less imputed interest"><span style="color: Black">(7,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="color: Black">)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Total operating lease liability</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td><td style="padding-bottom: 2.5pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98F_eus-gaap--OperatingLeaseLiability_iI_c20221231_zfb5OLuGIYr9" style="border-bottom: Black 2.5pt double; text-align: right" title="Total operating lease liability"><span style="color: Black">173,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="color: Black"> </span></td></tr> </table> 83000 73000 24000 180000 -7000 173000 <p id="xdx_80A_ecustom--EmploymentArrangementsAndOtherAgreementsTextBlock_z52sEKOSdXrg" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-variant: small-caps; color: Black"><b>Note J - <span id="xdx_825_zXyOb3WND5Uf">Employment Arrangements and Other Agreements</span></b></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>[1] </b>On March 22, 2022, the Company entered into a new employment agreement (“Agreement”) with its Chairman and Chief Executive Officer, pursuant to which he continues to serve as the Company’s Chairman and Chief Executive Officer for a four-year term (“Term”), at an annual base salary of $<span id="xdx_903_eus-gaap--SalariesWagesAndOfficersCompensation_c20220301__20220322__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--PlanNameAxis__custom--NewEmploymentAgreementMember_pp0p0" title="Annual base salary">535,000</span> which shall be increased by 3% per annum during the Term. The Agreement established an annual target bonus of $<span id="xdx_905_ecustom--AnnualTargetBonus_c20220301__20220322__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--PlanNameAxis__custom--NewEmploymentAgreementMember_pp0p0" title="Annual Target Bonus">175,000</span> for the Chairman and Chief Executive Officer based upon performance. For the year ended December 31, 2022 and 2021, the Chairman and Chief Executive Officer received an annual discretionary bonus of $<span id="xdx_90E_ecustom--AnnualDiscretionaryBonus_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_pp0p0" title="Annual discretionary bonus"><span id="xdx_90C_ecustom--AnnualDiscretionaryBonus_c20210101__20211231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_pp0p0" title="Annual discretionary bonus">175,000</span></span>.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">In addition, pursuant to the Agreement, the Company granted the Chairman and Chief Executive Officer, under its 2013 Plan, <span id="xdx_903_ecustom--RestrictedStockUnitsGranted_c20220301__20220322__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_pdd" title="Restricted stock units granted">600,000</span> restricted stock units (the “RSUs”, each RSU awarded by the Company to its officers, directors and consultants represents a contingent right to receive one share of the Company’s common stock) which terms provided for vesting in four tranches, as follows: (1) <span id="xdx_902_ecustom--RestrictedStockUnitsTranche1_c20220301__20220322__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_pdd" title="Restricted stock units Tranche 1">175,000</span> RSUs which shall vest <span id="xdx_902_ecustom--RestrictedStockUnitsToVestTranche1_c20230301__20230322__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zFGD1yAZutk5" title="Restricted stock units to vest (Tranche 1)">100,000</span> RSUs on March 22, 2023 and <span id="xdx_903_ecustom--RestrictedStockUnitsToVestTranche1_c20240301__20240322__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_pdd" title="Restricted Stock Units to vest (Tranche 1)">75,000</span> RSUs on March 22, 2024, subject to the Chairman and Chief Executive Officer’s continued employment by the Company through each such vesting date (the “Employment Condition”) (“Tranche 1”); (2) <span id="xdx_902_ecustom--RestrictedStockUnitsToVestTranche2_c20220301__20220322__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheTwoMember_zZ96iKAZjh2l" title="Restricted stock units to vest (Tranche 2)">150,000</span> RSUs shall vest if at any time during the Term that the Company’s common stock achieves a closing price for twenty (20) consecutive trading days (“Closing Price”) of a minimum of $<span id="xdx_903_ecustom--MinimumStockPriceForVesting_c20220301__20220322__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheTwoMember_pdd" title="Minimum stock price for vesting">3.50</span> per share (subject to adjustment for stock splits) and the Employment Condition is satisfied through the date such minimum per share Closing Price is achieved (“Tranche 2”); (3) <span id="xdx_907_ecustom--RestrictedStockUnitsToVestTranche3_c20220301__20220322__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheThreeMember_zJ4oNPxV8Gm3" title="Restricted stock units to vest (Tranche 3)">150,000</span> RSUs shall vest if at any time during the Term that the common stock achieves a Closing Price of a minimum of $<span id="xdx_904_ecustom--MinimumStockPriceForVesting_c20220301__20220322__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheThreeMember_pdd" title="Minimum stock price for vesting">4.00</span> per share (subject to adjustment for stock splits) and the Employment Condition is satisfied through the date such minimum per share Closing Price is achieved (“Tranche 3”); and (4) <span id="xdx_907_ecustom--RestrictedStockUnitsToVestTranche4_c20220301__20220322__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheFourMember_zZBIFxQKMpKk" title="Restricted stock units to vest (Tranche 4)">125,000</span> RSUs shall vest if at any time during the Term, that the common stock achieves a Closing Price of a minimum of $<span id="xdx_90B_ecustom--MinimumStockPriceForVesting_c20220301__20220322__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheFourMember_pdd" title="Minimum stock price for vesting">4.50</span> per share (subject to adjustment for stock splits) and the Employment Condition is satisfied through the date such minimum per share Closing Price is achieved (“Tranche 4”). In the event of a Change of Control (as defined), Termination Other Than for Cause (as defined) or a termination by the Chairman and Chief Executive Officer for Good Reason (as defined) in each case prior to the last day of the Term, the vesting of all RSUs (Tranches 1, 2, 3 and 4) shall accelerate (and not be subject to any conditions) and all RSUs shall become immediately fully vested. All RSUs granted by the Company to its officers, directors or consultants have dividend equivalent rights.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">Under the terms of the Agreement, so long as the Chairman and Chief Executive Officer continues to serve as an executive officer of the Company, whether pursuant to the Agreement or otherwise, the Chairman and Chief Executive Officer shall also receive incentive compensation in an amount equal to 5% of the Company’s gross royalties or other payments from Licensing Activities (as defined) (without deduction of legal fees or any other expenses) with respect to the Remote Power Patent and a 10% net interest (gross royalties and other payments after deduction of all legal fees and litigation expenses related to licensing, enforcement and sale activities, but in no event shall he receive less than 6.25% of the gross recovery) of the Company’s royalties and other payments relating to Licensing Activities with respect to patents other than the Remote Power Patent (including all of the Company’s patent portfolios and its investment in ILiAD) (collectively, the “Incentive Compensation”). During the year ended December 31, 2022 and 2021, the Chairman and Chief Executive Officer earned Incentive Compensation of $-<span id="xdx_90D_eus-gaap--SalariesAndWages_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_pp0p0" title="CEO Incentive Compensation">0</span>- and $<span id="xdx_90F_eus-gaap--SalariesAndWages_c20210101__20211231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_pp0p0" title="CEO Incentive Compensation">1,801,000</span>, respectively.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">The Incentive Compensation shall continue to be paid to the Chairman and Chief Executive Officer for the life of each of the Company’s patents with respect to licenses entered into with third parties during the term of his employment or at anytime thereafter, whether he is employed by the Company or not; provided, that, the employment of the Chairman and Chief Executive Officer has not been terminated by the Company “For Cause” (as defined) or terminated by him without “Good Reason” (as defined). In the event of a merger or sale of substantially all of the Company’s assets, the Company has the option to extinguish the right of the Chairman and Chief Executive Officer to receive future Incentive Compensation by payment to him of a lump sum payment, in an amount equal to the fair market value of such future interest as determined by an independent third party expert if the parties do not reach agreement as to such value. In the event that the Chairman and Chief Executive Officer’s employment is terminated by the Company “Other Than For Cause” (as defined) or by him for “Good Reason” (as defined), the Chairman and Chief Executive Officer shall also be entitled to (i) a lump sum severance payment of 12 months base salary, (ii) a pro-rated portion of the $<span id="xdx_90D_ecustom--ProratedTargetBonus_c20220301__20220322__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--PlanNameAxis__custom--NewEmploymentAgreementMember_pp0p0" title="Prorated target bonus">175,000</span> target bonus provided bonus criteria have been satisfied on a pro-rated basis through the calendar quarter in which the termination occurs and (iii) accelerated vesting of all unvested options, RSUs or other awards.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">In connection with the Agreement, the Chairman and Chief Executive Officer has also agreed not to compete with the Company as follows: (i) during the Term of the Agreement and for a period of 12 months thereafter if his employment is terminated “Other Than For Cause” (as defined) provided he is paid his 12 months base salary severance amount and (ii) for a period of two years from the termination date, if terminated “For Cause” by the Company or “Without Good Reason” by the Chairman and Chief Executive Officer.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>[2] </b>The Company’s Executive Vice President serves on an at-will basis at an annual base salary of $200,000. The Executive Vice President received a discretionary annual bonus of $<span id="xdx_900_ecustom--AnnualDiscretionaryBonus_c20220101__20221231__srt--TitleOfIndividualAxis__srt--VicePresidentMember_pp0p0" title="Annual discretionary bonus">25,000</span> and $<span id="xdx_901_ecustom--AnnualDiscretionaryBonus_c20210101__20211231__srt--TitleOfIndividualAxis__srt--VicePresidentMember_pp0p0" title="Annual discretionary bonus">40,000</span> for the year ended December 31, 2022 and 2021, respectively. On January 18, 2022, the Company’s Executive Vice President was granted 15,000 RSUs under the 2013 Plan, 50% of such RSUs vested on the one year anniversary of the date of grant (January 18, 2023) and 50% of such RSUs vest on the two year anniversary of the grant (January 18, 2024), subject to continued employment. On January 24, 2023, the Company’s Executive Vice President was granted 15,000 RSUs under the 2022 Plan, 50% of such RSUs vest on the one year anniversary of the date of grant (January 24, 2024) and 50% of such RSUs vest on the two year anniversary of the date of grant (January 24, 2025), subject to continued employment.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>[3] </b>The Company’s former Chief Financial Officer served on an at-will basis at an annual base salary of $<span id="xdx_90B_eus-gaap--SalariesWagesAndOfficersCompensation_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_pp0p0" title="Annual base salary">175,000</span> until his retirement in December 2022. In connection with his retirement, the Chief Financial Officer was granted severance of 6 months base salary and certain other benefits.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 16pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>[4] </b>In December 2022, the Company’s Board of Directors elected a new Chief Financial Officer who serves on a consulting basis at an annual base salary of $175,000.</span></p> 535000 175000 175000 175000 600000 175000 100000 75000 150000 3.50 150000 4.00 125000 4.50 0 1801000 175000 25000 40000 175000 <p id="xdx_804_eus-gaap--LegalMattersAndContingenciesTextBlock_zEliPSz8Ucsj" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-variant: small-caps; color: Black"><b>Note K – <span id="xdx_82D_zteBqMxCoace">Legal Proceedings</span></b></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>[1] </b>On April 4, 2014 and December 3, 2014, the <span id="xdx_902_ecustom--LitigationPendingDescription_c20170508__20170509__srt--TitleOfIndividualAxis__custom--GoogleMember_z2MiWwgtyEbb" title="Litigation pending, description">Company initiated litigation against Google Inc. (“Google”) and YouTube, LLC (“YouTube”) in the U.S. District Court for the Southern District of New York for infringement of several of its patents within its Cox Patent Portfolio acquired from Dr. Cox which relate to the identification of media content on the Internet. The lawsuit alleges that Google and YouTube have infringed and continue to infringe certain of the Company’s patents by making, using, selling and offering to sell unlicensed systems and related products and services, which include YouTube’s Content ID system. The litigations against Google and YouTube were subject to court ordered stays which were in effect from July 2, 2015 until January 2, 2019 as a result of proceedings at the Patent Trial and Appeal Board (PTAB) and the appeals of PTAB Final Written Decisions to the U.S. Court of Appeals for the Federal Circuit. Pursuant to a Joint Stipulation and Order Regarding Lifting of Stays, entered on January 2, 2019, the parties agreed, among other things, that the stays with respect to the litigations were lifted. In January 2019, the two litigations against Google and YouTube were consolidated. Discovery is complete and the parties have each submitted summary judgment motions. A trial date has not yet been set.</span></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>[2] </b>On May 9, 2017, Mirror Worlds Technologies, LLC, the <span id="xdx_903_ecustom--LitigationPendingDescription_c20170508__20170509__srt--TitleOfIndividualAxis__custom--FacebookMember_zk2PeMSKJQag" title="Litigation pending, description">Company’s wholly-owned subsidiary, initiated litigation against Facebook, Inc. (“now Meta Platforms, Inc. (“Meta”)) in the U.S. District Court for the Southern District of New York, for infringement of U.S. Patent No. 6,006,227, U.S. Patent No. 7,865,538 and U.S. Patent No. 8,255,439 (among the patents within the Company’s Mirror Worlds Patent Portfolio). The lawsuit alleged that the asserted patents are infringed by Meta’s core technologies that enable Meta’s Newsfeed and Timeline features.</span> On May 7, 2018, Meta filed a motion for summary judgment on non-infringement. On August 11, 2018, the Court issued an order granting Meta’s motion for summary judgment of non-infringement and dismissed the case. On August 17, 2018, the Company filed a Notice of Appeal to appeal the summary judgment decision to the U.S. Court of Appeals for the Federal Circuit. On January 23, 2020, the U.S. Court of Appeals for the Federal Circuit ruled in the Company’s favor and reversed the summary judgment finding on non-infringement of the District Court and remanded the litigation to the Southern District of New York for further proceedings.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">On March 7, 2022, the District Court entered a ruling granting in part and denying in part a motion for summary judgment by Meta. In its ruling the Court (i) denied Meta’s motion that the asserted patents were invalid by concluding that all asserted claims were patent eligible under §101 of the Patent Act and (ii) granted summary judgment of non-infringement in favor of Facebook and dismissed the case. The Company strongly disagrees with the decision on non-infringement and on April 4, 2022, the Company filed an appeal to the U.S. Court of Appeals for the Federal Circuit, which is pending.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>[3] </b>On December 15, 2020, the <span id="xdx_902_ecustom--LitigationPendingDescription_c20170508__20170509__srt--TitleOfIndividualAxis__custom--NetgearMember_zjxAcKsP068g" title="Litigation pending, description">Company filed a lawsuit against Netgear, Inc. (“Netgear”) in the Supreme Court of the State of New York, County of New York, for breach of a Settlement and License Agreement, dated May 22, 2009, with the Company for failure to make royalty payments, and provide corresponding royalty reports, to the Company based on sales of Netgear’s PoE products. On October 22, 2021, Netgear filed a Demand for Arbitration at the American Arbitration Association (AAA) seeking to arbitrate certain issues raised in the litigation. The Company objected to jurisdiction at the AAA. On April 22, 2022, Netgear filed a counterclaim in the N.Y. court action alleging that the Company breached the License Agreement by not offering Netgear lower royalties. On September 22, 2022, the arbitration brought by Netgear was dismissed by the AAA on jurisdiction grounds. The case remains pending in the Supreme Court of the State of New York, County of New York.</span></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>[4] </b>In October and November 2022, the <span id="xdx_908_ecustom--LitigationPendingDescription_c20170508__20170509__srt--TitleOfIndividualAxis__custom--AristaNetworksMember_zFfoz05u3XTj" title="Litigation pending, description">Company initiated separate litigation against ten defendants for infringement of its Remote Power Patent seeking monetary damages based upon reasonable royalties, as follows: (i) On October 6, 2022, the Company initiated such litigation against Arista Networks, Inc., Fortinet, Inc., Honeywell International Inc. and Ubiquiti Inc. in the United States District Court, District of Delaware; (ii) On October 27, 2022, and November 3, 2022, the Company initiated such litigation against TP-Link USA Corporation and Hikvision USA, Inc. in the United States District Court for the Central District of California; (iii) On November 4, 2022, the Company initiated such litigation against Panasonic Holdings Corporation and Panasonic Corporation of North America in the United States District Court for the Eastern District of Texas (Marshall Division); and (iv) On November 8, 2022 and November 16, 2022, the Company initiated such litigation against Antaira Technologies, LLC and Dahua Technology USA in the United States District Court for the Central District of California.</span></span></p> Company initiated litigation against Google Inc. (“Google”) and YouTube, LLC (“YouTube”) in the U.S. District Court for the Southern District of New York for infringement of several of its patents within its Cox Patent Portfolio acquired from Dr. Cox which relate to the identification of media content on the Internet. The lawsuit alleges that Google and YouTube have infringed and continue to infringe certain of the Company’s patents by making, using, selling and offering to sell unlicensed systems and related products and services, which include YouTube’s Content ID system. The litigations against Google and YouTube were subject to court ordered stays which were in effect from July 2, 2015 until January 2, 2019 as a result of proceedings at the Patent Trial and Appeal Board (PTAB) and the appeals of PTAB Final Written Decisions to the U.S. Court of Appeals for the Federal Circuit. Pursuant to a Joint Stipulation and Order Regarding Lifting of Stays, entered on January 2, 2019, the parties agreed, among other things, that the stays with respect to the litigations were lifted. In January 2019, the two litigations against Google and YouTube were consolidated. Discovery is complete and the parties have each submitted summary judgment motions. A trial date has not yet been set. Company’s wholly-owned subsidiary, initiated litigation against Facebook, Inc. (“now Meta Platforms, Inc. (“Meta”)) in the U.S. District Court for the Southern District of New York, for infringement of U.S. Patent No. 6,006,227, U.S. Patent No. 7,865,538 and U.S. Patent No. 8,255,439 (among the patents within the Company’s Mirror Worlds Patent Portfolio). The lawsuit alleged that the asserted patents are infringed by Meta’s core technologies that enable Meta’s Newsfeed and Timeline features. Company filed a lawsuit against Netgear, Inc. (“Netgear”) in the Supreme Court of the State of New York, County of New York, for breach of a Settlement and License Agreement, dated May 22, 2009, with the Company for failure to make royalty payments, and provide corresponding royalty reports, to the Company based on sales of Netgear’s PoE products. On October 22, 2021, Netgear filed a Demand for Arbitration at the American Arbitration Association (AAA) seeking to arbitrate certain issues raised in the litigation. The Company objected to jurisdiction at the AAA. On April 22, 2022, Netgear filed a counterclaim in the N.Y. court action alleging that the Company breached the License Agreement by not offering Netgear lower royalties. On September 22, 2022, the arbitration brought by Netgear was dismissed by the AAA on jurisdiction grounds. The case remains pending in the Supreme Court of the State of New York, County of New York. Company initiated separate litigation against ten defendants for infringement of its Remote Power Patent seeking monetary damages based upon reasonable royalties, as follows: (i) On October 6, 2022, the Company initiated such litigation against Arista Networks, Inc., Fortinet, Inc., Honeywell International Inc. and Ubiquiti Inc. in the United States District Court, District of Delaware; (ii) On October 27, 2022, and November 3, 2022, the Company initiated such litigation against TP-Link USA Corporation and Hikvision USA, Inc. in the United States District Court for the Central District of California; (iii) On November 4, 2022, the Company initiated such litigation against Panasonic Holdings Corporation and Panasonic Corporation of North America in the United States District Court for the Eastern District of Texas (Marshall Division); and (iv) On November 8, 2022 and November 16, 2022, the Company initiated such litigation against Antaira Technologies, LLC and Dahua Technology USA in the United States District Court for the Central District of California. <p id="xdx_802_eus-gaap--ConcentrationRiskDisclosureTextBlock_zENJRs5BjbUh" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 6pt 0 12pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-variant: small-caps; color: Black"><b>Note L - <span id="xdx_82B_zU2YmcTU9kkl">Concentrations</span></b></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">The Company had no revenue for the year ended December 31, 2022. Revenue from the Company’s Remote Power Patent constituted <span id="xdx_906_ecustom--PercentageRevenue_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--RemotePowerPatentMember_z7FL4LDlAJI2" title="Percentage revenue">100</span>% of the Company’s revenue for the year ended December 31, 2021, of which two licensees constituted an aggregate of <span id="xdx_90F_ecustom--PercentageRevenue_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--LicenseesTwoMember_z0ObkXedYiFh" title="Percentage revenue">99</span>% of the Company’s revenue for such year.</span></p> 1 0.99 <p id="xdx_804_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zp7VW4qwuNV1" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 6pt 0 12pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-variant: small-caps; color: Black"><b>Note M – <span id="xdx_823_zscvpR6pNgQ4">Related Party Transaction</span></b></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">On June 1, 2022, the Company repurchased from a director of the Company <span id="xdx_901_ecustom--NumberOfSharesCommonStockRepurchased_c20220529__20220601__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_pdd" title="Number of shares, common stock repurchased">41,500</span> shares of its common stock at a purchase price of $<span id="xdx_901_ecustom--PricePerShareCommonStockRepurchased_c20220529__20220601__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_pdd" title="Price per share, common stock repurchased">2.42</span> per share or aggregate consideration of $<span id="xdx_90E_ecustom--AggregateCostOfCommonStock_c20220529__20220601__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_pp0p0" title="Aggregate cost of common stock">100,430</span>.</span></p> 41500 2.42 100430 <p id="xdx_80E_eus-gaap--AcceleratedShareRepurchasesTextBlock_zaVfGMUAm3t6" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 6pt 0 12pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-variant: small-caps; color: Black"><b>Note N – <span id="xdx_82F_zhCk6u3rdm9h">Stock Repurchase Program</span></b></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">On June 11, 2021, the Company’s Board of Directors authorized an extension and increase of the Share Repurchase Program to repurchase up to $<span id="xdx_908_eus-gaap--StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_iI_c20210611__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_zn5VGjMQAdZg" title="Stock repurchase program, dollar amount">5,000,000</span> of the Company’s common stock over the subsequent 24-month period. The common stock may be repurchased from time to time in open market transactions or privately negotiated transactions in the Company’s discretion. The timing and amount of the shares repurchased are determined by management based on its evaluation of market conditions and other factors. The repurchase program may be increased, suspended or discontinued at any time.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">During the year ended December 31, 2022, the Company repurchased an aggregate of <span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20220101__20221231_pdd" title="Number of shares, common stock repurchased since inception">228,530</span> shares of its common stock pursuant to the Share Repurchase Program at a cost of approximately $<span id="xdx_90F_eus-gaap--PaymentsForRepurchaseOfEquity_c20220101__20221231_pp0p0" title="Aggregate cost of common stock repurchased since inception">531,000</span> (exclusive of commissions) or an average price per share of $<span id="xdx_903_ecustom--WeightedAveragePricePerShareCommonStockSubjectToRepurchase_c20220101__20221231_pdd" title="Average price per share, common stock repurchased since inception">2.33</span>.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">Since inception of the Share Repurchase Program (August 2011) through December 31, 2022, the Company has repurchased an aggregate of <span id="xdx_906_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20110801__20221231_pdd" title="Number of shares, common stock repurchased since inception">9,212,664</span> shares of its common stock at a cost of approximately $<span id="xdx_90A_eus-gaap--PaymentsForRepurchaseOfEquity_c20110801__20221231_pp0p0" title="Aggregate cost of common stock repurchased since inception">17,758,000</span> (exclusive of commissions) or an average per share price of $<span id="xdx_906_ecustom--WeightedAveragePricePerShareCommonStockSubjectToRepurchase_c20110801__20221231_pdd" title="Average price per share, common stock repurchased since inception">1.93</span>.</span></p> 5000000 228530 531000 2.33 9212664 17758000 1.93 <p id="xdx_808_eus-gaap--ScheduleOfDividendPaymentRestrictionsTextBlock_zDBLhQfSdwwk" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-variant: small-caps; color: Black"><b>Note O – <span id="xdx_826_z825wlwtqnr5">Dividend Policy</span></b></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">The Company’s dividend policy consists of a semi-annual cash dividend of $<span id="xdx_90C_ecustom--DividendsPerShare_c20220201__20220223__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_pdd" title="Dividends, per share - semi-annual">0.05</span> per common share ($<span id="xdx_90F_ecustom--DividendsPerShareAnnual_c20220101__20221231_pdd" title="Dividends, per share - annual">0.10</span> per common share annually) which have been paid in March and September of each year. On February 23, 2022, the Board of Directors declared a semi-annual cash dividend of $<span id="xdx_90F_ecustom--DividendsPerShare_c20210901__20210909__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_pdd" title="Dividends, per share - semi-annual">0.05</span> per share with a payment date of <span id="xdx_90B_eus-gaap--DebtInstrumentMaturityDate_dd_c20220201__20220223__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_zM8SIvaKEn15" title="Semi-annual cash dividend payment date">March 24, 2022</span> to all common shareholders of record as of <span id="xdx_90D_ecustom--SemiAnnualCashDividendRecordDate_dd_c20220201__20220223__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_zyMAxVXwvmSa" title="Semi-annual cash dividend record date">March 9, 2022</span>. On September 9, 2022, the Board of Directors declared a semi-annual dividend of $<span id="xdx_902_ecustom--DividendsPerShare_c20220101__20221231_pdd" title="Dividends, per share - semi-annual">0.05</span> per share with a payment date of <span id="xdx_90E_eus-gaap--DebtInstrumentMaturityDate_dd_c20210901__20210909__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_zt593L0OR7Xc" title="Semi-annual cash dividend payment date">September 30, 2022</span> to all common shareholders of record as of <span id="xdx_90E_ecustom--SemiAnnualCashDividendRecordDate_dd_c20210901__20210909__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_zk8NOvPvYQ5l" title="Semi-annual cash dividend record date">September 20, 2022</span>. The Company’s dividend policy undergoes a periodic review by the Board of Directors and is subject to change at any time depending upon the Company’s earnings, financial requirements and other factors.</span></p> 0.05 0.10 0.05 2022-03-24 2022-03-09 0.05 2022-09-30 2022-09-20 <p id="xdx_80B_eus-gaap--SubsequentEventsTextBlock_z8653qdirPog" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 6pt 0 12pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-variant: small-caps; color: Black"><b>Note P – <span id="xdx_820_zaGQMOt2v3Vh">Subsequent Events</span></b></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>[1] </b>On March 3, 2023, the Company’s Board of Directors declared a semi-annual cash dividend of $<span id="xdx_90E_eus-gaap--CommonStockDividendsPerShareDeclared_c20230301__20230303__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_zbKRbHJvq8e4" title="Semi-annual cash dividend per common share">0.05</span> per share with a payment date of <span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_dd_c20230301__20230303__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_zKRwk0EXS5Xe" title="Dividend payment date">March 31, 2023</span> to all common shareholders of record as of <span id="xdx_900_ecustom--SemiAnnualCashDividendRecordDate_dd_c20230301__20230303__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_zBoak6sZg3r" title="Semi-annual cash dividend record date">March 15, 2023</span>.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>[2] </b>On March 3, 2023, the Company’s Board of Directors approved the grant of <span id="xdx_903_ecustom--RestrictedStockUnitsGrantedToDirectors_c20230301__20230303__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zElBDME1Zuu9" title="Restricted stock units granted to directors">15,000</span> RSUs to each of the Company’s three non-management directors. The RSUs vest over a one year period in equal quarterly installments of 3,750 shares of common stock on each of March 15, 2023, June 15, 2023, September 15, 2023 and December 15, 2023.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"><b>[3] </b>During the period January 24, 2023 through March 10, 2023, the Company entered into settlement agreements with Arista Networks, Inc., Antiara Technologies LLC, Panasonic Holdings Corporation and TP-Link USA Corporation with respect to patent infringement litigation involving its Remote Power Patent, resulting in aggregate settlement payments to the Company of $<span id="xdx_902_ecustom--AggregateSettlementPayments_pp0p0_c20230124__20230310__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementsMember_zGT4Rui6sU3d" title="Aggregate settlement payments">537,300</span> and a conditional payment of $<span id="xdx_906_ecustom--ConditionalPayment_pp0p0_c20230124__20230310__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementsMember_zeC5CXO3dFsk" title="Conditional payment">150,000</span> (see Note K[4] hereof).</span></p> 0.05 2023-03-31 2023-03-15 15000 537300 150000 Includes $17,000,000 received from Hewlett-Packard related to settlement of a patent litigation (see Note K[1] hereof). Includes (1) $18,691,890 of royalty revenue from Cisco Systems, Inc. from resolution of a dispute under its license agreement with the Company and (2) $337,000 of royalty revenue received from Plantronics, Inc. EXCEL 75 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

#@*8P.P*[X06,BU9V2D7'%^;08?TH$7F(P@AT09"JR_YC"" M/#=,.H\?-:G7Q#3 ]><5^SLK7HNYPA)&//]*4I4-O'T/I3#%9:[.^>(]U(*Z MAB_AN;2?:%&MW=.+DU(J3FNPSH 25GWC96W$&B"\#Q#5@.AW0.<>0%P#K'-^ ME9F5=8(5'O8%7R!A5FLV\V"]L6BMAC#S,UXHH=\2C5/#"5; E$0[)Z PR24Z MPT)@8^TK] 9=7IR@G>>O^K[2H0S 3VK:XXHVNHAQY&0\@607Q>%K% 51U)+0Z.'PT)%.W/@66[[./7Q'E M%?F*[%V&I M3Y6$-ILJEJYE,4=J/HS#7A $?7^^GOR?RZ*#[OJR.TEVFB0[SB3'A!%:4O1M M#/0*Q/>V!)T,IH@UYO9>%[HO=D]6 M)S?$:;:(HU"Z*1YKA;_6)5 0,]L\22VL9*JZAS>S38-V9-N2W^:/3>-FNX]; MFJKK&V,Q(TRB'*::,MC=TQSP%U!+ P04 " 6A'Y6(I%ID"P# "I" &0 'AL+W=O)^% 2)7U$FO'3FSNY4.I.- MX4S G2*ZJ2JJ?B^ R^W<"[V7@WNV+HT]\--93=?P .9;?:=PY_[N2/+#?EW)MZ)(>"-MS?]%:OV! MW($B#R7%B_=+,)1Q/#LEVI[HF6_0MD7PL\[.HK43'; 31N2K%*;4Y$;DD+\& M\-'IWO/HQ?-%=!1Q"=D9B<./) JB:,"AZW]7#X^X$_>!C!U>? #OABK!Q%KO MQ.W'U4H;A0_UYU"\6KC1,)PMW@M=TPSF'E:G!K4!+SUY%R;!Y1#7_P3VBOFH M9SXZAIX^NE*!_)1N0&'E$WQ%%59H^U0(M@YMJ,@Q..3DW30*PTM;>"P;"DIK M*7&6; /:I%$\C<;GX63F;W8)#PB.PCB9VEQN!LB,>S+CHV26C#>VL1 H"NPT M1!;8JS"++$.&!,LQ>R*-8$83I-3M96T[TF!1'#4VG!3P938;) M)CW9Y']G+K?QV:_?EFORK[D;$!R-XV"<3(?I3'HZDZ-T[H<3!<\9;[#GD$+) MBIC2T:P;0]TPB0%:0T4:#T_G['E",-VZ*;67#>I[(2*J)&H@9N;G9"5D0;4Q:>JB60W($JYH6^/_4J M0CE.8^=;RS06>\THA[5$:E]51#XM@(DFP0$^.NYI46KK\-*X)@5L0'^MU])8 M7L^2TPJXHH(C";L$SX/98)]6Q PR+1E(.9S M@"4P9HE,&;\Z3MRGM,#A^:5%U8%-!17G[)8]='P: 8'H&$': \"5@? 80=8#( M"6TK<[)61),TEJ)!TD8;-GMPO7%HHX9R^R]NM#2WU.!T>L,S40%ZH>4O5.QITUFB_>R+LNBS1*>R1*$Z$YP72IT MS7/(GQ-XIN2^[O!8]R*\R+B";(2BX"T*_3 \4=#RW^'!A7*BOHV1XXO.\%T3 MR2DOU*"#/^9;I:5YIC]/]:NE&Y^FLZ,[4S7)(,%F-A7( ^#T]:M@ZG\\I?4_ MD3U3/NZ5CR^QIVNA@6M*&'M".65[^U0NO).6;.K([(8YI--PXOM^[!V&BOX. M"VQ8']66Z@W>?06R<.M H4SLN6Z?4N_M-\[<#=H+_\)LHG9Q_*%IU]@=D07E M"C'8&4I_]'Z"D6Q70VMH4;OIV@IM9M4=2[--0=H <[\3ID&=81/T^SG]#5!+ M P04 " 6A'Y6-V#NJOH" "X"@ &0 'AL+W=O?.\KD]\AEO&G\020*)=65 Q0+5ZPXD,PDE87K>U[LEB2G3C(T<[<\&;*U+'(*MQR)=5D2 M_F<,!=N.'.P<)N[RQ5+J"3<9KL@"9B ?5K=-I(B@@E5J"J,L&)E 46DEQ_-Z+.O4[=6+S M_J!^9T-U8#$2U@:C3P!5DP.W@G8GO *]TX@:XW_?Z1\GCFCSN)+]GDA2' M3::+%EWNU == #H9 X5Y+JT%VRGZ#E=QV]4@\H^ZZM6N>ET%I0IT#LI19D/O M?635?)#8"Y/]VF3_?ZNFWUK>*&XN;F6B'=4/COX%@YIN\*\E,6A31;B-U0[# MH1\=!\P'EO6'/'_9(<]-;SR:OQ1%[O3:N)0Y''16*&P):I M>KH;PAJM02N ]3S.6/R,- O MJ)O5Y"]02P,$% @ %H1^5G#1HR/0 @ L@@ !D !X;"]W;W)K&ULK99=;YLP%(;_BL6FJ976\I4O=0E2FVA:I6VJFK:[ MF';AP$EBU6!F.Z']]SL&PHAP62OM)MAPSNOW(?8Y3 LA']460).GE&=JYFRU MSB]<5\5;2*DZ%SED^&0M9$HU3N7&5;D$FI1)*7<#SQNY*669$TW+>SC[_$;BS&U4$I9"IIC( MB(3US+GT+^83$U\&/# H5&M,#,E*B$"!:"@,E$V^DIR6$J: M,K"/!N.QYWE3=]_FZEW9SD5ZD 8-TJ 7:4YSIBEOP=0L-I1*:M1""4._B]*[ MXMM1A@W*L!=EJ47\B/^/J6B*T"PAM\M[&\:PB^%U*7H7>SO%J*$8]5(\4+ZC M55'FV!5H%H.-8=1AF(23+D0W[&_$D;UQ8V_<:V\!:Y 2DK("?&5TQ3C3SS:' MX\[29[X_LFP72^!P.&C''3F=-$XGO4[OA-G7R<&O1K]4*=!8F?G!M[4>3SH' M]@7CED"K<;?544PW_T;EAN$6Y;#&3.]\C!*RZI#51(N\;#(KH;%EE<,M?E2 M- 'X?"V$/DQ,WVH^4Z(_4$L#!!0 ( !:$?E;0@M"KW@( .,( 9 M>&PO=V]R:W-H965TS#)A5AS;&8[T/[[V0EDP$S:A[TD_KCG^)P;VS?C'1>_9 &@ MT&-)F9PXA5*;*\^360$EEB[? -,S*RY*K'17K#VY$8#S&E12+_3]@5=BPIQT M7(\M1#KFE:*$P4(@694E%D]3H'PW<0+G,'!'UH4R UXZWN UW(/ZNED(W?-: MEIR4P"3A# E839SKX&HV,O%UP#<".WG41L;)DO-?IG.33QS?" (*F3(,6+^V M, -*#9&6\7O/Z;1+&N!Q^\#^J?:NO2RQA!FGWTFNBHF3."B'%:ZHNN.[S[#W MTS=\&:>R?J)=$QM%#LHJJ7BY!VL%)6'-&S_N\W $" 87 .$>$)X#X@N : ^( M:J.-LMK6'"N8KWBNA9XG&J?2&9;P$]( ?0:+> M'!0F5*+P[=A3FMW$>-F>:=HPA1>8@A#=!0/_@\WN?R([,1^WYN,N]H-YIV0S!K@*,3T7XP&-EE#UK9@\X%9P5F:T"$H2VF%6YN.*JO M6'Q!?S==+T[=B]^K")AA:4Q4F9]O 'A9U'>CV*YQ9,EE&"5G M.KVC>E&"6-=E5**,5TPUUW,[VE;JZ[I G8U/=05O"NY?FJ;\WV*Q)DPB"BM- MZ;M#?6Y$4U*;CN*;NBHMN=(UKFX6^B\$A G0\RO.U:%C%FC_:](_4$L#!!0 M ( !:$?E88)K(OB@( ((' 9 >&PO=V]R:W-H965T0?9%47(E'0MDI=5[5K]V+:"Y,<8-6),]L0 M^NUW=M(,1,IHM3?$=NYY?#\?.<>5D ]J :#).N>%&CH+KJ*$ M M_,A,RIQJF%[DYI053A+;M6N9Q&*I.2O@6A*US',J'\^! MBVKH^,[3P@V;+[19<).XI'.X!7U77DN!MP MSZ!2&V-B2*9"/)C)139T/),0<$BU<:#X6,$8.#=&F,;OQM-IMS3"S?&3^R?+ MCBQ3JF L^ ^6Z<70.75(!C.ZY/I&5%^@X1D8OU1P97])5D2Z5%WH@Q M@YP5]9.NFW/8$/C]9P1!(P@.%82-(+2@=686:T(U36(I*B)--+J9@3T;JT8: M5I@JWFJ);QGJ=')1I"('\IVN09&C"6C*N")75$IJSO>8O"=WMQ-R]/8X=C7N M9U1NVGB?U][!,]X32'LD]$](X 5!AWQ\N-S?EKM(V:(&+6I@_<)_HI()4RD7 M:BF!_!Q-E9;X;_K5!5@[]KL=S1=VIDJ:PM#!3TB!7(&3O'OC1]['+MS_9+8% M'[;PX3[WY%L)IJ+%G%P*I<@8"_R(/:"B,E-=X+7;P+J93K!* C\Z]3PO=E>; M3'MW?253OV7J[V6:P RDA,R6=*04:'5"/DODZR*JO:(-HM.P VCOEJ\$&K1 M@Y<#W5.^I+;EC3CV7%JDT(4W. QOL%/7OQ%;.4=MSM'A.5\R.F6<:0:8^!7H MKD2CG0Q\/_)W,]V[[4L+X6YT2',[?:5RS@I%.,S0WNM]P'QDW?'KB1:E;9I3 MH;$%V^$"+TF0)@#?SX303Q/3A]MK-_D#4$L#!!0 ( !:$?E;TZI4\4P, M %T+ 9 >&PO=V]R:W-H965T'M)FDFGZT.F#L!>LB2U128;D[RO)Q@%L*).T+V!)NT?G M['K7.U@Q?B]2 (D>\HR*H95*N3BS;1&GD&/180N@ZF3&>(ZE6O*Y+18<<&*< M\LSV'">TBR'/,'\>0L=70<-6GZ$2%&B\F&7"_*)59>M8*"Z$9'GEK!CDA);_^*$*Q(:#&^YQ M\"H';]>AN\?!KQQ\([1D9F1=8(E' \Y6B&MKA:8?3&R,MU)#J$[CK>3JE"@_ M.;J5++Y/698 %V_1Y>^"R$?T[@(D)IEXCT[1:V0CD6(.8F!+=:%VL^,*?%R" M>WO 70]=,2I3@2YI LDV@*V8UG2]-=VQ=Q#Q N(.\MT3Y#F>UT)HX". M7T?/-WC^'KPJ7C_/IT)R]4;^:HM1"=%MA]!E>B86.(:AI>I0 %^"-7KSR@V= M#VWZ_A'8EMINK;9["'UT THEB24D2.C7!A642'&"5'<0$M.$T#FB13X%CMAL M?3B%.:%4'TUQAFD,;2$J[PW-O;KQ+-6K$SC.P%YN:F^Q"K?,ME0%M:K@6:I6 MI@.H7;P$KCH:FG-,)4JP!#3#A*,ES@HX4F!)(=J@[G?\<$=?T\CK>$&[NK!6 M%QY4]TF3%CH?O%5G&]FP$>6G3%37BZW;Z MWHZJII'?"=QV4;U:5.^@J#LE11$^/@.]1FA/@ZA9$"UF;G]_#OHUW?[SZ;XD M ?U&;$^]3N3OJ&JUZD;MFESGZ4/G_*W.V]1\VVA>7W>;UV6Y/]Y?V-6E6\7B M!&PO=V]R:W-H965T!-!+EQ$Y26T#LI+L%&C1HT.U#T0=:&EM$)%(E:3O^^R4I6;8, MA9'CY"$F*WF>&*BT>9 BCTE&=,CKQ4J>+*]V6<0D[D*2^ Z2\S+G*B M=%?,?5D(((DURC,_#(*^GQ/*O&AHQ^Y%-.0+E5$&]P+)19X3L1Y#QE>/IO,Y&7F!B0@RB)6!(/IG"1/(,H.DX_A=@7JU3V.XV]Z@?[+D-9DI MD3#AV0^:J'3D77@H@1E99.H;7_T+%2$;8,PS:?^C53EW<.FA>"$5SRMC'4%. M6?E+GBHA=@QP_QF#L#((]PW.GC'H508]2[2,S-*Z(8I$0\%72)C9<TK#;6 M6K.AS"SC@Q+Z*]5V*GI0/'Y,>9: D._1[>\%56OTUPTH0C.)\-_HPV;P:V%U M_WD'^13$+_WA'?*13(D .?25CL4@^G'E=USZ#9_QBT-TQYE*);IE"21- %^3 MJ)F$&R;CT(EX _$IZN$3% 9AV!+0I+LY=H33JX7M6;S><\(:83Z,]0Y+T(3G M^MA)8@6\%H*P.>BCH-!TC7;GW9.U';Y>$9&@GU\T)/JL()>_V@0N_9^U^S?' M_TH6)(:1I\^W!+$$+_KS#]P//K:)\T9@#:G.:JG.7.A1N;,DTK>,5(0EE,U/ MT!3FE#';)&K;0WR&UD!$FR"EE[[U8JZO970>F+^AO]RE^N*T!HGSFL2YD\0/ M>V'H121+$/H"1/ $(J824"%H#">(M['L2JWT/=B)&9_BRSUB+TQJT.K7M/J= MUN8?O6G5_CDM8W,"M&\=U+8%C\=I,!S4# ?'+5P'"9P>#I#@>)R&!!>U!!>= M%OGVJ:"BG:$3X "&Q^,T&%[6#"_?9I$=$C@]'"#!\3@-"7"P?>J#CLM<(NZ?;V"QD[&@M]J+5T\<9&PO=V]R:W-H965TP-T-SKFS8)?KZ./_[Y=3S: M,'XO%@ 2/21Q*LX;"RF79ZV6"!>0$-%D2TC5+S/&$R+5+9^WQ)(#B;*@)&YA MS^NU$D+3QGB4/;OFXQ%;R9BF<,V16"4)X=M+B-GFO.$W'A_M\6A) MYG +\FYYS=5=:Z<2T01205F*.,S.&Q?^68#[.B!+\97"1E2ND2[*E+%[??,Q M.F]X^HT@AE!J":+^K6$"<:R5U'O\*$0;NSQU8/7Z4?U]5GA5F"D1,&'Q-QK) MQ7ECT$ 1S,@JEC=L\P&* G6U7LABD?U%FR*MUT#A2DB6%,'J#1*:YO_)0P&B M$J!TS &X",![ ;AS)*!=!+3W/EB@/W^.W3U8T7E%KT*0!(:"_29 M<$YT];Q&;]'=;8!>_?%ZU)(J=ZW1"HN<+O.<\)&Z_0=C#V/1"]O PB9J^T?#@U\/]RVE:>]J MLIWIM8_5Y()P>'NI^D"$)BQ1 X,@6=>Z4+67SD%U5HFF6U1-=TVVV>.+#>$1 M^OZGDD0?)23B;U/]YOEWS/GK >I,+$D(YPTU @G@:VB,7[[P>]X[$UN78H$C ML1KWSHY[QZ8^OIC/.H!PI4<.]&4VHR%P]/T3)%/@QO9EE3^5@DNQP)%8#6MOA[7WS/VZYY*[ M2[' D5B->W_'O6]OSBQ)%&6A)T@D-%R!EBL>+C+"><=^[-?&3IW+]RJ]3/3V3A2J[/!)1ML97,# M0JW30JD:4^9^T%U*I4"O;F[OQ&OK L4N?.I,Z50M<*56AUJ:#_^YW8?OU'XX M50MJ$8_-4_JOPL%_CXQ31U*H56U7O]TSD'D*M^&7=L.W MKJK'W[*M,@6,J F7S &1A'&9T5P"I\P\D3CU$#]Y0XRV0+A ?93D&T)#%)&M M:>X/7+U7G65I(7R[A_CM4?$->J],-?J:[2=<"+%*\@V%-^B&BGOTGH,:,E,) MNIVC&[76-%:.2XLQ*=2&U?V%IH?WUU.!JUSKZ$LSXMO=R!.BOU(C1C:D_ 4\ M,0)WZ6$F/REH)^\-QM;_%/;'+_V/;S= _T<5?&6QTHSU?O71YN_2&TT*M4&M M^7?VV_Y3."A<.BAL=U 94'1]S(;;HT\%4JA573UN=OI[1%SE62=2^B%L]T,7 M8O8Y)F'S*L!L@N>C("IP;(E5H=:&F \',;(.S4 #E5 M"URIU>&7!@C;#5!MRXBL"8WUEQ8T8QQ1-6T0U:9BPW3 =&0K\MGTH<.J-G*H%KM3J0$L'A9_[BPUV:K>M.8K:20),VVBHF&;-PKMHN?#/;P$U /&_9"7.6: M(VM53H,DP.?9J1J!0K9*97XX8O=T=W+G(CNOLO=\XI\%^?F;4B8_#O2)\#E- M!8IAIB2]9E]U.)Z?L,EO)%MF9TZF3$J69)<+(&H U@G4[S/&Y..-SF!WSFG\ M'U!+ P04 " 6A'Y6$7RF;K<$ W&P &0 'AL+W=O[7CY15R8(H)G*=O"22?._A/5?DO8?4:,OXHU@2(L%3GA5B["RE M7)VYKI@M28[%*5N10OVR8#S'4MWR!U>L.,'STBG/7.1YD9MC6CB34?GLAD]& M;"TS6I ;#L0ZSS'_?DXRMAT[T/GQX)8^+*5^X$Y&*_Q [HB\7]UP=>?6*'.: MDT)05@!.%F/G#WAV@5+M4%I\I60K]JZ!IC)E[%'?7,_'CJ_4N4G)Y\Q?R023S," M[LALS:FD1(#WE^H9S<0'< +N[R[!^WT(/W$5,.ON)L3<"WSR2?$OZ/B9,51"^J M,['",S)VU*H1A&^(,_GU%QAYOYL8'@FLQ=>O^?HENM_#]XM<$GY=;(B0:ME) M<:L6.&%3@<0 M]6PW,=[!A"6,KH2;"?*2(/$\;^1N]ME8QSN035BS">TSFCZ1.:#%C.4$Y&NY MQAE8K(NYD=$.*MIC!+TT2;N,P@YU&/@HW#=L11O5T4;6:"\(EW1!9UBJ L,6 MJM:NF*#2%&O4B16E<=0-U3K@@3G$W M^;%A,G7-$@_V)CZI(TVLD?[%I)H8>5/H[5,_Z03A!VD*N]%V#6$(4=0;;UK' MFSZ362'!.1946 NU%61H43H26(LO])H>[+U5J:Y&.E):CH76SLN>-H''*=<5 M3JMB>'%BF+3V$0]EU&@0^(P(&5*R*ZS6"H.I%QA8&2R#($*]:Q$V*@):&_*0 MLETAM4J'!PTMQC[DH2^A$0'0K@(&E>X*JY7:%!DX=>T2Z/>_@*;)0WN7'UB^ M8;?1^V&2&KJGP1*&*.[O]+!I]=#>ZZ\X$P+<%VICF='_U(R_4AM*>SFW(PXN M7*\A#6"C#6#\9@7=*D,&Y^5(:.V\-$H$VJ7(RPMZ5UQ$L6$*6X<[E$XC5*!= MJ0RKY@=H#&!\AS\/U-Y -SH%6?O]D%Y@1QK ]A"@9U\Q:B0(LDN00;W"CC6$ M],\#M?GN'9+8!B3NB?V5F2'''P&]!IB M!S5B!P5OU8K0D0X[JKR\QM$):F05LLNJ%[M! M[R(RLE">WFFL(/CN*\WN1K)5^:%CRJ1D>7FY5-6.<&V@?E\PE>SJ1G\[J;^5 M3?X'4$L#!!0 ( !:$?E;3%&[?S0( ,P( 9 >&PO=V]R:W-H965T ML JJ>S!DOL51;OK!%Q0%G!E06MN!RQ6A:$PAU' MHBY+S%]'4+#5T'*M]<$]6>12']AQ5.$%3$$^5'=<[>R.)2,E4$$811SF0^O: MO4I";6\,'@FLQ,8:Z4AFC#WIS4TVM!SM$!202LV U6T)8R@*3:3<>&XYK4Y2 M S?7:_9O)G85RPP+&+/B%\ED/K0N+)3!'->%O&>K[]#&8QQ,62',%:T:VW!@ MH;06DI4M6'E0$MK<\4N;APV NPO@M0#O/2#8 ?!;@'\H(&@!P:& L 68T.TF M=I.X"98XCCA;(:ZM%9M>F.P;M,H7H?H]F4JNGA*%DW'R7!/YBF[H$H14]9?H M9 (2DT)\1J?H83I!)Q\_1[944AI@IRWMJ*'U=M"Z'KIE5.8")32#["V!K7SL M'/76CHZ\O8P32,^0[WY!GN-Y/0Z-]\.G4"FXLQ,^.5S=[8$GAZN[>Y+A=U7S M#9^_OVJW('.6;11/($PS](,15<='M:\Y"/3[>B8D5U_DG[XZ-D)!OY#N4E>B MPBD,+=6&!/ E6/&G#^[ ^=I7@V.238Y)EAR)[$VU@JY:P3[V^"<3 LTY*U&J MO@E":T(72'5ZCG6O%'U5V4OXOU5IR$)#IN?&,G9#+Q@XCA/9R\V,'U,UZ5%U M7=_?5'V3S;#+9K@WFV-6*OE=[%ULQC[<-W?-+U]]. M3H]AX)U?;ADF/8:.?Q%L!VYOM.T2^,+,2Z%>DIK*IC%VI]U(OC:3Z-WY2(WJ M9K+^HVGF_"WF"T(%*F"N*)VS<^46;V9GLY&L,L-AQJ0:-6:9J]\-X-I /9\S M)M<;+=#]P,1_ 5!+ P04 " 6A'Y61 &5N/0$ ")&P &0 'AL+W=O M/E!3)LA4V+KC$0"S).N\A'][.(:=[+C[+ M#<8*?,THD[/>1JGME>?)>(,S)"_Y%C/]RYJ+#"E]*U)/;@5&26&442_P_:&7 M(<)Z\VGQ[$[,ISQ7E#!\)X#,LPR)IR6F?#_KP=[S@X\DW2CSP)M/MRC%]U@] M;.^$OO-JE81DF$G"&1!X/>LMX%44% ;%&W\2O)<'U\!4Y9'SS^;F.IGU?%,B M3'&LC 327SN\PI0:)5V.+Y5HK_9I# ^OG]5_+2JO*_.()%YQ^A=)U&;6&_= M@M%89Z_N,L/(;?:U '!C X0L& M0640'!OT7S (*X/PM0;]RJ!?D"FK4G"(D$+SJ>![(,S;6LU<%# +:UU]PDR[ MWRNA?R7:3LT_?,F)>@+7;(>ETNVIP+L(*T2H!+\C(9!IE??@ CS<1^#=C^^G MGM).C:D75PZ6I8/@!0

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end XML 76 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 77 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 78 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 99 339 1 true 40 0 false 5 false false R1.htm 00000001 - Document - Cover Sheet http://network-1.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://network-1.com/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://network-1.com/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) Sheet http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) Statements 4 false false R5.htm 00000006 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY Sheet http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY Statements 5 false false R6.htm 00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://network-1.com/role/ConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 00000008 - Disclosure - Business Sheet http://network-1.com/role/Business Business Notes 7 false false R8.htm 00000009 - Disclosure - Summary of Significant Accounting Policies Sheet http://network-1.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 00000010 - Disclosure - Patents Sheet http://network-1.com/role/Patents Patents Notes 9 false false R10.htm 00000011 - Disclosure - Income (Loss) Per Share Sheet http://network-1.com/role/IncomeLossPerShare Income (Loss) Per Share Notes 10 false false R11.htm 00000012 - Disclosure - Income Taxes Sheet http://network-1.com/role/IncomeTaxes Income Taxes Notes 11 false false R12.htm 00000013 - Disclosure - Stockholders??? Equity Sheet http://network-1.com/role/StockholdersEquity Stockholders??? Equity Notes 12 false false R13.htm 00000014 - Disclosure - Marketable Securities Sheet http://network-1.com/role/MarketableSecurities Marketable Securities Notes 13 false false R14.htm 00000015 - Disclosure - Equity Investment Sheet http://network-1.com/role/EquityInvestment Equity Investment Notes 14 false false R15.htm 00000016 - Disclosure - Commitments and Contingencies Sheet http://network-1.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 15 false false R16.htm 00000017 - Disclosure - Employment Arrangements and Other Agreements Sheet http://network-1.com/role/EmploymentArrangementsAndOtherAgreements Employment Arrangements and Other Agreements Notes 16 false false R17.htm 00000018 - Disclosure - Legal Proceedings Sheet http://network-1.com/role/LegalProceedings Legal Proceedings Notes 17 false false R18.htm 00000019 - Disclosure - Concentrations Sheet http://network-1.com/role/Concentrations Concentrations Notes 18 false false R19.htm 00000020 - Disclosure - Related Party Transaction Sheet http://network-1.com/role/RelatedPartyTransaction Related Party Transaction Notes 19 false false R20.htm 00000021 - Disclosure - Stock Repurchase Program Sheet http://network-1.com/role/StockRepurchaseProgram Stock Repurchase Program Notes 20 false false R21.htm 00000022 - Disclosure - Dividend Policy Sheet http://network-1.com/role/DividendPolicy Dividend Policy Notes 21 false false R22.htm 00000023 - Disclosure - Subsequent Events Sheet http://network-1.com/role/SubsequentEvents Subsequent Events Notes 22 false false R23.htm 00000024 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://network-1.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://network-1.com/role/SummaryOfSignificantAccountingPolicies 23 false false R24.htm 00000025 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://network-1.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://network-1.com/role/SummaryOfSignificantAccountingPolicies 24 false false R25.htm 00000026 - Disclosure - Patents (Tables) Sheet http://network-1.com/role/PatentsTables Patents (Tables) Tables http://network-1.com/role/Patents 25 false false R26.htm 00000027 - Disclosure - Income (Loss) Per Share (Tables) Sheet http://network-1.com/role/IncomeLossPerShareTables Income (Loss) Per Share (Tables) Tables http://network-1.com/role/IncomeLossPerShare 26 false false R27.htm 00000028 - Disclosure - Income Taxes (Tables) Sheet http://network-1.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://network-1.com/role/IncomeTaxes 27 false false R28.htm 00000029 - Disclosure - Stockholders??? Equity (Tables) Sheet http://network-1.com/role/StockholdersEquityTables Stockholders??? Equity (Tables) Tables http://network-1.com/role/StockholdersEquity 28 false false R29.htm 00000030 - Disclosure - Marketable Securities (Tables) Sheet http://network-1.com/role/MarketableSecuritiesTables Marketable Securities (Tables) Tables http://network-1.com/role/MarketableSecurities 29 false false R30.htm 00000031 - Disclosure - Equity Investment (Tables) Sheet http://network-1.com/role/EquityInvestmentTables Equity Investment (Tables) Tables http://network-1.com/role/EquityInvestment 30 false false R31.htm 00000032 - Disclosure - Commitments and Contingencies (Tables) Sheet http://network-1.com/role/CommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://network-1.com/role/CommitmentsAndContingencies 31 false false R32.htm 00000033 - Disclosure - Business (Details Narrative) Sheet http://network-1.com/role/BusinessDetailsNarrative Business (Details Narrative) Details http://network-1.com/role/Business 32 false false R33.htm 00000034 - Disclosure - Summary Of Significant Accounting Policies (Details) Sheet http://network-1.com/role/SummaryOfSignificantAccountingPoliciesDetails Summary Of Significant Accounting Policies (Details) Details 33 false false R34.htm 00000035 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) Sheet http://network-1.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative Summary of Significant Accounting Policies (Details Narrative) Details http://network-1.com/role/SummaryOfSignificantAccountingPoliciesTables 34 false false R35.htm 00000036 - Disclosure - Patents (Details) Sheet http://network-1.com/role/PatentsDetails Patents (Details) Details http://network-1.com/role/PatentsTables 35 false false R36.htm 00000037 - Disclosure - Patents (Details 1) Sheet http://network-1.com/role/PatentsDetails1 Patents (Details 1) Details http://network-1.com/role/PatentsTables 36 false false R37.htm 00000038 - Disclosure - Patents (Details Narrative) Sheet http://network-1.com/role/PatentsDetailsNarrative Patents (Details Narrative) Details http://network-1.com/role/PatentsTables 37 false false R38.htm 00000039 - Disclosure - Disclosure -Income (Loss) Per Share (Details) Sheet http://network-1.com/role/Disclosure-incomeLossPerShareDetails Disclosure -Income (Loss) Per Share (Details) Details 38 false false R39.htm 00000040 - Disclosure - Income (Loss) Per Share (Details Narrative) Sheet http://network-1.com/role/IncomeLossPerShareDetailsNarrative Income (Loss) Per Share (Details Narrative) Details http://network-1.com/role/IncomeLossPerShareTables 39 false false R40.htm 00000041 - Disclosure - Income Taxes (Details) Sheet http://network-1.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://network-1.com/role/IncomeTaxesTables 40 false false R41.htm 00000042 - Disclosure - Income Taxes (Details 1) Sheet http://network-1.com/role/IncomeTaxesDetails1 Income Taxes (Details 1) Details http://network-1.com/role/IncomeTaxesTables 41 false false R42.htm 00000043 - Disclosure - Income Taxes (Details 2) Sheet http://network-1.com/role/IncomeTaxesDetails2 Income Taxes (Details 2) Details http://network-1.com/role/IncomeTaxesTables 42 false false R43.htm 00000044 - Disclosure - Income Taxes (Details Narrative) Sheet http://network-1.com/role/IncomeTaxesDetailsNarrative Income Taxes (Details Narrative) Details http://network-1.com/role/IncomeTaxesTables 43 false false R44.htm 00000045 - Disclosure - Stockholders' Equity (Details) Sheet http://network-1.com/role/StockholdersEquityDetails Stockholders' Equity (Details) Details 44 false false R45.htm 00000046 - Disclosure - Stockholders' Equity (Details 1) Sheet http://network-1.com/role/StockholdersEquityDetails1 Stockholders' Equity (Details 1) Details 45 false false R46.htm 00000047 - Disclosure - Stockholders??? Equity (Details Narrative) Sheet http://network-1.com/role/StockholdersEquityDetailsNarrative Stockholders??? Equity (Details Narrative) Details http://network-1.com/role/StockholdersEquityTables 46 false false R47.htm 00000048 - Disclosure - Marketable Securities (Details) Sheet http://network-1.com/role/MarketableSecuritiesDetails Marketable Securities (Details) Details http://network-1.com/role/MarketableSecuritiesTables 47 false false R48.htm 00000049 - Disclosure - Equity Investment (Details) Sheet http://network-1.com/role/EquityInvestmentDetails Equity Investment (Details) Details http://network-1.com/role/EquityInvestmentTables 48 false false R49.htm 00000050 - Disclosure - Equity Investment (Details Narrative) Sheet http://network-1.com/role/EquityInvestmentDetailsNarrative Equity Investment (Details Narrative) Details http://network-1.com/role/EquityInvestmentTables 49 false false R50.htm 00000051 - Disclosure - Commitments And Contingencies (Details) Sheet http://network-1.com/role/CommitmentsAndContingenciesDetails Commitments And Contingencies (Details) Details 50 false false R51.htm 00000052 - Disclosure - Commitments And Contingencies (Details 1) Sheet http://network-1.com/role/CommitmentsAndContingenciesDetails1 Commitments And Contingencies (Details 1) Details 51 false false R52.htm 00000053 - Disclosure - Commitments And Contingencies (Details 2) Sheet http://network-1.com/role/CommitmentsAndContingenciesDetails2 Commitments And Contingencies (Details 2) Details 52 false false R53.htm 00000054 - Disclosure - Commitments and Contingencies (Details Narrative) Sheet http://network-1.com/role/CommitmentsAndContingenciesDetailsNarrative Commitments and Contingencies (Details Narrative) Details http://network-1.com/role/CommitmentsAndContingenciesTables 53 false false R54.htm 00000055 - Disclosure - Employment Arrangements and Other Agreements (Details Narrative) Sheet http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative Employment Arrangements and Other Agreements (Details Narrative) Details http://network-1.com/role/EmploymentArrangementsAndOtherAgreements 54 false false R55.htm 00000056 - Disclosure - Legal Proceedings (Details Narrative) Sheet http://network-1.com/role/LegalProceedingsDetailsNarrative Legal Proceedings (Details Narrative) Details http://network-1.com/role/LegalProceedings 55 false false R56.htm 00000057 - Disclosure - Concentrations (Details Narrative) Sheet http://network-1.com/role/ConcentrationsDetailsNarrative Concentrations (Details Narrative) Details http://network-1.com/role/Concentrations 56 false false R57.htm 00000058 - Disclosure - Related Party Transaction (Details Narrative) Sheet http://network-1.com/role/RelatedPartyTransactionDetailsNarrative Related Party Transaction (Details Narrative) Details http://network-1.com/role/RelatedPartyTransaction 57 false false R58.htm 00000059 - Disclosure - Stock Repurchase Program (Details Narrative) Sheet http://network-1.com/role/StockRepurchaseProgramDetailsNarrative Stock Repurchase Program (Details Narrative) Details http://network-1.com/role/StockRepurchaseProgram 58 false false R59.htm 00000060 - Disclosure - Dividend Policy (Details Narrative) Sheet http://network-1.com/role/DividendPolicyDetailsNarrative Dividend Policy (Details Narrative) Details http://network-1.com/role/DividendPolicy 59 false false R60.htm 00000061 - Disclosure - Subsequent Events (Details Narrative) Sheet http://network-1.com/role/SubsequentEventsDetailsNarrative Subsequent Events (Details Narrative) Details http://network-1.com/role/SubsequentEvents 60 false false All Reports Book All Reports network1_10k-123122.htm exh21-1_18704.htm exh23-1_18704.htm exh23-2_18704.htm exh31-1_18704.htm exh31-2_18704.htm exh32-1_18704.htm exh32-2_18704.htm nssi-20221231.xsd nssi-20221231_cal.xml nssi-20221231_def.xml nssi-20221231_lab.xml nssi-20221231_pre.xml http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 80 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "network1_10k-123122.htm": { "axisCustom": 0, "axisStandard": 17, "baseTaxonomies": { "http://fasb.org/us-gaap/2022": 437, "http://xbrl.sec.gov/dei/2022": 36 }, "contextCount": 99, "dts": { "calculationLink": { "local": [ "nssi-20221231_cal.xml" ] }, "definitionLink": { "local": [ "nssi-20221231_def.xml" ] }, "inline": { "local": [ "network1_10k-123122.htm" ] }, "labelLink": { "local": [ "nssi-20221231_lab.xml" ] }, "presentationLink": { "local": [ "nssi-20221231_pre.xml" ] }, "schema": { "local": [ "nssi-20221231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 498, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 60, "http://network-1.com/20221231": 45, "http://xbrl.sec.gov/dei/2022": 4, "total": 109 }, "keyCustom": 89, "keyStandard": 250, "memberCustom": 24, "memberStandard": 15, "nsprefix": "nssi", "nsuri": "http://network-1.com/20221231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://network-1.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - Income (Loss) Per Share", "menuCat": "Notes", "order": "10", "role": "http://network-1.com/role/IncomeLossPerShare", "shortName": "Income (Loss) Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - Income Taxes", "menuCat": "Notes", "order": "11", "role": "http://network-1.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - Stockholders\u2019 Equity", "menuCat": "Notes", "order": "12", "role": "http://network-1.com/role/StockholdersEquity", "shortName": "Stockholders\u2019 Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "nssi:MarketableSecuritiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - Marketable Securities", "menuCat": "Notes", "order": "13", "role": "http://network-1.com/role/MarketableSecurities", "shortName": "Marketable Securities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "nssi:MarketableSecuritiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - Equity Investment", "menuCat": "Notes", "order": "14", "role": "http://network-1.com/role/EquityInvestment", "shortName": "Equity Investment", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - Commitments and Contingencies", "menuCat": "Notes", "order": "15", "role": "http://network-1.com/role/CommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "nssi:EmploymentArrangementsAndOtherAgreementsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - Employment Arrangements and Other Agreements", "menuCat": "Notes", "order": "16", "role": "http://network-1.com/role/EmploymentArrangementsAndOtherAgreements", "shortName": "Employment Arrangements and Other Agreements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "nssi:EmploymentArrangementsAndOtherAgreementsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LegalMattersAndContingenciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - Legal Proceedings", "menuCat": "Notes", "order": "17", "role": "http://network-1.com/role/LegalProceedings", "shortName": "Legal Proceedings", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LegalMattersAndContingenciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - Concentrations", "menuCat": "Notes", "order": "18", "role": "http://network-1.com/role/Concentrations", "shortName": "Concentrations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - Related Party Transaction", "menuCat": "Notes", "order": "19", "role": "http://network-1.com/role/RelatedPartyTransaction", "shortName": "Related Party Transaction", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - CONSOLIDATED BALANCE SHEETS", "menuCat": "Statements", "order": "2", "role": "http://network-1.com/role/ConsolidatedBalanceSheets", "shortName": "CONSOLIDATED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AcceleratedShareRepurchasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - Stock Repurchase Program", "menuCat": "Notes", "order": "20", "role": "http://network-1.com/role/StockRepurchaseProgram", "shortName": "Stock Repurchase Program", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AcceleratedShareRepurchasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDividendPaymentRestrictionsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - Dividend Policy", "menuCat": "Notes", "order": "21", "role": "http://network-1.com/role/DividendPolicy", "shortName": "Dividend Policy", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDividendPaymentRestrictionsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - Subsequent Events", "menuCat": "Notes", "order": "22", "role": "http://network-1.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - Summary of Significant Accounting Policies (Policies)", "menuCat": "Policies", "order": "23", "role": "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "us-gaap:RevenueRecognitionPolicyTextBlock", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - Summary of Significant Accounting Policies (Tables)", "menuCat": "Tables", "order": "24", "role": "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesTables", "shortName": "Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:RevenueRecognitionPolicyTextBlock", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "nssi:PatentsTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - Patents (Tables)", "menuCat": "Tables", "order": "25", "role": "http://network-1.com/role/PatentsTables", "shortName": "Patents (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "nssi:PatentsTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - Income (Loss) Per Share (Tables)", "menuCat": "Tables", "order": "26", "role": "http://network-1.com/role/IncomeLossPerShareTables", "shortName": "Income (Loss) Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - Income Taxes (Tables)", "menuCat": "Tables", "order": "27", "role": "http://network-1.com/role/IncomeTaxesTables", "shortName": "Income Taxes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - Stockholders\u2019 Equity (Tables)", "menuCat": "Tables", "order": "28", "role": "http://network-1.com/role/StockholdersEquityTables", "shortName": "Stockholders\u2019 Equity (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "nssi:MarketableSecuritiesDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MarketableSecuritiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000030 - Disclosure - Marketable Securities (Tables)", "menuCat": "Tables", "order": "29", "role": "http://network-1.com/role/MarketableSecuritiesTables", "shortName": "Marketable Securities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "nssi:MarketableSecuritiesDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MarketableSecuritiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://network-1.com/role/ConsolidatedBalanceSheetsParenthetical", "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000031 - Disclosure - Equity Investment (Tables)", "menuCat": "Tables", "order": "30", "role": "http://network-1.com/role/EquityInvestmentTables", "shortName": "Equity Investment (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "nssi:OperatingLeasesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000032 - Disclosure - Commitments and Contingencies (Tables)", "menuCat": "Tables", "order": "31", "role": "http://network-1.com/role/CommitmentsAndContingenciesTables", "shortName": "Commitments and Contingencies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "nssi:OperatingLeasesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:GainContingencyPatentsFoundInfringedUponNumber", "reportCount": 1, "unique": true, "unitRef": "Integer", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000033 - Disclosure - Business (Details Narrative)", "menuCat": "Details", "order": "32", "role": "http://network-1.com/role/BusinessDetailsNarrative", "shortName": "Business (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:GainContingencyPatentsFoundInfringedUponNumber", "reportCount": 1, "unique": true, "unitRef": "Integer", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2021-01-012021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000034 - Disclosure - Summary Of Significant Accounting Policies (Details)", "menuCat": "Details", "order": "33", "role": "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesDetails", "shortName": "Summary Of Significant Accounting Policies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "us-gaap:RevenueRecognitionPolicyTextBlock", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2021-01-012021-12-31_custom_FullyPaidLicensesMember", "decimals": "0", "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "span", "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashFDICInsuredAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000035 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)", "menuCat": "Details", "order": "34", "role": "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "shortName": "Summary of Significant Accounting Policies (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashFDICInsuredAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "nssi:PatentsTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000036 - Disclosure - Patents (Details)", "menuCat": "Details", "order": "35", "role": "http://network-1.com/role/PatentsDetails", "shortName": "Patents (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "nssi:PatentsTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nssi:PatentsTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000037 - Disclosure - Patents (Details 1)", "menuCat": "Details", "order": "36", "role": "http://network-1.com/role/PatentsDetails1", "shortName": "Patents (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nssi:PatentsTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "span", "p", "nssi:PatentsTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AmortizationOfFinancingCosts", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000038 - Disclosure - Patents (Details Narrative)", "menuCat": "Details", "order": "37", "role": "http://network-1.com/role/PatentsDetailsNarrative", "shortName": "Patents (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "nssi:PatentsTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AmortizationOfFinancingCosts", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000039 - Disclosure - Disclosure -Income (Loss) Per Share (Details)", "menuCat": "Details", "order": "38", "role": "http://network-1.com/role/Disclosure-incomeLossPerShareDetails", "shortName": "Disclosure -Income (Loss) Per Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2021-01-012021-12-31", "decimals": "INF", "lang": null, "name": "us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000040 - Disclosure - Income (Loss) Per Share (Details Narrative)", "menuCat": "Details", "order": "39", "role": "http://network-1.com/role/IncomeLossPerShareDetailsNarrative", "shortName": "Income (Loss) Per Share (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2021-01-012021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)", "menuCat": "Statements", "order": "4", "role": "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss", "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2021-01-012021-12-31", "decimals": "0", "lang": null, "name": "nssi:CostOfRevenues", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2021-01-012021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CurrentStateAndLocalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000041 - Disclosure - Income Taxes (Details)", "menuCat": "Details", "order": "40", "role": "http://network-1.com/role/IncomeTaxesDetails", "shortName": "Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2021-01-012021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CurrentStateAndLocalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000042 - Disclosure - Income Taxes (Details 1)", "menuCat": "Details", "order": "41", "role": "http://network-1.com/role/IncomeTaxesDetails1", "shortName": "Income Taxes (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000043 - Disclosure - Income Taxes (Details 2)", "menuCat": "Details", "order": "42", "role": "http://network-1.com/role/IncomeTaxesDetails2", "shortName": "Income Taxes (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000044 - Disclosure - Income Taxes (Details Narrative)", "menuCat": "Details", "order": "43", "role": "http://network-1.com/role/IncomeTaxesDetailsNarrative", "shortName": "Income Taxes (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "AsOf2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000045 - Disclosure - Stockholders' Equity (Details)", "menuCat": "Details", "order": "44", "role": "http://network-1.com/role/StockholdersEquityDetails", "shortName": "Stockholders' Equity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "AsOf2020-12-31", "decimals": "INF", "lang": null, "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "AsOf2021-12-31_us-gaap_StockOptionMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000046 - Disclosure - Stockholders' Equity (Details 1)", "menuCat": "Details", "order": "45", "role": "http://network-1.com/role/StockholdersEquityDetails1", "shortName": "Stockholders' Equity (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "AsOf2020-12-31_us-gaap_StockOptionMember", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000047 - Disclosure - Stockholders\u2019 Equity (Details Narrative)", "menuCat": "Details", "order": "46", "role": "http://network-1.com/role/StockholdersEquityDetailsNarrative", "shortName": "Stockholders\u2019 Equity (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:MarketableSecuritiesTextBlock", "nssi:MarketableSecuritiesDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "AsOf2022-12-31_custom_FairValueMember", "decimals": "0", "first": true, "lang": null, "name": "nssi:GovernmentSecurities", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000048 - Disclosure - Marketable Securities (Details)", "menuCat": "Details", "order": "47", "role": "http://network-1.com/role/MarketableSecuritiesDetails", "shortName": "Marketable Securities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:MarketableSecuritiesTextBlock", "nssi:MarketableSecuritiesDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "AsOf2022-12-31_custom_FairValueMember", "decimals": "0", "first": true, "lang": null, "name": "nssi:GovernmentSecurities", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:EquityMethodInvestmentsTextBlock", "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2021-10-012022-09-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromEquityMethodInvestments", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000049 - Disclosure - Equity Investment (Details)", "menuCat": "Details", "order": "48", "role": "http://network-1.com/role/EquityInvestmentDetails", "shortName": "Equity Investment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:EquityMethodInvestmentsTextBlock", "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2021-10-012022-09-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromEquityMethodInvestments", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtSecuritiesUnrealizedGainLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000050 - Disclosure - Equity Investment (Details Narrative)", "menuCat": "Details", "order": "49", "role": "http://network-1.com/role/EquityInvestmentDetailsNarrative", "shortName": "Equity Investment (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtSecuritiesUnrealizedGainLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "AsOf2020-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY", "menuCat": "Statements", "order": "5", "role": "http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity", "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "AsOf2020-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000051 - Disclosure - Commitments And Contingencies (Details)", "menuCat": "Details", "order": "50", "role": "http://network-1.com/role/CommitmentsAndContingenciesDetails", "shortName": "Commitments And Contingencies (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R51": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000052 - Disclosure - Commitments And Contingencies (Details 1)", "menuCat": "Details", "order": "51", "role": "http://network-1.com/role/CommitmentsAndContingenciesDetails1", "shortName": "Commitments And Contingencies (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000053 - Disclosure - Commitments And Contingencies (Details 2)", "menuCat": "Details", "order": "52", "role": "http://network-1.com/role/CommitmentsAndContingenciesDetails2", "shortName": "Commitments And Contingencies (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-03-012022-03-25", "decimals": "0", "first": true, "lang": null, "name": "nssi:HftPatentAcqusitionCashAtClosing", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000054 - Disclosure - Commitments and Contingencies (Details Narrative)", "menuCat": "Details", "order": "53", "role": "http://network-1.com/role/CommitmentsAndContingenciesDetailsNarrative", "shortName": "Commitments and Contingencies (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-03-012022-03-25", "decimals": "0", "first": true, "lang": null, "name": "nssi:HftPatentAcqusitionCashAtClosing", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "span", "span", "p", "nssi:EmploymentArrangementsAndOtherAgreementsTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-012022-12-31_srt_ChiefExecutiveOfficerMember", "decimals": "0", "first": true, "lang": null, "name": "nssi:AnnualDiscretionaryBonus", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000055 - Disclosure - Employment Arrangements and Other Agreements (Details Narrative)", "menuCat": "Details", "order": "54", "role": "http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative", "shortName": "Employment Arrangements and Other Agreements (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "p", "nssi:EmploymentArrangementsAndOtherAgreementsTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-012022-12-31_srt_ChiefExecutiveOfficerMember", "decimals": "0", "first": true, "lang": null, "name": "nssi:AnnualDiscretionaryBonus", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:LegalMattersAndContingenciesTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2017-05-082017-05-09_custom_GoogleMember", "decimals": null, "first": true, "lang": "en-US", "name": "nssi:LitigationPendingDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000056 - Disclosure - Legal Proceedings (Details Narrative)", "menuCat": "Details", "order": "55", "role": "http://network-1.com/role/LegalProceedingsDetailsNarrative", "shortName": "Legal Proceedings (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:LegalMattersAndContingenciesTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2017-05-082017-05-09_custom_GoogleMember", "decimals": null, "first": true, "lang": "en-US", "name": "nssi:LitigationPendingDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2021-01-012021-12-31_custom_RemotePowerPatentMember", "decimals": "INF", "first": true, "lang": null, "name": "nssi:PercentageRevenue", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000057 - Disclosure - Concentrations (Details Narrative)", "menuCat": "Details", "order": "56", "role": "http://network-1.com/role/ConcentrationsDetailsNarrative", "shortName": "Concentrations (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2021-01-012021-12-31_custom_RemotePowerPatentMember", "decimals": "INF", "first": true, "lang": null, "name": "nssi:PercentageRevenue", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-05-292022-06-01_custom_BoardOfDirectorsMember", "decimals": "INF", "first": true, "lang": null, "name": "nssi:NumberOfSharesCommonStockRepurchased", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000058 - Disclosure - Related Party Transaction (Details Narrative)", "menuCat": "Details", "order": "57", "role": "http://network-1.com/role/RelatedPartyTransactionDetailsNarrative", "shortName": "Related Party Transaction (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-05-292022-06-01_custom_BoardOfDirectorsMember", "decimals": "INF", "first": true, "lang": null, "name": "nssi:NumberOfSharesCommonStockRepurchased", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:AcceleratedShareRepurchasesTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000059 - Disclosure - Stock Repurchase Program (Details Narrative)", "menuCat": "Details", "order": "58", "role": "http://network-1.com/role/StockRepurchaseProgramDetailsNarrative", "shortName": "Stock Repurchase Program (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:AcceleratedShareRepurchasesTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ScheduleOfDividendPaymentRestrictionsTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "nssi:DividendsPerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000060 - Disclosure - Dividend Policy (Details Narrative)", "menuCat": "Details", "order": "59", "role": "http://network-1.com/role/DividendPolicyDetailsNarrative", "shortName": "Dividend Policy (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ScheduleOfDividendPaymentRestrictionsTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "nssi:DividendsPerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS", "menuCat": "Statements", "order": "6", "role": "http://network-1.com/role/ConsolidatedStatementsOfCashFlows", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockDividendsPerShareDeclared", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000061 - Disclosure - Subsequent Events (Details Narrative)", "menuCat": "Details", "order": "60", "role": "http://network-1.com/role/SubsequentEventsDetailsNarrative", "shortName": "Subsequent Events (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2023-01-242023-03-10_us-gaap_SubsequentEventMember_custom_SettlementAgreementsMember", "decimals": "0", "lang": null, "name": "nssi:AggregateSettlementPayments", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - Business", "menuCat": "Notes", "order": "7", "role": "http://network-1.com/role/Business", "shortName": "Business", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - Summary of Significant Accounting Policies", "menuCat": "Notes", "order": "8", "role": "http://network-1.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "nssi:PatentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - Patents", "menuCat": "Notes", "order": "9", "role": "http://network-1.com/role/Patents", "shortName": "Patents", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123122.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "nssi:PatentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 40, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r428" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r428" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r425", "r427", "r428" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r425", "r427", "r428" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r425", "r427", "r428" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r427" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r425", "r427", "r428" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r426" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r414" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r427" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r427" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r429" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r417" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r420" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r416" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/BusinessDetailsNarrative", "http://network-1.com/role/EquityInvestmentDetailsNarrative" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r416" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r433" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r416" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r430" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r428" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r416" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r416" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r416" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r416" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r431" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/BusinessDetailsNarrative", "http://network-1.com/role/EquityInvestmentDetailsNarrative" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r427" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r421" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r422" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r415" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r419" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r418" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r423" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r424" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r432" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "nssi_AadditionalConsideration": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Additional consideration payable upon occurrence of certain future events", "label": "Additional consideration payable upon occurrence of certain future events" } } }, "localname": "AadditionalConsideration", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "nssi_AccruedContingencyFeesAndRelatedCosts": { "auth_ref": [], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Accrued contingency fees and related costs" } } }, "localname": "AccruedContingencyFeesAndRelatedCosts", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "nssi_AccruedDividendRightsOnRestrictedStockUnit": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Accrued dividend rights on restricted stock unit" } } }, "localname": "AccruedDividendRightsOnRestrictedStockUnit", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "nssi_AccruedDividendRightsOnRestrictedStockUnits": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Accrued dividend rights on restricted stock units" } } }, "localname": "AccruedDividendRightsOnRestrictedStockUnits", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "nssi_AccruedInterestOnConvertibleNote": { "auth_ref": [], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "AccruedInterestOnConvertibleNote", "negatedLabel": "Accrued interest on convertible note" } } }, "localname": "AccruedInterestOnConvertibleNote", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "nssi_AdditionalInvestedAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Additional invested amount - D units" } } }, "localname": "AdditionalInvestedAmount", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/EquityInvestmentDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "nssi_AggregateCostOfCommonStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Aggregate cost of common stock" } } }, "localname": "AggregateCostOfCommonStock", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/RelatedPartyTransactionDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "nssi_AggregateSettlementPayments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Aggregate settlement payments" } } }, "localname": "AggregateSettlementPayments", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "nssi_AmortizationOfRightOfUseAsset": { "auth_ref": [], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Amortization of right of use asset, net" } } }, "localname": "AmortizationOfRightOfUseAsset", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "nssi_AnnualDiscretionaryBonus": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Annual discretionary bonus" } } }, "localname": "AnnualDiscretionaryBonus", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "nssi_AnnualTargetBonus": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Annual Target Bonus" } } }, "localname": "AnnualTargetBonus", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "nssi_AristaNetworksMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Arista Networks [Member]" } } }, "localname": "AristaNetworksMember", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/LegalProceedingsDetailsNarrative" ], "xbrltype": "domainItemType" }, "nssi_BoardOfDirectorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The member represent board of directors.", "label": "Board Of Directors [Member]" } } }, "localname": "BoardOfDirectorsMember", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/DividendPolicyDetailsNarrative", "http://network-1.com/role/RelatedPartyTransactionDetailsNarrative", "http://network-1.com/role/StockRepurchaseProgramDetailsNarrative", "http://network-1.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "nssi_BookValueOfInvestment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Book value of investment" } } }, "localname": "BookValueOfInvestment", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/EquityInvestmentDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "nssi_CashPaidDuringTheYearsForAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash paid during the years for:" } } }, "localname": "CashPaidDuringTheYearsForAbstract", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "nssi_CertificatesOfDeposit": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "CertificatesOfDeposit", "verboseLabel": "Certificates of deposit" } } }, "localname": "CertificatesOfDeposit", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/MarketableSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "nssi_ChairmanAndChiefExecutiveOfficerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Chairman And Chief Executive Officer [Member]" } } }, "localname": "ChairmanAndChiefExecutiveOfficerMember", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "nssi_ClassCUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class C Units [Member]" } } }, "localname": "ClassCUnitsMember", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/EquityInvestmentDetailsNarrative" ], "xbrltype": "domainItemType" }, "nssi_CommonStockSharesDeliveredToCompanyWithholdingTaxes": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock shares delivered to company - withholding taxes" } } }, "localname": "CommonStockSharesDeliveredToCompanyWithholdingTaxes", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "nssi_CommonStockSubjectToOutstandingAwards": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock subject to outstanding awards" } } }, "localname": "CommonStockSubjectToOutstandingAwards", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "nssi_ConditionalPayment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Conditional payment" } } }, "localname": "ConditionalPayment", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "nssi_ContingentCommonStockIssuedUponAchievingCertainMilestones": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Contingent common stock issued upon achieving certain milestones" } } }, "localname": "ContingentCommonStockIssuedUponAchievingCertainMilestones", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "nssi_ConvertibleNoteInvestment": { "auth_ref": [], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "ConvertibleNoteInvestment", "negatedLabel": "Convertible note investment" } } }, "localname": "ConvertibleNoteInvestment", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "nssi_ConvertibleNoteInvestments": { "auth_ref": [], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_OtherAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Convertible note investment" } } }, "localname": "ConvertibleNoteInvestments", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "nssi_CorporateBonds": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Corporate bonds and notes" } } }, "localname": "CorporateBonds", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/MarketableSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "nssi_CostBasisMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cost Basis [Member]" } } }, "localname": "CostBasisMember", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/MarketableSecuritiesDetails" ], "xbrltype": "domainItemType" }, "nssi_CostOfRevenues": { "auth_ref": [], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Costs of revenue" } } }, "localname": "CostOfRevenues", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "nssi_CostsofRevenueandRelatedCostsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Costs of Revenue and Related Costs" } } }, "localname": "CostsofRevenueandRelatedCostsPolicyTextBlock", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "nssi_CoxPatentPortfolioMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cox Patent Portfolio [Member]" } } }, "localname": "CoxPatentPortfolioMember", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "nssi_DecreaseInBasicAndDilutedEarnings": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Decrease in basic and diluted earnings" } } }, "localname": "DecreaseInBasicAndDilutedEarnings", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "perShareItemType" }, "nssi_DeferredTaxAssetsLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Total deferred tax assets (liability)" } } }, "localname": "DeferredTaxAssetsLiability", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "nssi_DeferredTaxAssetsStockOptionsAndRsu": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Stock options and RSU" } } }, "localname": "DeferredTaxAssetsStockOptionsAndRsu", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "nssi_DeferredTaxLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Deferred Tax Liability" } } }, "localname": "DeferredTaxLiability", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "nssi_DisclosureEmploymentArrangementsAndOtherAgreementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Employment Arrangements And Other Agreements" } } }, "localname": "DisclosureEmploymentArrangementsAndOtherAgreementsAbstract", "nsuri": "http://network-1.com/20221231", "xbrltype": "stringItemType" }, "nssi_DisclosureMarketableSecuritiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Marketable Securities" } } }, "localname": "DisclosureMarketableSecuritiesAbstract", "nsuri": "http://network-1.com/20221231", "xbrltype": "stringItemType" }, "nssi_DisclosurePatentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Patents" } } }, "localname": "DisclosurePatentsAbstract", "nsuri": "http://network-1.com/20221231", "xbrltype": "stringItemType" }, "nssi_DividendsAndDividendEquivalentsDeclared": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Dividends and dividend equivalents declared" } } }, "localname": "DividendsAndDividendEquivalentsDeclared", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "nssi_DividendsPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dividends, per share - semi-annual" } } }, "localname": "DividendsPerShare", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/DividendPolicyDetailsNarrative" ], "xbrltype": "perShareItemType" }, "nssi_DividendsPerShareAnnual": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dividends, per share - annual" } } }, "localname": "DividendsPerShareAnnual", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/DividendPolicyDetailsNarrative" ], "xbrltype": "perShareItemType" }, "nssi_EmploymentArrangementsAndOtherAgreementsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Employment Arrangements and Other Agreements" } } }, "localname": "EmploymentArrangementsAndOtherAgreementsTextBlock", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/EmploymentArrangementsAndOtherAgreements" ], "xbrltype": "textBlockItemType" }, "nssi_EquityInvestmentNetLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Equity investment net loss" } } }, "localname": "EquityInvestmentNetLoss", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/EquityInvestmentDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "nssi_ExpirationDatesOfPatentsWithinCompanysM2miotPatentPortfolio": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Expiration dates of the patents within the Company's M2M/IoT Patent Portfolio" } } }, "localname": "ExpirationDatesOfPatentsWithinCompanysM2miotPatentPortfolio", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/PatentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "nssi_ExpirationDatesOfPatentsWithinCoxPatentPortfolio": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Expiration dates of the patents within the Cox patent portfolio" } } }, "localname": "ExpirationDatesOfPatentsWithinCoxPatentPortfolio", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/PatentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "nssi_ExpirationDatesWithinCompanysHftPatentPortfolio": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Expiration dates within companys HFT patent portfolio" } } }, "localname": "ExpirationDatesWithinCompanysHftPatentPortfolio", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/PatentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "nssi_ExpiredPatents": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Expired patents" } } }, "localname": "ExpiredPatents", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/BusinessDetailsNarrative" ], "xbrltype": "integerItemType" }, "nssi_FacebookMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The member represent facebook.", "label": "Facebook [Member]" } } }, "localname": "FacebookMember", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/LegalProceedingsDetailsNarrative" ], "xbrltype": "domainItemType" }, "nssi_FairValueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value [Member]" } } }, "localname": "FairValueMember", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/MarketableSecuritiesDetails" ], "xbrltype": "domainItemType" }, "nssi_First100": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represent percentage of first $100 million.", "label": "First $100 Million" } } }, "localname": "First100", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "nssi_First125Million": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represent percentage of first $125 million.", "label": "First $125 Million" } } }, "localname": "First125Million", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "nssi_First50Million": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "First $50 million of HFT net proceeds" } } }, "localname": "First50Million", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "nssi_ForeignPatentsOwnedByCompany": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Foreign patents owned by the company" } } }, "localname": "ForeignPatentsOwnedByCompany", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/BusinessDetailsNarrative" ], "xbrltype": "integerItemType" }, "nssi_FullyPaidLicensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fully Paid Licenses [Member]" } } }, "localname": "FullyPaidLicensesMember", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "nssi_GainOnEquityMethodInvestment": { "auth_ref": [], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Gain on equity method investment", "negatedLabel": "Gain on equity method investment" } } }, "localname": "GainOnEquityMethodInvestment", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows", "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "nssi_GoogleMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Google [Member]" } } }, "localname": "GoogleMember", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/LegalProceedingsDetailsNarrative" ], "xbrltype": "domainItemType" }, "nssi_GovernmentSecurities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Government securities" } } }, "localname": "GovernmentSecurities", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/MarketableSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "nssi_GreaterThan50Million": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Greater than $50 million of HFT net proceeds" } } }, "localname": "GreaterThan50Million", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "nssi_GrossUnrealizedGainsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Gross Unrealized Gains [Member]" } } }, "localname": "GrossUnrealizedGainsMember", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/MarketableSecuritiesDetails" ], "xbrltype": "domainItemType" }, "nssi_GrossUnrealizedLossesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Gross Unrealized Losses [Member]" } } }, "localname": "GrossUnrealizedLossesMember", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/MarketableSecuritiesDetails" ], "xbrltype": "domainItemType" }, "nssi_HftPatentAcqusitionCashAtClosing": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "HFT patent acqusition - cash at closing" } } }, "localname": "HftPatentAcqusitionCashAtClosing", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "nssi_ILiADBiotechnologiesLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "I Li A D Biotechnologies L L C [Member]" } } }, "localname": "ILiADBiotechnologiesLLCMember", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/BusinessDetailsNarrative", "http://network-1.com/role/EquityInvestmentDetailsNarrative" ], "xbrltype": "domainItemType" }, "nssi_IliadMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Iliad [Member]" } } }, "localname": "IliadMember", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/EquityInvestmentDetailsNarrative" ], "xbrltype": "domainItemType" }, "nssi_IncreaseInNetLossesOfEquityMethodInvestee": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Increase in net losses of equity method investee" } } }, "localname": "IncreaseInNetLossesOfEquityMethodInvestee", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "nssi_InvestedAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Invested amount - multi-national pharma" } } }, "localname": "InvestedAmount", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/EquityInvestmentDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "nssi_IssuanceWeightedaverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Grants of restricted stock units, weighted average grant date fair value" } } }, "localname": "IssuanceWeightedaverageGrantDateFairValue", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "nssi_LicenseesTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Licensees Two [Member]" } } }, "localname": "LicenseesTwoMember", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "nssi_LitigationPendingDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Litigation pending, description.", "label": "Litigation pending, description" } } }, "localname": "LitigationPendingDescription", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/LegalProceedingsDetailsNarrative" ], "xbrltype": "stringItemType" }, "nssi_LossIncomeBeforeShareOfNetLossesOfEquityMethodInvestee": { "auth_ref": [], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "LossIncomeBeforeShareOfNetLossesOfEquityMethodInvestee", "totalLabel": "(LOSS) INCOME BEFORE SHARE OF NET LOSSES OF EQUITY METHOD INVESTEE:" } } }, "localname": "LossIncomeBeforeShareOfNetLossesOfEquityMethodInvestee", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "nssi_MarketableSecuritiesDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "MarketableSecuritiesDisclosureTextBlock", "verboseLabel": "Marketable Securities" } } }, "localname": "MarketableSecuritiesDisclosureTextBlock", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/MarketableSecurities" ], "xbrltype": "textBlockItemType" }, "nssi_MinimumStockPriceForVesting": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Minimum stock price for vesting" } } }, "localname": "MinimumStockPriceForVesting", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "nssi_NetLossIncomePerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net (Loss) Income Per Share:" } } }, "localname": "NetLossIncomePerShareAbstract", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "nssi_NetSharesReceived": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net shares received" } } }, "localname": "NetSharesReceived", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "nssi_NetUnrealizedLossOnCorporateBondsAndNotes": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Net unrealized loss on corporate bonds and notes" } } }, "localname": "NetUnrealizedLossOnCorporateBondsAndNotes", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "nssi_NetgearMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Netgear [Member]" } } }, "localname": "NetgearMember", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/LegalProceedingsDetailsNarrative" ], "xbrltype": "domainItemType" }, "nssi_NewEmploymentAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The member represent new employment agreement.", "label": "New Employment Agreement [Member]" } } }, "localname": "NewEmploymentAgreementMember", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "nssi_Next100": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represent percentage of next $100 million.", "label": "Next $100 Million" } } }, "localname": "Next100", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "nssi_Next125Million": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represent next $125 Million.", "label": "Next $125 Million" } } }, "localname": "Next125Million", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "nssi_NonCashConversionOfNoteReceivable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Conversion of note receivable" } } }, "localname": "NonCashConversionOfNoteReceivable", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "nssi_NumberOfSharesCommonStockRepurchased": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Number of shares, common stock repurchased" } } }, "localname": "NumberOfSharesCommonStockRepurchased", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/RelatedPartyTransactionDetailsNarrative" ], "xbrltype": "sharesItemType" }, "nssi_ObligatedToPayMtmAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Obligated to pay MTM" } } }, "localname": "ObligatedToPayMtmAbstract", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "nssi_ObligatedToPayRecognitionNetProceedsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Obligated to pay Recognition, net proceeds" } } }, "localname": "ObligatedToPayRecognitionNetProceedsAbstract", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "nssi_ObligatedToPaySellerNetProceedPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Obligated to pay Cox, net proceeds percentage.", "label": "Obligated to pay Cox, net proceeds percentage" } } }, "localname": "ObligatedToPaySellerNetProceedPercentage", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "nssi_ObligationToPayHftSellerAdditionalCashBasedOnAchievingCertainMilestones": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Obligation to pay HFT seller additional cash based on achieving certain milestones" } } }, "localname": "ObligationToPayHftSellerAdditionalCashBasedOnAchievingCertainMilestones", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "nssi_OperatingLeasesImputedInterest": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Less imputed interest" } } }, "localname": "OperatingLeasesImputedInterest", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetails2" ], "xbrltype": "monetaryItemType" }, "nssi_OperatingLeasesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of operating leases obligations" } } }, "localname": "OperatingLeasesTableTextBlock", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesTables" ], "xbrltype": "textBlockItemType" }, "nssi_OtherInvestment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Total marketable securities" } } }, "localname": "OtherInvestment", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/MarketableSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "nssi_OtherInvestmentReadilyMarketablesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OtherInvestmentReadilyMarketablesTable [Table]" } } }, "localname": "OtherInvestmentReadilyMarketablesTable", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/MarketableSecuritiesDetails" ], "xbrltype": "stringItemType" }, "nssi_OtherInvestmentsReadilyMarketableLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OtherInvestmentsReadilyMarketableLineItems [Line Items]" } } }, "localname": "OtherInvestmentsReadilyMarketableLineItems", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/MarketableSecuritiesDetails" ], "xbrltype": "stringItemType" }, "nssi_Over250Million": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Over $250 Million", "label": "Over $250 Million" } } }, "localname": "Over250Million", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "nssi_OwnershipPercentageFullyDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ownership percentage fully diluted" } } }, "localname": "OwnershipPercentageFullyDiluted", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/EquityInvestmentDetailsNarrative" ], "xbrltype": "percentItemType" }, "nssi_PatentsAcquisition": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "PatentsAcquisition [Line Items]" } } }, "localname": "PatentsAcquisition", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "nssi_PatentsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "PatentsPolicyTextBlock", "verboseLabel": "Patents" } } }, "localname": "PatentsPolicyTextBlock", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "nssi_PatentsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "PatentsTextBlock", "verboseLabel": "Patents" } } }, "localname": "PatentsTextBlock", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/Patents" ], "xbrltype": "textBlockItemType" }, "nssi_PercentageRevenue": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Percentage revenue" } } }, "localname": "PercentageRevenue", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "percentItemType" }, "nssi_PricePerShareCommonStockRepurchased": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Price per share, common stock repurchased" } } }, "localname": "PricePerShareCommonStockRepurchased", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/RelatedPartyTransactionDetailsNarrative" ], "xbrltype": "perShareItemType" }, "nssi_ProratedTargetBonus": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of Target annual bonus paid Chairman and CEO.", "label": "Prorated target bonus" } } }, "localname": "ProratedTargetBonus", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "nssi_RecognitionNetProceedsPaymentRelatedToMirrorWorldsPatents": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Recognition net proceeds payment related to Mirror Worlds patents" } } }, "localname": "RecognitionNetProceedsPaymentRelatedToMirrorWorldsPatents", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "nssi_RemotePowerPatentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Remote Power Patent [Member]" } } }, "localname": "RemotePowerPatentMember", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "nssi_RestrictedStockUnitsExcludedFromComputationOfDilutedIncomePerShareBecauseEffectOfInclusionWouldHaveBeenAntidilutive": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restricted stock units excluded from the computation of diluted income per share because the effect of inclusion would have been anti-dilutive" } } }, "localname": "RestrictedStockUnitsExcludedFromComputationOfDilutedIncomePerShareBecauseEffectOfInclusionWouldHaveBeenAntidilutive", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/Disclosure-incomeLossPerShareDetails" ], "xbrltype": "sharesItemType" }, "nssi_RestrictedStockUnitsGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restricted stock units granted" } } }, "localname": "RestrictedStockUnitsGranted", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "nssi_RestrictedStockUnitsGrantedToDirectors": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restricted stock units granted to directors" } } }, "localname": "RestrictedStockUnitsGrantedToDirectors", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "nssi_RestrictedStockUnitsToVestTranche1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restricted Stock Units to vest (Tranche 1)" } } }, "localname": "RestrictedStockUnitsToVestTranche1", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "nssi_RestrictedStockUnitsToVestTranche2": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restricted stock units to vest (Tranche 2)" } } }, "localname": "RestrictedStockUnitsToVestTranche2", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "nssi_RestrictedStockUnitsToVestTranche3": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restricted stock units to vest (Tranche 3)" } } }, "localname": "RestrictedStockUnitsToVestTranche3", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "nssi_RestrictedStockUnitsToVestTranche4": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restricted stock units to vest (Tranche 4)" } } }, "localname": "RestrictedStockUnitsToVestTranche4", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "nssi_RestrictedStockUnitsTranche1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restricted stock units Tranche 1" } } }, "localname": "RestrictedStockUnitsTranche1", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "nssi_RightOfUseAssetObtainedInExchangeForLeaseLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Right of use asset obtained in exchange for lease liability" } } }, "localname": "RightOfUseAssetObtainedInExchangeForLeaseLiability", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "nssi_RoyaltyBearingLicensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Royalty Bearing Licenses [Member]" } } }, "localname": "RoyaltyBearingLicensesMember", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "nssi_SemiAnnualCashDividendRecordDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Semi-annual cash dividend record date", "label": "Semi-annual cash dividend record date" } } }, "localname": "SemiAnnualCashDividendRecordDate", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/DividendPolicyDetailsNarrative", "http://network-1.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "dateItemType" }, "nssi_SettlementAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Settlement Agreements [Member]" } } }, "localname": "SettlementAgreementsMember", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "nssi_ShareBasedCompensationAwardTrancheFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Based Compensation Award Tranche Four [Member]" } } }, "localname": "ShareBasedCompensationAwardTrancheFourMember", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "nssi_ShortTermBondFunds": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Fixed income mutual funds" } } }, "localname": "ShortTermBondFunds", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/MarketableSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "nssi_StockIncentivePlan2013Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock Incentive Plan 2013 [Member]" } } }, "localname": "StockIncentivePlan2013Member", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "nssi_StockIncentivePlan2022Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock Incentive Plan 2022 [Member]" } } }, "localname": "StockIncentivePlan2022Member", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "nssi_TotalStockholdersEquityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Total Stockholders\u2019 Equity" } } }, "localname": "TotalStockholdersEquityMember", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "nssi_TreasuryStockPurchasedAndRetired": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Treasury stock purchased and retired" } } }, "localname": "TreasuryStockPurchasedAndRetired", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "nssi_TreasuryStockPurchasedAndRetiredShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Treasury stock purchased and retired, shares" } } }, "localname": "TreasuryStockPurchasedAndRetiredShares", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "nssi_ValueOfSharesDeliveredToFundWithholdingTaxes": { "auth_ref": [], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "ValueOfSharesDeliveredToFundWithholdingTaxes", "negatedLabel": "Value of shares delivered to fund withholding taxes" } } }, "localname": "ValueOfSharesDeliveredToFundWithholdingTaxes", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "nssi_ValueOfSharesDeliveredToPayWithholdingTaxes": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Value of shares delivered to pay exercise price and withholding taxes" } } }, "localname": "ValueOfSharesDeliveredToPayWithholdingTaxes", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "nssi_ValueOfSharesDeliveredToPayWithholdingTaxesShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Value of shares delivered to pay withholding taxes, Shares" } } }, "localname": "ValueOfSharesDeliveredToPayWithholdingTaxesShares", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "nssi_VestingOfRestrictedStockUnits": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Vesting of restricted stock units" } } }, "localname": "VestingOfRestrictedStockUnits", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "nssi_VestingOfRestrictedStockUnitsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Vesting of restricted stock units, shares" } } }, "localname": "VestingOfRestrictedStockUnitsShares", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "nssi_WeightedAveragePricePerShareCommonStockSubjectToRepurchase": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price per share common stock subject to repurchase.", "label": "Average price per share, common stock repurchased since inception" } } }, "localname": "WeightedAveragePricePerShareCommonStockSubjectToRepurchase", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/StockRepurchaseProgramDetailsNarrative" ], "xbrltype": "perShareItemType" }, "nssi_WeightedaverageCommonSharesOutstandingDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted-average common shares outstanding \u2013 diluted" } } }, "localname": "WeightedaverageCommonSharesOutstandingDiluted", "nsuri": "http://network-1.com/20221231", "presentation": [ "http://network-1.com/role/Disclosure-incomeLossPerShareDetails" ], "xbrltype": "sharesItemType" }, "srt_ChiefExecutiveOfficerMember": { "auth_ref": [ "r453" ], "lang": { "en-us": { "role": { "label": "Chief Executive Officer [Member]" } } }, "localname": "ChiefExecutiveOfficerMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ChiefFinancialOfficerMember": { "auth_ref": [ "r453" ], "lang": { "en-us": { "role": { "label": "Chief Financial Officer [Member]" } } }, "localname": "ChiefFinancialOfficerMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_EquityMethodInvesteeNameDomain": { "auth_ref": [], "localname": "EquityMethodInvesteeNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://network-1.com/role/EquityInvestmentDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r229", "r230", "r231", "r232", "r260", "r363", "r376", "r387", "r388", "r402", "r406", "r413", "r463", "r511", "r512", "r513", "r514", "r515", "r516" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://network-1.com/role/PatentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r229", "r230", "r231", "r232", "r260", "r363", "r376", "r387", "r388", "r402", "r406", "r413", "r463", "r511", "r512", "r513", "r514", "r515", "r516" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://network-1.com/role/PatentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r212", "r364", "r403", "r412", "r457", "r458", "r464", "r517" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r212", "r364", "r403", "r412", "r457", "r458", "r464", "r517" ], "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r229", "r230", "r231", "r232", "r259", "r260", "r286", "r287", "r288", "r362", "r363", "r376", "r387", "r388", "r402", "r406", "r413", "r456", "r463", "r512", "r513", "r514", "r515", "r516" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://network-1.com/role/PatentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r229", "r230", "r231", "r232", "r259", "r260", "r286", "r287", "r288", "r362", "r363", "r376", "r387", "r388", "r402", "r406", "r413", "r456", "r463", "r512", "r513", "r514", "r515", "r516" ], "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://network-1.com/role/PatentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "auth_ref": [ "r215" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]" } } }, "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://network-1.com/role/EquityInvestmentDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r453", "r507" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://network-1.com/role/DividendPolicyDetailsNarrative", "http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative", "http://network-1.com/role/LegalProceedingsDetailsNarrative", "http://network-1.com/role/RelatedPartyTransactionDetailsNarrative", "http://network-1.com/role/StockRepurchaseProgramDetailsNarrative", "http://network-1.com/role/StockholdersEquityDetailsNarrative", "http://network-1.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://network-1.com/role/DividendPolicyDetailsNarrative", "http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative", "http://network-1.com/role/LegalProceedingsDetailsNarrative", "http://network-1.com/role/RelatedPartyTransactionDetailsNarrative", "http://network-1.com/role/StockRepurchaseProgramDetailsNarrative", "http://network-1.com/role/StockholdersEquityDetailsNarrative", "http://network-1.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_VicePresidentMember": { "auth_ref": [ "r453" ], "lang": { "en-us": { "role": { "label": "Vice President [Member]" } } }, "localname": "VicePresidentMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AcceleratedShareRepurchasesTextBlock": { "auth_ref": [ "r77" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of accelerated share repurchase (ASR) programs. An ASR is a combination of transactions that permits an entity to purchase a targeted number of shares immediately with the final purchase price of those shares determined by an average market price over a fixed period of time. An accelerated share repurchase program is intended to combine the immediate share retirement benefits of a tender offer with the market impact and pricing benefits of a disciplined daily open market stock repurchase program. ASRs can be disclosed as part of stockholders' equity.", "label": "Stock Repurchase Program" } } }, "localname": "AcceleratedShareRepurchasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/StockRepurchaseProgram" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r10", "r411" ], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesAndOtherLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.", "label": "Accrued Liabilities and Other Liabilities", "verboseLabel": "Accrued expenses" } } }, "localname": "AccruedLiabilitiesAndOtherLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r19", "r20", "r21", "r142", "r372", "r381", "r382" ], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r18", "r21", "r99", "r352", "r377", "r378", "r438", "r439", "r440", "r449", "r450", "r451" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "Accumulated Other Comprehensive (Loss)" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r5", "r411" ], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r292", "r293", "r294", "r449", "r450", "r451", "r500" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentForAmortization": { "auth_ref": [ "r37", "r65" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 4.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.", "label": "Amortization of patents" } } }, "localname": "AdjustmentForAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows", "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r85", "r86", "r262" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "Stock-based compensation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net (loss) income to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r290" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Restricted stock unit compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCosts": { "auth_ref": [ "r27", "r243", "r343", "r445" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt issuance costs.", "label": "Amortization expense" } } }, "localname": "AmortizationOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/PatentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r113", "r123", "r141", "r160", "r202", "r206", "r210", "r216", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r325", "r329", "r335", "r411", "r461", "r462", "r509" ], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "TOTAL ASSETS" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS:" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r136", "r144", "r160", "r216", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r325", "r329", "r335", "r411", "r461", "r462", "r509" ], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CURRENT ASSETS:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative", "http://network-1.com/role/StockholdersEquityDetails1", "http://network-1.com/role/StockholdersEquityDetailsNarrative", "http://network-1.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r43" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.", "label": "Summary of Significant Accounting Policies" } } }, "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r323", "r404", "r405" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r96", "r97", "r323", "r404", "r405" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "auth_ref": [ "r0", "r43", "r54" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Business" } } }, "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/Business" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r39", "r138", "r389" ], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r40" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r34", "r39", "r42" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "CASH AND CASH EQUIVALENTS, end of year", "periodStartLabel": "CASH AND CASH EQUIVALENTS, beginning of year" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r34", "r108" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "totalLabel": "NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFDICInsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.", "label": "FDIC insured limit" } } }, "localname": "CashFDICInsuredAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashUninsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation.", "label": "Cash in excess of FDIC insured limit" } } }, "localname": "CashUninsuredAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CertificatesOfDepositAtCarryingValue": { "auth_ref": [ "r435" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A savings certificate entitling the Entity (that is, bearer) to receive interest at an established maturity date, based upon a fixed interest rate. A certificate of deposit may be issued in any denomination. Certificates of deposit are generally issued by commercial banks and, therefore, insured by the FDIC (up to the prescribed limit). Certificates of deposit generally restrict holders from withdrawing funds on demand without the incurrence of penalties. Generally, only certificates of deposit with original maturities of three months or less qualify as cash equivalents. Original maturity means original maturity to the entity holding the investment. As a related example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.", "label": "Certificates of deposit" } } }, "localname": "CertificatesOfDepositAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r257" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Exercise price" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r15", "r116", "r126" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "COMMITMENTS AND CONTINGENCIES (See Note I)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r71", "r227", "r228", "r386", "r460" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Aggregate number of common shares reserved for future issuance.", "label": "Common stock available for issuance under 2022 Plan" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockDividendsPerShareDeclared": { "auth_ref": [ "r76" ], "lang": { "en-us": { "role": { "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.", "label": "Cash dividends declared per share", "verboseLabel": "Semi-annual cash dividend per common share" } } }, "localname": "CommonStockDividendsPerShareDeclared", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss", "http://network-1.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r449", "r450", "r500" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r4", "r75" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r4", "r411" ], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock, $0.01 par value; authorized 50,000,000 shares; 23,863,639 and 23,792,212 shares issued and outstanding at December 31, 2022 and December\u00a031, 2021, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationRelatedCostsPolicyTextBlock": { "auth_ref": [ "r81" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.", "label": "Stock-Based Compensation" } } }, "localname": "CompensationRelatedCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r22", "r147", "r149", "r155", "r367", "r373" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive loss", "totalLabel": "COMPREHENSIVE (LOSS) INCOME" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss", "http://network-1.com/role/EquityInvestmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r48", "r49", "r104", "r105", "r214", "r385" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/MarketableSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r48", "r49", "r104", "r105", "r214", "r384", "r385" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/MarketableSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r48", "r49", "r104", "r105", "r214", "r385", "r518" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "auth_ref": [ "r54" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.", "label": "Concentrations" } } }, "localname": "ConcentrationRiskDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/Concentrations" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Concentration Risk [Line Items]" } } }, "localname": "ConcentrationRiskLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskTable": { "auth_ref": [ "r47", "r48", "r49", "r50", "r104", "r106", "r385" ], "lang": { "en-us": { "role": { "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Concentration Risk [Table]" } } }, "localname": "ConcentrationRiskTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r48", "r49", "r104", "r105", "r214", "r385" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r98", "r392" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current" } } }, "localname": "CurrentFederalStateAndLocalTaxExpenseBenefitAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/IncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "auth_ref": [ "r448", "r495", "r497" ], "calculation": { "http://network-1.com/role/IncomeTaxesDetails": { "order": 2.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Federal" } } }, "localname": "CurrentFederalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "auth_ref": [ "r95", "r308", "r316", "r448" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 }, "http://network-1.com/role/IncomeTaxesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.", "label": "Current", "totalLabel": "Total Current Tax Expense (Benefit)" } } }, "localname": "CurrentIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss", "http://network-1.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "auth_ref": [ "r448", "r495", "r497" ], "calculation": { "http://network-1.com/role/IncomeTaxesDetails": { "order": 1.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "State and local" } } }, "localname": "CurrentStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r109", "r110", "r242", "r344", "r400", "r401" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Principal amount - convertible note" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/EquityInvestmentDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [ "r145", "r399", "r501" ], "lang": { "en-us": { "role": { "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.", "label": "Semi-annual cash dividend payment date", "verboseLabel": "Dividend payment date" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/DividendPolicyDetailsNarrative", "http://network-1.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_DebtSecuritiesUnrealizedGainLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), investment in debt security measured at amortized cost (held-to-maturity) and investment in debt security measured at fair value with change in fair value recognized in net income (trading).", "label": "Unrealized gain securities" } } }, "localname": "DebtSecuritiesUnrealizedGainLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/EquityInvestmentDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]" } } }, "localname": "DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/DividendPolicyDetailsNarrative", "http://network-1.com/role/LegalProceedingsDetailsNarrative", "http://network-1.com/role/RelatedPartyTransactionDetailsNarrative", "http://network-1.com/role/StockRepurchaseProgramDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "auth_ref": [ "r448", "r496", "r497" ], "calculation": { "http://network-1.com/role/IncomeTaxesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Deferred Federal Income Tax Expense (Benefit)", "verboseLabel": "Federal" } } }, "localname": "DeferredFederalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred" } } }, "localname": "DeferredFederalStateAndLocalTaxExpenseBenefitAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/IncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r37", "r95", "r309", "r315", "r316", "r448" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 }, "http://network-1.com/role/IncomeTaxesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred taxes, net", "totalLabel": "Total Deferred Tax Expense" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss", "http://network-1.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r297", "r298" ], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred tax liability" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredOtherTaxExpenseBenefit": { "auth_ref": [ "r92", "r94", "r448" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other deferred income tax expense (benefit) pertaining to income (loss) from continuing operations. For example, but not limited to, acquisition-date income tax benefits or expenses recognized from changes in the acquirer's valuation allowance for its previously existing deferred tax assets resulting from a business combination and adjustments to beginning-of-year balance of a valuation allowance because of a change in circumstance causing a change in judgment about the realizability of the related deferred tax asset in future periods.", "label": "Deferred tax expense" } } }, "localname": "DeferredOtherTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "auth_ref": [ "r448", "r496", "r497" ], "calculation": { "http://network-1.com/role/IncomeTaxesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Deferred State and Local Income Tax Expense (Benefit)", "verboseLabel": "State and local" } } }, "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsCapitalLossCarryforwards": { "auth_ref": [ "r91", "r494" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capital loss carryforwards.", "label": "Capital loss carryforward" } } }, "localname": "DeferredTaxAssetsCapitalLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r304" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Gross" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r91", "r494" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Net operating loss carry forwards" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r305" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Valuation allowance", "verboseLabel": "Deferred Tax Assets, Valuation Allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/IncomeTaxesDetails1", "http://network-1.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilities": { "auth_ref": [ "r87", "r493" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.", "label": "Deferred Tax Liabilities, Net" } } }, "localname": "DeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/EquityInvestmentDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r100", "r101", "r102", "r103", "r391" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/EquityInvestmentDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r464" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Schedule of disaggregation of revenue" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r156", "r168", "r169", "r170", "r171", "r172", "r176", "r179", "r185", "r186", "r187", "r191", "r333", "r334", "r368", "r374", "r395" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Basic" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r156", "r168", "r169", "r170", "r171", "r172", "r179", "r185", "r186", "r187", "r191", "r333", "r334", "r368", "r374", "r395" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Diluted" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r45", "r46" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r188", "r189", "r190", "r192" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Income (Loss) Per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/IncomeLossPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r161", "r300", "r317" ], "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Income tax - statutory rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/IncomeTaxesDetails2" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r492", "r498" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.", "label": "Change in valuation allowance" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/IncomeTaxesDetails2" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": { "auth_ref": [ "r492", "r498" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.", "label": "Permanent difference" } } }, "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/IncomeTaxesDetails2" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": { "auth_ref": [ "r492", "r498" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.", "label": "Other" } } }, "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/IncomeTaxesDetails2" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments.", "label": "Total" } } }, "localname": "EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/IncomeTaxesDetails2" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": { "auth_ref": [ "r492", "r498" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).", "label": "State" } } }, "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/IncomeTaxesDetails2" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r13" ], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued payroll" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r291" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Weighted average amortized period" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "auth_ref": [ "r491" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.", "label": "Unrecognized restricted stock unit compensation expense" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r58" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Ownership percentage not fully diluted" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/EquityInvestmentDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal": { "auth_ref": [ "r442", "r443", "r445" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of an equity method investment.", "label": "Equity Method Investment, Realized Gain (Loss) on Disposal", "negatedLabel": "Loss allocated from equity investment" } } }, "localname": "EquityMethodInvestmentRealizedGainLossOnDisposal", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestments": { "auth_ref": [ "r57", "r203", "r436" ], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_OtherAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.", "label": "Equity investment" } } }, "localname": "EquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity Method Investments and Joint Ventures [Abstract]" } } }, "localname": "EquityMethodInvestmentsAndJointVenturesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": { "auth_ref": [ "r217" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.", "label": "Equity Investment" } } }, "localname": "EquityMethodInvestmentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/EquityInvestment" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityMethodInvestmentsPolicy": { "auth_ref": [ "r33", "r59", "r107" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.", "label": "Equity Method Investments" } } }, "localname": "EquityMethodInvestmentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityMethodInvestmentsTextBlock": { "auth_ref": [ "r61" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.", "label": "Schedule of equity method investments" } } }, "localname": "EquityMethodInvestmentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/EquityInvestmentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value Measurements" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r139", "r219" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedLabel": "Accumulated amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/PatentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": { "auth_ref": [], "calculation": { "http://network-1.com/role/PatentsDetails1": { "order": 6.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Thereafter" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/PatentsDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r66" ], "calculation": { "http://network-1.com/role/PatentsDetails1": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/PatentsDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r66" ], "calculation": { "http://network-1.com/role/PatentsDetails1": { "order": 5.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2027" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/PatentsDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r66" ], "calculation": { "http://network-1.com/role/PatentsDetails1": { "order": 4.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2026" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/PatentsDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r66" ], "calculation": { "http://network-1.com/role/PatentsDetails1": { "order": 3.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/PatentsDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r66" ], "calculation": { "http://network-1.com/role/PatentsDetails1": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/PatentsDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r64", "r366" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Gross carrying amount" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/PatentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r64", "r365" ], "calculation": { "http://network-1.com/role/PatentsDetails1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "totalLabel": "Total" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/PatentsDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": { "auth_ref": [ "r365" ], "lang": { "en-us": { "role": { "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Estimated remaining economic useful of patents" } } }, "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/PatentsDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedPatentsGross": { "auth_ref": [ "r64" ], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_OtherAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross carrying amount before accumulated amortization as of the balance sheet date of the costs pertaining to the exclusive legal rights granted to the owner of the patent to exploit an invention or a process for a period of time specified by law. Such costs may have been expended to directly apply and receive patent rights, or to acquire such rights.", "label": "Patents, net of accumulated amortization", "verboseLabel": "Patents, net" } } }, "localname": "FiniteLivedPatentsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets", "http://network-1.com/role/PatentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainContingencyPatentsFoundInfringedUponNumber": { "auth_ref": [ "r459" ], "lang": { "en-us": { "role": { "documentation": "Number of entity's patents that another entity was found to have infringed.", "label": "Patents owned by the company" } } }, "localname": "GainContingencyPatentsFoundInfringedUponNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/BusinessDetailsNarrative" ], "xbrltype": "integerItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r37", "r73", "r74" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Gain on conversion of note", "negatedLabel": "Gain on conversion of note", "verboseLabel": "Unrealized gain on conversion - convertible note" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows", "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss", "http://network-1.com/role/EquityInvestmentDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r28" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": { "auth_ref": [ "r37", "r68", "r69" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).", "label": "Company impairment patents and equity investment" } } }, "localname": "ImpairmentOfLongLivedAssetsHeldForUse", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "auth_ref": [ "r67", "r70" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.", "label": "Carrying Value, Recoverability and Impairment of Long-Lived Assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet": { "auth_ref": [], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "nssi_LossIncomeBeforeShareOfNetLossesOfEquityMethodInvestee", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, nonoperating income (expense) and income (loss) from equity method investments, before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of interest income (expense).", "label": "Income (Loss) from Continuing Operations before Interest Expense, Interest Income, Income Taxes, Noncontrolling Interests, Net", "totalLabel": "(LOSS) INCOME BEFORE INCOME TAXES AND SHARE OF NET LOSSES OF EQUITY METHOD INVESTEE" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r24", "r37", "r57", "r117", "r128", "r200" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).", "label": "Loss from continuing operations" } } }, "localname": "IncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/EquityInvestmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions": { "auth_ref": [ "r37" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.", "label": "SHARE OF NET LOSSES OF EQUITY METHOD INVESTEE" } } }, "localname": "IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r161", "r301", "r302", "r307", "r313", "r318", "r320", "r321", "r322" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r162", "r174", "r175", "r201", "r299", "r314", "r319", "r375" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "nssi_LossIncomeBeforeShareOfNetLossesOfEquityMethodInvestee", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Total Income Taxes", "totalLabel": "Total income taxes expense" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss", "http://network-1.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "INCOME TAXES PROVISION:" } } }, "localname": "IncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r150", "r295", "r296", "r302", "r303", "r306", "r310" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "verboseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r41" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income taxes" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r36" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "verboseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": { "auth_ref": [ "r36" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.", "label": "Increase (Decrease) in Income Taxes Payable", "verboseLabel": "Income taxes payable" } } }, "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r36" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Accrued expenses" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "auth_ref": [ "r444", "r504" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation for operating lease.", "label": "Operating lease obligations" } } }, "localname": "IncreaseDecreaseInOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherCurrentAssets": { "auth_ref": [ "r444" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in current assets classified as other.", "label": "Increase (Decrease) in Other Current Assets", "negatedLabel": "Other current assets" } } }, "localname": "IncreaseDecreaseInOtherCurrentAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidTaxes": { "auth_ref": [ "r36" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of consideration paid in advance for income and other taxes that provide economic benefits in future periods.", "label": "Increase (Decrease) in Prepaid Taxes", "negatedLabel": "Prepaid taxes" } } }, "localname": "IncreaseDecreaseInPrepaidTaxes", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInSecurityDeposits": { "auth_ref": [ "r36" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in security deposits.", "label": "Security deposit" } } }, "localname": "IncreaseDecreaseInSecurityDeposits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants": { "auth_ref": [ "r180", "r181", "r182", "r187" ], "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.", "label": "Dilutive effect of restricted stock units and stock options" } } }, "localname": "IncrementalCommonSharesAttributableToCallOptionsAndWarrants", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/Disclosure-incomeLossPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_InterestIncomeExpenseNet": { "auth_ref": [ "r119" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of operating interest income (expense).", "label": "Interest and dividend income, net" } } }, "localname": "InterestIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaid": { "auth_ref": [ "r446" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.", "label": "Interest" } } }, "localname": "InterestPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrent": { "auth_ref": [ "r13" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued interest - convertible note" } } }, "localname": "InterestPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/EquityInvestmentDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_Investments": { "auth_ref": [ "r127" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.", "label": "Aggregate investment amount", "verboseLabel": "Aggregrate investment" } } }, "localname": "Investments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/BusinessDetailsNarrative", "http://network-1.com/role/EquityInvestmentDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCost": { "auth_ref": [ "r350", "r410" ], "calculation": { "http://network-1.com/role/CommitmentsAndContingenciesDetails1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease cost recognized by lessee for lease contract.", "label": "Lease, Cost", "totalLabel": "Total lease cost" } } }, "localname": "LeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r505" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Schedule of leases cost" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LegalMattersAndContingenciesTextBlock": { "auth_ref": [ "r72" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.", "label": "Legal Proceedings" } } }, "localname": "LegalMattersAndContingenciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/LegalProceedings" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r347" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Leases" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseDiscountRate": { "auth_ref": [ "r409" ], "lang": { "en-us": { "role": { "documentation": "Discount rate used by lessee to determine present value of operating lease payments.", "label": "Borrowing rate - incremental" } } }, "localname": "LesseeOperatingLeaseDiscountRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r351" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Total future minimum lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r351" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "verboseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r351" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "verboseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r351" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "verboseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": { "auth_ref": [ "r503" ], "lang": { "en-us": { "role": { "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Remaining lease term" } } }, "localname": "LesseeOperatingLeaseRemainingLeaseTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock": { "auth_ref": [ "r506" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturity of undiscounted cash flows to be received by lessor on annual basis for operating lease.", "label": "Schedule of future minimum leases payments" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r12", "r160", "r216", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r326", "r329", "r330", "r335", "r396", "r461", "r509", "r510" ], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "TOTAL LIABILITIES" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r9", "r115", "r125", "r411", "r447", "r454", "r502" ], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY:" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r14", "r137", "r160", "r216", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r326", "r329", "r330", "r335", "r411", "r461", "r509", "r510" ], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total Current Liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CURRENT LIABILITIES:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilityForUncertainTaxPositionsCurrent": { "auth_ref": [ "r13" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount recognized for uncertainty in income taxes classified as current.", "label": "Uncertain tax positions" } } }, "localname": "LiabilityForUncertainTaxPositionsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCredit": { "auth_ref": [ "r1", "r114", "r121" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Private financing - D units" } } }, "localname": "LineOfCredit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/EquityInvestmentDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermNotesPayableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LONG TERM LIABILITIES:" } } }, "localname": "LongTermNotesPayableAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_MarketableSecuritiesCurrent": { "auth_ref": [], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in marketable security, classified as current.", "label": "Marketable securities, at fair value" } } }, "localname": "MarketableSecuritiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketableSecuritiesGainLoss": { "auth_ref": [], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized and realized gain (loss) on investment in marketable security, including other-than-temporary impairment (OTTI).", "label": "Marketable Securities, Gain (Loss)", "negatedLabel": "Sales of marketable securities" } } }, "localname": "MarketableSecuritiesGainLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketableSecuritiesPolicy": { "auth_ref": [ "r120" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for investment classified as marketable security.", "label": "Marketable Securities, Policy [Policy Text Block]", "verboseLabel": "Marketable Securities" } } }, "localname": "MarketableSecuritiesPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_MarketableSecuritiesRealizedGainLoss": { "auth_ref": [], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 4.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized gain (loss) on investment in marketable security, including other-than-temporary impairment (OTTI).", "label": "Net realized and unrealized loss on marketable securities" } } }, "localname": "MarketableSecuritiesRealizedGainLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketableSecuritiesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.", "label": "Schedule of marketable securities" } } }, "localname": "MarketableSecuritiesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/MarketableSecuritiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_MarketableSecuritiesUnrealizedGainLoss": { "auth_ref": [ "r26" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) on investment in marketable security.", "label": "Marketable Securities, Unrealized Gain (Loss)", "negatedLabel": "Unrealized loss on marketable securities" } } }, "localname": "MarketableSecuritiesUnrealizedGainLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r158" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "NET CASH USED IN FINANCING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM FINANCING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r158" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "NET CASH (USED IN) PROVIDED BY INVESTING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM INVESTING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r34", "r35", "r38" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "NET CASH (USED IN) PROVIDED BY OPERATING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM OPERATING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r25", "r38", "r118", "r129", "r135", "r146", "r148", "r153", "r160", "r166", "r168", "r169", "r170", "r171", "r174", "r175", "r183", "r202", "r205", "r209", "r211", "r216", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r334", "r335", "r397", "r461" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "totalLabel": "NET (LOSS) INCOME" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r168", "r169", "r170", "r171", "r176", "r177", "r184", "r187", "r202", "r205", "r209", "r211", "r397" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "negatedLabel": "Net (loss) income" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NON-CASH FINANCING ACTIVITY" } } }, "localname": "NoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r29" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total other income, net" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OTHER INCOME" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "TOTAL OPERATING EXPENSES" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OPERATING EXPENSES:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r202", "r205", "r209", "r211", "r397" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "OPERATING INCOME (LOSS)" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r348", "r410" ], "calculation": { "http://network-1.com/role/CommitmentsAndContingenciesDetails1": { "order": 1.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating lease cost" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r346" ], "calculation": { "http://network-1.com/role/CommitmentsAndContingenciesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Total operating lease liability", "totalLabel": "Total lease obligations" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetails", "http://network-1.com/role/CommitmentsAndContingenciesDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r346" ], "calculation": { "http://network-1.com/role/CommitmentsAndContingenciesDetails": { "order": 1.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 }, "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating lease obligations, current", "verboseLabel": "Operating lease obligations \u2013 current" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetails", "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r346" ], "calculation": { "http://network-1.com/role/CommitmentsAndContingenciesDetails": { "order": 2.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 }, "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating lease obligation, non-current", "verboseLabel": "Operating lease obligations \u2013 non-current" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetails", "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r345" ], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_OtherAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating leases right of use asset", "verboseLabel": "Operating lease right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetails", "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r90" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operating Loss Carryforwards" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r13" ], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other accrued expenses" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssets": { "auth_ref": [ "r112", "r122", "r140" ], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets classified as other.", "label": "Other Assets", "totalLabel": "Total Other Assets" } } }, "localname": "OtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OTHER ASSETS:" } } }, "localname": "OtherAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r143", "r411" ], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": { "auth_ref": [ "r21", "r23", "r152", "r336", "r338", "r341", "r438" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).", "label": "Net unrealized holding loss on corporate bonds and notes arising during the year, net of tax" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossTaxAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OTHER COMPREHENSIVE LOSS" } } }, "localname": "OtherComprehensiveIncomeLossTaxAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OtherInvestmentNotReadilyMarketableAxis": { "auth_ref": [ "r111" ], "lang": { "en-us": { "role": { "documentation": "Group of items that represent other investments not readily marketable, including description of investment, fair value, and value as measured by quoted value method.", "label": "Other Investment Not Readily Marketable [Axis]" } } }, "localname": "OtherInvestmentNotReadilyMarketableAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/MarketableSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherInvestmentNotReadilyMarketableNameDomain": { "auth_ref": [ "r111" ], "lang": { "en-us": { "role": { "documentation": "Name of the investment category or actual investment title." } } }, "localname": "OtherInvestmentNotReadilyMarketableNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/MarketableSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Liabilities Disclosure [Abstract]" } } }, "localname": "OtherLiabilitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r32" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Repurchases of common stock, inclusive of commissions" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfEquity": { "auth_ref": [ "r32" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common and preferred stock.", "label": "Aggregate cost of common stock repurchased since inception" } } }, "localname": "PaymentsForRepurchaseOfEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/StockRepurchaseProgramDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividendsCommonStock": { "auth_ref": [ "r32" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.", "label": "Payments of Ordinary Dividends, Common Stock", "negatedLabel": "Cash dividends paid" } } }, "localname": "PaymentsOfDividendsCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireEquityMethodInvestments": { "auth_ref": [ "r30" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.", "label": "Payments to Acquire Equity Method Investments", "negatedLabel": "Equity Investment" } } }, "localname": "PaymentsToAcquireEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "auth_ref": [ "r31" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.", "label": "Payments to Acquire Intangible Assets", "negatedLabel": "Development of patents" } } }, "localname": "PaymentsToAcquireIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireMarketableSecurities": { "auth_ref": [ "r56" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for purchase of marketable security.", "label": "Payments to Acquire Marketable Securities", "negatedLabel": "Purchases of marketable securities" } } }, "localname": "PaymentsToAcquireMarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative", "http://network-1.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement." } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative", "http://network-1.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PolicyholdersDividendPolicy": { "auth_ref": [ "r370", "r371", "r383" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for method of allocating earnings and dividends to policyholder. Includes, but is not limited to, policyholder in participating insurance contract.", "label": "Policyholders' Dividend [Policy Text Block]", "verboseLabel": "Dividend Policy" } } }, "localname": "PolicyholdersDividendPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r3", "r244" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r3", "r244" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r3", "r411" ], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock, $0.01 par value; authorized 10,000,000 shares; none issued and outstanding at December 31, 2022 and December 31, 2021" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidTaxes": { "auth_ref": [ "r390", "r398", "r455" ], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid taxes" } } }, "localname": "PrepaidTaxes", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "auth_ref": [ "r434" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.", "label": "Reclassifications" } } }, "localname": "PriorPeriodReclassificationAdjustmentDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ProductInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Information [Line Items]" } } }, "localname": "ProductInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ProfessionalFees": { "auth_ref": [ "r131", "r132" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.", "label": "Professional fees and related costs" } } }, "localname": "ProfessionalFees", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r135", "r146", "r148", "r157", "r160", "r166", "r174", "r175", "r202", "r205", "r209", "r211", "r216", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r324", "r327", "r328", "r334", "r335", "r369", "r397", "r407", "r408", "r440", "r461" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r133", "r355", "r356", "r508" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/EquityInvestmentDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r133" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party." } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/EquityInvestmentDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r353", "r354", "r356", "r357", "r358" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transaction" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/RelatedPartyTransaction" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative", "http://network-1.com/role/StockholdersEquityDetailsNarrative", "http://network-1.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r6", "r76", "r124", "r380", "r382", "r411" ], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r134", "r163", "r164", "r165", "r167", "r173", "r175", "r218", "r292", "r293", "r294", "r311", "r312", "r332", "r377", "r379" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r393", "r394" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue Recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r154", "r160", "r198", "r199", "r204", "r207", "r208", "r212", "r213", "r214", "r216", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r335", "r369", "r461" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "REVENUE", "verboseLabel": "Total Revenue" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss", "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RisksAndUncertaintiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Risks and Uncertainties [Abstract]" } } }, "localname": "RisksAndUncertaintiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SalariesAndWages": { "auth_ref": [ "r441" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for salary and wage arising from service rendered by nonofficer employee. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.", "label": "CEO Incentive Compensation" } } }, "localname": "SalariesAndWages", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalariesWagesAndOfficersCompensation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for salary and wage arising from service rendered by nonofficer and officer employees. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.", "label": "Annual base salary" } } }, "localname": "SalariesWagesAndOfficersCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r93" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "Schedule of components of the income taxes" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable": { "auth_ref": [ "r79", "r80" ], "lang": { "en-us": { "role": { "documentation": "Schedule, table or text reflecting arrangements that are not equity-based payments, or pension and other postretirement benefits, with individual employees. The arrangements (for example, profit sharing, deferred bonuses or certain split-dollar life insurance arrangements) are generally based on employment contracts between the entity and one or more selected officers or key employees, and which contain a promise by the employer to pay certain amounts at designated future dates, sometimes including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period and the carrying amount as of the balance sheet date of the related liability.", "label": "Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table]" } } }, "localname": "ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/DividendPolicyDetailsNarrative", "http://network-1.com/role/LegalProceedingsDetailsNarrative", "http://network-1.com/role/RelatedPartyTransactionDetailsNarrative", "http://network-1.com/role/StockRepurchaseProgramDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r89" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule of components of deferred tax assets and liability" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDividendPaymentRestrictionsTextBlock": { "auth_ref": [ "r130" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of statutory restrictions on the payment of dividends as prescribed by the National Association of Insurance Commissioners or state regulatory authorities.", "label": "Dividend Policy" } } }, "localname": "ScheduleOfDividendPaymentRestrictionsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/DividendPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r452" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of earnings per share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/IncomeLossPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r88" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of reconciliation of income tax" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Schedule of Equity Method Investments [Line Items]" } } }, "localname": "ScheduleOfEquityMethodInvestmentsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/EquityInvestmentDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEquityMethodInvestmentsTable": { "auth_ref": [ "r60", "r135", "r160", "r216", "r335" ], "lang": { "en-us": { "role": { "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.", "label": "Schedule of Equity Method Investments [Table]" } } }, "localname": "ScheduleOfEquityMethodInvestmentsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/EquityInvestmentDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": { "auth_ref": [ "r62" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.", "label": "Schedule of patent" } } }, "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/PatentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.", "label": "Schedule of Product Information [Table]" } } }, "localname": "ScheduleOfProductInformationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "auth_ref": [ "r220", "r221", "r222", "r223", "r224", "r225", "r226" ], "lang": { "en-us": { "role": { "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.", "label": "Schedule of Restructuring and Related Costs [Table]" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r261", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative", "http://network-1.com/role/StockholdersEquityDetails1", "http://network-1.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": { "auth_ref": [ "r82" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.", "label": "Schedule of restricted stock units" } } }, "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r82", "r83", "r84" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Schedule of stock option activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r63" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "Schedule of future amortization of current intangible" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/PatentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SecurityDeposit": { "auth_ref": [ "r437" ], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_OtherAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.", "label": "Security deposits" } } }, "localname": "SecurityDeposit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r36" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Noncash Expense", "verboseLabel": "Stock-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r286" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r288" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative", "http://network-1.com/role/StockholdersEquityDetails1", "http://network-1.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r269" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Option exercisable at end of year" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/StockholdersEquityDetails1" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r269" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Option exercise price at end of year" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/StockholdersEquityDetails1" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r273" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Options Expired" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/StockholdersEquityDetails1" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r271" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Options Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/StockholdersEquityDetails1" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r267", "r268" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Weighted average exercise price, Options outstanding, at end of year", "periodStartLabel": "Options outstanding, beginning, at beginning of year" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/StockholdersEquityDetails1" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r267", "r268" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Weighted average exercise price, options outstanding, at end of year", "periodStartLabel": "Weighted average exercise price, options outstanding, at beginning of year" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/StockholdersEquityDetails1" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": { "auth_ref": [ "r284" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Aggregate intrinsic value of options exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative", "http://network-1.com/role/StockholdersEquityDetails1", "http://network-1.com/role/StockholdersEquityDetailsNarrative", "http://network-1.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r272" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Weighted average exercise price, Options Exercised" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/StockholdersEquityDetails1" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r273" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Weighted average exercise price, Options Expired" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/StockholdersEquityDetails1" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r271" ], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Weighted average exercise price, Options Granted" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/StockholdersEquityDetails1" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationAwardTrancheOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.", "label": "Share-Based Payment Arrangement, Tranche One [Member]" } } }, "localname": "ShareBasedCompensationAwardTrancheOneMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationAwardTrancheThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Third portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.", "label": "Share-Based Payment Arrangement, Tranche Three [Member]" } } }, "localname": "ShareBasedCompensationAwardTrancheThreeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.", "label": "Share-Based Payment Arrangement, Tranche Two [Member]" } } }, "localname": "ShareBasedCompensationAwardTrancheTwoMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r285" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of non-vested options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares", "periodEndLabel": "Resricted stock units, Outstanding Number of units, Ending Balance", "periodStartLabel": "Restricted stock units, outstanding number of units, beginning balance" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of non-vested options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price", "periodEndLabel": "Restricted stock units, weighted average grant date fair value, ending balance", "periodStartLabel": "Restricted stock units, weighted average grant date fair value, beginning balance" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of options vested.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares", "negatedLabel": "Vested restricted stock units" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of options vested.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value", "negatedLabel": "Vested restricted stock units, weighted average grant date fair value" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Ending Balance, Shares", "periodStartLabel": "Beginning Balance, Shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermLeaseCost": { "auth_ref": [ "r349", "r410" ], "calculation": { "http://network-1.com/role/CommitmentsAndContingenciesDetails1": { "order": 2.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.", "label": "Short-term lease cost" } } }, "localname": "ShortTermLeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r17", "r75", "r134", "r151", "r152", "r153", "r163", "r164", "r165", "r167", "r173", "r175", "r193", "r218", "r258", "r292", "r293", "r294", "r311", "r312", "r332", "r336", "r337", "r338", "r339", "r340", "r341", "r352", "r377", "r378", "r379" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/BusinessDetailsNarrative", "http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity", "http://network-1.com/role/PatentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r163", "r164", "r165", "r193", "r364" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/BusinessDetailsNarrative", "http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity", "http://network-1.com/role/PatentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r3", "r4", "r75", "r76" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Common stock shares purchased option exercise" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": { "auth_ref": [ "r75", "r76" ], "lang": { "en-us": { "role": { "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.", "label": "Grants of restricted stock units" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r3", "r4", "r75", "r76", "r272" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Cashless exercise of options, Shares", "verboseLabel": "Options Exercised" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity", "http://network-1.com/role/StockholdersEquityDetails1" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r17", "r75", "r76" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Cashless exercise of stock options" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).", "label": "Equity Option [Member]" } } }, "localname": "StockOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/StockholdersEquityDetails1" ], "xbrltype": "domainItemType" }, "us-gaap_StockOptionPlanExpense": { "auth_ref": [ "r37" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for option under share-based payment arrangement.", "label": "Plan expense" } } }, "localname": "StockOptionPlanExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.", "label": "Stock repurchase program, dollar amount" } } }, "localname": "StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/StockRepurchaseProgramDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r4", "r7", "r8", "r55", "r411", "r447", "r454", "r502" ], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balance \u2013 December 31, 2022", "periodStartLabel": "Balance \u2013 December 31, 2021", "totalLabel": "TOTAL STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets", "http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "STOCKHOLDERS' EQUITY" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r78", "r159", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r258", "r331" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders\u2019 Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r342", "r360" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r342", "r360" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r342", "r360" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r342", "r360" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r359", "r361" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TaxesPayableCurrent": { "auth_ref": [ "r11" ], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Income taxes payable" } } }, "localname": "TaxesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquitySharesIssued": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Aggregate common stock shares delivered to company" } } }, "localname": "TemporaryEquitySharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r499" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r51", "r52", "r53", "r194", "r195", "r196", "r197" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates and Assumptions" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_VestingAxis": { "auth_ref": [ "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490" ], "lang": { "en-us": { "role": { "documentation": "Information by vesting schedule of award under share-based payment arrangement.", "label": "Vesting [Axis]" } } }, "localname": "VestingAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_VestingDomain": { "auth_ref": [ "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490" ], "lang": { "en-us": { "role": { "documentation": "Vesting schedule of award under share-based payment arrangement." } } }, "localname": "VestingDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": { "auth_ref": [ "r452" ], "lang": { "en-us": { "role": { "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.", "label": "Potentially dilutive shares" } } }, "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/IncomeLossPerShareDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r178", "r187" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "verboseLabel": "Diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation": { "auth_ref": [ "r44" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock subject to repurchase or cancellation determined by relating the portion of time within a reporting period that these shares have been outstanding to the total time in that period. Common stock subject to repurchase are outstanding common shares that are contingently returnable (that is, subject to recall).", "label": "Number of shares, common stock repurchased since inception" } } }, "localname": "WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/StockRepurchaseProgramDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted average common shares outstanding:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r176", "r187" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted-average common shares outstanding \u2013 basic", "verboseLabel": "Basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss", "http://network-1.com/role/Disclosure-incomeLossPerShareDetails" ], "xbrltype": "sharesItemType" } }, "unitCount": 5 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "820", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=35710923&loc=d3e45360-110995", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(13)(f))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.10)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62652-112803", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(10))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.1(h))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(10))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "505", "Topic": "944", "URI": "https://asc.fasb.org/subtopic&trid=4738323", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(k)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=124433917&loc=SL114874205-224268", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07.2(a),(b),(c),(d))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1828-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org/topic&trid=2144383", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "323", "URI": "https://asc.fasb.org/topic&trid=2196965", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(1))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(12))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(7)(c))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(8))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "21D", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=SL94080555-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=6480747&loc=d3e6772-158386", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(14)(b)(2))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=6483535&loc=d3e16392-158451", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)(4)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r414": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r415": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r416": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r417": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r418": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r419": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r421": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r422": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r423": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r424": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r425": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r426": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r427": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r428": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r429": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r43": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r431": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r432": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r433": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(10))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2646-109256", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(7)(c))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(9)(a))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=6397426&loc=d3e17499-108355", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919396-209981", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r54": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(b)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.CC)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405686&loc=d3e22802-112653", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "710", "URI": "https://asc.fasb.org/extlink&oid=6409733&loc=d3e19524-108361", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "710", "URI": "https://asc.fasb.org/extlink&oid=6409875&loc=d3e20015-108363", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f(1))", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 81 0001072613-23-000275-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001072613-23-000275-xbrl.zip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�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

_0EGSB4L5CYM] MCK/E.H*DS(BQ*FAXNHW9L464,:?!74(]_5K\$_J[BJ9K.V5UV@5.?YTN7=#) MN@5K2X*E'9PKZ$U ]GWJZX)-5=J3\2S43QXA2Y"@+C=/\#C&J)/YEWE=Q-HM M=APM]EY@VU/S-1LR_\Q\/XB6^Q@ %@7OYC)Q7>U-TR)?[:I0*^_NE]]C3/Z^ M])S]5.*=;S[:[C*O=CFGE8UVEMT=+1ULB9&>.H/B PD3X9,F3'@7E,%,&Z^B M!3EW&G+N_W14(OC'P[^/F3-QSOC@$<_[\*/=/QUMO!$72*0]NK#AD.8-Z_-K M/MKG!><_+75Y.2Z0?\[KN.=%G?J\]G7#0%WK=<3EDXLLQ;XN0@ENDFP\Y)^[ MH<_)?]H#P>[L8/%QQ-H;G8K M7SFF#GJ/WBR#YXC[^\M?% M6S3:$GCA1Q.$NH31S M>L=(E-$4>C.R9M'/SDFWW@4?%HO:-]AT]+C2.N_P'@43AYEMWIZ/!\4X3A+ MVKWB=\]HU7\Z+HW58N&MK25L[.RK.D5LH0X+2NV@RJ, 5 @0,TH-O59(Z*AKFY, A+=,=N M,@NV597@B7_#A,O:CB+\O5;+'>,X.94/' MKA+:C]B6-<-=D!6F(]1FRA*-I5KU)$_.F-$DYJ8Q=E,6RLGIRESJ*!H1_?^T?(E_DH^0Y405@B8$9E#7$QR3XW!FX"#GU(:3PK@7DIC]1NOXF<+[6\*7+,0C'^ "2\2?2'5F#]5N)^"Y*GH7@&-'[%^*D8 D6 _/B".Q@9NVX]GN?]H%!\T"-;T M7\YB^&9-\"XQD">-J[!#LX/<^\6Z'VV1VJ?+V\)E>)U3* M&P_9EAI;4E36'LYFCG.Z /M)BXD_H83X^*'UQ.MBVLX6WL.M:E M1]?.2R=?%ZV7UG-[D&C']?[.>FIUT4J%1<+I3(="SD)M@?/2X]YZA/6 MSDMG7A=<,UN_/&Y0;7(B'A)\,#HL>/$ZV4F=N0A*NG16%*071MWIN5H<9DOP6$Y<7L: MCCL'Q,5'R;BCM._]J-=%B-;2N5*5;ZK]\QW@L>=U0PQ'([N?B+NE2551.O2Z M:,Y+'>:EF K5>[_^.$ BW%!"5? (3H0#*!LO/"ARK'0J.G)\D*T YG^I_R/@ M^DOR]56!4[L# N8]X>PG]R0G%.C'III"<(0,7B XD+*',A$WL)J$)O^V@83^ M3?W]&T\8A',9DP-.!(J,C&>E#T2A1Z3? 9+"":S75R4TJU$->.8BXQEP.(D+ MS5)' Y8U09VB]"R_-@>;WD*8+T']#SCPUU#O4 L$6+UQ?67M >:36\L/$!S8 MIFS-4(;SYZQ1SDIO=<:NV_E>A9>)@O8") JB-OQR#:Y8D#74M,&<,L=88XE) MAJ9?7S55O[NK046VU,O*0%"A"8[Q=U$S?T/[LK=E/KB LMA>7^T%P*&[1 M BUX'7(A>;BRO4M"(RJR!8WLN6^[<"\\!-,8PR'R@HK6!NR(>ZRW9/9I[1+ M#05V>JMJ)H&ZT-,[9GX]EJ:7L33EOM&-K-[Y[(1!%"+LT"V4;"V+#I'86@N=O7S9L]#@6AH<\VY50'G"H EA4F-P91[5GB M G]]Y8;/#<0E4R\'*]5,O3Q "!S0N\ W! 5@W?;?=4XT]+H@W]=7R$G%WR2*?O0V'D-[@B*.3_KHZN, M1HJ,3_BW:;Y XP).I5< [H!U0E$_!;N%VJ H(R.$T,%I=@>0&%U%)UB>WU"_ M <]8H@AZ,T74\..H+T@2SEL:& 9+[T;XDH *CMMDP"O%NRK)PN[D9=Y#4'L3 MF 7# M4M0\WC;T86@;<@+&@N!Y8V/I[_W1U -<7V1E;&1E+AM9MX@0A*P 8AYW%H.X M_9X:A0_&LC;&LM\,8]=P4;1HHGY.1&5M1&4O&E%W8:K+>,H&",WHO $-Q>[? MNHN[U*5X8 4]=/?Q W]^R#Y0']+G:4V4RSYT(Z%Q5R\_3:@I;WE WT@V=%?5)FQ MP7.8? CM(!]<:HS8P[Y]0!C $%YVT((/X-=M.CX!2$D4P..@Y2 I&GS"&(!, M,%UZ,T!!4QW<\TFIZ1Y?QG>;Q,;,#0X.]-V3N*! M@0QL^=ZXY!3'0[\3$A,0P@CBP'X?2V"SOY'@@@3D)TP($= BV(S6$Y'#"$LF M>#6214@Z65COO-M#(O 1)OGQRS()V\ZT+9>NKVZ85<$4V4,P,=^3@F"=C"6: MGEBE6'YO1!]&S-ZBB3E0-#%?E;P< 'U)X;1.&'DI9:L08?_!0L1% O]@,7(@ MGKL%"7N_ =%M9@Y8\A9)0IQ)D%Q?;94DC&/AP,7&>XL2]D!1PIZ5Q,S\@7W (.=> &W,..@TX_ MN8^(#/9&4Q6)N.$ $?)"3Y0%_G< $:THXX%/."VU!FY!NTURAB; ZPGK<@*E M.>JN6RR/X*Y)D@^*PA,5@=,4&FULQ M4HO/"+:[$6X5\"?$JBRVKQ$P.2E 8(<]D*^8AW'=KB#!FAFX,_"#K.C75QW! M[2R%O*UK':1YSO;CKBN%8>=H M\O45V+D[FCS@ P1ZQ' 0H2)(4XY"1XPBB9KEYD.4H=Y&I@><#C;/%M7(HBF M$)("#M?*R]T%Q?S3>L%-@GVI"?*E@'L 9EX*"/_7YJ9 [%?@)3-1$P*[+\I$ M/$ESXOZB##N>P4]=%]\#7P/Y"!XV4@R8PCE!*9L*$?K7NO2 OJIH&J$JN-I9F47NKL7!NV"73CS8U%Z>>X2=9,$@0 APR%T7 MGRF\4P/T1' V9 )$QX!+!+S!9*7H!*^OP-:L Y1@V;$..67XGG;.Q]P-X Y3 M09W_7G=LF[:+UXQT*L7WX "F+L%\C$"LF0]"JUIW##>XZRE\(@3AFO7A!Q)C M1=5[BB0J>)TB:IH*.=P(9;, "&7S8CP%L AN 6^+ M+2+EJ(^[)YAZR YFF_K3'7@>P&W"?PE(U;Q;UC53/NGV<9E'V>V@?^4";(G!O]G))@&HB2UR;@+6%P$$>YE M:A)HIND:&L>2UU(*(*OLP+XR(K]+3-RCMR(]5.PA31JIJ?Z<\_K*XL7+/!J+ M'[ M3P$4NDH?B"H/EJ4BB> RJ-$,&/"B 3 $7%%X*(F1!8X,<,CS!20A X2I MPB!)9=^SJGR"!P"U]V\[A1 ;[9BUNM_3VQU& Z!,@&<"^ JR;2# W,NE5YMB M(6.9%Z8D6+$RG$? Q0_$$6$I*.837(:$WS/N";\V"""T1"V[;16D'X MH2+B<#8!'19WG+2P 1T?1Q BU=G57 MV 7 K>A>0.UW*H("U.M,%0@N;44,IQR/6UE5T#T74P9F+=A3ZK;1)>:SQ6]4 M"N:! Q!/5M8X+J[JJB*@#I'#3@;$O!VO%0"3&VL 3D%B<@5$X(ID'FCM@*NH MT$0#O,9,43>EE^4F4KI=PTR4!]@H_@8X;OMA^&4WCB%C+XK)6 '7Q1ENEFV+ M$O17_1[KV@>$7AP1SN0V-IV(,G71;&>2O#5?.XA MRYVP'4CZ=<'7(RTZH0NQ1O=H[4!H^Y?5#H0%9T36 M^N]**3(L,Y?4_N(T[4 S@K-L5X;Y08=/7H>>.Q+G&L73[TNU/H;JT?I0:Q! M?9-6&/NTNH"^(C.S^/=6%#C:+*'3US:"7LS!7D/36_WLO(! M VZ!ZRMHD*PL?D7=7S65S2M?3/O31]O?(PAV"A_+.5 <=GBA_P]V*>I C\N* M?>QLM $CEV5@-8K(,D1!&%2> &CW\U$23)5R8V-4&A#S"!&SG],2!?0,(45&?AD[;.<",I M?HC\E^V$0E=9IJ",@\6P8!IM!- W>)>JF?S"3JP G]'+B)NE93,XD._[ FNT MGR5(_)[N?>KUE?E8]K>GT,JO; I"D;!6 PNSX&J. \3K*S<4P3EN@**UR0^ MT%PTNP&$UU<[P'#SXT,[@/*"Q2>S07Q"%@".$2L-&:"BR%VP!\GK7'%!J10EIP%"@X-&C**QN\V>X M6N017S8OO#=9]H4_]KAYAZ-4 _P(^ZG=J)F%H.H<3$;!#K>.( ,5_OBI1N$S M4A]K4E]V";K^?#BA<"HR+5)VDP\!)C@@11/V+%P+ZX'B5GFM1"YHD5GTBE-\ M_ G6Q)@50)^N-Z@S$*//205.!R82)"O/)-5U+4%9STR0'>Y_7:0EL5Q=1.M= M[>T;.#]RR#BD@ FXW TT];K0A<2D\)Y4N*X 1TW 7*6RJG2!40\ <^*6G^>B M*LJD*J#@Q,>J*)EIJ5"<4RQB)8ZJB;_$]+:AHCMOIW&5@;(*0)4":*N*8TL> M41$R1$:A/$*?8IOED?548+7W);LPC2Z(+[.^/D]WG%F-SGN),7YQ '!Y^]6_ MMA,=%;DC0W=DU/X4LR) [K=[FO)NVNRO/Y830@12141>"U>.&]<''%I#_@CP M;!@FOK>3A/%W=LDO/(>68M2,#O2#Y/-)^T+S6_M*@"\J>I(UE#@JMPQ0R,T,"I[&!%Z)6 MKLJ[E:%6MI+."*X[,428*H&\.BGU'EV& TPXL<]*XT ZL@@XL)W:A?)R\1G) MMN:+IG'(@HZ="A(WTPP1LF-)$OJ"AF/-)CA=(,.Q,6M3O-7MR4XIL7ZQI.;F MI#H->HM&W!#AEX'S$35!DL 'G!F@]'J":J;_P1^ EF#FC@#I/0?&T @[5JW4 MQK&JP+Q(_"44/>!B+6""R9QQ3KC.&3>U-0&339G/-$%BHQ?,NO0BF!LB:)RY M1U6'&(*"1J@8!U:AXP6@*V%J-]@5N!:=Y),AS0G4I8(*F3J0:0F85;8!\[\D M%0/+@-6'P X"4A1"=NRP4,),#3 1IP99)%IF?#P6P$HG135+L"E>Z+L M2A[FB"=%!!^KNC@V))-JH4L#-]J6W9[ M80A4?F# D$//A(X3E!8+?;_0GRU!A[9U+M:.$+&9#44Z(W@JO#4!'D@POH^8 MRDA!*[@GXH0.3_WZ"EF65A+27# 3D30!6HQ+NI.GF>(E"EW:$;H%;D[$$&9$ M D1!5%6 ER^**O$:41.Z QGYM22-P/TGXZB#"W9.Z3+0J&: M>WKF^F>1O=[W[R]];9X)5'M)FM\I,QFA9$<3@8B!^34;Q;/U^@!*4G1$M*S, MB(*@<]!CHT-#$QR2YP+XHR67#Q?,@17)C/@9>I[)/XO*/1$&UD9%F*:=7$AS \M Q3A[?64B[;(.\-LC MJ@DLJ7F'M<&T/!5)0?-5G.H6U4#46F T.ZVH,#3D$ 9^DB##43*>2Z^O .2T MGF#*>TB20$0+1$_@8&:#D6^ MBU#U\]**F&;B!,I*]V,J'HL2SZXUO[:V\%6V8%[41 M>+K9>Q769'D68VT/2R-+3[6V"8PCL[+3E,10&)J?H#Q:7@1O2MU5H4OL(G/= M/FH:F1DT&=C_081J2"@OUQ=1>]P45>A,I('/UHYPPI&MCET3[9:(3RN6;LVV1(K=UO M^'71>Y#G]6SHI?Q\A(R:+[+?W3/"(N3:C+#TZT*4\O7&3.D5&.:$&6',ZT(N M]Z,ILJ7EJL/C9811NV6$Q5\7J1>&51[23$B)7EQ&F#PN:NEVLKH8<0?@[P5E M?0&:K-HP\2M-9WI2ZTU[:QXR(.DK;B[RNHC%:L^* MGBJ$WX]\#DD^_ J; 7PDQ^=FS7R\U1?/F%EZ!G_\ MBK_].^8=.K.V(N[,C"7UTG(F<5#!A9JI;24 51>Z7;#"+\ASSW<;S0;3L(*. MHNLKZ, U'XTU9_A66*\"G@GK"/R,D?46G.DQG *8(0,.')M5L8QN0K7TUDU= MB1-'T)4,;S*KEH&AUA>A/8=3(R!]1/ZF2,K2ODT;,]YU913:X5%_^^C__1<; M^MNCR<-&^\@B4'K75Y:-O]9RSAJ**@]P7.[F[U M]A[OYK0R&8Z>QR?F>?T' E*6H6_[94QGE_G<)4^6^>URD*EJC&'V@H.4Z$N= M@XS#.V23L*&@MFMP:ZWA$,U9-Y*9H8^)>A55[#5;UVK"K#(#GKA%<\+ M\*@M6)K,28*&]V1#!S'(LI*V8SK(YU+JZDH'UB>:G;VI@'6/?0XIY#U JX^K M'5%731\D9K%QA" P=V_Q35-Z8KX\TT\'O]-:((P-.-.G'FA$]-"GB; YCE1 M@U6]YA$ZC@HOCU-09 @7+KX9JJCQ8M>SHG@PUOD,ANEQ<@%Z"B=A 8@" M)1UQ D2DB+^QPCC@_6@D!EB#MJ2O!^Q_(S&8$B18[RK\C155U\YH6^GWX#NS MUX;M@ZN5 1'(0Z)>C8.[U+%BR1#88>=1'$ZQ8@I^#NR\%5N]3(+CA>JEVWN= M!#P!_"Z+W-^X)ACNS=X%Z[,+*':V;:/,R1!! (D\*A(V_)9VX[K$_0MDDN!L M!Y:TW+P_*P!C;3#-:?JR>[XFO .\O $&&FY#DA(Q#*V6K^+4N^6H*Q7?_I+: MC+_75^L $9>!W%:YU3 PSLKB!H;KMSDZ]D-.%.&J?*EHH\=:I#S[N14'9L%_#CY+WF6^> M>%W4Z=:H6ZO'AD,)R@479+Y!.F,-AU6MUBZP\A*%^F"6URXE-/= J)E76T6( MRS%$OX9L,$<&* $&)+EE!27LZL,!M&!P.1"'YEM>^;%_?=1ZU$W,G0:X3F=I MN"2T(KP@2TN)9/)L/B7%G[*TTUO#7H0%FZ #^ H9H-L.8V>V?!,USX-!+TP?62-_4 MW7WZH9T: ?+6PEPCA_QE-?%.-)X82%UIV.*^%QL?_,_OIC@HE <")<@+I\08?290Q9("@_U5(5QH;:'2"+"PDR MSFY-O$0A*]S*5=(+\![0;*F'6V\G42=XU":\XCS>+"X+T3&SCU28W%)<9CT= M)?:6>G9MCD^/=+P E'V.EA#PMJ-W[7(C&]ME'^NJS4)W= Q_"@,ZMSB;_]H/ MZN#/4H'0ABHS# #+\O9VY8=Q'FLC9B=YO[I!RMT0#)8P"RIZ^2<<+.Z,;G=, M_^"Y[K"+3SM6=\MZ^IZE-[6L!_8?GAZMNA0)J&&(,)YC][E=/L^TJ_C>NBVI M:'JIYX+%\8_16_KI6J^&#&;W26XNQ%^[YC,>VJ:Z3Y(,L,Q:BOP$W2'N=%M# MJ.7@^=KBOK1+:=CE]M<%U^@]%.KQ$:.'OX6V4%RK+61>%X/D,&PP*C^*#7[] MP;-M':C Q(.^RHV^D[)@VS4[ULMRACY05'&!S1RP1-C(W'3!B7(7.G+MJ?<( MJ7S@A]NA6M]>7QEC^,T*.XNZR]J];-Q\D%>.Q^VEU92$X)9<8M:TJ<+48;QN M(8<:#V^%YSC?=D*ZU249!>-\<'4!@E,:Z4>ML/" M=]0I=114UKRQ&'Y-U9Q'O,/R(3/MNJ.A;%:=H-D[5,5N]H,RPV?NNT;<''93 M7=%L8?MDU'T6]5&&A7MC0;;ZX>HNVPB*5Z <3?&@#UGH*Z87VG/1FL1QI\L, M7AIX&>J^#^N84!'V\.F1AU>Y>8 UD/3T4!HO3:VR3Y:'@6S+*=@)S(L MJ) E92FRW!C0TCM8%.(7&Z<N,VMHR^GH)Q]<9C#XH MOI4PX_XK.IP^D7'T\86?E!J]5BW#[&P<78@4J<+3@1%J\XRVJK8W9BT=P!3J MM]U6>XO4@17.^TB>\*DD#T61T>\F>2B Z%%/BZB#Y$XL " 3"(?9=:AN.F\V MN.9V%"CQ?03*ZLE]58'RX?/8V)(K$ E%CR11;%FRWG,:/I9$V4APER11CD1E M;GE"W<=VER?KBF'(UT69BI,&HR24!?]MBD+7[I=Y740&BE3(4HRB=K[_?N/@ M?.565F^.J+=)Z-OL=X^B7VIMT6_J=5%,]5)9D67:6OB$1;^PTISN#JG0H!I^ MBAROZ)?>K>@7X'P_32VH=C>5+E.75?0;>UWDU +SW$I3+_D#'.S?90P$X-=D M+OKXK!??C=0!:7_4;]=Z5Q:YSD-#V6##Z#BS_M"D!Y#T9VCC%WM+Y M\3![/^_CVM/ [9BW.K#6P/4C(,5O/)OGB;RGUAM^*\##&Y+FOW$BY_65,R4- MS2X18:\G6'X-@RM.?9@U(A3E"<(4_XS04=W=B4RGCD_0%.Q!XG"Q-L125 #L M1VK.#N-_\"4H>LMS9L.JIR.YRKMRLK<@/+J"<0(Y>$S>EMZ+ MMQU3""WT4(S)DZ5*I-D] 6\[2.0CT=F1PKGX!FP_0TSIAK0&&FMGT%=CSV[9,R]4 ?5G M=V8]>O.+SI_E6K6SPM)P>/A:MX=G#,ZZ>X#9'PXQ$UY4R\H!+=F^4#YK>:V/ M@WQ=< _/A9).3YD&S&=UTNLP5"[?R[$TK0*K'\RF65R[*QC;72!I3TFQ'3); M40!2Y@L0IV7L&>OP$^.J[%M"6J>J;]T5UISU0WAU)U?I/#Y-)U&!W474+AG3 MVZ+#NT#%5SUB[+'L^!-C >'5'P9?U6A$PGI39'^[9O7%$"97F0W)=+,::@HK M&O/>JM@)C_D81JB9KL.

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�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�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